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LAY SUMMARY 
Parasitic infection often evokes disgust, outrage and horror, as the idea of a worm 
nesting inside us and eating our food makes us feel uneasy to say the least. But 
becoming infected with a parasite constitutes a risk mainly on travels to tropical 
areas of the world, and this generally gives us at other times a sense of security that 
life-threatening worms are far, far away.  
 
However, anyone who suffers from allergic reactions, such as hay fever, already has 
a lot in common with a parasite-infested individual; the type of immune response is 
on many levels identical. To elucidate further: the immune system has evolved a 
form of response that is essential for controlling long-term parasitic infection. 
However, it is this type of immune response that goes wrong in allergic and some 
autoimmune disorders. So why can we mount a protective immune response against 
parasites, but not control such a similar response in allergies?  
 
The answer to this question remains very unclear. In contrast to immune responses 
against the common cold, the flu and other viral and bacterial infections, immune 
responses vital for our defences against parasites are still largely a mystery.  
 
As a model for parasitic infection we have been using a blood fluke called 
Schistosoma mansoni. Schistosomiasis is a devastating disease in sub-Saharan Africa 
causing about 200,000 deaths per year, and in 2012 249 million infections were 
recorded. Infection with the parasite occurs when freshwater sources are 
contaminated with the excreta of infected individuals. Once inside the host, mature 
worms live in the blood vessels and, rather romantically, male and female worms 
pair for life. Fertile females produce up to 300 eggs per day, and it is the release of 
these eggs which triggers strong immune responses causing most of the symptoms 
experienced during infection.  
 
Most eggs find their way out of the body through the faeces. However some eggs get 
carried to the liver by the blood stream, or get stuck in intestinal tissue. This causes 
dramatic damage to the tissue in these areas. As a response immune cells gather 
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around the egg to protect the surrounding tissue from toxins release by the egg, 
forming a so-called “granuloma”.  
 
Dendritic cells (DCs) play an essential role in stimulating this immune response. 
They are professionals at identifying a potential threat and travel around the body to 
alert and activate other immune cells, such as T cells. However, the exact 
mechanisms for the direction of T cell responses by DCs during S. mansoni infection 
remains unclear. Furthermore, distinct DC subsets are present within different tissue 
sites. Thus we have studied the importance of DC subsets for the induction of T cell 
responses and the formation of granulomas during S. mansoni infection.  
 
A greater understanding of the anti-parasite immune cocktail will provide further 
essential clues on how we fight worms. Furthermore, this will ultimately help piece 
together why and how the immune response goes haywire in allergies, opening doors 
for therapies in all of those areas. 
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ABSTRACT 
Schistosoma mansoni infection leads to chronic inflammation and detrimental 
granulomatous pathology mediated largely by Th2 immune responses. Dendritic 
cells (DCs) provide an essential link between the innate and the adaptive immune 
response, and are critical for Th2 induction during S. mansoni infection. But the 
function of DCs in this process and the specific mechanisms they employ are not yet 
fully understood. Indeed, the role for individual DC subsets during the induction of 
Th2 responses is also unclear. Furthermore, the importance of DCs during the 
formation of granulomatous legions, and whether they interact with T cells at this 
site, is yet to be determined.  
 
The formation of granulomatous pathology is initiated by the onset of S. mansoni egg 
production, as eggs get stuck in the intestine and the liver. In the first part of this 
thesis the formation of granulomas in the liver during S. mansoni infection is studied. 
Novel methods for quantification of histological data are used to examine the 
kinetics of granuloma development and the location of CD11c+ DCs throughout 
infection. Additionally, CD11c-diphtheria toxin receptor mice are used to investigate 
the importance of DCs during granuloma formation. Depletion of CD11c+ DCs 
resulted in a striking reduction in granuloma formation at the time-point for initial 
egg arrival in the liver. Two weeks later, depletion of CD11c+ DCs did not impede 
granuloma formation, however led to altered structural arrangement of the 
granuloma. These data highlight the importance of DCs during the initial granuloma 
formation process, so as to prevent the toxic damage to hepatocytes by the S. 
mansoni egg. 
 
DC subsets display unique functions in infection settings. The function of CD8α+ 
cDCs during the induction of Th1 responses is well understood, however their role 
during Th2 induction is yet to be determined. In the second part of this thesis the 
importance of one of these subsets, CD8α+ cDCs, during Th2 induction is assessed 
using Batf3-/- mice. Lacking CD8α+ cDCs and migratory CD103+ cDCs, Batf3-/- mice 
displayed dysregulated induction of immune responses during S. mansoni infection. 
This altered the immunological balance to an enhanced Th2 and impaired Th1 
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response ultimately leading to fatality of Batf3-/- mice. This underlines that CD8α+ 
cDCs are not fundamentally required for the induction of Th2 immune responses, yet 
they play a role either directly or indirectly for the induction of appropriate immune 
responses during S. mansoni infection. 
 
As implied DCs are capable of inducing very strong Th2 immune responses, 
however S. mansoni does not classically activate DCs. To elucidate further, the 
expression of activation markers is muted in response to SEA compared to bacterial 
or viral stimuli. In the final part of this thesis a co-culture system is used to address 
whether S. mansoni infection alters the function of DCs in the liver during infection. 
More specifically, the ability of DCs to take up, process and present antigen to CD4+ 
T cells and thereby induce T cell proliferation and cytokine production was assessed. 
Comparing cDCs to pDCs revealed that cDC are more efficient inducers of CD4+ T 
cell responses, however no major changes were found after S. mansoni infection. In 
contrast, co-culture with specific DC subsets illuminated that only CD8α− cDCs have 
enhanced capabilities to induce CD4+ T cell responses during S. mansoni infection. 
These data demonstrate that distinct DC subsets may hold the key for unravelling the 
mechanisms for Th2 induction. 
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1 General Introduction 
On encountering a pathogen the host relies heavily on its immune system for the 
recognition and neutralization of the threat, thereby guarding the host’s health and 
survival. Various complex mechanisms and many molecular components are 
essential for a fast and specific immune response, and the interplay between all 
constituents must be regulated for a successful elimination of the pathogenic agent. 
The first-line of defence is the innate immune system, comprising many different 
immune cells that act broadly using anti-pathogenic strategies to combat the threat 
whilst also educating adaptive immune cells to induce specific immune responses 
(Janeway, 1989). The extensive coordination and communication between these two 
systems showcases the intricacy of this highly evolved and sophisticated immune 
system so vital for host survival.  
1.1 Innate immune responses  
If skin or mucosal barriers are broken, innate cells including neutrophils, 
macrophages (MΦs), basophils, mast cells, eosinophils and dendritic cells (DCs) 
rapidly migrate to the site of infection (Janeway, 1989; Janeway and Medzhitov, 
2002). Antimicrobial activities kill the pathogen, such as the release of reactive 
oxygen species (ROS) and nitric oxide (NO) by classically activated MΦs (CAMΦs), 
and the expression of cytokines including tumour necrosis factor-α (TNF-α), 
interleukin (IL) 12p70 and IL-6 to attract and activate other immune cells (Janeway, 
1992).  
 
The detection of a pathogenic threat is initiated by the recognition of components 
that are non-self and conserved among microbial species, termed pathogen-
associated molecular patterns (PAMPs) (Janeway, 1989; Janeway and Medzhitov, 
2002). A large number of innate immune cells express pattern recognition receptors 
(PRRs) encoded by the host’s germline (Takeuchi and Akira, 2010). It was initially 
thought that PRRs exclusively recognise non-self antigens, but they can also bind to 
endogenous ligands such as nucleic acids and heat shock proteins released by 
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damaged or necrotic cells termed danger-associated molecules (DAMPs) (Bianchi, 
2007; Matzinger, 1994). In the mid 1990’s, Toll-like receptors (TLRs) were the first 
PRRs to be identified (Belvin and Anderson, 1996), and were subsequently found to 
signal via an intracellular adaptor protein myeloid differentiation primary response 
88 (MyD88) to induce specific immune responses towards microbes (Kawai and 
Akira, 2010). TLRs can be grouped depending on their location in the cell and the 
type of microbial ligands they recognise; TLR1, TLR2, TLR4, TLR5, TLR6, and 
TLR11 are expressed on the cell surface and predominantly bind microbial 
membrane components including lipids, lipoproteins and proteins, whereas TLR3, 
TLR7, TLR8 and TLR9 are found within intracellular vesicles such as endosomes, 
lysosomes, endolysosomes and the endoplasmic reticulum, where they are exposed 
to and recognise pathogen derived nucleic acids (Kawai and Akira, 2010). The 
discovery of TLR4 proved to be significant, as this particular TLR recognises 
bacterial lipopolysaccharide (LPS), which is found on the outer membrane of gram-
negative bacteria that can cause septic shock (Poltorak et al., 1998). Following the 
discovery of TLRs, various cytosolic PRRs such as RIG-I-like receptors (RLRs) and 
Nod-like receptors (NLRs) were identified (Kawai and Akira, 2010). These PRRs 
can share ligands with TLRs and together perform critical roles in innate immune 
responses, including the induction of proinflammatory responses. 
 
Although one of the main functions of the innate immune system is to detect 
microorganisms and mount a first-line defence against the pathogenic threat, innate 
immunity must also efficiently regulate inflammation and maintain immunological 
homeostasis (Janeway and Medzhitov, 2002). Many innate immune cells have dual 
functional roles in initiating immune responses whilst also controlling the extent of 
this response. For example, MΦs exhibit potent antimicrobial activities including the 
production of NO and ROS, but when the infection clears MΦs produce anti-
inflammatory cytokines such as IL-10 and transforming growth factor-β (TGF-β) to 
tune down immune responses (Murray and Wynn, 2011). In addition, a crucial part 
of the innate immune system is carried out by antigen presenting cells (APCs) such 
as DCs and MΦs, which communicate specific information about the microbial 
invasion to the adaptive immune response.  
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1.2 Dendritic cells  
In 1973, DCs were first identified as APCs by Ralph Steinman in the mouse spleen 
due to their unique dendritic morphology compared with MΦs (Steinman and Cohn, 
1973). Since this discovery it has become clear that, although other immune cells can 
act as APCs, DCs are the most potent immune cells in this regard (Mildner and Jung, 
2014; Steinman, 2012). Their location in peripheral tissues, such as the skin or 
mucosal tissues, as well as lymph nodes (LNs), places DCs in ideal positions for 
pathogen encounter at body barriers or entries to organs (Banchereau and Steinman, 
1998). DCs efficiently take up antigen in the periphery and migrate to lymphoid 
organs, where they present processed antigen to different subsets of naive T 
lymphocytes, including CD4+ and CD8+ αβ T cells that are part of the adaptive 
immune response (Bonasio and Andrian, 2006). Presenting a pathogen-derived 
peptide to adaptive T cells conveys specific information about the particular 
pathogenic threat that the DC has encountered. Thus, as part of the innate immune 
system DCs provide a rapid non-specific response upon activation following 
recognition of microbial product, and induce a second-line defence that is antigen-
specific by T cells (Janeway and Medzhitov, 2002). 
1.2.1 Dendritic cell activation and function  
1.2.1.1 Dendritic cell activation 
Conventional DC activation occurs through interaction with PAMPs or DAMPs from 
a pathogen via PRRs expressed on the cell surface (Janeway, 1989; Kapsenberg, 
2003; Matzinger, 2002). Upon stimulation with antigen, DC expression of various 
surface molecules including the chemokine receptor CCR7 is increased (Förster et 
al., 1999), which enables DCs to migrate to the peripheral T cell zones within LNs 
via the afferent lymph (MartIn-Fontecha et al., 2003; Saeki et al., 1999). CCR7 
recognises chemokines CCL19, produced by stromal cells and DCs in the T cell 
zone, and CCL21, expressed by endothelial cells of lymphatic vessels and high 
endothelial venules (HEV) (Gunn et al., 1998; Kriehuber et al., 2001; Ngo et al., 
1998; Willimann et al., 1998). Recognition and uptake of antigen results in 
substantial upregulation in a range of surface markers and cytokines, which are 
required for efficient communication with T cells (Banchereau et al., 2000). This 
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enhanced ability to migrate to LNs and upregulate surface markers and cytokine 
expression after encountering a pathogen distinguishes DCs from other APCs 
(Banchereau and Steinman, 1998; Förster et al., 2012; Geissmann et al., 2010). 
1.2.1.2 Antigen uptake, processing and presentation by DCs 
Unactivated DCs, sometimes termed 'immature' DCs, are scavengers that sample the 
tissue environment for harmful pathogenic agents by various mechanisms including 
receptor mediated endocytosis, phagocytosis and macropinocytosis (Guermonprez et 
al., 2002). The first two uptake pathways require receptor recognition for 
internalisation of macromolecules and particulate antigen respectively (Guermonprez 
et al., 2002). Macropinocytosis is the main antigen uptake mechanism that DC utilise 
to take up soluble antigen, and this process is critical for non-specific and rapid 
sampling of a large amount of surrounding fluid in the environment (Guermonprez et 
al., 2002). Notably, macropinocytosis can be induced transiently in MΦs (Racoosin 
and Swanson, 1989; 1992) and epithelial cells (West et al., 1989) by growth factors, 
but this process is constitutive in unactivated DCs (Sallusto et al., 1995). Thus, 
continuous and effective sampling of the environment further distinguishes DCs 
from other APCs.  
  
Once inside DCs, antigen is processed and degraded by DC machinery, which 
produces a short peptide that is loaded on major histocompatibility complex (MHC) 
molecules (Mellman and Steinman, 2001). The effectiveness of antigen processing is 
dependent on the activation status of DCs, as interaction with microbial components 
that potently activate DCs, such as LPS, substantially enhances lysosomal 
acidification and antigen proteolysis (Trombetta et al., 2003). Uniquely, regulation of 
lysosomal acidity allows for efficient preservation of antigen within DCs for 
subsequent presentation to T cells, and it is thought that the ability of DCs to take up 
and process antigen is unrivalled by other APCs that also express MHC, including 
MΦs (Mildner and Jung, 2014). 
 
Effective presentation of antigen to naive T cells by DCs in lymphoid tissue is 
promoted by high level MHC expression, which further implicates DCs as the main 
APC for T cell activation (Steinman et al., 1979). It is generally thought that antigen 
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peptides derived from the external environment are loaded onto class II MHC 
molecules (MHC-II) in endocytic organelles, and that peptide loaded on MHC-II is 
recognised by CD4+ T cells (Neefjes et al., 2011). In contrast, endogenously derived 
antigen is recognised by CD8+ T cells, and is loaded onto class I MHC (MHC-I) 
molecules after translocation into the endoplasmic reticulum by transporter 
associated with antigen processing (TAP) (Neefjes et al., 2011). However, cross-
presentation pathways exist that allow for the presentation of exogenous antigen on 
MHC-I (Joffre et al., 2012; Villadangos and Schnorrer, 2007) (Diagram. 1.1). Cross-
presentation of peptides enables the induction of immune responses by healthy APCs 
via presentation of intracellular antigen derived from damaged cells such as tumour 
cells or those infected with a virus (Heath et al., 2004). Thus, some flexibility in 
antigen presentation pathways via MHC molecules exists, which extends their 
capacity to activate different T cell subsets. 
1.2.2 The diversity of murine DCs 
Although all DCs exhibit similar functions in antigen recognition, uptake and 
processing, DCs are a heterogeneous population of professional APCs that can be 
broadly divided into two main groups: conventional or classical DCs (cDCs) and 
plasmacytoid DCs (pDCs) (Merad and Manz, 2009). cDCs play a major role in the 
induction of adaptive immune responses against pathogens, but are also important in 
the maintenance of immune tolerance against self antigens (Merad et al., 2013). 
pDCs on the other hand are primarily involved in anti-viral responses and produce 
copious amounts of type I interferons (IFNs), which aid in eliminating virus infected 
cells (Reizis et al., 2011).  
1.2.2.1 Conventional dendritic cell subsets 
cDCs represent a small group of haematopoietic cells that reside in most lymphoid 
and non-lymphoid tissues (Merad et al., 2013). This group of DCs displays an 
enhanced ability compared with pDCs in tissue injury detection, the capture of both 
exogenous and endogenous antigens, and the processing and presentation of antigen 
to T cells (Mildner and Jung, 2014; Villadangos and Young, 2008). LN resident 
cDCs differentiate from cDC precursors formed in the bone marrow (BM), and 
reside in the LN from then on (Diagram. 1.2) (Merad et al., 2013). Lymphoid cDCs 
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are frequently divided into two main subsets; CD8α+ cDCs and CD11b+ cDCs 
(Merad et al., 2013). Tissue resident cDC subsets on the other hand are commonly 
referred to as CD103+ and CD11b+ cDCs, and together these subsets account for 
approximately 1-5% of all cells in peripheral tissue (Merad et al., 2013). Tissue 
resident CD11b+ cDCs closely resemble their counterparts in the LNs, whereas 
CD103+ cDCs represent the migratory non-lymphoid equivalent of lymphoid CD8α+ 
cDCs and express low levels of CD8α (Bursch et al., 2007; Ginhoux et al., 2007; 
Poulin et al., 2007). Indeed migratory CD103+ cDCs and lymphoid CD8α+ cDCs are 
thought to be both developmentally and functionally equivalent (Bedoui et al., 2009; 
Edelson et al., 2010; Ginhoux et al., 2009). Notably, migratory CD103+ cDCs should 
not be confused with intestinal CD103+ cDCs that are located in Peyer’s patches 
(PPs) and the lamina propria (LP) (Coombes et al., 2007), as intestinal CD103+ cDCs 
are thought to be functionally specialised due to their distinct location in the gut 
(Denning et al., 2011). Intestinal CD103+ cDCs traffic to the mLNs, where 
interaction with T cells leads to upregulation of gut-homing markers CCR9 and a4β7 
(Jaensson et al., 2008; Johansson-Lindbom et al., 2005). This process is dependent 
on the ability of intestinal CD103+ cDCs to metabolise dietary retinoids to retinoic 
acid (RA) (Iwata et al., 2004). 
 
Lymphoid CD8α+ cDCs and migratory CD103+ cDCs are FMS-like tyrosine kinase 3 
ligand (Flt3L) dependent and are phenotypically immature in the steady state 
(Shortman and Heath, 2010). Ιn accordance with their name CD8α+ cDCs express 
CD8α homodimers, but not CD8αβ heterodimers as seen on T cells (Vremec et al., 
2000). However, the term “CD8α+ cDCs” is a somewhat inappropriate name for this 
subset since CD8α itself is only expressed in later stages of development, and can be 
found on certain migratory cDCs as well as on pDCs (Shortman and Heath, 2010). 
Thus, other markers including the glycoprotein CD24 (Askew and Harding, 2008) 
and C-type lectins CD205 (DEC205) (Jiang et al., 1995) and Clec9a (Sancho et al., 
2008) are currently used to distinguish CD8α-lineage cDCs. In recent years a 
chemokine receptor, XCR1, has been identified as a more specific marker since it is 
found on both CD8α+ and CD8α− cDCs belonging to the CD8α cDC lineage, 
including peripheral CD103+ cDCs (Annabell Bachem, 2012). As such, XCR1 will 
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perhaps replace the current name for CD8α+ cDCs in future. Clearly cDC subsets are 
still confusing in terms of their surface marker expression, and the nomenclature has 
not yet been universally adopted. For the purpose of this thesis, DC subset names 
outlined in table 1.1 will be used, as in most tissues these are still commonly 
accepted names for each subset. 
 
In early reports, ex vivo CD8α+ cDCs were shown to be proficient in cross-
presentation of cell-associated antigen to CD8+ T cells via MHC-I, indicating that 
they are important for cytotoxic lymphoid (CTL) responses (Haan et al., 2000). 
CD8α+ cDCs are also known to produce high levels of the inflammatory cytokine IL-
12 upon stimulation in vitro and in vivo (Maldonado-López et al., 1999; Reis e Sousa 
et al., 1997). By measuring CD4+ and CD8+ T cell proliferation to targeted antigen in 
vivo it was shown that CD8α+ cDCs are superior antigen cross-presenters, whereas 
CD11b+ cDCs are proficient in the uptake of exogenous antigen and display an 
enhanced capacity to present peptide to CD4+ T cells via MHC-II (Dudziak et al., 
2007). This is due to different machinery within these subsets: CD8α+ cDCs contain 
enhanced levels of TAP proteins required for the loading of processed peptide on 
MHC-I, whereas CD11b+ cDCs are enriched in components such as cathepsins and 
proteases required for antigen processing to peptide ligands and subsequent loading 
onto MHC-II (Dudziak et al., 2007; Joffre et al., 2012). However, CD8α+ cDCs are 
capable of presenting antigen and activating CD4+ T cells, even though this occurs at 
a lower level relative to CD11b+ cDCs (Shortman and Heath, 2010).  
 
Similar to CD8α+ cDCs, CD11b+ cDCs rely on Flt3L and are reduced in Flt3L 
deficient mice, albeit to a lesser extent than CD8α+ cDCs (McKenna et al., 2000; 
Waskow et al., 2008). Lymphoid CD11b+ cDCs represent a more heterogeneous 
population in comparison with CD8α+ cDCs, and remain less well characterised. 
CD11b+ cDCs do not express CD8α and are often found to be the dominant subset in 
the lymphoid resident cDC population (Merad et al., 2013). CD11b is also expressed 
on a group of monocytes that are recruited during inflammation via CCR2 (Robays 
et al., 2007). These monocytes express CD64 and FcεRIα, which can be used to 
distinguish monocytes from CD11b+ cDCs (Plantinga et al., 2013). On the other 
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hand, CD11b+ cDCs can be further distinguished by their high level of CD172a 
(Sirp-α) expression (Lahoud et al., 2006). Preferential antigen presentation to CD4+ 
T cells by CD11b+ cDCs via MHC-II described above extends to responses against 
viral infection with influenza, when CD8α+ cDC induce CTL responses (Kim and 
Braciale, 2009). Recently, a role for CD11b+ cDCs during the induction of CD4+ T 
cell responses against helminth infection and allergic inflammation has been 
proposed, and this will be discussed in more detail in section 1.9.3 (Plantinga et al., 
2013; Williams et al., 2013). 
 
Models depleting DCs have been used to uncover the importance of distinct DC 
subsets in the steady state and immune responses during infection with a pathogen. 
Depletion of CD11c+ DCs has been achieved by using a model in which CD11c-
expressing cells also express the transgene for the diphtheria toxin receptor (DTR) 
(Hochweller et al., 2008; Jung et al., 2002). Treatment with Diphtheria toxin (DTx) 
efficiently depletes CD11c-expressing cells by terminating protein synthesis and 
causing cells to die by apoptosis (Diagram 1.3) (Bar-On and Jung, 2010). An early 
CD11c.DTR model used a primate DTR transgene and enabled short-term depletion 
of cDCs without side-effects (Jung et al., 2002). However, from around 5 days after 
initial treatment, DTx mediated side effects are caused by the expression of DTR on 
non-haematopoietic cells resulting in the death of the animal. A more recent system 
using CD11c.DOG mice has a human DTR inserted into a bacterial artificial 
chromosome (BAC) construct, and this can be used for long-term depletion of 
CD11c-expressing cells lasting 11-12 days (Hochweller et al., 2008). Within 12 
hours of DTx treatment 80% depletion is achieved, but after 72 hours CD11chigh cells 
begin to repopulate the mouse and consistent DTx administration is required to 
maintain depletion (Hochweller et al., 2008). The depletion of DC subsets in this 
model extends to both cDCs and pDCs, whereas in CD11c.DTR mice pDCs are not 
depleted in every tissue site (Sapoznikov et al., 2007). Although high level 
expression of the integrin CD11c in addition to MHC-II (Metlay et al., 1990) is 
frequently used to distinguish DCs from other immune cells, CD11c is also 
expressed by other immune cells including MΦs (Jakubzick et al., 2006; Lloyd et al., 
2008; Niess et al., 2005). As such, CD11c+ MΦs are likely also depleted in both 
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CD11c.DTR and CD11c.DOG mice, and this is an important factor to consider when 
using this model (van Blijswijk et al., 2013). 
 
In recent years transcription factors unique to cDC differentiation and developmental 
stages have been discovered, and this research has delivered some clarity on cDC 
ontogeny and also provided a platform for the identification of novel depletion 
models (Satpathy et al., 2012a). For example, transcription factor Zbtb46 is specific 
to cDCs and can be used to distinguish cDCs from other myeloid populations 
(Meredith et al., 2012a; Satpathy et al., 2012a). Zbtb46 is expressed by committed 
cDC progenitors as well as lymphoid resident and peripheral cDC subsets (Meredith 
et al., 2012a; Satpathy et al., 2012a). It is also notable that Zbtb46 is expressed by 
erythroid cells and endothelial cells, but its expression in haematopoietic cells is 
limited to cDCs (Satpathy et al., 2012a). For this reason models such as zDC-DTR 
mice, which can be used to deplete all cells expressing Zbtb46 in the steady state 
(Meredith et al., 2012a), and Zbtb46+/gfp mice that label these cells (Satpathy et al., 
2012a), have been proposed as more specific tools for investigating cDC function 
compared with inducible CD11c depletion models (Hochweller et al., 2008; Jung et 
al., 2002). However, zDC protein is downregulated in splenic CD11c+ populations 
after treatment with PRR ligands such as poly I:C (a synthetic analogue of double-
stranded RNA) in vivo, which suggests that these models cannot be used to examine 
cDC function during immune responses against pathogens (Meredith et al., 2012b).  
 
Recently, Schraml et al., (2013) described a model to genetically trace cDCs by 
labelling them with yellow fluorescent protein (YFP) based on the expression of C-
type lectin Clec9a (DNGR1). This model was generated by crossing mice expressing 
Cre recombinase under control of the Clec9a locus (Clec9a-Cre) with Rosa26-
stopflox-enhanced YFP reporter mice, referred to as Clec9a+/creRosa+/EYFP mice. 
Detection of YFP identifies cDC precursors and cDCs, but not common MΦ-DC 
progenitors (MDPs) in Clec9a+/creRosa+/EYFP mice. Specifically, 
Clec9a+/creRosa+/EYFP mice enable the genetic labelling and tracing of cDC precursors 
and cDCs that have historically expressed Clec9a, and the authors propose that this 
model can be used to examine the location and proportion of cDCs during 
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inflammation (Schraml et al., 2013). In a subsequent study, an inducible cDC 
depletion model was generated by crossing Rosa26-lox-stop-lox(LSL)-DTR mice 
with Clec9a-Cre mice and administrating DTx to deplete cDCs (van Blijswijk et al., 
2014). These mice are referred to as Clec9a+/CreROSAiDTR mice, and allow for 
efficient cDC depletion following DTx administration. Notably, the use of these 
animals revealed that Clec9a+/CreROSAiDTR mice develop LN hypocellularity and 
reduced DC frequency even when DTx was not injected, and the authors suggest that 
this phenotype is a feature common to other murine models that express DTR on 
DCs (van Blijswijk et al., 2014). This finding underlines the importance of using 
appropriate controls when utilising DTR based models (i.e. PBS injected DTR 
expressing mice as well as wild type (WT) mice), and caution should be taken when 
interpreting the data obtained from these mice as the naïve setting is different. 
Although current models for cDC depletion exhibit various caveats, they provide a 
valuable tool for the examination of the role of this large DC group during the steady 
state and inflammatory conditions. 
  
Similar to “bulk” cDCs, differential dependence on transcription factors by distinct 
cDC subsets has helped understanding of CD8α+ and CD11b+ cDC ontogeny and 
function. CD11b+ cDCs rely on IFN regulatory factor 4 (IRF4) (Suzuki et al., 2004) 
and Notch2 (Lewis et al., 2011) for their development, whilst CD8α+ cDCs are 
dependent on IRF8, inhibitor of DNA binding 2 (Id2) and Basic leucine zipper 
transcription factor ATF-like 3 (Batf3) (Jackson et al., 2011). In fact, transcription 
factors IRF8, Id2 and Batf3 are required sequentially during the development of 
CD8α+ cDCs, which was established using Id2-GFP reporter mice (Jackson et al., 
2011). Jackson et al., (2011) showed that IRF8 is required for the development of all 
Id2 expressing cDC progenitors (as well as pDCs (Becker et al., 2012; Schiavoni et 
al., 2002)), but Batf3 is necessary specifically during later developmental stages of 
CD8α+ cDCs. Batf3 is an activator protein 1 (AP-1) transcription factor (Murphy et 
al., 2013), which forms a heterodimer with Jun before binding AP-1 (Iacobelli et al., 
2000). AP-1 regulates gene expression involved in cell proliferation, cytokine 
expression and apoptosis (Wagner and Eferl, 2005). Notably, Batf3 is related to Batf 
and Batf2 (Murphy et al., 2013), and these transcription factors have been reported to 
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be important for the development of Th17 cells (Schraml et al., 2009) or a subset of 
lung resident DCs and MΦs (Tussiwand et al., 2012) respectively. 
 
In 2008, a transgenic mouse deficient in the transcription factor Batf3 was shown to 
specifically lack splenic CD8α+ cDCs and the equivalent migratory CD103+ cDC 
subset (Hildner et al., 2008). This study showed that Batf3-/- mice exhibit impaired 
CTL responses against West Nile virus (Hildner et al., 2008) and display reduced 
protection against tumourogenesis (Fuertes et al., 2011; Hildner et al., 2008). Further 
studies using the Batf3 model have since shown that CD8α+ cDCs are required for 
the induction of CD8+ T cell responses against infection with Sendai virus (Edelson 
et al., 2010), influenza virus (Waithman et al., 2013), and cytomegalovirus (Torti et 
al., 2011). Batf3 dependent DCs are also essential for intact CD4+ T cell responses 
during Toxoplasma gondii (Mashayekhi et al., 2011) and Leishmania major (Ashok 
et al., 2014) infection. Thus, research using Batf3-/- mice has elevated our 
understanding on the important role of CD8α+ cDCs during antigen cross-
presentation to CD8+ Τ cells and the induction of CD4+ T cell responses in vivo 
against acute viral and bacterial infections. However, the role of CD8α+ cDCs in 
chronic infections remains unclear, including infection with helminths (Pearce and 
MacDonald, 2002). Taken together, the identification of transcription factor 
dependence by distinct cDC subsets has enabled the generation of mouse models for 
the investigation of the function of different DC types during immune responses 
against pathogens. 
1.2.2.2 Plasmacytoid dendritic cells 
pDCs display distinct life cycles and functions compared with cDC (Reizis, 2010; 
Villadangos and Young, 2008). Although pDCs share a similar origin to cDCs, as 
both develop from a common DC progenitor (CDP), cDCs require additional 
development to pre-cDCs in the blood whilst pDCs fully differentiate in the BM 
(Naik et al., 2007) (Diagram 1.2). pDCs rely on the transcription factor E2-2 for their 
development in the BM (Cisse et al., 2008) and maintenance in the periphery (Ghosh 
et al., 2010). In addition, pDCs rely on both IRF4 (Schiavoni et al., 2002) and IRF8 
(Tsujimura et al., 2003) for their development. In the steady state, pDCs are 
commonly found in the blood from where they enter lymphoid tissue (Cella et al., 
12 
1999). Murine pDCs can be distinguished by their low level expression of MHC-II 
and CD11c, as well as their expression of CD45R (B220), PDCA-1, Ly6C, Siglec-H 
and Ly49Q (Reizis et al., 2011). 
 
pDCs are generally thought to be poorer APCs than cDCs (Villadangos and Young, 
2008). Young et al., (2008) showed that purified pDCs capture fluorescently labelled 
OVA protein more slowly than cDCs in vitro, but pDCs generate degradation 
products of OVA at a similar rate. This indicates that pDC endocytic vesicles are 
more degenerative preventing effective preservation of antigen. On the other hand, 
slow degradation in cDCs enables sufficient preservation of exogenous antigen for 
subsequent processing and presentation to CD4+ T cells (Savina et al., 2006). 
Furthermore, persistent turn over of antigen complexed MHC-II on the cell surface 
of pDCs as well as low expression of MHC-II generally renders interaction with T 
cells ineffective (Villadangos and Young, 2008). Instead, pDCs are well known for 
their enhanced ability relative to cDCs to produce type I IFNs in response to TLR7 
or TLR9 detection of viruses (Satpathy et al., 2012b; Swiecki et al., 2010; Wang et 
al., 2008). During viral infection, pDCs are rapidly recruited to infection sites 
(Baldwin et al., 2004; Smit et al., 2006) and contribute to natural killer (NK) cell and 
CD8+ T cell recruitment and activation (Pinto et al., 2011; Swiecki et al., 2010). A 
study that administered an antibody depleting pDCs (120G8) showed that pDCs 
drastically limit replication of respiratory syncytial virus and also reduce pulmonary 
inflammation and airway hyperresponsiveness (Wang et al., 2006). Further, 
depletion models using the BDCA2-DTR transgenic mouse model (Table 1.2) 
indicated that pDCs induce early activation of NK cells during infection with murine 
cytomegalovirus and promote the survival of CD8+ T cells in vesicular stomatitis 
viral infection (Swiecki et al., 2010). These studies have placed pDCs as a dominant 
DC subset for limiting viral replication by the production of type I IFNs and 
enhancing viral clearance (Satpathy et al., 2012b).  
1.2.2.3 Monocyte derived dendritic cells 
Similar to pDCs, monocytes circulate in the blood in the steady state and develop 
from BM precursors (Diagram 1.2) (Domínguez and Ardavín, 2010). Blood derived 
monocytes can differentiate into either MΦs or DCs (Satpathy et al., 2012b). Two 
13 
distinct monocyte subsets have been identified: Ly6Clow CX3CR1high CCR2low and 
Ly6Chigh CX3CR1low CCR2high monocytes (Geissmann et al., 2008; Satpathy et al., 
2012b). The former constitute patrolling monocytes that migrate along the blood 
endothelium, and this process facilitates rapid recruitment to sites of inflammation. 
Within inflamed tissue, these monocytes are thought to be responsible for the 
secretion of inflammatory cytokines or for contributing to wound healing (Auffray et 
al., 2007; Geissmann et al., 2008). Instead, the latter subset is termed “inflammatory 
monocytes” and arrives later at the site of inflammation compared with patrolling 
monocytes. These monocytes have been reported to differentiate into cells 
sometimes termed TNF- and inducible nitric oxide synthase- producing 
inflammatory DCs (Tip-DCs) (Merad et al., 2013), which represent a dominant cell 
type during inflammation (Geissmann et al., 2003; Serbina et al., 2003). Although 
frequently named DCs, these cells do not express Zbtb46, the transcription factor 
expressed by cDCs (Meredith et al., 2012a; Satpathy et al., 2012a). This indicates 
that “Tip-DCs” may be inflammatory MΦs or monocytes rather than DCs. 
Furthermore, MΦs and DCs can originate from MDPs in the BM, whereas a distinct 
pathway leads to monocyte development (Geissmann et al., 2010) (Diagram 1.2). 
Additionally, recent studies have highlighted that the development and maintenance 
of cDCs and most tissue resident MΦs is independent of monocytes (Ginhoux and 
Jung, 2014). For example, it is now known that in particular some tissue resident 
MΦs have an embryonic origin (Davies et al., 2013). However, monocyte derived 
cells have been reported as being capable of antigen presentation in some settings 
including during allergic responses (Hammad et al., 2010; Plantinga et al., 2013), 
and these monocytes express CD64 and MAR-1 (Plantinga et al., 2013). Taken 
together, “Tip-DCs“ are not strictly DCs when defined by their transcription factor 
usage and ontogeny, but they can exhibit some DC similarity in their function during 
immune responses. Thus, monocytes have emerged as a distinct cellular system that 
is highly dynamic and plastic, and is capable of acquiring both DC and MΦ-like 
functions in certain immune settings (Ginhoux and Jung, 2014).  
1.2.2.4 Human dendritic cells 
In 2012, Ralph Steinman was awarded the Nobel prize in Physiology or Medicine for 
his discovery of DCs in 1973, and their role in adaptive immunity. Thus, it has long 
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been known that DCs are critical for the immune system (Steinman, 2012), but only 
recently has it become clear that DCs are crucial for human health and disease 
(Collin et al., 2011; Steinman, 2012). Spontaneous DC deficiency in humans has 
been identified surprisingly late, which explains the relative paucity of data 
describing human DC subsets (Collin et al., 2011; Steinman, 2012). However, recent 
research has highlighted the importance of DCs for human health, as mutations in 
GATA binding protein 2 (GATA2) or IRF8 lead to DC deficiency resulting in severe 
immunodeficiency (Dickinson et al., 2011; Hambleton et al., 2011). Most knowledge 
arises from studies on human circulating blood DCs, with both cDCs and pDCs 
identified (Merad and Manz, 2009). To date, it is unclear whether CDPs exist in 
human BM or in the blood, but there is some evidence that tissue derived human DC 
subsets require continuous replenishment from blood–borne pre-cursors (Collin et 
al., 2013). A human equivalent of murine LN resident CD8α+ cDCs and migratory 
CD103+ cDCs has been described as expressing Clec9a and XCR1 similar to the 
murine counterpart, but uniquely expresses the integral membrane protein CD141 
and intracellular adhesion protein Necl2, and does not express CD8α (Diagram. 1.4) 
(Collin et al., 2013; Villadangos and Shortman, 2010). CD141+ DCs have been 
identified among resident LN, spleen, tonsil and BM resident DCs (Collin et al., 
2013), as well as in peripheral tissues such as the skin, liver and lung (Haniffa et al., 
2012). Both human and murine CD8α+ cDCs rely on Batf3 and IRF8 for their 
development and each expresses TLR3 (Jongbloed et al., 2010; Poulin et al., 2010). 
In addition human CD8α+ DC counterparts are functionally similar to murine DCs, 
since they take up dead cells and cross-present antigen to CD8+ T cells (Collin et al., 
2013; Villadangos and Shortman, 2010). The human counterparts for CD11b+ cDCs 
are thought to be CD1c+ DCs, which represent the major population of human 
myeloid DCs in the blood (Collin et al., 2013). CD1c+ DCs are efficient activators of 
naive CD4+ T cells, but are less effective at cross-presenting antigen to CD8+ T cells 
compared with CD141+ DCs (Collin et al., 2013). Thus, recent advances have 
improved our understanding on DC heterogeneity in humans, but many open 
questions remain about DC origin and the generation of immune responses by human 
DCs.   
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1.3 T cell activation by dendritic cells  
Although DC diversity underlines the heterogeneity of this innate immune cell 
population, one of the key roles for all DCs is the activation of T cells via the 
presentation of antigen (Kapsenberg, 2003). T cell activation by peptide loaded DCs 
requires the interaction of various cellular components, and the recognition of MHC-
peptide complex via the T cell receptor (TCR) is the first stimulatory signal that T 
cells receive (Kapsenberg, 2003). Indeed, the activation of CD4+ T cells is dependent 
on MHC-II and their antigen recognition ability is restricted to MHC-II presentation. 
Following signal 1, which determines antigen specificity, signal 2 comprises co-
stimulatory or co-inhibitory mechanisms that direct T cell function and fate 
(Kapsenberg, 2003). Signal 2 is critical for this process, given that the provision of 
signal 1 in the absence of an appropriate signal 2 results in T cell unresponsiveness 
to antigen, sometimes termed T cell anergy (this will be discussed in section 1.8.2) 
(Bour-Jordan and Bluestone, 2009). The provision of signal 1 and 2 is dependent on 
upregulation of MHC and co-stimulatory molecule expression such as CD40, CD80, 
CD86 and OX40-L by the DC, which are required for efficient communication with 
T cells (Banchereau et al., 2000). Thus, these molecules are often used as markers for 
DC activation. Co-stimulatory/-inhibitory molecules are present on the cell surface 
of DCs and bind to the corresponding receptor or ligand on the T cell surface, 
frequently co-localising with the TCR (Chen and Flies, 2013). Further, these 
molecules synergise with TCR signals to promote or inhibit T cell function and 
activation, often controlling signals for the survival and proliferation of the cell 
(Saito et al., 2010). Notably, co-stimulation is also important for effective APC 
function mediated by DCs (Kobayashi et al., 2004). For example, CD40 engagement 
activates intracellular signalling pathways that are implicated in the promotion of 
cytokine production and upregulation of CD80 and CD86 surface marker expression 
by DCs (Kobayashi et al., 2004).  
 
Signal 3 is delivered mainly in the form of cytokines provided by DCs and probably 
also from other APCs, which determine T cell polarisation (Kapsenberg, 2003). 
Thus, signal 3 is thought to provide qualitative information determined by the 
interaction of the DC with the pathogen at the site of inflammation (Kaliński et al., 
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1999). For instance, the production of cytokines such as IL-6, IL-12p70 and TNF-α 
by DCs is substantially increased upon TLR ligation during conventional DC 
activation (Morelli et al., 2001), and these cytokines are thought to induce a potent 
inflammatory immune response. In fact, CD8α+ cDCs have been identified as the 
main producers of IL-12 in T. gondii and L. major infection (Ashok et al., 2014; 
Mashayekhi et al., 2011). However, in some cases (i.e. certain helminth infections) 
the polarisation of T cells is largely independent of TLR stimulation (Layland et al., 
2005), and this will be described in more detail in section 1.9.  
 
There are two main groups of co-stimulatory/-inhibitory molecules: immunoglobulin 
superfamily (IgSF) and the TNF receptor superfamily (TNFRSF). One of the main 
surface molecules expressed by T cells that is important for co-stimulation/-
inhibition is CD28, which belongs to the IgSF (Linsley and Ledbetter, 1993). The B7 
family ligands CD80 and CD86, both of which are often expressed by APCs 
(Greenwald et al., 2005; Linsley and Ledbetter, 1993), provide co-stimulatory signals 
to the T cell when bound to CD28. Another receptor member of the IgSF expressed 
by T cells is ICOS, which is bound by its activatory ligand ICOS-L on APCs 
(Hutloff et al., 1999). Receptor-ligand pairs CD40-CD154 (CD40L) (Caux et al., 
1994), OX40-OX40-L  (Fillatreau and Gray, 2003; Ohshima et al., 1997) and 
RANK-RANK-L (Anderson et al., 1997) are members of the TNFRSF that 
orchestrate co-stimulatory mechanisms and are important for activated T cell 
survival, differentiation and proliferation, such as the promotion of IL-2 production 
by T cells (Chen and Flies, 2013). To ensure optimal T cell activation via these 
processes, co-stimulatory ligands expressed by DCs are upregulated following 
activation as mentioned above, and naïve T cells consistently express CD28 on their 
cell surface (Chen and Flies, 2013; Kapsenberg, 2003). Thus, naïve T cells are 
dependent on interaction with DCs for efficient primary activation (Boyman et al., 
2009).  
 
During DC:T cell interaction, co-inhibitory mechanisms are in place to regulate the 
activatory mechanisms described above (Chen and Flies, 2013). One molecule 
belonging to the IgSF performing this task is cytotoxic T-lymphocyte-associated 
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protein 4 (CTLA-4), which is released from intracellular compartments and 
transported to the site of ligation on the T cell surface when TCR molecules have 
bound MHC on the APC (Egen and Allison, 2002; Linsley et al., 1996). Similar to 
CD28, CTLA-4 binds to CD80 and CD86 (Linsley et al., 1996) leading to the 
transduction of inhibitory signals as well as the endocytosis and degradation of CD28 
(Berg and Zavazava, 2008). Further inhibition can occur through capture and 
degradation of CD80 and CD86 by CTLA-4, removing the ligands from the surface 
of the APC (Qureshi et al., 2011). IgSF member programmed cell death 1 (PD-1) is 
another inhibitory receptor on T cells (Ishida et al., 1992), and is most known for 
driving CD8+ T cell anergy (Chikuma et al., 2009; Tsushima et al., 2007). Moreover, 
DCs have been shown to be responsible for upregulation of PD-1 on antigen-specific 
CD4+ T cells in experimental autoimmune encephalomyelitis (Yogev et al., 2012). 
Thus, DCs are important for the provision of a cohort of co-signals to T cells for 
their activation, polarisation and function, and the interaction with CD28 is thought 
to be the key primary process that determines T cell fate (Chen and Flies, 2013).  
1.4 Homeostasis of naïve, effector and memory T 
cells 
DC: T cell interaction is not only a process that is critical for T cell activation, but is 
also a fundamental requirement for T cell homeostasis in the steady state and during 
immune responses (Boyman et al., 2009). T cell homeostasis is thought to refer to 
the maintenance of a consistent number of T cells within the T cell pool. T 
lymphocyte homeostasis varies depending on the type of T cells; the main groups are 
thought to be aβ and γδ T cells, and little is known about the survival of γδ T cells in 
comparison with αβ T cells (Marrack and Kappler, 2004). Thus, for the purpose of 
this thesis only αβ T cells will be discussed. A pool of mature naïve T cells exists in 
secondary lymphoid organs and is consistently replenished by T cells generated in 
the thymus (Surh and Sprent, 2008; Takada and Jameson, 2009). Stringent thymic 
homeostatic processes control de novo T cell generation; immature double positive 
CD4+ CD8+ T cells that display high avidity to self peptides bound to MHC 
molecules are deleted during negative selection, whereas positive selection occurs 
when T cells that receive weak but significant TCR signals during this process 
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survive and differentiate into CD4+ CD8− or CD4− CD8+ single positive T cells via 
contact with self peptide bound MHC-II or MHC-I respectively (Sprent and Surh, 
2011). Approximately 98% of double positive T cells die rapidly due to a lack of a 
TCR signal, i.e. these T cells die from “neglect” rather than targeted deletion (Sprent 
and Surh, 2011).  
 
Differentiated single positive naïve CD4+ or CD8+ T cells that have migrated from 
the thymus to secondary lymphoid organs are long-lived, and express low levels of 
CD44 and CD69 (Sprent and Surh, 2011). Instead, naïve T cells express the selectin 
CD62L (L-Selectin) (Giblin et al., 1997) and chemokine receptor CCR7 (Miyasaka 
and Tanaka, 2004). These molecules aid migration of T cells to LNs and PPs, which 
express the appropriate ligands for these molecules (CD34 and glycam-1 for CD62L, 
CCL19 and CCL21 for CCR7). Naïve T cells consistently recirculate secondary 
lymphoid organs and do not enter tissue sites directly. In the LN, CCR7 expression 
enables naïve T cells to enter through the HEV into the T cell zone, and exit through 
sinuses into the efferent lymph (Takada and Jameson, 2009). A fibroblastic reticular 
cell (FRC) network expressing CCL19 and CCL21 facilitates T cell motility and 
confinement within the T cell zone. In addition, FRCs produce the survival cytokine 
IL-7 and thereby promote the metabolism and survival of naïve T cells in the LN 
(Takada and Jameson, 2009). The expression of IL-7Rα (CD127) on naïve T cells is 
induced by transcription factor FoxO1, which also induces CD62L and CCR7 
expression (Link et al., 2007). Together with survival cytokines, DC mediated self 
peptide MHC stimulation can upregulate the expression of anti-apoptotic proteins 
including Bcl-2 and Bcl-XL in T cells (McKinstry et al., 2010a). It is currently 
thought that the dependence on consistent low level TCR signalling for survival of 
naïve T cells that have left the thymus is set by positive selection within the thymus 
during T cell development (Garbi et al., 2010; Surh and Sprent, 2008).  
 
Cell death is an essential component during T cell homeostasis, allowing for the 
maintenance of the naïve T cell pool size by counteracting the remarkable 
proliferative capacity of T cells (Marrack and Kappler, 2004). The fairly constant 
number of naïve T cells as well as the fact that T cells in the pool divide only at low 
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levels in the steady state indicates that competition for resources, such as IL-7 or 
MHC stimulation, may be limiting the size of the naïve T cell pool (Marrack and 
Kappler, 2004). Thus, T cell apoptosis is thought to occur due to a lack of survival 
signals, which increases the expression of pro-apoptotic proteins and caspases, such 
as Bim, that mediate the breakdown of mitochondrial pathways (McKinstry et al., 
2010b).  
 
T cell responses are initiated within the T cell zone of the LN, where antigen loaded 
DCs activate naïve T cells via antigen-peptide MHC stimulation and co-stimulation 
including CD28 ligation (Jenkins et al., 2001; Takada and Jameson, 2009). 
Proliferation of activated T effector cells is characteristic of a T cell response against 
a pathogen, and this results in upregulation of CD44 and CD69 on the T cell surface 
(Sprent and Surh, 2011). T cell activation also increases the expression of IL-2 by T 
cells, which signals through both autocrine and paracrine pathways (Boyman et al., 
2009). IL-2 signalling via ligation with CD25 (the IL-2R) promotes metabolic 
processes, the expression of anti-apoptotic survival factors and proliferation of T 
cells (Boyman et al., 2009). T cell proliferation is followed by a contraction phase, 
which is controlled by distinct processes (Dutton et al., 1998). A small population of 
antigen-specific T cells survive T cell contraction and express high levels of CD44; 
these cells are termed memory T cells (Sprent and Surh, 2011).  
 
Homeostatic mechanisms that control the effector and memory T cell pool are 
currently under active research, and are less well understood compared with naïve T 
cell homeostasis. The mechanisms identified to date which regulate effector/memory 
T cell reactivation, proliferation, cytokine production and survival are thought to be 
similar, but not identical, to homeostatic regulation of naïve T cells.  For example, 
naïve, effector and memory CD4+ T cells require MCH-II:TCR signalling for 
activation and IL-7 for prolonged survival, whereas co-stimulation via CD28 is only 
essential in initial priming events of naïve CD4+ T cells (Boyman et al., 2009). 
Rather, activated CD4+ T cells require co-stimulation through various members of 
the TNFRSF, including OX40 (Redmond et al., 2009) or ICOS (Simpson et al., 
2010) for their differentiation, effector function, survival and the formation of 
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memory CD4+ T cells (Chen and Flies, 2013). Nevertheless, the cytokine response 
by activated CD4+ T cells is at least in part dependent on CD28 interaction (Harris 
and Ronchese, 1999). For example, Rulifson et al., (1997) showed that in particular 
the production of cytokines IL-4 and IL-5 by effector CD4+ T cells is promoted by 
CD28 ligation upon restimulation of CD4+ T cells with immobilised αCD3 (a T cell 
co-receptor).  
 
The type of survival factors involved in the promotion of T cell proliferation also 
varies slightly depending on the activation state of the T cell. Administration of IL-
7/αIL-7 mAb complexes in vivo can induce low level naïve T cell proliferation in 
steady state conditions, whereas cytokines IL-2 (and to a lesser extent IL-15) 
normally lead to rapid proliferation and differentiation into effector/memory CD4+ T 
cells (Boyman et al., 2009).  Responsiveness to IL-2 is enhanced following 
activation of CD4+ T cells, as activated CD4+ T cells have upregulated the 
expression of CD25 (Boyman et al., 2009). Taken together, the mechanisms that 
drive T cell homeostasis are thought to vary depending on the activation state of the 
lymphocyte, but the factors mediating these processes are similar.  
1.5 CD4+ T cell subsets 
Activation of CD4+ T cells by APCs during immune responses results in rapid 
proliferation and the secretion of cytokines that activate and recruit other immune 
cells, as well as inducing humoral responses orchestrated by B cells and cytotoxic 
responses by CD8+ T cells (Broere et al., 2011). Particularly, their ability to help B 
cell antibody class-switching via CD40-L provision has given CD4+ T cells the name 
“T helper” (Th) cells (Wykes, 2003). Th cells can differentiate into distinct subsets, 
which can be identified based on the cocktail of cytokines that they secrete following 
successful activation. In 1986, two main Th subsets were identified: Th1 and Th2 
cells (Mosmann et al., 1986). Since then other T helper subsets including IL-17 
producing Th17 cells, T regulatory cells (Treg) and T follicular helper (Tfh) cells 
have been identified, all of which will be discussed in this section.  
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The main factor determining T cell subset fate is the type of signal (signal 3) 
provided by the APC, which depends on the type of DAMPs or PAMPS that the 
PRRs on the APC recognise (Kapsenberg, 2003). Typically, viruses, bacteria and 
protozoa induce IL-12 production by APCs, particularly by DCs, which is a central 
mechanism for polarising CD4+ T cells towards a Th1 immune response (Hilkens et 
al., 1997; Macatonia et al., 1995) (Diagram. 1.5). IL-12 leads to downstream 
signalling through signal transducer and activator of transcription protein 4 (STAT4) 
(Thierfelder et al., 1996), and induces the transcription factor T-bet (Lazarevic et al., 
2013). T-bet activates IFN-γ production, which is a typical hallmark of CD4+ T cell 
differentiation into Th1 cells (Szabo et al., 2000). IFN-γ is a potent mediator of 
CAMΦ activation resulting in NO and ROS production that aids intracellular 
pathogen killing (Young and Hardy, 1995). Additionally, IFN-γ activates CTL 
responses by CD8+ T cells against viral infection (Walsh and Mills, 2013). Th1 cells 
also activate B cell humoral responses and induce antibody class-switching 
predominantly to IgG2a (Stevens et al., 1988) and IgG2c (Barr et al., 2009) in mice. 
These particular antibody isotypes in the mouse orchestrate opsonisation, 
complement fixation and neutralisation of viruses (Bluestone et al., 2009). Although 
initial priming of Th1 subsets requires interaction with APCs, IFN-γ produced by 
NK cells or differentiated Th1 cells can also help determine T cell polarisation 
(Boehm et al., 1997).  
 
Th17 responses were discovered when it became clear that many autoimmune 
diseases are not mediated by IFN-γ, but by CD4+ T cells producing IL-17 
(Harrington et al., 2005; Langrish et al., 2005). Since then, Th17 cells have been 
viewed as a distinct subset to Th1 and Th2 cells, and their development is negatively 
regulated by IFN-γ (Harrington et al., 2005). In addition, IL-12 mediates the 
suppression of IL-17 and induces IFN-γ production by human CD4+ T cells in vitro 
(Hoeve et al., 2006). Th17 differentiation is dependent on signalling through 
transcription factors STAT3 (Egwuagu, 2009) and RORγt (Ivanov et al., 2006). Th17 
responses are now thought to be responsible for the development of pathology during 
autoimmune diseases (Ivanov et al., 2006; Langrish et al., 2005) as well as asthma 
(Cosmi et al., 2011), colitis and psoriasis (Weaver et al., 2013). Functions of Th17 
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cells during immune responses are focused mainly in the gastrointestinal tract, 
airway, lungs and the skin and act against extracellular bacteria and fungi (Khader et 
al., 2009). Thus, Th17 cells are predominantly found at mucosal sites including the 
LP of the intestine (Ivanov et al., 2006). Th17 cells produce IL-22 as well as a large 
amount of IL-17, and both cytokines are taken up by surrounding epithelial cells 
(Khader et al., 2009). Subsequently, the release of antimicrobial peptides and 
chemokines by epithelial cells recruits granulocytes including neutrophils and 
induces inflammation, which aids in the clearance of fungal and bacterial pathogens 
(Singh et al., 2014).  
 
Similar to Th1 development, signal 3 for Th17 is now fairly well understood; 
cytokines TGF-β and IL-6 are important for Th17 differentiation (Singh et al., 2014). 
Th17 induction in response to Propionibacterium acnes (a gram-positive bacterium) 
and Salmonella typhimurium (a gram-negative bacterium) is dependent on DC 
derived CD40 expression and IL-6 production (Perona-Wright et al., 2009). An 
alternative pathway for Th17 induction involves the production of IL-21, which 
suppresses the induction of Tregs and together with TGF-β induces IL-17 production 
by naïve CD4+ T cells (Korn et al., 2007). CD4+ T cells are likely sources for both 
TGF-β and IL-21, the latter of which may act in an autocrine feedback loop (Nurieva 
et al., 2007). IL-23 (Hoeve et al., 2006) and IL-1β (Ikeda et al., 2014), which are 
likely DC derived, further promote Th17 development and activity (Walsh and Mills, 
2013). 
 
Th2 immune responses are active mainly during parasitic infection with helminths, 
and are less well understood compared with Th1/17 responses (Kool et al., 2012). 
Although Th2 immune responses provide protection against helminth infection, they 
can also be detrimental to the host in allergic or fibrotic diseases (MacDonald and 
Maizels, 2008). Unlike Th1/17 responses, the identity of signal 3 provided by APCs 
for the direction of Th2 differentiation remains unknown. Despite insufficient 
understanding of the initiation mechanism governing Th2 responses, major advances 
have been made in characterising this distinct adaptive response. As such, it has been 
reported that a low TCR signal and co-stimulation via CD28, OX40 and ICOS are 
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implicated in Th2 induction, resulting in transcription factor GATA3 expression 
(Kapsenberg, 2003). Th2 differentiation is thus determined by the stabilisation of 
GATA3 in a CD4+ T cell, triggering activation of the il4 gene locus and subsequent 
production of IL-4 (Lee and Rao, 2004).  
 
In addition to IL-4 production, stabilisation of GATA3 in CD4+ T cells induces 
production of IL-5, IL-9, IL-10 and IL-13 by Th2 cells (Pulendran and Artis, 2012) 
(Diagram. 1.5). IL-4 and IL-13 enhance smooth muscle contraction and epithelial 
cell turnover, which can help in the expulsion of parasites particularly in the intestine 
(Anthony et al., 2007) (Diagram 1.6). IL-4 drives antibody class-switching by B cells 
towards the production of IgE, which is a potent stimulator of mast cell and basophil 
degranulation resulting in the release of antimicrobial components including 
histamine and proteoglycans (Kool et al., 2012). IL-5 drives the differentiation of 
eosinophils (Takatsu and Nakajima, 2008), which harbour granules containing 
various cytokines, chemokines, enzymes and growth factors including major basic 
protein (MBP) that can mediate anti-pathogenic responses and trigger histamine 
release by mast cells (Rothenberg and Hogan, 2006). Th2 cytokines, in particular IL-
4, promote alternatively activated MΦs (AAMΦ), which are involved in anti-
inflammatory processes important in wound healing and resolution of inflammation 
(Murray and Wynn, 2011; Sica et al., 2014). Thus, type 2 immune responses are 
often characterised by the activation of eosinophils, AAMΦs, basophils and mast 
cells as well as goblet cell hyperplasia, but the exact mechanisms that induce Th2 
immune responses remain unknown (Allen and Sutherland, 2014; Kool et al., 2012; 
Licona-Limón et al., 2013) (Diagram. 1.6).   
 
To better understand the mechanisms and key cytokines that may be involved in the 
induction of Th2 responses, the involvement of IL-4 during Th2 priming has been 
extensively studied. Exogenous IL-4 triggers STAT6 signalling, which further 
promotes TCR mediated gata3 expression (Cote-Sierra et al., 2004). TCR interaction 
also causes IL-2 production that activates STAT5 via an autocrine feedback system, 
lowering the requirement for exogenous IL-4 at later stages of Th2 development 
(Yamane et al., 2005). It has been suggested that basophils can provide an early IL-4 
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signal (Perrigoue et al., 2009; Sokol et al., 2009; Yoshimoto et al., 2009) and that 
they can present antigen and prime Th2 responses (Perrigoue et al., 2009; Yoshimoto 
et al., 2009). However, some experiments depleting basophils may also have 
depleted a subset of DCs, thus a specific requirement for basophils in Th2 
differentiation has not yet been confirmed (Hammad et al., 2010; Okoye and Wilson, 
2011; Sokol et al., 2008). Indeed, various studies have found basophils to be 
redundant during Th2 priming in vivo (Hammad et al., 2010; Ohnmacht et al., 2010; 
Phythian-Adams et al., 2010; Smith et al., 2012). While basophils can interact with 
antigen-specific T cells in the periphery, they do not interact with naïve T cells 
within the LNs and production of IL-4 by basophils is T cell dependent (Sullivan et 
al., 2011). Critically, basophils do not possess the cellular machinery that is required 
for efficient uptake and processing of antigen described in section 1.2.1 (Otsuka et 
al., 2013). Thus, their potent ability to process and present complex antigens and 
high MHC-II expression levels makes DCs a more likely APC for Th2 induction 
compared with basophils (Lambrecht et al., 2009; Paul and Zhu, 2010; Voehringer, 
2009). In support of this various studies using DC depletion models have shown DCs 
to be necessary for the induction of Th2 responses in various settings (Kool et al., 
2008; Phythian-Adams et al., 2010; van Rijt et al., 2005). 
 
Recently, a group of lineage negative cells, innate lymphoid cells 2 (ILC2s), was 
identified as a further possible innate source of Th2 cytokines in type 2 immunity 
(Halim et al., 2014). ILC2 are found in the mLNs and intestines of mice infected 
with gastrointestinal helminths (Fallon et al., 2006; Neill et al., 2010; Saenz et al., 
2010) and in the lungs of mice during allergic airway responses (Halim et al., 2012). 
ILC2s produce Th2 cytokines and a pathway has been described by which ILC2 IL-
13 production promotes DC migration from the periphery to LNs, where they prime 
Th2 immune responses (Halim et al., 2014). MHC-II dependent interaction between 
T cells and ILCs has been shown to occur during type 2 responses to the 
gastrointestinal nematode Nippostrongylus brasiliensis (Oliphant et al., 2014). In 
addition, ILC2s express CD80 and CD86 indicating that they are capable of 
providing co-stimulatory signals to T cells (Oliphant et al., 2014). Thus, ILC2s may 
play a previously unappreciated role in the orchestration of Th2 immune responses. 
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However, a recent study shows that although ILC2s may play a critical role in the 
induction of local immune responses when antigen is delivered through mucosal 
routes, they are not required for responses against systemically delivered antigens 
(Gold et al., 2014). This highlights that the initiation of Th2 responses during 
systemic infection likely requires antigen loaded DC migration to the draining LN 
(dLN), and this cannot be replaced by ILC2s. These findings further underline the 
important role for DCs during the induction of Th2 responses, and this will be 
described in more detail in section 1.9.  
 
An additional CD4+ T cell subset that has been implicated in the production of Th2 
cytokines, in particular IL-4, is the Tfh group. Tfh cells are a subset of CD4+ T cells 
that specialise in the provision of B cell help and the formation of germinal centres in 
the spleen and LNs (Crotty, 2011). Upon antigen binding via the B cell receptor 
(BCR), B cells migrate from the marginal zone to the edge of the T cell zone in the 
spleen or LN enabling them to receive help from activated CD4+ T cells (Vinuesa et 
al., 2005). Activated B cells then differentiate either into short-lived, low-affinity 
plasma cells and localise to the LN medullary chords (red pulp in the case of the 
spleen), or seed follicles to form germinal centres for the development of high-
affinity memory B cells and long-lived plasma cells (Vinuesa et al., 2005). Tfh cells 
form an integral part of the germinal centre by inducing antibody class-switching and 
plasma cell formation, and have been found to contribute to various human health 
problems including autoimmunity, immunodeficiency and lymphomas (Tangye et 
al., 2013). Tfh cells were initially described in human tonsils, where high level 
expression of CXCR5 was found on a large proportion of CD4+ T cells (Breitfeld et 
al., 2000; Schaerli et al., 2000). CXCR5 is a chemokine receptor that uniquely 
enables Tfh cells to enter the B cell zone in the germinal centre (Crotty, 2011). 
Recently, it has been shown that the transcription factor Ascl2 initiates Tfh 
development by upregulating CXCR5 and downregulating CCR7 expression (Liu et 
al., 2014). Tfh differentiation can be induced by IL-6 and IL-21, most likely 
provided by DCs, B cells or T cells (Eto et al., 2011), and relies on ICOS to activate 
transcription factor Bcl6 expression (Choi et al., 2011). The expression of Bcl6 is 
currently thought to be the defining transcription factor for Thf differentiation 
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(Crotty, 2011). Similar to Th17 cells, Tfh cells secrete IL-21 but can be distinguished 
by their surface expression of ICOS, PD-1 and CXCR5 (Crotty, 2011). Notably, Tfh 
development is normal in both IL-6 and IL-21 deficient mice, probably due to 
redundancy in signalling pathways (Crotty, 2011). Thus, Tfh developmental 
pathways remain unclear and ongoing research aims to further understand this 
follicular CD4+ T cell subset and to develop novel therapies targeted to Tfh cells. 
 
The above CD4+ T cell responses are critical for the orchestration of distinct immune 
responses against a pathogenic threat, but the regulation of these subsets by Tregs is 
essential to prevent detrimental pathology driven by overt inflammation. The 
induction of Tregs is hallmarked by the expression of the transcription factor 
forkhead box P3 (foxp3) as well as CD25 and CD4 (Fontenot et al., 2003; Hori et al., 
2003). Similar to CD4+ Foxp3− T cells, IL-2 is crucial for the survival and function 
of differentiated Tregs (Fontenot et al., 2003; Zheng et al., 2008; 2007). There are 
two principal types of Treg cells: natural Tregs (nTregs) that develop in the thymus 
and regulate immunity against self peptides, and inducible Tregs (iTregs) which are 
generated within peripheral organs and regulate immunity mainly against commensal 
bacteria (Horwitz et al., 2008; Larkin, 2013). TGF-β (Chen, 2003; Cobbold et al., 
2004) and RA (Coombes et al., 2007) are involved in the differentiation and 
promotion of Treg cells, and DCs are capable of inducing Treg responses (Coombes 
et al., 2007; Yamazaki et al., 2008). Tregs are thought to produce substantial 
amounts of TGF-β and IL-10, which are principal cytokines involved in the 
downmodulation of effector/memory CD4+ T cell responses (Sakaguchi et al., 2009). 
Microscopy techniques have also depicted direct interaction between DCs and Tregs 
through the expression of neuronal guidance protein neurophili-1 by Tregs (Sarris et 
al., 2008; Tang et al., 2006), which is important for Treg mediated suppression 
(Solomon et al., 2011). These studies underline the importance of DCs during Treg 
function and activity in vivo. 
27 
1.5.1 Transcriptional control of T cell subset development 
and plasticity 
The CD4+ T cell nomenclature described above suggests that the CD4+ T cell subsets 
are completely distinct from each other, and this was believed to be the case for 
numerous years. However, studies have since shown that a degree of flexibility exists 
during T cell differentiation, allowing for T cell plasticity in vivo (Bluestone et al., 
2009). It is likely that plasticity in Th2 populations in particular exists due to the 
rather large cohort of cytokines that they produce. In support of this, T cells 
producing IL-4 but not IL-13 or IL-5 are located in the B cell zone within the dLN 
(Liang et al., 2011). Furthermore, Tfh cells have been shown to differentiate from 
IL-4 producing Th2 cells within the LN during helminth infection (Glatman Zaretsky 
et al., 2009). In fact, it has been suggested that Tfh cells are the primary cell type 
responsible for IL-4, but not IL-13, production in lymphoid tissue in response to 
helminth antigen (Liang et al., 2011).  
 
Additional evidence for T cell plasticity is provided by the discovery of GATA3+ T-
bet+ T cells in helminth infection with Schistosoma mansoni (Peine et al., 2013). This 
cell type expresses both IL-4 and IFN-γ, and it has been suggested that the presence 
of IL-4/IFN-γ double producers prevents severe immunopathology by maintaining a 
critical balance between Th1 and Th2 immune responses during infection (Peine et 
al., 2013). Recently it has been shown that IL-4/IFN-γ double positive cells 
generated during S. mansoni infection display a distinct DNA methylation signature 
at key cytokine genes as well as gata3, which indicates that DNA methylation 
processes may be important for the co-existence of Th1 and Th2 characteristics 
(Deaton et al., 2014).  
 
Although CD4+ T cell plasticity evidently occurs during differentiation, key 
processes are equally important to maintain and balance distinct CD4+ T cell 
responses. This is achieved by various counter-regulatory and antagonistic 
mechanisms between the molecular components driving CD4+ T cell differentiation. 
For example, IL-6 inhibits the generation of iTregs and favours the generation of 
Th17 cells (Veldhoen et al., 2006). Transcription factor T-bet expression inhibits 
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transcription of genes encoding IL-4 and IL-5 (Szabo et al., 2000), whereas GATA3 
expression suppresses IL-12 signalling (Ouyang et al., 1998). Furthermore, 
numerous reports have outlined reciprocal antagonisation between IL-4 and IFN-γ 
during CD4+ T cell differentiation (Paludan, 1998). IFN-γ represses IL-4 secretion 
by Th2 cells (Gajewski et al., 1988) and inhibits IL-4 mediated induction of the IgE 
receptor, FcεRII (Rousset et al., 1988). It has been shown that IFN-γ directly 
suppresses the transcription of the il4 gene via IRF-1 and IRF-2, which bind IL-4 
promotor sites (Elser et al., 2002). In contrast, IL-4 inhibits Th1 polarisation by 
activating STAT6, which has been reported to bind to the same DNA oligonucleotide 
as STAT4 (Schindler et al., 2001). Indeed, IL-4/IFN-γ cross-regulation is thought to 
occur predominantly through competition for transcription signalling pathways 
(Paludan, 1998).  
1.6 Schistosomiasis 
The initiation of CD4+ Th2 cell responses has been extensively studied during 
infection with helminths that are potent inducers of Th2 responses, such as S. 
mansoni (Pearce and MacDonald, 2002). At least 200 million people are thought 
to be chronically infected with schistosomiasis worldwide (Gryseels et al., 
2006). Primarily sub-Saharan regions of Africa are affected, but the disease is 
classed as endemic in over 74 countries (Ross et al., 2002). Five species of 
schistosomes are responsible for human infections: S. mansoni, S. japonicum, S. 
haematobium, S. intercalatum and S. mekongi. The first three are the most 
extensively studied in clinical research. An estimated 280,000 deaths occur 
every year as a consequence of S. mansoni or S. haematobium infection in sub-
Saharan Africa alone (van der Werf et al., 2003). With the exception of S. 
haematobium, all species cause hepatosplenic and intestinal schistosomiasis, 
whereby the adult worms reside in the mesenteric vasculature and produce eggs. 
S. haematobium resides in the blood supply surrounding the bladder and causes 
urogenital schistosomiasis (Ross et al., 2002). Currently, therapeutics for the 
disease rely on the anti-parasitic activity of praziquantal, but the distribution of 
praziquantal to populations at risk is challenging (Doenhoff et al., 2009; 
Fenwick et al., 2003). Furthermore, there is a danger that with increases in mass 
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treatment resistance to praziquantal could begin to develop (Fallon and 
Doenhoff, 1994). An effective vaccine would be greatly beneficial for the 
control of the disease in endemic areas, and an open question in schistosome 
biology revolves around how immune mechanisms in individuals that have 
acquired resistance to reinfection mediate protection. Unravelling the immune 
responses that govern disease progression upon S. mansoni infection will aid the 
design of new vaccines and therapies against schistosomiasis (Pearce and 
MacDonald, 2002). 
1.6.1 The life cycle of Schistosoma mansoni 
Schistosomes are rather unusual in several respects when one compares their 
biology with that of other digenian parasites. As such S. mansoni displays 
unique features that include the following: schistosomes only infect two rather 
than three hosts; reproduction in the mammalian host occurs through pairing of 
separate male and female schistosomes as opposed to hermaphrodite or asexual 
reproduction; infection with schistosomes occurs through the skin rather than by 
ingestion; they reside in the intravascular system of the host (Pearce and 
MacDonald, 2002). The life cycle of S. mansoni begins with asexual 
reproduction within the intermediate host, the Biomphalaria glabrata fresh 
water snail, from which microscopic Schistosoma cercariae are shed by the 
snails and released into the water at which point this free living aquatic stage of 
the parasite can survive for up to 72h (Gryseels et al., 2006; Pearce and 
MacDonald, 2002) (Diagram. 1.7). Infection of the definitive (mammalian) host 
occurs through direct contact with contaminated water, when highly motile 
cercariae burrow through the skin and transform into schistosomula. Immature 
schistosomula then enter the vasculature and migrate through the body until 
settling in the portal vasculature where they mature into adult worms (Pearce 
and MacDonald, 2002).  
 
After approximately 28 days of infection, established worm pairs produce up to 
300 eggs per day (Gryseels et al., 2006). S. mansoni eggs normally migrate 
through the intestinal tissue into the lumen, and consequently become excreted 
in the faeces. However, a proportion of the S. mansoni eggs are also swept in the 
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bloodstream to the liver, where they enter through the sinusoids and become 
lodged in the parenchyma (Pearce and MacDonald, 2002). Upon arrival of eggs 
in intestinal or liver tissue, the immune system responds by enveloping the egg 
in collagen rich granulomas, which protect the surrounding tissue from toxins 
released by the egg. It is thought that granuloma formation is required for 
efficient egg migration through the tissue, as eggs themselves are not motile 
(Doenhoff et al., 1981). Immunocompromised hosts such as HIV infected 
patients display impaired S. mansoni egg migration, which highlights that an 
intact immune system is essential for efficient S. mansoni egg transit (Karanja et 
al., 1997). Granuloma mediated protection has also been reported as a critical 
process for the progression of bacterial infection with Mycobacterium 
tuberculosis (Doenhoff, 1998). Although initially protective to the host, chronic 
accumulation of granulomas causes fibrotic legions to form, and much of the 
pathology associated with S. mansoni infection is caused by eggs lodged within 
the intestine and the liver (Pearce and MacDonald, 2002). Fibrosis in the liver 
leads to high blood pressure and subsequent enlargement of the portal vessel. 
The poor blood flow into the organ then results in the formation of new but 
fragile blood vessels that bypass the fibrotic liver, leading to portal shunting 
(Pearce and MacDonald, 2002). This dramatically increases the risk of 
haemorrhages in the peritoneum, which ultimately leads to fatality (Pearce and 
MacDonald, 2002). Thus, the regulation of the host’s immune responses is 
essential to control the outcome of the disease.  
1.7 Structural arrangement of the granuloma 
Given that the occurrence of granulomatous inflammation is a key mediator of 
pathology during S. mansoni infection, the formation and development of 
granulomas has been a central area of research associated with schistosomiasis. 
The structure of S. mansoni granulomas has been well characterised using 
electron microscopy and other histology methods to show two major stages in 
granuloma development: the pre-granulomatous or exudative phase, and the 
mature granuloma or exudative-productive phase (Lenzi et al., 1998). Much like 
a beehive, the granuloma forms an entity that is organised and intricate. Early 
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stages of development involve innate immune cells that form an initial barrier 
around the egg (Lenzi et al., 2006; Weinstock et al., 1999). Only a few 
lymphocytes are found at this initial stage (Almadi et al., 2011; Chuah et al., 
2014). The production of fibrous and extracellular material gradually transforms 
these loose clusters of innate immune cells into a more organised network (Lenzi 
et al., 2006; 1999). Extracellular matrix components, such as fibronectin and 
tenascin, are located predominantly but not exclusively in the central zone of the 
developing exudative granuloma (Lenzi et al., 2006; Silva et al., 2000). Fibre 
radiation centres (collagen anchorage points) shape this collagen mesh, whereas 
fibres in the peripheral zone are mostly thin and loosely arranged (Lenzi et al., 
1999; 2006; Silva et al., 2000). The granuloma architecture is thus determined 
by an irregular collagenic topology, enabling cells to move bidirectionally from 
the periphery to the egg (Lenzi et al., 2006; Steinberg, 1996). 
 
Myofibroblasts derived from hepatic stellate cells (HSCs) are thought to be the 
main source of collagen in the liver (Wynn, 2008). During early stages of 
granuloma development in murine S. mansoni infection collagen type III (thick 
fibres) is more frequent. However, this is replaced by collagen type I (thin 
fibres) in later stages (Grimaud et al., 1987; Silva et al., 2000). This transition 
from type III to type I collagen during granuloma development also occurs 
during human S. mansoni infection (Adnani, 1985). Other types of collagen (e.g. 
type IV) have also been found in granulomas, but these are thought to be less 
abundant in comparison with type I and III collagen (Grimaud et al., 1987; Silva 
et al., 2000). 
 
As the granuloma matures, the fibrous framework creates a scaffold for a 
compact and spherical shape displaying three distinct layers: the internal or peri-
ovular layer, the medial or paracentral layer and the external layer (Lenzi et al., 
1998). By isolating cells from granulomas, Lenzi et al., (2006) reported that 
mature exudative-productive granulomas contain more than 40,000 cells, 
highlighting the importance of an organised extracellular matrix. The mature 
granuloma contains a cohort of adaptive immune cells including T cells and B 
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cells, as well as the established innate cell network (Jacobs et al., 1999; Lenzi et 
al., 1998; Weinstock and Boros, 1983). The outer layer of cells appears to flatten 
(Bentley et al., 1982), forming a boundary between granulomatous tissue and the 
liver parenchyma (Hams et al., 2013). Such cellular morphology has been 
described in granulomas formed in vitro by co-culturing isolated spleen cells 
from S. mansoni infected mice with live eggs obtained from adult worm pairs 
(Bentley et al., 1982). This closure of the granuloma is created by intimate cell 
connections through pan-cadherins, occludin and connexin-43 (Lenzi et al., 
2006). The granuloma persists around the S. mansoni egg until inflammatory 
processes are downmodulated and collagen is degraded (Lenzi et al., 1998), but 
often a fibrotic plaque or scarring remains (Pearce and MacDonald, 2002). The 
exact processes that allow granulomas to resolve are not yet fully understood, 
but a role for MΦ collagen degradation has been suggested (Barron and Wynn, 
2011; Duffield et al., 2005; Herbert et al., 2004; Silva et al., 2000; Wynn and 
Barron, 2010). Many fundamental open questions remain about granuloma 
formation and development, including what the exact functional roles are that 
distinct immune cells play, and which cells interact with each other, during this 
important process (this will be described in more detail in chapter 3, when 
granuloma formation during S. mansoni infection will be investigated).  
1.8 The development of immune responses 
against S. mansoni infection  
The formation of granulomas is highly dependent on the type of immune 
response induced against the S. mansoni egg (Wynn, 2004). Schistosomes have 
evolved to co-exist with their hosts for many years, and this relationship can 
even last for decades in some cases (Pearce and MacDonald, 2002). In the 
course of chronic infection with S. mansoni, the immune response progresses 
through at least three stages, which are intimately linked to the development of 
the parasite (Pearce and MacDonald, 2002). Initial immune responses in the first 
21 to 35 days are induced against migrating parasite larval schistosomes, and 
these are characterised by a fine-tuned balance, or mix, of Th1 and Th2 immune 
responses (Grzych et al., 1991; Pearce and MacDonald, 2002). The different 
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developmental stages of schistosomes that are present in mammals are known to 
produce cross-reactive antigens, and immune responses formed against larval 
forms of the parasite likely exhibit cross-reactivity against S. mansoni eggs later 
on in infection (Lukacs and Boros, 1991). When egg production begins 28-42 
days after infection, a shift to a dominant Th2 immune response occurs and 
granulomatous inflammation as well as collagen deposition becomes apparent 
(Grzych et al., 1991; Pearce et al., 1991). Downmodulation of Th1 responses at 
this time-point also correlates with an increase in IL-10 production (Sher et al., 
1991). Given that the parasite is long-lived and worm pairs continue to produce 
hundreds of eggs per day (Gryseels et al., 2006; Pearce and MacDonald, 2002), 
Th2 responses and granuloma development continue to increase until 
approximately day 56, when the strength of the Th2 response reaches its peak 
(Pearce and MacDonald, 2002). At this time-point fibrotic pathology is 
prevalent, and Th2 cytokines are implicated in the promotion of collagen 
formation (Fallon et al., 2000a). Subsequently, it is thought that consistent egg 
antigen exposure leads to Th2 response modulation, resulting in a decline of the 
Th2 response and an increase in regulatory responses between days 70 to 105 
(Lundy and Lukacs, 2013; Pearce and MacDonald, 2002). During this time-
frame effector/memory CD4+ T cells are thought to be unresponsive, or 
hyporesponsive, and this will be described in more detail in section 1.8.2. As a 
result of Th2 hyporesponsiveness, granulomatous inflammation is 
downmodulated but fibrosis around newly deposited eggs is increased, and this 
persists throughout the remainder of the infection. 
1.8.1 Consequences of dysregulated CD4+ T cell 
responses against S. mansoni eggs  
The development of immune responses during S. mansoni infection underlines 
that the induction of CD4+ Th2 immune responses and fibrotic mechanisms is 
intricately linked to the pathological outcome of the disease (Grzych et al., 1991; 
Pearce et al., 1991; Pearce and MacDonald, 2002; Vella and Pearce, 1992). In 
fact, the balance or mix between Th1 and Th2 responses throughout S. mansoni 
infection is critical to prevent overt pathology, morbidity and mortality that is 
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associated with skewed Th1 or Th2 responses (Hoffmann et al., 2000; Wynn, 
2004). The importance of T cells during granuloma pathology was first shown 
by several groups using severe combined immunodeficiency (SCID) or nude 
mice, which revealed that T cell deficiency leads to severely impaired 
granuloma formation during infection (Amiri et al., 1992; Boros, 1989; Byram 
and Lichtenberg, 1977; Cheever et al., 1993; 1999; Doenhoff et al., 1981; Dunne 
and Doenhoff, 1983). A dominant role of CD4+ αβ T cells in hepatic granuloma 
formation was established by the use of depleting antibodies (Mathew and 
Boros, 1986), whilst γδ T cells are not required for initial granulomatous 
processes (Iacomini et al., 1995). These findings led to the investigation of the 
requirement for intact Th2 responses during granuloma formation, and studies 
using MHC-II-/- (Hernandez et al., 1997) or STAT6-/- (Kaplan et al., 1998) mice 
showed that impaired Th2 mechanisms result in reduced or even absent 
granuloma formation in the liver during S. mansoni infection. An impairment in 
granuloma formation leads to tissue exposure to egg derived toxins, including 
Omega-1, which can lead to tissue necrosis in the liver (Dunne et al., 1991). 
Subsequent death of animals that lack Th2 immune responses has also been 
linked to changes in the intestines, as severe damage caused by egg transit 
through the tissue when granuloma formation is reduced can lead to 
haemorrhages that are thought to allow entry of bacteria and endotoxins into the 
blood circulation (Fallon et al., 2000b).  
 
The importance of Th2 responses for granulomatous inflammation promoted the 
investigation of the role of individual cytokines during S. mansoni granuloma 
formation. IL-4-/- mice develop acute cachexia mediated by TNF-α resulting in 
increased mortality, but overall granuloma size and eosinophilia within the liver 
is unchanged compared with WT controls (Brunet et al., 1997). This finding led 
to the hypothesis that, although animals in Th2 deprived environments can 
succumb to septic shock and die, individual Th2 cytokines are not a fundamental 
requirement for granuloma formation (Wynn et al., 2004). Jankovic et al., 
(1999) showed that both IL-4 and IL-4R deficient mice, the latter of which 
cannot respond to IL-13 as well as IL-4, remain able to develop a Th2 immune 
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response during infection, albeit to a lesser extent compared with WT mice. The 
same study showed that IL-4, but not IL-4R knockout mice, can form 
granulomatous tissue around the egg in the liver (Jankovic et al., 1999a). This 
observation suggests that cells capable of responding to IL-4 and IL-13 
including AAMΦs, DCs, endothelial cells and/or fibroblasts are important for 
granuloma formation (Jankovic et al., 1999a). Indeed, when IL-4/IL-13 double 
deficient mice were examined, overall granuloma formation is reduced in the 
lung following intravenous injection of S. mansoni eggs (McKenzie et al., 1999). 
A similar trend is seen in the liver when residual IL-13 is depleted from IL-4-/- 
mice using an αIL-13 antibody (Chiaramonte et al., 1999), or when using IL-
4/IL-13 deficient mice (Fallon et al., 2000a). This suggests that IL-4 and IL-13 
largely compensate for each other during the formation of granulomatous 
inflammation. In addition, a critical feature of Th2 responses is enhanced 
eosinophilia, which is thought to be induced by IL-5 (Takatsu and Nakajima, 
2008). IL-5-/- mice develop significantly smaller granulomas devoid of 
eosinophils that appear less fibrotic and contain larger populations of MΦs and 
fibroblasts (Reiman et al., 2006). Thus, we know that intact Th2 immune 
responses and IL-4R signalling pathways are important for the formation of 
granulomas during S. mansoni infection, thereby protecting host tissues from 
toxins produced by the egg.   
 
Although it is clear that intact Th2 immune responses are required for granuloma 
formation, initial granulomas are in fact formed in a mixed Th1/Th2 
environment (Hams et al., 2013), which raises the possibility that Th1 immune 
cells may also play a role. It has been shown that Th1 impairment in mice 
deficient in IFN-γ or CD8+ T cells does not alter granulomatous inflammation in 
the liver at D56 or D112 post S. mansoni infection (Yap et al., 1997). 
Furthermore, STAT4 deficient mice, which have defects in the signal 
transduction pathways affecting Th1 development, also form normal 
granulomatous legions during S. mansoni infection in comparison with WT mice 
(Kaplan et al., 1998). Notably, smaller and more fibrotic granulomas have been 
reported in Th1 deficient MyD88-/- mice, and the authors suggest that TLR-
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mediated antigen-specific Th1 responses could be important indirectly for the 
suppression of Treg responses during granuloma formation (Layland et al., 
2005). Overall, these reports indicate that the formation of granulomas during S. 
mansoni infection is largely independent of Th1 elements, but TLR-mediated 
antigen-specific Th1 responses may be important indirectly for this process.  
 
Although the induction of Th1 responses is not critical for granuloma formation, 
there is some evidence to suggest that Th1 components are crucial for the 
regulation of Th2 mediated pathology. For example, enhancement of Th1 
responses achieved by IFN-γ administration to S. mansoni infected mice 
suppresses liver granuloma size and hepatic fibrosis (Czaja et al., 1989; Lukacs 
and Boros, 1993). This suggests that Th1 responses may be involved in the 
downregulation of granulomatous inflammation by regulating Th2 immune 
responses, due to cross-regulatory activity between IL-4 and IFN-γ described in 
section 1.5.1. CD8+ T cells have been reported as important players for the 
downmodulation of granuloma size, but their presence in vivo is not critical for 
this process (Chensue et al., 1993; 1981; Yap et al., 1997). Although desirable 
for alleviating Th2 mediated pathology, enhanced Th1 responses are often 
associated with elevated levels of TNF-α resulting in more severe disease (Boros 
and Whitfield, 2006; Brunet et al., 1997; Fallon and Dunne, 1999; Fallon et al., 
2000b; Hoffmann et al., 2000). For example, IL-10/IL-4 double cytokine 
deficient mice develop elevated Th1 responses, but not Th2 responses, 56 days 
post infection marked by increased IFN-γ (Hoffmann et al., 2000). These mice 
form granulomas that appear normal in size, but are less fibrotic, and contain 
fewer eosinophils. Hoffmann et al., (2000) additionally showed that IL-10/IL-4 
deficient mice display elevated levels of TNF-α in the serum compared with WT 
mice, and cannot survive acute S. mansoni infection. TNF-α has been shown to 
promote liver fibrosis and hepatomegaly (Joseph and Boros, 1993; Mwatha et 
al., 1998) and increases hepatic granuloma area of chronically infected mice 
(Joseph and Boros, 1993). Thus, it seems likely that the granulomas forming in 
IL-10/IL-4 deficient mice are driven at least in part by TNF-α. However, TNF-α 
is dispensable during granuloma formation (Davies et al., 2004) and instead may 
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play a more important role in parasite survival or fecundity (Amiri et al., 1992; 
Oliveira et al., 2009). Closer investigation of Th1 mediated granulomatous 
inflammation in IL-10/IL-4 deficient mice revealed a significant influx of 
neutrophils in these granulomas, and this may contribute to increased morbidity 
experienced by IL-10/IL-4 deficient mice during S. mansoni infection 
(Hoffmann et al., 2001). This highlights the absolute necessity of balanced Th1 
and Th2 responses during S. mansoni infection to prevent severe pathology and 
morbidity, when neither Th1 or Th2 elements of the immune response against 
the parasite are extreme (Wynn et al., 2004). 
 
During chronic stages of S. mansoni infection Th2 immune responses are 
gradually downmodulated and granulomatous lesions resolve (Boros et al., 
1975; Chensue et al., 1992; Henderson et al., 1992; Lundy and Lukacs, 2013). It 
is probable that these two processes are linked, as repeated administration of 
rIL-4 or rIL-2 to chronically infected mice restores granuloma size to that 
generated during peak growth (Mathew et al., 1990; Yamashita and Boros, 
1992). A role for IL-10 in immune response suppression has been reported, as 
IL-10 deficient mice do not downregulate immune responses in the mLN and the 
spleen or granulomatous inflammation in the liver during chronic stages of 
infection (D105) (Sadler et al., 2003). However, multiple cell types including B 
cells, Tregs, DCs, MΦs and CD4+ T cells produce IL-10, which complicates 
investigation of regulatory responses during S. mansoni infection (Stadecker, 
1999; Wilson et al., 2007). 
 
Treg responses are also known to regulate Th1 and Th2 immune responses 
during S. mansoni infection, but the role for IL-10 in this process is disputed as 
suppression of IL-4 and IFN-γ can be IL-10 independent (Wilson et al., 2007). 
Treg activity during helminth infections was initially described in patients 
infected with filarial or schistosome parasites, who displayed a hyporesponsive 
T cell response (Wilson et al., 2007). Tregs expand in unison with Th2 responses 
during S. mansoni infection and maximum numbers in the liver are observed at 
D112 when modulatory processes are prevalent (Singh et al., 2005; Taylor et al., 
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2006). Taylor et al., (2006) additionally showed that a single dose of S. mansoni 
eggs is sufficient to induce a Treg response in the dLN. This indicates that S. 
mansoni eggs are potent inducers of Treg responses as well as effectors of Th2 
immune responses. Treg mediated modulation during S. mansoni infection has 
been reported for intestinal granulomas, where CD4+ CD25+ Foxp3+ Tregs 
downregulate the development of granulomas in the colon via TGF-β as well as 
the production of collagen (Turner et al., 2011). In the liver, severe pathology is 
also prevented by Tregs (Layland et al., 2007) via both IL-10 dependent and 
independent mechanisms (Dewals et al., 2010; Hesse et al., 2004).  
 
In addition to Tregs, a role for B cells in T cell downmodulatory processes has 
been identified, as B cell deficient mice fail to downmodulate CD4+ T cell 
mediated granulomas during chronic stages of infection (Jankovic et al., 1998). 
Notably, Jankovic et al., (1998) showed that granulomatous responses were 
downmodulated via Fc receptor signalling independent of IL-10. Suppression of 
Th2 responses during S. mansoni infection by AAMΦs expressing arginase 1 
(Arg-1) is also thought to be IL-10 independent, and the mechanism that 
orchestrates this process will be described in more detail in chapter 3 (Pesce et 
al., 2009). Taken together, Tregs, B cells and AAMΦs are implicated in the 
downmodulation of CD4+ T cell responses during S. mansoni infection, and the 
mechanisms beyond the secretion of IL-10 are under active research (Wilson et 
al., 2007). 
1.8.2 T cell anergy/hyporesponsiveness during S. 
mansoni infection 
During CD4+ T cell downmodulation in later stages of S. mansoni infection, 
CD4+ T cells are thought to become anergic or hyporesponsive, and a decrease 
in splenic Th2 cell activity is first observed around D56 of murine infection 
(Taylor et al., 2009). Anergic T cells are antigen experienced T cells that do not 
become fully activated, but survive for an extended period of time in this 
unresponsive state (Kuklina, 2013; Schwartz, 2003). There are two distinct types 
of T cell anergy: clonal anergy and adaptive tolerance (Chiodetti et al., 2006). 
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Clonal anergy principally occurs through growth arrest and can be overcome by 
IL-2 administration (Chiodetti et al., 2006). Adaptive tolerance, also termed in 
vivo anergy, is characterised by inhibition of proliferative and effector functions 
frequently initiated by CTLA-4 ligation (Schwartz, 2003). In contrast to clonal 
anergy, adaptive tolerance cannot be overcome by IL-2 (Chiodetti et al., 2006). 
An E3 ubiquitin ligase termed gene related to anergy in lymphocytes (GRAIL) 
has been reported as being expressed by hyporesponsive/anergic T cells, which 
provides a cell intrinsic mechanism for the induction of anergy 
(Anandasabapathy et al., 2003; Seroogy et al., 2004). Taylor et al., (2009) 
showed that chronic hyporesponsive CD4+ T cells from D105 of S. mansoni 
infection which express GRAIL did not revert to a proliferative state when 
transferred into D49 infected mice (Taylor et al., 2009). The fundamental role of 
GRAIL in this process was shown by suppressing GRAIL, which prevented the 
development of hyporesponsiveness in CD4+ T cells (Taylor et al., 2009).  
 
In addition to cell intrinsic processes, extracellular mechanisms have been 
reported to orchestrate T cell hyporesponsiveness during S. mansoni infection: 
repeated antigen stimulation leads to elevated expression of inhibitory CD200-
CD200R ligand-receptor pairs on Th2 cells, eventually resulting in the loss of 
proliferative capacity (Caserta et al., 2012; Gorczynski, 2012). However, 
whether this extrinsic mechanism represents clonal anergy or in vivo adaptive 
tolerance remains unclear.  
 
T cell anergy, or hyporesponsiveness, is dissimilar to cell extrinsic PD-1 
mediated T cell exhaustion mechanisms classically described during chronic 
viral infections (Morou et al., 2014; Shin and Wherry, 2007; Yi et al., 2010). 
Loss of T cell function during exhaustion is accompanied by the expression of 
PD-1, which was first identified on virus-specific CD8+ T cells during chronic 
lymphocytic choriomeningitis (LCMV) (Barber et al., 2006). During T cell 
exhaustion GRAIL and other anergy related genes are not expressed by T cells 
(Kim and Ahmed, 2010; Wherry et al., 2007). Increased expression of PD-1L on 
MΦs has been reported in S. mansoni infection when animals are infected with 
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single sex worms resulting in infection lacking egg production (Smith et al., 
2004). However, PD-1L is predominantly recognised by Th1 cells (Loke and 
Allison, 2003), and the observation that PD-1L is upregulated may not hold 
relevant implications for the downmodulation of Th2 responses against S. 
mansoni eggs. Thus, it is highly probable that immune downregulation during S. 
mansoni infection is mechanistically distinct from PD-1 mediated T cell 
exhaustion described above, although the possibility that PD-1-dependent 
mechanisms play a role cannot be dismissed (Smith et al., 2004).  
1.9 The importance of dendritic cells during S. 
mansoni infection 
1.9.1 Dendritic cell activation for Th2 polarisation in 
response to S. mansoni egg antigens 
Although the character and development of CD4+ T cell responses during S. 
mansoni infection are well understood, little is known in comparison of how 
schistosome antigens activate APCs including DCs to drive Th2 polarisation. 
Several studies have investigated the capacity of schistosome experienced DCs 
to induce Th2 immune responses following recognition of the parasite, and most 
have used S. mansoni soluble egg antigen (SEA) to assess this process (Perona-
Wright et al., 2006). SEA represents a soluble extract obtained from isolated S. 
mansoni eggs (MacDonald et al., 2001) (section 2.3.4, chapter 2), and is 
predominantly composed of hundreds of proteins as well as some sugars and 
lipids (Mathieson and Wilson, 2010; Meevissen et al., 2011). Stimulation with 
SEA is sufficient to induce murine Th2 immune responses in vivo (Okano et al., 
1999). This effect can be replicated in vitro with BMDCs or purified splenic 
DCs stimulated with SEA, which efficiently prime CD4+ T cell responses 
towards a Th2 phenotype in vivo and in vitro (Jankovic et al., 2004; MacDonald 
et al., 2001). In addition, human DCs stimulated with SEA polarise Th2 immune 
responses effectively in vitro (de Jong et al., 2002). Yet, SEA-pulsed BMDCs, 
splenic or human DCs exhibit only minor upregulation of activation markers 
including MHC-II, CD40, CD80, CD86 and OX40-L in comparison with 
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bacterial antigens (Agrawal et al., 2003; de Jong et al., 2002; Jankovic et al., 
2004; MacDonald et al., 2001). In addition, SEA-pulsed BMDCs do not produce 
substantial amounts of inflammatory cytokines including IL-6 and IL-12p70 or 
cytokines associated with Th2 responses such as IL-4 or IL-10 in vitro 
(MacDonald et al., 2001). Indeed, DCs do not produce IL-4 (MacDonald et al., 
2001) or require to produce IL-4 for efficient Th2 induction (Jankovic et al., 
2004; MacDonald and Pearce, 2002). In line with these findings, some reports 
have indicated that exogenous IL-4 may not be critical for Th2 induction: Th2 
responses can be induced both in vitro and in vivo when CD4+ T cells are not 
able to respond to IL-4 (i.e. T cells that lack the IL-4R), albeit at a lower level 
compared with WT T cells (Jankovic et al., 2000; Yamane et al., 2005). 
Microarray analysis of BMDCs exposed to SEA revealed that less than 30 out of 
12,000 mouse genes were significantly altered in the array compared with 
unstimulated DCs, which emphasises the low level changes in the DC phenotype 
that occur in response to SEA on a mRNA level (Kane et al., 2004). Thus, the 
activation phenotype of schistosome experienced DCs is distinct from 
conventional activation status of DCs that mediate Th1/17 responses, yet enables 
the induction of potent Th2 responses (Perona-Wright et al., 2006). 
 
The potency of SEA to influence DC activation has been outlined by studies that 
have reported SEA mediated inhibition of BMDC cytokine production and 
surface marker expression following bacterial stimulation or TLR ligation with 
ligands including LPS, which results in dampened upregulation of MHC-II, co-
stimulatory molecules and IL-12 production (Cervi et al., 2004; Kane et al., 
2004; Perona-Wright et al., 2012). It has been suggested that suppression of 
classical DC activation may occur through downmodulation of signalling 
pathways such as nuclear factor kappa B (NFκB) and extracellular signal-
regulated kinase (ERK) by SEA (Kane et al., 2004). However, SEA has also 
been reported to activate c-Fos in human monocyte DCs via ERK signalling, 
which directly represses the transcription of IL-12 (Agrawal et al., 2003). 
Recently, the impact of SEA on the mTOR signalling pathway in human 
monocyte derived DCs was examined (Hussaarts et al., 2013). The mTOR 
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signalling pathway represents a key metabolic pathway that incorporates signals 
from growth factors and nutrients, which is involved in DC differentiation and 
function including antigen presentation to T cells (Salmond and Zamoyska, 
2011). Hussaarts et al., (2013) reported that although mTOR inhibitors dampen 
DC maturation and promote Th2 induction, neither SEA or omega-1 altered 
signalling through the mTOR pathway. Taken together, the activation phenotype 
of DCs stimulated with SEA differs from classically activated DCs, but the exact 
mechanisms that mediate schistosome experienced DC activation are largely 
unclear. 
1.9.2 Recognition of S. mansoni antigens by DCs 
Numerous SEA components have been closely examined to clarify how the egg 
stage of the parasite may interact with DCs for the polarisation of Th2 immune 
responses. In particular, two glycoproteins IPSE/α-1 (or SmEP25) (Schramm et 
al., 2006) and omega-1 (Dunne et al., 1991) are major constituents of SEA. 
IPSE/α-1 activates various immune cells such as mast cells, basophils, 
eosinophils and MΦs (Abdulla et al., 2011; Donnelly et al., 2008; Sabin et al., 
1996; Schramm et al., 2003; Williams et al., 2005). For example, IPSE/α-1 
activates basophil IL-4 production (Schramm et al., 2006), which is dependent 
on the production of IgE in vivo (Schramm et al., 2007). This suggests that 
efficient induction of Th2 immune responses likely requires activation of 
multiple accessory cell types (Allen and Sutherland, 2014).  
 
Omega-1 is a T2 ribonuclease that is highly toxic to host cells including 
hepatocytes (Fitzsimmons et al., 2005), which underlines the importance of 
granuloma formation around the S. mansoni egg in the liver for efficient 
protection of the surrounding parenchyma. Omega-1 is a more recently 
discovered Th2 inducing glycoprotein present in SEA, yet omega-1 depleted 
SEA retains its Th2 induction ability (Everts et al., 2009; Steinfelder et al., 
2009). Once inside the cell, Omega-1 acts as an RNase and degrades both 
messenger and ribosomal RNA (mRNA and rRNA), which ultimately halts 
protein synthesis (Everts et al., 2012). The same study showed that omega-1 is 
taken up by DCs via the mannose C-type lectin receptor (CLR) (Everts et al., 
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2012). Indeed, the examination of various Th2 inducing components within SEA 
has aided the identification of the PRRs which recognise these antigens. Various 
other glycoproteins present in SEA have been shown to bind to CLRs, including 
DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-
SIGN) and the MΦ galactose-type lectin (MGL) (Meevissen et al., 2011; van 
Liempt et al., 2007). On the other hand, numerous studies have shown that Th2 
induction during S. mansoni infection is MyD88 independent, which is a 
classical signalling pathway following TLR stimulation (Layland et al., 2005). 
Further understanding of how S. mansoni Th2 inducing antigens are recognised 
and how they activate DCs will help investigation into the mechanisms required 
for Th2 induction.  
 
Isolated glycan moieties from SEA have been suggested to be sufficient to 
stimulate DCs to induce Th2 responses, which underlines the potential 
importance of SEA glycosylation for its antigenicity (Faveeuw et al., 2002; 
Okano et al., 1999). One such glycan is lacto-N-fucopentaose III (LNFPIII) 
(Okano et al., 2001), which binds TLR4 on BMDCs (Thomas et al., 2003). 
Following TLR4 ligation LNFPIII activates ERK consistently (Thomas et al., 
2003) and NFκB transiently (Thomas et al., 2005). In contrast, LPS ligation with 
TLR4 results in the stimulation of mitogen-activated protein kinases (MAPK) 
kinases p39, JNK and ERK, as well as prolonged activation of NFκΒ (Thomas et 
al., 2005). However, expression of TLR4 and various other TLRs is not essential 
for the induction of Th2 immune responses against S. mansoni (Jankovic et al., 
2004; Kane et al., 2004; Layland et al., 2005; Vanhoutte et al., 2008). Therefore, 
it is plausible that additional co-receptors such as certain CLRs may contribute 
to determining the downstream intracellular signalling events that succeed TLR4 
binding of LNFPIII (Hokke and Yazdanbakhsh, 2005). Further investigation of 
the signalling pathways that are activated after SEA recognition by DCs will 
help in understanding the activatory phenotype required for Th2 polarisation. 
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1.9.3 Dendritic cells are necessary for the induction of Th2 
immune responses against S. mansoni 
Although the mechanisms DCs employ for the induction of Th2 immune 
responses remain elusive, extensive progress has been made in understanding 
the fundamental components orchestrating the interaction between DCs and 
CD4+ T cells during Th2 initiation. Studies using BMDCs have shown that 
although upregulation of activation markers is subtle, co-stimulatory molecules 
OX40-L (Jenkins et al., 2007) and MHC-II (MacDonald et al., 2001) on the cell 
surface of BMDCs are necessary for the optimal induction of Th2 immune 
responses against S. mansoni antigen. CD40:CD154 interaction is also essential 
for DC mediated Th2 induction in vivo, as CD40 deficient mice develop 
impaired Th2 responses during S. mansoni infection (MacDonald et al., 2002a; 
2002b). In addition, splenic DCs from CD154-/- S. mansoni infected animals are 
not activated even at a low level (Straw et al., 2003). These findings highlight 
that even though the activation level of DCs in Th2 settings is low in comparison 
with bacterial stimuli, this activation phenotype is indeed an important feature 
during Th2 induction. In addition to DC surface markers, DC cell intrinsic 
expression of NFkB is also a crucial component for this process, as NFκB 
deficient BMDCs show a reduced ability to induce Th2 responses in culture with 
CD4+ T cells (Artis et al., 2005).  
 
Investigation into the contribution of tissue factors produced in response to Th2 
inducing antigens has provided further insight into DC activation in a Th2 
setting. Infection with parasites including Heligmosomoides polygyrus, N. 
brasiliensis and S. mansoni, or exposure to allergens, triggers the release of 
multiple tissue factors including thymic stromal-derived lymphopoietin (TSLP), 
IL-25 and IL-33, which have been shown to promote Th2 responses and worm 
expulsion (Kool et al., 2012). TSLP is thought to induce the expression of 
OX40-L by DCs during allergic responses (Ito et al., 2005), and activate human 
DCs to produce cytokines such as CCL17 and CCL22 (Fontenot et al., 2009; Ito 
et al., 2005). The expression of these chemokines recruits Th2 cells in particular, 
as their receptor (CCR4) is thought to be expressed preferentially by Th2 cells 
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(Bonecchi et al., 1998; D'Ambrosio et al., 1998; Sallusto et al., 1998). This 
provides a mechanism by which DCs may recruit Th2 cells to the tissue site 
during helminth infection or allergic responses. However, the role for TSLP in 
this process is not critical, as TSLP deficient animals induce intact Th2 
responses during S. mansoni infection (Massacand et al., 2009). Taken together, 
numerous studies highlight the importance of core DC functions for CD4+ T cell 
priming towards a dominant Th2 immune response during S. mansoni infection. 
 
To date, the best evidence for the requirement of DCs during the induction of 
Th2 responses has recently been provided through use of cell specific DC 
depletion models, such as CD11c.DOG mice. In 2010 our laboratory reported 
that CD11c+ DC depletion in CD11c.DOG mice impairs the induction of Th2 
immune responses either after injection of S. mansoni eggs or during active S. 
mansoni infection at D42 (Phythian-Adams et al., 2010). This identified DCs as 
the major cell type that is required for the induction of Th2 responses against S. 
mansoni infection. Although a cohort of S. mansoni stimulated innate immune 
cells including ILC2s, basophils and MΦs is likely required for optimal Th2 
induction, the requirement for DCs to induce Th2 immune responses during S. 
mansoni infection makes them key to identifying the exact mechanisms that 
govern this process. Indeed, the requirement for DCs in the induction of Th2 
responses has also been established in non-schistosome Th2 settings such as 
allergic asthma (Kool et al., 2008; van Rijt et al., 2005).   
 
Given that DCs are necessary for the induction of Th2 responses in various 
settings, the involvement of specific DC subsets during the induction of Th2 
responses is currently an area of active research. Recently, IRF4 dependent 
CD11b+ cDCs have been shown to represent the main subset for the induction of 
Th2 responses in the lung to house dust mite allergen (HDM) (Plantinga et al., 
2013). Plantinga et al., (2013) used Flt3l-deficient mice, which lack CD103+ 
cDCs and CD11b+ cDCs but not monocyte derived CD11b+ cDCs, and exposed 
these animals to HDM. They showed that Flt3l-deficient animals display 
significantly less eosinophil and lymphocytic infiltration in the lung compared 
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with WT mice, indicating impaired Th2 induction in response to HDM allergen. 
To exclude the requirement of CD103+ cDCs for Th2 induction in this model, 
langerin-DTR mice were used (Plantinga et al., 2013), which lack CD103+ cDCs 
in the lung (Kissenpfennig et al., 2005). Thus, CD11b+, but not CD103+ cDCs, 
appear to be the main DC subset required for the induction of allergic airway 
Th2 responses in the lung (Plantinga et al., 2013).  
 
Additional evidence implicating IRF4 dependent DCs in the induction of Th2 
responses has been obtained by using another model for the specific depletion of 
CD11b+ cDCs; mice with CD11c restricted deficiency in the Irf4 gene (CD11c-
crepos IRF4flox) lack CD11b+ cDCs in the spleen, skin and gut LNs (Vander Lugt 
et al., 2014). However, Gao et al., (2013) used CD11c-crepos IRF4flox mice and 
showed that IRF4 controls the function and differentiation of a distinct DC 
subset in the skin expressing CD301b and PDL2. The authors reported that 
depletion of dermal CD301b+ PDL2+ DCs results in impaired induction of Th2 
responses in vivo during allergic inflammation and infection with the helminth 
N. brasiliensis (Gao et al., 2013). This finding is in line with another study that 
used an alternative model (Mgl2DTR mice) to deplete dermal CD301b+ DCs, 
which shows that these DCs are required for antigen presentation to CD4+ T 
cells in vitro and the development of Th2 responses during N. brasiliensis 
infection (Kumamoto et al., 2013). Thus, the type of DCs that are depleted using 
IRF4 deficient mice remains controversial, and this may be due to differential 
developmental requirements for IRF4 of DCs within different tissues, which 
further underlines the vast heterogeneity within the CD11b+ cDC group (Mildner 
and Jung, 2014). Nevertheless, the transcription factor IRF4 appears to be a key 
mediator of Th2 differentiation induced by DCs, as IFR4 deficient GM-CSF 
differentiated BM derived DCs (BMDCs) show an impaired ability to induce 
Th2 responses in vitro and in vivo (Gao et al., 2013; Williams et al., 2013). It has 
been proposed that IRF4 is required for effective antigen presentation by 
CD11b+ cDCs to CD4+ T cells (Vander Lugt et al., 2014) or the production of 
cytokines by DCs that are associated with Th2 responses (i.e. IL-10 and IL-33) 
(Gao et al., 2013). Yet, it is likely that multiple mechanisms are important for 
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effective initiation of Th2 responses, and further research is necessary to 
delineate the mechanisms that are mediated by IFR4 (Tjota and Sperling, 2014). 
Taken together, emerging evidence implicating IRF4 dependent DCs during the 
induction of Th2 responses in various disease settings suggests that this DC 
subset may also be the critical DC for this process during S. mansoni infection.  
48 
 
1.10  Thesis aims 
The work detailed in this thesis broadly aims to better understand the role of distinct 
DC subsets during the induction of Th2 immune responses and the formation of Th2-
mediated pathology. 
 
The first aim of this thesis was to determine whether DCs are critical for the 
formation and development of granulomatous inflammation during parasitic S. 
mansoni infection. 
 
The second aim was to assess whether deficiency in a distinct DC subset, CD8α+ 
cDCs, alters the initiation of Th2 immune responses and subsequent pathology 
during later stages of S. mansoni infection. 
 
The final aim of this thesis was to examine whether S. mansoni infection alters core 
functions exhibited by different DC subsets. 
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1.10  Figures and tables 
Table 1.1  
 
This table showing the surface marker expression by mouse lymphoid or peripheral 
DC subsets is adapted from Merad et al., (2013) and Mildner et al., (2014) (+ = 
expressed by DC, − = not expressed, subset = expressed by some DCs belonging to a 
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Table 1.2  
 










+ and migratory 
CD103+ cDCs Hilder et al., 2008 
CD11c.DTA 
cDCs, pDCs, LCs, and 
possibly certain 
macrophages, 
plasmablasts, activated T 
cells, NK cells, and 
Ly-6Clow monocytes 
Ohnmacht et al., 2009 
Irf4-/- pDCs, CD11b
+ cDCs, 
plasma cells Suzuki et al., 2004 
Irf8-/- 
CD8!+ and migratory 
CD103+ cDCs, pDCs, 
Langerhans cells 
 
Schiavoni et al., 2002 
Inducible depletion 
CD11c.DTR 
cDCs and to a lesser 
extent pDCs, but also 
certain macrophages, 
plasmablasts, activated T 
cells, NK cells, and 
Ly-6Clow monocytes 
Jung et al., 2002 
CD11c.DOG 
cDCs, pDCs, but also 
certain macrophages, 
plasmablasts, activated T 
cells, NK cells, and 
Ly-6Clow monocytes 
Hochweller et al., 2008 
zDC.DTR cDCs and probably certain activated monocytes Meredith et al., 2012 
BDCA.DTR / SiglecH.DTR pDCs Swiecki et al., 2010, Takagi et al., 2011 
Clec9a.DTR 
CD8!+ DCs and, likely, 
nonlymphoid tissue 
CD103+ CD11b" DCs. 
Partial depletion of pDCs. 
Piva et al., 2012 
CD205.DTR CD8!
+ DCs, dermal 
DCs,and LCs Fukaya et al., 2012 
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Diagram 1.1 Cross-presentation of antigen by DCs 
All DCs are capable of presenting antigen via MHC-I and MHC-II presentation 
pathways. Antigen derived from proteins degraded in the cytosol comprise almost 
exclusively endogenous peptides synthesised by the cell and are presented mainly by 
MHC-I molecules. Exogenous antigen is taken up and degraded in endosomes, and is 
typically presented on MHC-II molecules. Notably, endogenous components 
including plasma membrane proteins, components of the endocytic pathway and 
cytosolic proteins can access endosomes by autophagy, and are also presented on 
MHC-II molecules. CD8α+ cDCs uniquely deliver exogenous antigens to the MHC 
class I pathway, which is termed cross-presentation. The mechanisms involved in this 
pathway are still poorly understood. TAP = transporter associated with antigen 
processing. This figure is adapted from Villadangos and Schnorrer et al., (2007). 
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Diagram 1.2  The development of myeloid populations from the bone 
marrow 
This figure summarises developmental stages of myeloid populations and the 
transcription factors (blue) involved. The first developmental events occur in the BM, 
where granulocyte-MΦ progenitors (GMP) give rise to macrophage-DC progenitors 
(MDP). MDPs differentiate into common myeloid progenitors (CMP) and monocytes. 
CDPs can give rise to pDCs or pre-cDCs. pDCs fully differentiate in the BM and 
circulate in the blood, whereas pre-cDCs migrate via the blood to differentiate into 
cDC subsets in the periphery. MΦs can be derived from monocytes that have 
migrated from the blood to peripheral tissues. During inflammation, monocytes can 
also give rise to a DC-like population, which are referred to as Tip-DCs. This figure is 














































Diagram 1.3  DTx mediated CD11c depletion in CD11c.DOG mice  
This figure illustrates the receptor mediated Diphtheria Toxin (DTx) endocytosis in 
cells expressing high affinity DTx receptor (DTR). The DTR binds the B subunit of 
the DTx, which initiates the uptake of the DTR-DTx complex. Endocytic release of 
the DT A subunit inhibits protein synthesis in the cell by catalysing an inactivating 
ADP-ribosylation of elongation factor 2, which leads to apoptosis. This figure is 

















































Diagram 1.4  Batf3 dependent dendritic cells in human and mouse 
This figure compares surface markers, transcription factor expression and main 
functions of Batf3 dependent DCs in the human and mouse. Notably, the human 
counterpart does not express CD8α and is commonly referred to as CD141+ DCs. 
Batf3, Id2 and IRF8 have been shown to be expressed in both human and murine 
CD141+/CD8α+ cDCs (Villadangos and Shortman, 2010), whereas Zbtb46 has only 
been identified in the murine counterpart (Satpathy et al., 2012b). This figure was 
adapted from Collin et al. (2011). 
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Diagram 1.5  
 
Diagram 1.5 T helper cell polarisation by dendritic cells 
DCs are activated through stimulation by PAMPS (or in some cases DAMPS) via 
PRRs, and subsequently take up and process antigen for presentation on MHC 
molecules (signal 1). Upon activation DCs upregulate the expression of co-
stimulatory molecules required for efficient interaction with CD4+ T cells (signal 2). 
The type of pathogen the DC encounters determines the type of signalling pathway 
that leads to the production of a polarising factor often in the form of a cytokine 














































Diagram 1.6  
 
Diagram 1.6  The induction and promotion of type 2 responses during 
helminth infection  
Type 2 responses are initiated by helminths that damage the epithelium, which 
induces the secretion of IL-25, IL-33, TSLP and IL-1β. Those cytokines derived 
from epithelial cells activate ILC2 cells that subsequently secrete type 2 cytokines. 
The secretion of type 2 cytokines by ILC2 cells induces mucus secretion by goblet 
cells and contributes to alternative activation of MΦs (IL-13). Secretion of IL-5 by 
ILC2 cells results in the recruitment and activation of mast cells and eosinophils. In 
addition, certain antigens such as omega-1 from the helminth S. mansoni and 
cytokines released by other innate immune cells likely prime DCs to induce Th2 
responses in lymphoid tissue, which further amplifies the secretion of type 2 
cytokines in the microenvironment. The production of IL-4 by Th2 cells leads to the 
antibody class-switching to IgE by B cells in lymphoid organs, and IL-13 production 
induces wound healing and collagen deposition orchestrated by AAMΦs and 
fibroblasts. This diagram is adapted from Allen et al., (2011), Pulendran et al., 
(2010) and Licona-Limon et al., (2013). 
































































Diagram 1.7  The life cycle of Schistosoma mansoni 
The S. mansoni life cycle is complex and involves the infection of multiple hosts. A. 
The intermediate host, an infected biomphalaria glabrata fresh water snail, releases 
infectious highly motile cercariae into the water that are attracted to lipids found on 
human skin (the definitive host). The cercariae often enter the epidermis through hair 
follicles, where they shed their tails and become schistosomulae. In the skin, 
schistosomulae secrete proteases and degrade basement membranes to aid transit 
from the skin into the blood. B. Once in the vasculature, immature schistosomulae 
begin to mature and are swept though the blood circulation into the heart and become 
lodged in the lungs, where they must cross capillary beds to enter the arterial blood 
flow. C. Mature adult schistosomes settle in mesenteric veins, where female and 
male worms pair and begin laying eggs. The eggs normally transverse from the 
vasculature through intestinal tissue, where granulomatous inflammation occurs, and 
are excreted through in the faeces of the infected host. D. Some eggs are swept by 
the blood flow into the liver, where they are trapped in small sinusoidal vessels. This 
initiates the formation of hepatic granulomas around the egg. Notably, parasite 
migration through the body causes significant tissue damage and haemorrhaging in 
the mammalian host at almost every stage. This figure was adapted from Allen and 
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2 Materials and Methods 
2.1 Use of animals 
Experiments were performed using 8–12 week old mice. C57BL/6 Batf3-/- mice were 
kindly provided by Ken Murphy (Washington University), and OT-IIxLy5.1 mice by 
David Gray (The University of Edinburgh). All mice were kept under specific 
pathogen–free (SPF) conditions at the University of Edinburgh Animal Facilities. 
The fewest number of animals possible were used in all experiments, whilst 
achieving statistical significance. All experiments were approved under a Project 
Licence granted by the Home Office (U.K.) and conducted in accordance with local 
guidelines. 
2.2 Maintenance of the S. mansoni life cycle  
S. mansoni infected fresh water Biomphalaria glabrata snails were obtained from 
Dr. Fred Lewis (Biomedical Research Institute, Rockville, MD). At delivery, snails 
were pre-patent (2 weeks post-infection) and maintained in aerated tanks containing 
carbon filtered water. This water was chlorine free and pre-warmed, and the tanks 
were cleaned periodically. Little gem or romaine lettuce, rinsed in carbon filtered 
water, was given to the snails 3 times per week. The room was maintained at 26-
27°C.  
 
Infected snails become patent between 4 and 5 weeks after infection. To prevent 
infection when handling the snails, two layers of nitrile gloves, a face-mask and lab 
coat were worn. In preparation for infection approximately 30-40 snails were 
transferred from the tank to a beaker containing a small amount of carbon filtered 
water. The beaker containing the infectious snails was placed under a heat lamp for 
50 min to encourage cercarial ‘shedding’. The carbon filtered water containing the 
cercariae was then poured into a 50 ml Falcon tube and the snails were returned to 
their tanks. Once shed, the cercariae swim to the top of the tube, and so the cercarial 
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water was gently stirred with a figure of eight motion using a 1 ml/gilson (blue tip, 
with the end removed with scissors to reduce shear forces) to collect a 200 µl aliquot 
for counting to calculate accurate concentrations. 200 µl of Lugol’s iodine solution 
was added to the aliquot, which killed the cercariae and stained them for counting 
with a dissection microscope. The average of three counts was taken to determine the 
concentration of cercariae. Carbon filtered water was then added to dilute the 
cercariae to the appropriate concentration for infection. For transfer to the animal 
facility, the tube containing the cercariae was sealed securely and carried in 
secondary containment to reduce risk of exposure. 
2.3 S. mansoni infection procedure  
The infection procedure was the same for experimental and egg harvest infections. 
Egg harvest infections were conducted to isolate S. mansoni eggs from the liver, 
which could be used in egg injection experiments (section 2.3.3). To avoid possible 
complications associated with lower susceptibility to infection with older male mice 
(Nakazawa et al., 1997), female animals were used exclusively for infection. Female 
mice were anaesthetised with a mix of medatomidine (domitor) and ketamine 
(vetalar) diluted in sterile PBS (e.g. 0.25 ml domitor and 0.19 ml vetalar diluted in 
2.6 ml PBS; injected i.p. 0.01 ml/g per female mouse). The abdomen of the 
anaesthetised animals was shaved. The mice were then placed onto a heat-mat with a 
1 cm diameter steel ring securely taped over the shaved region. 200 µl of the 
previously prepared cercarial water was transferred into the ring with a Gilson 
pipette, and a further 200 µl of pond water was added to cover the entire exposed 
skin with water. This water was carefully removed after 30 min and added to a tube 
containing ethanol to kill any remaining cercariae. The animals were then revived 
with atipamezole (antisedan) diluted in PBS (0.04 ml of antisedan and 0.96 ml of 
PBS; injected s.c. 0.1 ml per female mouse). While the animals were coming round, 
they were placed into a heat chamber and observed. 
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2.3.1 Immunisation with Diphtheria toxin for CD11c+ cell 
depletion 
Mice were injected i.p. daily for a period of 9 to 12 days with 8 ng/g diphtheria toxin 
(DTx) (Sigma D0564) in PBS, or with PBS alone (Phythian-Adams et al., 2010). The 
dose was based on previous optimisation in the MacDonald lab. Solid DTx, which is 
highly toxic to humans, was dissolved by injecting sterile tissue culture grade ddH20 
through the lid of the vial. Once dissolved to a final concentration of 0.5 mg/ml, 10 
µl aliquots were stored at -80°C. 
2.3.2 Preparation of serum 
For analysis of antibody isotypes present in the blood, blood samples were collected 
1 day before the harvest date of infection experiments. A maximum of 270 µl blood 
was collected per 25g mouse into eppendorf tubes, and the samples were stored at 
4°C for 10 min to allow the blood to clot. Then the samples were centrifuged for 10 
min at 8°C, which collects the coagulated blood in the pellet of the tube below a 
layer of serum. The serum was carefully transferred into fresh eppendorf tubes. 
Serum aliquots were stored at -80°C. 
2.3.3 Isolation of eggs 
Livers of mice infected with ~180 cercariae were harvested on D49 (2-3 weeks 
following the onset of egg production) of infection, and transferred into tubes 
containing PBS and penicillin/streptomycin (pen/strep) (Gibco - Invitrogen). Eggs 
were purified exclusively from livers to limit the amount of endotoxin contamination 
that may occur from using intestinal tissues from mice, as the high bacterial load of 
the intestines likely presents a greater risk for endotoxin contamination than does the 
liver. The livers were then rinsed with 70% ethanol and washed three times with 
sterile PBS before being minced under aseptic conditions using sterile razor blades in 
Petri dishes. Minced livers were digested overnight (o/n) at 37°C with filter-sterilised 
1.47 U/ml solution of collagenase D in the presence of Polymyxin B sulfate (Sigma 
Aldrich) and pen/strep to ensure the breakdown of collagen whilst limiting bacterial 
contamination. Following o/n digestion, the liver fragments were washed with PBS 
and resuspended in PBS before being layered onto a 33% percoll gradient to separate 
the eggs from hepatocytes. After centrifugation at 420 xg the upper layers were 
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removed gently to leave the eggs in a pellet at the bottom of the tube. The eggs were 
collected and washed with PBS. Freshly isolated eggs were then counted and stored 
at  -80°C. 
2.3.4 Production of SEA 
Endotoxin-free soluble egg antigen (SEA) was prepared in-house as previously 
described (MacDonald et al., 2001). After thawing, S. mansoni eggs were transferred 
to a Tenbroeck 7 ml tissue grinder to which sterile PBS was added. The eggs were 
then carefully homogenised using a twisting and grinding motion. After ~20 
rotations the eggs were checked for disruption. This was repeated ~15 times on ice 
until 95% of the eggs were disrupted. The resulting homogenate was then transferred 
to a 15 ml tube and centrifuged at 2800 xg for 15 min at 4°C. The supernatants were 
transferred to 1 ml micro-centrifuge tubes and spun at 16,000 xg for 10 min. The 
pooled supernatants were filter sterilised through a 0.45 µm filter. The isolated SEA 
protein concentration was determined using a Bradford (coomassie) protein assay 
and a known BSA standard. The SEA was aliquoted before storage at -80°C. 
2.4 Parasitology of S. mansoni infected mice 
2.4.1 Tissue for egg counts 
A caudate liver lobe and gut tissue (the small intestine) were harvested and stored at 
-80°C to preserve the tissue for egg counting. After thawing, each sample was 
removed from the tube and weighed. 15 ml/g of liver tissue or 7.5 ml/g of gut tissue 
of 4% KOH dissolved in ddH20 was added to each sample and digested o/n at 37°C. 
The next day, 100 µl of digested tissue was transferred to a gridded Petri dish and 
each sample was counted 3 times using a dissection microscope. The average egg 
count per sample, the weight of the tissue taken before digestion and the total tissue 
weight taken on the harvest date were used to calculate the total number of eggs per 
liver or intestine. 
2.4.2 Collection of worms 
Animals were perfused immediately after schedule 1 killing using sterile-filtered cell 
isotonic citrate saline solution (15 g/ml sodium citrate and 8.5 g/ml sodium chloride, 
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Sigma). The hepatic portal vein was careful severed, avoiding damage to the 
intestines, and approximately 25-30 ml saline solution slowly injected into the heart, 
using constant pressure and a 30 ml syringe, enabling the collection of worms 
perfused out of the mesenteric veins. The perfused blood and buffer containing the 
worms was collected into a Petri dish and then transferred to a 50 ml Falcon tube. 
Collected worms were stored in perfusion buffer for up to 48h at 4°C prior to 
counting. 
 
Settled blood was resuspended by inverting the Falcon tubes and spun at 400 xg for 5 
min. Excess perfusion buffer was removed and the pellet resuspended. 3 ml of 1x BD 
FACS fix/lysis solution was added per sample and incubated for 2-5 min. The 
worm/fix/lysis solution was poured through a 100 µm cell strainer and washed with 
PBS to collect the worms in the cell strainer. Collected worms were washed onto a 
gridded Petri dish with 10 ml PBS. All worms were counted using a dissection 
microscope, and numbers of identified female, male and immature worms were 
recorded.  
2.5 Immunisation with S. mansoni eggs 
For egg injections, mice were immunised s.c. in the top of each hind foot with 2,500 
eggs in 50 µl PBS, or PBS alone for controls, as described previously (Phythian-
Adams et al., 2010). 
2.6 Preparation of tissue for histology  
For histological analysis by light microscopy, the median liver lobe and 
approximately 1.5 cm of the ileum were harvested and gently transferred to 10% 
NBF for at least 24h for fixation. The fixed tissue was then transferred to 20% 
ethanol at room temperature (RT) for storage prior to processing. The tissues were 
sent to a Histology department (QMRI, Edinburgh), where they were processed, 
embedded in paraffin, cut into 5 µm thick sections and stained with either Masson’s 
Trichrome (MT) to stain granulomatous inflammation including type III collagen 
deposition, or Picrosirius Red (PSR) to measure type I and III collagen more 
specifically. The median liver lobe was cut from the top in such a way that the 
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maximum surface area was available for analysis. Tissue from the ileum was 
mounted to give longitudinal cross sections. To enable the comparison of subsequent 
sections for each stain, two consecutive sections were mounted (one per slide). To 
maximise the number of unique granulomas in each section per stain on each slide, a 
minimum distance of 50 µM was cut away between sections after two consecutive 
sections were taken. The eggs are approximately 60 µM wide and 140 µM long 
(Ross et al., 2002). Every slide was blinded before subsequent analysis to avoid 
misinterpretation of the results. 
 
For immunohistochemical analysis by confocal microscopy, a protocol was used that 
was previously optimised in the MacDonald laboratory. Approximately 0.5 cm tissue 
sections from the left liver lobe were cut and placed into optimum cutting 
temperature formulation (OCT) for storage at -80°C. 20 µm cryosections were cut 
using a cryostat set to -21°C and laid onto microscope slides (C.A.Hendley). Freshly 
cut tissue sections were placed into a box to avoid dust particle deposition on the 
slides, and left at RT to dry o/n. Dried tissue sections were then fixed in ice-cold 
acetone for 5 min before storage at -20°C.  
 
For confocal staining, frozen cryosections were thawed and rehydrated with 1x PBS 
for 5 min at RT, with washes repeated 3 times. To avoid high background staining 
(i.e. through dust particles), sections were kept in a humidifying chamber throughout 
the rest of the staining procedure. Slides were then washed once in PBS-T (Tween20 
diluted 1:1,000 in PBS). FcR-Block (2.4G2) was added to a 10% block solution (1% 
BSA, 10% FCS  in PBS-T) at 0.005 µg/µl, and this blocking solution was added to 
the sections and incubated for 1h at RT to prevent non-specific staining. Blocked 
sections were then stained o/n at 4°C with fluorescently labelled monoclonal 
antibodies in 2% block solution (0.2% BSA, 2% FCS in PBS-T) (Table 2.1). Stained 
cryosections were washed once with PBS-T followed by 2 washes with PBS, and 
then stained with 1 µg/ml DAPI dissolved in PBS for 15 min at RT. Finally, 
cryosections were allowed to dry and were mounted in ProLong Gold antifade 
reagent (LifeTechnologies) with coverslips (thickness n1), which preserves the 
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signals of the fluorescently labelled target cells for long-term storage and suppresses 
photobleaching. 
2.6.1 Quantification of histological analysis. 
2.6.1.1 Quantification of granulomatous inflammation or fibrosis  
To determine the proportion of granulomatous inflammation in liver sections 
objectively, a novel quantification method was developed. For median liver lobe 
sections stained with MT or PSR, a dotslide digital slide scanner (Olympus BX51, 
VS-ASW FL Software) was used to scan the sections creating bright field (BF) 
overview images of the whole slide (see Fig. 2.1). Staining with MT results in 
differential colouring of granulomas and inflammatory infiltrate (blue) compared 
with the liver parenchyma (purple), and this is an essential feature for effective 
quantification of granulomatous inflammation by this method. Specifically, MT is 
described as staining type III collagen, as well as nuclei of immune cells, blue (Amin 
and Mahmoud-Ghoneim, 2011; Calvi et al., 2012; Diaz Encarnacion et al., 2004; 
Whittaker et al., 1994). Using FIJI imaging analysis software (ImageJ 1.48r) 
individual liver sections were cropped to obtain an image consisting solely of the 
liver section with all background removed. The colour threshold was then set using 
hue, saturation and brightness (HSB) settings to select either granulomas alone (only 
blue staining) or the whole liver section. These HSB threshold settings were 
introduced into an algorithm developed by Dr. Tim Kendall (Western General 
Hospital, Edinburgh), which enabled the quantification of the number of pixels for 
the region of interest. Two algorithms were used for the analysis of each image: one 
containing HSB settings for the selection of granulomatous inflammation (blue 
pixels only), and the other containing HSB settings for the selection of the whole 
tissue (all pixels). The algorithm essentially enabled the automatic application of the 
HSB settings to each sample, and then produced a new black and white image for the 
quantification step. In each new black and white image the black pixels represent the 
region of interest (i.e. either granulomatous inflammation or whole tissue), and the 
number of black pixels was quantified by the algorithm. The number of black pixels 
calculated by the algorithm for each image was then used to determine the proportion 
of granulomatous inflammation per tissue section (i.e. proportion of granulomatous 
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inflammation = (n of pixels for granulomatous inflammation / n of pixels for whole 
tissue section) x 100.). Thus, this novel technique allows for efficient and objective 
quantification of the proportion of granulomatous inflammation in livers of S. 
mansoni infected mice. 
 
For more precise measurement of fibrosis, liver sections were stained with PSR. The 
slides were scanned and images cropped as described above. PSR stains type I and 
type III collagen red, whereas the rest of the tissue is stained yellow (Calvi et al., 
2012). Although MT stains type III collagen and is frequently used as a measure of 
fibrosis (Calvi et al., 2012), other components within the tissue, as mentioned above, 
are also stained by MT (Amin and Mahmoud-Ghoneim, 2011; Diaz Encarnacion et 
al., 2004; Whittaker et al., 1994). Thus, PSR was used for more specific analysis of 
collagen deposition, and the HSB threshold was set to select for red pixels. The 
proportion of collagen per liver section was then quantified using the algorithm as 
explained above. 
 
All tissue samples in each experiment were stained on the same day to avoid 
different staining levels. Notably, variation in staining intensity was often evident 
between experiments that were processed and stained on separate days. 
2.6.1.2 Granuloma and muscle scoring of intestinal tissue 
Due to the complex structure of the ileum and the lack of ability to distinguish 
between granulomatous inflammation and the surrounding gut tissue when using MT 
staining, granulomatous legions in the intestine were instead quantified using a 
scoring system. Similar scoring systems are standard methods for the assessment of 
intestinal inflammation in other systems, such as colitis (Horino et al., 2008). Ileal 
sections stained with MT were analysed using a light microscope at x20 or x40 
magnification (Leica DM2000 camera). Single egg granulomas were scored for their 
intensity and severity of inflammation using a scoring system (0,+,++,+++) developed 
together with Dr. Mark Arends (Western General Hospital, Edinburgh) (See Fig.  
2.2). Scoring was determined as a measure of numerous features: the approximate 
number of the immune cells around the egg, the type of immune cells present 
(eosinophils, MΦs, lymphocytes etc), the size of the granuloma, the density of 
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immune cells, and the level of damaged ileal tissue surrounding the granuloma (i.e. 
crypt architecture, goblet cell size and collagen deposition). A score of 0 represents 
no inflammation visible around the egg with no or mild damage to the surrounding 
tissue, whereas a score of +++ indicates severe inflammation due to large granulomas 
densely packed with immune cells such as eosinophils, structural damage to adjacent 
ileal crypts, and increased goblet cell size and collagen deposition. The level of 
inflammation in the granulomatous legion likely correlates with the number of eggs 
trapped in the granuloma, thus only single egg granulomas were analysed to enable 
comparison across experiments.  
 
Damage to the circular muscle in the ileum found in infected mice was scored for 
each sample in a similar way as above (0,+,++,+++) based on scoring techniques 
developed previously for different kinds of pathology (Horino et al., 2008). This 
specific scoring system for muscle injury was developed together with Dr. Mark 
Arends (Western General Hospital). Higher scores indicate architectural damage to 
the muscle, a large number vacuole-like structures formed in the muscle, and 
increased collagen deposition between the muscle and the submucosa compared with 
muscle in naïve mice (see Fig. 2.3).  
2.6.1.3 Confocal microscopy analysis 
Cryosections stained with fluorescently labelled antibodies (section 2.6) were 
analysed using a Leica Confocal SP5 microscope. The offset (the minimal signal 
intensity detected by the sensor), gain (signal amplification at the camera sensor) and 
laser power (light intensity) were adjusted for each experiment using isotype and 
single stained controls, to obtain optimum detection of the fluorochromes. Cross-
section photographs of granulomas were approximately 5 µm thick, and consisted of 
individual Z-stacked images each 0.25 µm thick (400Hz, 1024x1024, 8-16bit, x20 or 
x40 magnification). These were overlaid using extended focus for subsequent 
analysis. As in section 2.6.1.2, only single egg granulomas were photographed to 
enable comparison across experiments.  
 
Analysis of confocal photographs was carried out using Volocity imaging software 
(PerkinElmer). For each photograph, the contrast was enhanced to remove 
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background staining, which was determined by analysing images of unstained and 
isotype control samples. The egg was then cropped out of the image to exclude 
possible autofluorescence during subsequent quantification steps. Snapshots of 
cropped images were captured separately for each fluorochrome used (i.e. a separate 
image was captured for CD11c, Siglec-F and TCR-β staining). For each snapshot, 
the surface area of positive staining around the egg was then measured by the 
software, which detects positive staining of the fluorochromes above a fixed 
intensity. The intensity was set using isotype controls for each fluorochrome labelled 
antibody used. Therefore, this technique enables the quantification of staining for 
specific immune cells in cross-sections of granulomas in the liver. 
2.7 Preparation of samples for cell culture 
2.7.1 Use of antibiotics 
To prevent bacterial contamination during culture, pen/step was added to DC:T cell 
co-culture assays, cell isolations, egg isolations and wash media. Although this could 
have an inhibitory effect on cell growth in culture, antibiotics were necessary to 
prevent erroneous results obtained due to variation in bacterial contamination. This is 
particularly important when culturing DCs, as LPS contamination by gram-negative 
bacteria can have a dramatic impact on DC activation and function (Granucci et al., 
1999). 
2.7.2 Heat-inactivation of FCS 
The foetal calf serum (FCS) used in BMDC medium and other media was inactivated 
through heat treatment at 58°C for 50 min. Heat inactivation was used to denature 
the components of the complement cascade in the serum that could damage the cells 
being cultured or prepared (Rahman et al., 2011). 
2.8 Preparation of tissue for cell culture 
Popliteal (pLN) and inguinal (iLN) LNs were harvested at D5, D7 or D9 after egg 
injection in immunisation experiments. Tissue samples of livers and mesenteric LNs 
(mLN) were obtained from both naïve and S. mansoni infected mice, which were 
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killed by CO2 asphyxiation between D28 and D105 of infection, according to licence 
regulations.  
2.8.1 Cell isolation methods for culture  
In preparation for single cell suspensions, tissues were first enzymatically digested to 
obtain maximum numbers of rare cell types. Whole LNs were digested at 37°C for 
30 min with 1.75 Wunsch Units/ml Liberase TL (Roche) and 80 Kunitz Units/ml 
DNase I type VI (Sigma-Aldrich) in HBSS (Sigma-Aldrich) containing 50 U/ml 
penicillin and 50 µg/ml streptomycin (Invitrogen) based on previous optimisation in 
the MacDonald laboratory. To stop the digestion, 10 µl 0.1M, pH 7.3, EDTA 
(Ambion) stop solution/ml was added, the tube was topped up with DMEM 
containing 50 U/ml penicillin and 50 µg/ml streptomycin, then contents filtered using 
a 70 µm cell strainer to obtain single-cell suspensions. Livers were digested using the 
same method, following perfusion and dicing of the tissue. A syringe plunger was 
used to pass the digested liver through a 100 µm cell strainer. The resulting 
suspension was then resuspended in 33% isotonic Percoll (GE Healthcare) and 
centrifuged at 700 xg in order to separate leukocytes from other liver cells. Isolated 
leukocytes were then resuspended and passed through a 40 µm cell strainer to 
remove S. mansoni eggs. The single cell suspension was treated with RBC lysis 
solution. Cell suspensions from all tissues were counted using trypan blue to 
distinguish live and dead cells, and resuspended for use.  
2.8.2 Cell culture for cytokine analysis 
LN cells or isolated liver leukocytes (1x106 – 2x106 cells/ml) were cultured in X-
vivo 15 medium (BioWhittaker) containing 2mM L-Glutamine and 50µM 2-ME 
(Invitrogen) in 96-well plates at 37°C in a humidified atmosphere of 5% CO2 with or 
without 15 µg/ml SEA for antigen-specific restimulation. For polyclonal 
restimulation with αCD3 culture plates were incubated for 24h with 16.7µg/ml αCD3 
at 4°C. Before culture, the αCD3 was removed and the wells were washed with PBS 
prior to transfer of the cells into the well. 
 
In preparation for intracellular cytokine staining (ICC), LN cells or liver leukocytes 
were restimulated o/n in αCD3 coated plates for polyclonal restimulation as above, 
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with the addition of 2 µg/ml soluble αCD28. αCD3/CD28 was chosen for 
restimulation, as this is thought to be a physiologically relevant stimulation for T 
cells in culture, and is less cytotoxic in comparison with other components 
commonly used in vitro or ex vivo including PMA/Ionomycin (Olsen and Sollid, 
2013). After o/n incubation, 2 µg/ml Monesin (Golgistop, BD) was added to all 
cultures for 6h to block the transport and thus secretion of cytokines prior to cell 
harvest and staining (Mascher et al., 1999; Mollenhauer et al., 1990).  
2.8.3 Liver dendritic cell purification 
DC: T cell co-culture experiments were conducted to examine the capacity of DC 
subsets to process and present antigen to T cells (Schnorrer et al., 2006; Wilson et 
al., 2003; Young et al., 2007). Liver DCs were enriched from 12-36 naïve C57BL/6 
mice and 4-8 S. mansoni infected C56BL/6 mice using a Dynabeads® Mouse DC 
Enrichment kit (Invitrogen, 11429D) following the manufacturer’s protocol. Pooled 
enriched DCs were counted and stored in complete media o/n at 4°C at a 
concentration of 2x106 cells/ml. This step was necessary for practical reasons due to 
the length of the protocol, and an optimisation experiment was carried out to 
compare the functionality of enriched DCs before and after o/n resting. This 
experiment confirmed that DCs retain antigen presentation and processing abilities 
after o/n storage at 4°C. The following day, the enriched DCs were counted again, 
centrifuged at 300 xg for 5 min and resuspended at 10x106 cells/ml in flow buffer 
(0.5% FCS/PBS). Enriched DCs were then stained with fluorescently labelled 
antibodies for 15 min at 4°C. After staining, DCs were washed with flow buffer and 
resuspended to 2.5x107 cells/ml for fluorescence activated cell sorting (FACS). 5 µl 
7-AAD (BD Pharmingen) was added to 1 ml of enriched DCs to determine the 
proportion of live cells within the cell preparation. To distinguish cDC and pDC 
subsets in the DC enriched population and to prevent contamination with MΦs 
(expressing F4/80) or NK cells (expressing NK1.1), cDCs were sorted as CD11chigh 
PDCA-1− F4/80− NK1.1− cells and pDCs as CD11cint PDCA-1+ F4/80− NK1.1− cells 
using a BD FACS Aria II cytometer (see table 2.1) (Rahman and Aloman, 2013). 
cDCs and pDCs were sorted into 15 ml tubes containing 1 ml pure FCS with 1% 
PenStrep, and sorted samples were kept at RT until culture. 
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For cDC subset purification, enriched DCs were stained additionally with CD8α and 
CD205 fluorescent antibodies. This allowed for sorting of CD8α+ CD205+ CD11chigh 
PDCA− 1− F4/80− NK1.1- cDCs (CD8α+ cDCs) and CD8α− CD205− CD11chigh PDCA-
1−  F4/80− NK1.1−  cDCs (CD8α- cDCs) (Hildner et al., 2008; Pillarisetty et al., 
2004).  
2.8.4 Purification of ex-vivo naïve CD4+ T cells  
To obtain pure CD4+ T cell populations, the spleen and LNs were harvested from 1-2 
female OT-IIxLy5.1 mice and a single cell suspension prepared by crushing through 
gauze to release the cells, with the resulting suspension then being centrifuged at 300 
xg for 5 min. For the spleen, RBC lysis buffer (Sigma) was used to lyse RBCs, 
following which cells were washed and pooled with isolated LN cells. Naïve CD4+ 
(OT-II) T cells were enriched using a Dynabeads® Untouched™ Mouse CD4 Cells 
Kit (Invitrogen, 11415D) following the manufacturer’s protocol. Enriched naïve 
CD4+ T cells were washed and resuspended in DMEM for CFSE labelling.  
 
To ascertain the purity of CD4+ T cells that express the TCR V alpha 2 chain specific 
for class II OVA peptide (pOVA) (Barnden et al., 1998), the proportion of naïve 
CD4+ Vα2+ T cells was assessed by flow cytometry using a FACS LSR II.  In 
addition, the activation status of naïve CD4+ Vα2+ T cells was confirmed by 
analysing the expression of CD44 and CD69; naïve T cells only express very low 
levels of CD44 and CD69 compared with effector/ memory T cells (Sprent and Surh, 
2011). 
2.8.5 Purification of in vitro activated CD4+ T cells  
For in vitro activation of CD4+ T cells, the spleen was harvested from an OT-
IIxLy5.1 female mouse, and a single cell suspension obtained using the method 
described in section 2.8.4. Freshly isolated spleen cells were cultured in a flask in the 
presence of 1 mg/ml sterile-filtered endotoxin-free OVA protein (Sigma, A5503) for 
7 days at 37°C in a humidified atmosphere of 5% CO2. Endotoxin was removed from 
OVA protein in-house to avoid activation of DCs by LPS (Granucci et al., 1999); 
sterile-filtered 20 mg/ml OVA protein dissolved in ddH20 was passed through a 
HiTrap Q Sepharose FF column using an AKTA Prime liquid chromatography 
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system. At day 3 of culture, 2 ng/ml IL-2, 10 ng/ml IL-7 and 10 ng/ml IL-15 were 
added to the culture flask containing spleen cells and OVA protein to promote 
effector/memory CD4+ T cell differentiation (Caserta et al., 2010; Van Belle et al., 
2012). At day 5, cultured spleen cells were split 1:1 and transferred to new culture 
flasks containing fresh media with cytokines as above. After 7 days of culture the 
cells were harvested, centrifuged at 300 xg for 5 min, and resuspended in DMEM for 
CFSE labelling.  
 
The purity (CD4 and Vα2 expression) and activation status (CD44 and CD69 
expression) of in vitro activated CD4+ T cells after 7 days of culture with OVA was 
assessed by flow cytometry as described in section 2.8.4.  
2.8.6 CFSE labelling of CD4+ T cells 
To measure the proliferation of CD4+ T cells in culture, freshly isolated enriched 
naïve and in vitro activated CD4+ T cells were labelled with 5 µM CFSE (Invitrogen) 
for 15 min at 37°C (Cook et al., 2012). Excess CFSE was allowed to leach from the 
cells for 45 min at 37°C. CFSE-labelled CD4+ T cells were washed and counted 
before culture with DCs. To calculate final numbers of CD4+ T cells the trypan blue 
cell count of CD4+ T cells was multiplied by the % purity obtained from flow 
cytometry analysis.   
2.8.7 DC : T cell co-culture  
The protocol conducted to set up DC:T cell co-cultures is summarised in figure 2.4. 
For assays with class II pOVA, purified liver DCs from naïve or S. mansoni infected 
mice were pulsed with 10µM, 1µM or 0.01µM OVA323-339 (08503-5mg, Cambridge 
Bioscience) in 15 ml Falcon tubes for 45 min at 37°C following a protocol 
previously optimised in the MacDonald laboratory (Cook et al., 2012). Before co-
culture with CD4+ T cells, pOVA pulsed DCs were washed to remove free peptide. 
For assays with OVA protein, 500µg/ml, 50µg/ml or 0.5µg/ml endotoxin-free soluble 
OVA protein was added to sorted liver DCs from naïve or S. mansoni infected mice 
in 15 ml Falcon tubes. The dose of OVA protein for the addition to the culture, as 
well as the length of the culture (3 vs. 4 days) was tested and optimised in the 
MacDonald laboratory. 5000 OVA323-339 pulsed DCs or DCs in the presence of 
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soluble OVA protein were then cultured with 50,000 CFSE-labelled naïve or in vitro 
activated OT-II TCR transgenic CD4+ T cells in 96-well plates (U-bottom) for 68-
72h (Schnorrer et al., 2006; Wilson et al., 2003; Young et al., 2007). Cells were 
harvested to assess CFSE dilution by flow cytometry as a measure for cell 
proliferation, and supernatants were stored at -20°C for subsequent cytokine analysis 
by enzyme linked immune sorbent assay (ELISA). 
2.9 Cell staining by flow cytometry 
2.9.1 Cell surface staining 
For cells isolated from liver and LNs and for purified naïve or in vitro activated 
CD4+ T cells, cell staining was commenced directly after tissue preparation was 
completed to ascertain the viability of the cells. After incubation with FcR-Block 
(2.4G2 produced in-house) for 15 min at 4°C, cells were stained for 30 min at 4°C 
with cell surface markers for several different cell populations (see Table 2.1). 
Appropriate isotype controls were used to identify cell populations of interest. All 
antibodies for flow cytometry were purchased from BD, eBioscience, or BioLegend. 
Samples were acquired using a FACS LSR II or FACSCanto II flow cytometer using 
BD FACSDiva software and analysed with FlowJo v.9.5.2 software (Tree Star, Inc.). 
 
For enriched hepatic DCs, staining was conducted after o/n resting at 4°C as 
described in section 2.8.3. Enriched DCs were stained for 15 min with antibodies in 
the presence of FcR-Block at 4°C. Stained DCs were then washed and resuspended 
in flow buffer for FACS sorting. 
2.9.2 Intracellular cytokine staining  
After restimulation (section 2.8.2) and surface staining, liver leukocytes or LN cells 
were fixed with 1% isotonic formaldehyde. BD Perm/Wash buffer (BD) was then 
used to permeabilise the cells, which were then stained with antibodies for 
intracellular cytokines in BD Perm/Wash buffer (Table 2.1).  
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2.10 ELISA  
2.10.1 Cytokine analysis of culture supernatants  
For cytokine analysis, protocols were used that were previously optimised in the 
MacDonald laboratory. Paired capture and detection antibodies (produced from 
hybridomas in-house or purchased from R&D Systems, BD, or eBioscience, Table 
2.2) were used for analysis of murine IL-4, IL-5, IL-10, IL-13, IL-17, IFN-γ and 
ΤΝF-α. Plates (NUNC Maxisorp) were washed with 0.05% Tween20 in PBS and 
blocked with 10% NCS/PBS. Recombinant cytokine standards (Peprotech or BD) 
were used to determine the quantity using a standard curve. Plates were developed by 
incubation with 50 µl 1:1,000 HR-peroxidase–labelled streptavidin (KPL), and the 
addition of 100 µl TMB substrate solution (Sigma-Aldrich). The reaction was 
stopped with 100 µl 0.18M H2SO4 and the absorbance was read at 450 nm using a 
Laboratory Systems Multiskan Ascent plate reader. 
2.10.2 Analysis of serum antibodies 
Serum was collected 1 day before the end of infection experiments (section 2.3.2) 
and the antibody isotypes present were measured using previously optimised 
protocols in the MacDonald laboratory. Total IgE was measured using paired capture 
and detection antibodies (BD Pharmingen) and murine IgEκ (BD Pharmingen) to 
assess quantity using a standard curve. Plates were blocked with 10% NCS/PBS, 
washed, developed and read as above. SEA-specific total Ig, IgG1, IgG2b, IgG2c, 
IgG3 and IgM antibody titres were determined using endpoint dilutions measured by 
ELISA. Plates were coated with 0.25 µg per well of SEA in 0.1M pH 9.6 
Carbonate/Bicarbonate buffer, washed as above and blocked with 1% BSA/PBS. 
Serum samples were analysed using serial 2-fold dilutions. SEA-specific isotypes 
were detected using Alkaline Phosphatase (AP) conjugated anti-mouse total Ig, 
IgG1, IgG2b, IgG2c, IgG3 and IgM antibodies (SouthernBiotech). Absorbance at 
405nm was determined as above after addition of 50µl PNPP substrate 
(SouthernBiotech). All antibodies for ELISA were purchased from BD Pharmingen, 
eBioscience, Biolegend or SouthernBiotech (Table 2.2). 
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2.11  Statistical analysis of results 
Statistical analyses were performed using GraphPad Prism 5.0d software or JMP 11 
(Statistal DiscoveryTM, SAS). Student’s t tests were used to determine if there were 
significant differences between two sample groups. One-way ANOVA was used for 
more than 2 sample groups and two-way ANOVA if there was more than one 
independent variable. Analysis of pooled data from experimental repeats conducted 
on different days was carried out using a mixed model analysis, labelling the day of 
the experiment as a random factor. Subsequently, a Tukey’s honest significant 
difference (HSD) test was performed to determine significance between groups. *, P 
< 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001. 
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Table 2.1 Flow cytometry and confocal microscopy antibodies 
Antigen Clone Isotype Host Conjugate Flow: Titration Confocal: Titration Manufacturer
B220 RA3-6B2 IgG2a, k Rat BV605 1:200 - BioLegend
CD103 2E7 IgG Ar Ham PerCP/Cy5.5 1:50 - eBioscience
CD11b M1/70 IgG2b, ! Rat BV711 1:300 - BioLegend
CD11c N418 IgG Ar Ham BV421 1:50 - BioLegend
CD11c N418 IgG Ar Ham AF647 - 1:250 eBioscience
CD19 1D3 IgG2a, ! Rat PE/CF594 1:400 - BioLegend
CD205 NLDC-145 IgG2a, k Rat APC 1:200 - BioLegend
CD24 M1/69 IgG2b, ! Rat PE/Cy7 1:800 - BioLegend
CD25 7D4 IgM ! Rat PerCP/Cy5.5, 1:100 - BioLegend
CD3 17A2 IgG2b Rat APC/eFluor780 1:100 - eBioscience
CD4 RM4-5 IgG2a, ! Rat AF700 1:400 - eBioscience
CD4 RM4-5 IgG2a, ! Rat BV650 1:200 - BioLegend
CD40 3/23 IgG2a, ! Rat FITC 1:200 - BioLegend
CD44 IM7 IgG2b, ! Rat BV570 1:100 - BioLegend
CD49b DX5 IgM, ! Rat APC/eFluor780 1:200 - eBioscience
CD69 H1.2F3 IgG Ar Ham FITC 1:100 - BioLegend
CD80 16-10A1 IgG2, ! Ar Ham PerCP/Cy5.5 1:200 - BD Pharmingen
CD8" 53-6.7 IgG2a, ! Rat PE/CF594 1:300 - BD Pharmingen
CD8" 53-6.7 IgG2a, ! Rat PE/Cy7 1:800 - BioLegend
CD8" 53-6.7 IgG2a, ! Rat PerCP/Cy5.5 1:200 - BioLegend
F4/80 BM8 IgG2a Rat PE/Cy7 1:200 - BioLegend
F4/80 BM8 IgG2a Rat PE 1:150 - BioLegend
FoxP3 (intranuclear) FJK-16s IgG2a, ! Rat eF450 1:200 - eBioscience
IFN-# (intracellular) XMG1.1 IgG1, ! Rat eF450 1:200 - eBioscience
IgM RMM-1 IgG2a ! Rat APC/eFluor780 1:200 - BioLegend
IL-10 (intracellular) JES5-16E3 IgG2b Rat PE 1:200 - eBioscience
IL-13 (intracellular) eBio13A IgG1, ! Rat AF488 1:200 - eBioscience
IL-17 (intracellular) TC11-18H10.1 IgG1 Rat PE/Cy7 1:200 - eBioscience
IL-4 (intracellular) 11B11 IgG1 Rat APC, 1:200 - eBioscience
Ly6C AL-21 IgM, ! Rat BV570 1:100 - BioLegend
Ly6G 1A8 IgG2a, ! Rat APC/eFluor780 1:200 - BD Pharmingen
MHCII M5114 IgG2b Rat AF700 1:800 - eBioscience
MHCII M5114 IgG2b Rat eF450 1:800 - eBioscience
MHCII M5114 IgG2b Rat PerCP/Cy5.5 1:800 - eBioscience
NK1.1 PK136 IgG2a, ! Ms APC/780 1:100 - eBioscience 
PDCA1 JF05-1C2.4.1 IgG2b Rat PE 1:25 - Miltenyi Biotec
SiglecF E50-2440 IgG2a, ! Rat PE - 1:100 eBioscience
TCR-$ H57-597 IgG2, % Ar Ham APC/eFluor780 1:200 - eBioscience
TCR-$ H57-597 IgG Ar Ham AF488 - 1:50 BioLegend
Terr119 TER-119 IgG2b, ! Rat AF700 1:100 - eBioscience
Va2 B20.1 IgG2a, % Rat PE 1:400 - BD Pharmingen
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Table 2.2 ELISA antibodies 
 
Antigen Clone Host Conjugate Concentration Manufacturer
IL-4 11B11 Rat Purified 2ug/ml Homegrown 
IL-5 TRFK5 Rat Purified 2ug/ml Homegrown 
IL-10 JES16-E3 Rat Purified 1ug/ml eBioscience
IL-13 Ebio13A Rat Purified 2ug/ml eBioscience
IL-17 TC11-18H0 Rat Purified 0.5ug/ml BD Pharmingen
IFN-y R4-6A2 Rat Purified 2ug/ml eBioscience
TNF-a Duoset DY410 Rat Purified 0.8ug/ml R&D
IgE R35-72 Rat Purified 1ug/ml BD Pharmingen
IL-4 Recombinant 20ng/ml Peprotech
IL-5 Recombinant 20ng/ml Peprotech
IL-10 Recombinant 20ng/ml BD Pharmingen
IL-13 Recombinant 50ng/ml Peprotech
IL-17 Recombinant 20ng/ml eBioscience
IFN-y Recombinant 50ng/ml Peprotech
TNF-a Recombinant 0.4ng/ml R&D
IgE C48-2 Purified 2ug/ml BD Pharmingen
IL-4 BVD6-24G2 Rat Biotin 0.25ug/ml BD Pharmingen
IL-5 TRFK4 Rat Biotin 0.3ug/ml eBioscience
IL-10 SXC-1 Rat Biotin 0.2ug/ml BD Pharmingen
IL-13 Polyclonal sera Rabbit Biotin 0,1ug/ml Peprotech
IL-17 TC11-8H4.1 Rat Biotin 0.25ug/ml BD Pharmingen
IFN-y XMG1.2 Rat Biotin 0.2ug/ml BD Pharmingen
TNF-a Duoset Dy410 Biotin 0.2ug/ml R&D
IgE R35-118 Rat Biotin 0.5ug/ml BD Pharmingen
Dilution
IgM Alkaline Phosphatase Polyclonal Sera Goat 1:2000 Southern Biotech
IgG1 Alkaline Phosphatase Polyclonal Sera Goat 1:2000 Southern Biotech
IgG2b Alkaline Phosphatase Polyclonal Sera Goat 1:2500 Southern Biotech
IgG2c Alkaline Phosphatase Polyclonal Sera Goat 1:1000 Southern Biotech
IgG3 Alkaline Phosphatase Polyclonal Sera Goat 1:1000 Southern Biotech





Figure 2.1  
 
Figure 2.1 Histological quantification of hepatic granulomatous 
inflammation  
1. Microscope slides containing sections of the median liver lobe were stained with 
MT, blinded and scanned with a dotslide digital slide scanner (Olympus BX51, VS-
ASW FL Software) to create a BF image of the whole slide. 2. FIJI imaging analysis 
software (ImageJ 1.48r) was used to crop individual liver sections and create an 
image consisting solely of the liver section with all background removed. 3. The 
colour threshold was set using HSB settings to select for granulomatous 
inflammation (blue) or the whole tissue section. These HSB threshold settings were 
inserted into an algorithm developed by Dr. Tim Kendall. The algorithm was then 
run on each image twice, creating one image with black pixels representing 
granulomatous inflammation (A) and a second image where black pixels represent 
the whole of the tissue section (B). 4. After black and white images of the tissue 
section were created, the number of black pixels in each image was calculated by the 
algorithm. These numbers were used to determine the total proportion of 
granulomatous inflammation present in the liver section, providing an objective 
measurement of the total burden of granulomatous inflammation in the liver. 
% Granulomatous inflammation = 
(number pixels from A / number  
pixels from B) x 100  
Digital slide scanner used 
to scan blinded slides 
Masson’s Trichrome stains 





Imaging software selects 




calculates the number of 
pixels for A and B 
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Figure 2.2  
 
Figure 2.2 Scoring system for ileal granulomas  
Median liver lobe sections were stained with MT, blinded and analysed using a light 
microscope. Representative BF images are shown from D42 of infection for scored 
granulomas in the ileum. Single egg granulomas present in the ileum were scored for 
their intensity and density of immune cells, and the amount of damage visible in the 
surrounding tissue (including crypt architecture, goblet cell size and collagen 
deposition). Score 0 represents absent granuloma formation around the egg, and 
score +++ represents the highest pathological score. No statistics can be performed on 
scores.  
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Figure 2.3  
 
Figure 2.3 Scoring system for ileal circular muscle injury   
Median liver lobe sections were stained with MT, blinded and analysed using a light 
microscope. Representative BF images are shown from D42 of infection for scored 
muscle injury in the ileum. Score 0 represents absent muscle injury (i.e. comparable 
muscle structure with that of naïve animals), and score +++ represents the highest 
pathological score, representing damage to muscle architecture, substantial vacuole 
deposition in the muscle (identified as white and round features in the muscle) and 
collagen formation (blue) in between the muscle and the submucosa.  
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Figure 2.4 DC:T cell co-culture assay method 
This figure summarises the protocol used for the set up of DC:T cell co-culture 
assays used in chapter 5 to investigate hepatic DC function during S. mansoni 
infection. 1. Liver leukocytes were isolated from naïve or D42 infected WT mice and 
enriched for DCs by negative selection (Dynabeads). Enriched DCs were then further 
purified by FACS to obtain pure populations of live DC subsets (i.e. cDCs and 
pDCs), and assessed for activation status by flow cytometry. 2. Naïve splenic and 
lymphoid CD4+ T cells were enriched from OT-IIxLy5.1 mice by negative selection 
(Dynabeads). 3. Splenic CD4+ T cells were activated in vitro in the presence of OVA 
protein 7 days prior to culture with DCs. 4. Naïve and in vitro activated CD4+ T cells 
were assessed for purity and activation status by flow cytometry, and labelled with 
CFSE. 5. For pOVA assays, FACS sorted DCs were pulsed with pOVA (323-339) 
prior to culture. This assay was done to investigate the ability of DCs to present 
antigen to naïve or previously activated CD4+ T cells. For soluble protein assays, 
soluble OVA protein was added to FACS sorted DCs and was present throughout the 
culture period. In this case the ability of DCs to take up, process and present antigen 
was examined. 5,000 FACS sorted DCs (either pulsed with OVA for 45 min or in the 
presence of soluble OVA protein) were co-cultured with 50,000 naive or in vitro 
activated CD4+ T cells for 3 days. After culture, T cell proliferation was analysed by 
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3  The importance of dendritic cells in the 
formation of granulomatous 




Although granuloma formation during S. mansoni infection forms a pathological 
pillar of the disease, the underlying cellular mechanisms for initial granuloma 
development are not well-defined. We have conducted a detailed study investigating 
changes in granulomatous tissue during the entire course of infection, from acute to 
chronic stages. DCs were found to be present within the granuloma throughout its 
development, and close positioning with T cells provided a further indication of their 
behaviour in the dynamic granuloma. Using CD11c-diphtheria toxin receptor mice 
we could show that DC depletion reduces granuloma formation. In contrast, 
granuloma formation was unimpaired in Batf3-/- mice, which lacked a specific subset 
of DCs called CD8α+ cDCs. These data highlight the critical role of CD8α− cDCs 
during granuloma formation thus providing further insight into the granulomatous 
processes that govern the disease.  
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3.2 Introduction 
S. mansoni associated pathology and the polarisation of CD4+ T cell immune 
responses are intimately linked to parasite egg production by mature worm pairs in 
the mesentery (Grzych et al., 1991; Pearce et al., 1991; 1998; Vella and Pearce, 1992) 
(section 1.8, chapter 1). A female worm will produce around 300 eggs per day, which 
then transit from the mesentery through intestinal tissue into the lumen (Gryseels et 
al., 2006). Consequent excretion of the eggs completes the mammalian section of the 
life cycle, which then resumes in fresh water snails that are infected with miracidia 
that hatch from the egg when it contacts fresh water (Pearce and MacDonald, 2002) 
(see diagram 1.7). Yet, in murine S. mansoni infection approximately 70% of eggs are 
swept away by the bloodstream, eventually becoming lodged in liver sinusoids 
(Cheever, 1987). This makes the liver a major site for egg accumulation as arrival in 
the parenchyma is a dead end for the parasite, and thus hepatic granulomatous 
inflammation contributes greatly to the overall disease burden for the host (Pearce and 
MacDonald, 2002). The exact mechanisms and immune cells that are important for 
hepatic granuloma formation and development remain unclear. Thus, work in this 
chapter aims to investigate granuloma development in the liver during S. mansoni 
infection, and to better understand the role of the immune response during this 
process. Additionally, work in this chapter aims to overcome some of the technical 
challenges associated with granuloma research.  
 
Most early reports used a pulmonary model of granuloma formation developed by 
Von Lichtenberg (Lichtenberg, 1962). Persistent egg delivery into the liver during 
natural S. mansoni infection challenges granuloma research, as new and old 
granulomas will be present at every time-point. Thus, the inspiration for Von 
Lichtenberg’s pulmonary model was based on synchronous egg delivery into the 
tissue, creating a more controlled time-frame for study of granuloma formation and 
development. However, egg injection models have been shown to result in less 
intense granulomas and fewer fibrotic responses (Cheever et al., 2002; Edungbola and 
Schiller, 1979; Eltoum et al., 1995; Mansy, 1998) possibly due to a lack of cross-
reactive memory T cells established during prepatent infection, which aid the 
generation of granulomas at the onset of egg laying (Lukacs and Boros, 1991). The 
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use of eggs that have been kept in vitro for 2 to 3 days prior to egg injection in some 
studies may also contribute to a reduced granulomatous response as a result of weaker 
antigenic secretions by the egg (Eltoum et al., 1995). Therefore, the investigation of 
hepatic granulomas during natural infection is beneficial towards understanding the 
type of immune cells and mechanisms that are required for their formation and 
development. 
3.2.1 The location and function of immune cells in the 
granuloma 
Granuloma development in the liver is determined by various different cell types and 
an intricate network of extracellular components, as described in chapter 1 (Lenzi et 
al., 2006). These components work together to form a stable and efficient entity 
protecting the host against toxic and damaging properties secreted by the egg (Hams 
et al., 2013). Given that the granuloma forms such an organised structure, we 
hypothesized that investigation into the location of immune cells will provide an 
essential insight into their behaviour and function within the granuloma.  
 
Due to various technical challenges associated with the investigation of immune cell 
location within the granuloma, the location of cells easily recognised by morphology, 
such as MΦs and eosinophils, has been most extensively studied. Eosinophils are 
easily distinguishable from other immune cells using eosin dyes, such as H&E, which 
stain the characteristic granules within the cells (Lugo-Villarino et al., 2010). Initial 
recruitment of eosinophils to the liver most likely occurs before substantial egg 
deposition, when they are located diffusely in the parenchyma presumably responding 
to hepatocyte injury (Hams et al., 2013; Moore et al., 1977; Wynn et al., 2004). As 
such eosinophils are one of the first responders after S. mansoni egg arrival in the 
liver (Lenzi et al., 1998). Eosinophil interaction with the egg has previously been 
investigated using in vitro granulomas, which are formed by co-culturing spleen cells 
from S. mansoni infected mice with live eggs obtained from adult worm pairs 
(Bentley et al., 1982; Doughty and Phillips, 1982). Bentley et al., (1982) showed that 
initial eosinophil contact with the egg during the formation of in vitro granulomas 
occurs at the spine. After granuloma formation eosinophils have been observed to 
occupy most parts of the granuloma although they also uniquely locate close to the S. 
mansoni egg (Lenzi et al., 2006). Degranulation and death of eosinophils on the egg 
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shell surface has been described and is termed the Splendore-Hoeppli phenomenon, 
which indicates that eosinophils are involved in the killing of the egg (Kephart et al., 
1988).  
 
Efficient recruitment of eosinophils to the liver requires Th2 cytokines such as IL-5 
and IL-13 (Reiman et al., 2006; Sher et al., 1990), and eosinophils have been shown 
to enhance IL-5 production by CD4+ T cells in the granuloma, thereby promoting Th2 
responses (Metwali et al., 1993). To show this, Metwali et al., (1993) isolated hepatic 
S. mansoni granulomas by liver homogenisation and sedimentation of granulomas, 
followed by digestion for characterisation of granuloma specific immune cells. 
Although eosinophil infiltration is a well established feature of granulomatous 
inflammation, eosinophil deficiency does not alter granuloma formation or pathology, 
which suggests that other immune cells compensate for eosinophils in their absence 
(Swartz et al., 2006).  
 
MΦs have typically been found close to eosinophils and are also present in initial 
granuloma formation (Geuskens et al., 1991). Due to their large size MΦs are also 
distinguishable from other cell types using most dyes. In vitro granuloma studies have 
described MΦs surrounding and covering the egg shell surface by exhibiting a 
flattened morphology (Bentley et al., 1982). As part of the innate first-line defence 
against a pathogen, it is likely that hepatic MΦs are involved in the recruitment and 
activation of immune cells for granuloma formation during schistosomiasis (Sica et 
al., 2014). For example, in early pulmonary granulomas CAMΦs have been shown to 
produce large amounts of TNF-α and IL-1β (Chensue et al., 1989), and together with 
IL-6 these cytokines are thought to be the main primary inducers of cellular 
aggregation during granuloma formation (Boros, 1994). In addition, CAMΦs may be 
involved in egg killing similar to eosinophils, as they exhibit a microbicidal activity 
against the parasite through the production of NO (Gazzinelli et al., 1992; Oswald et 
al., 1992).  
 
As the granuloma develops, MΦs are thought to be influenced by the dominant Th2 
cytokine milieu and become alternatively activated (Metwali et al., 1996; Sandler et 
al., 2003). This hypothesis is supported by high expression of proteins associated with 
alternative activation such as Arg-1, FIZZ-1 and YM-1 by granulomatous tissue 
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(Hesse et al., 2001). Recent studies have shown that AAMΦs in the liver differentiate 
primarily from blood circulating monocytes during S. mansoni infection (Girgis et al., 
2014; Nascimento et al., 2014). The fundamental importance of AAMΦs during S. 
mansoni infection was elucidated in a study using LysMcreIL-4Rα-/flox mice, which are 
deficient in AAMΦs marked by a reduction in Arg-1 and an inability to mediate 
normal wound healing (Herbert et al., 2004). Herbert et al., (2004) showed that mice 
deficient in AAMΦs are unable to survive acute S. mansoni infection. This is linked 
to hepatic damage caused by egg toxins leaking from the granuloma and entry of 
endotoxins into the blood circulation ultimately leading to critical weight loss and 
sepsis. In addition, AAMΦs expressing Arg-1 are thought to act as Th2 suppressor 
cells in more chronic stages of S. mansoni infection (Pesce et al., 2009). Arg-1 is an 
enzyme that catalyses the hydrolysis of arginine to urea and ornithine (Mills, 2001), 
and arginine is a critical resource for CD4+ T cell function (Rodriguez et al., 2007). 
Pesce et al., (2009) showed that Th2 suppression by Arg-1+ MΦs is independent of 
TGF-β and IL-10 production, and the authors suggest that MΦs deplete arginine in the 
environment instead. Thus, AAMΦs are currently thought to contribute to the 
suppression of Th2 immune responses and fibrotic processes particularly during later 
stages of infection (Herbert et al., 2004; Pesce et al., 2009). This is in line with current 
thinking in the literature that a switch from parasite killing functions to wound repair 
by MΦs is likely critical in the face of chronic helminth infection (Barron and Wynn, 
2011). Notably, Nascimento et al., (2014) show that CAMΦs likely remain present 
after the induction of Th2 responses, as expression of iNOS and TNF persists in the 
liver (Nascimento et al., 2014). This suggests that MΦ heterogeneity exists in the 
granuloma throughout S. mansoni infection. Indeed, the type and role of MΦs in the 
S. mansoni granuloma are areas of active research, and it is likely that their functions 
change depending on the immune environment and the stage of granuloma maturity 
(Barron and Wynn, 2011). 
 
The largest cells within the granuloma are the giant cells, which have been described 
in the granuloma after about 45 days of infection (Lenzi et al., 1998). Two different 
types of giant cells have been described in both human and murine infection (el-
Shoura, 1994; Lenzi et al., 1998). One appears randomly and typically locates distant 
to the egg (Lenzi et al., 1998). Its cytoplasm is rich with schistosome pigment 
suggesting they may have similar phagocytic roles compared with MΦs (Lenzi et al., 
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1998). The second type of giant cell is more frequent and found on the surface of the 
egg shell (Lenzi et al., 1998). It is conceivable that giant cells are in fact formed by 
MΦs merging together, and this may be induced by IL-4 (Helming and Gordon, 
2007). However, whether this is the case or what specific role giant cells play in the 
granuloma remains unclear.  
 
Other innate immune cells such as mast cells, DCs, NK cells, NKT cells and 
neutrophils also populate the granuloma although less is known about their location 
and interaction with other cell types compared with eosinophils and MΦs (Hams et 
al., 2013; Weinstock and Boros, 1983). Interestingly, an electron microscopy study in 
1982 using the in vitro granuloma model observed cellular extensions into the egg 
shell pores (Bentley et al., 1982). Although these cells appeared to have a similar 
morphology to MΦs, it is possible that they were in fact DCs, especially as some of 
them were markedly smaller in comparison with MΦs and giant cells, and given that 
DC research was at that time in its infancy. This hypothesis clearly requires further 
investigation, but these early studies may have depicted for the first time DC 
interaction with the S. mansoni egg. The proportion of neutrophils in S. mansoni 
granulomas induced by egg injection was found to be around 10% compared with 
70% eosinophilia (Moore et al., 1977), whereas neutrophils are more frequent in S. 
japonicum granulomas (Hsü et al., 1972; Lichtenberg et al., 1973). Pronounced 
neutrophilia accompanied by increased apoptotic cell populations in the S. mansoni 
granuloma has been reported in Th1 polarised mice (IL-10/IL-4-/-), and these mice do 
not survive acute infection (Hoffmann et al., 2000; 2001). Thus, changes in 
neutrophilia in S. mansoni granulomas may provide an indication of the type of 
immune response orchestrating granulomatous inflammation, which can substantially 
impact the progression of the disease.  
 
Although innate immune responses are clearly involved in the initial formation of 
granulomas, the adaptive immune response including T and B cells forms a major 
constituent of the established granuloma (Lenzi et al., 1998; Weinstock and Boros, 
1983). It has been reported that B cells locate to all regions of the granuloma (Jacobs 
et al., 1999). Although B cells are not required for granuloma formation, they play a 
role in downregulating CD4+ T cell responses during granuloma development 
(Jankovic et al., 1998) (section 1.8.1, chapter 1). T cells have been described mostly 
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in the periphery of the granuloma, but some can be found dispersed throughout every 
zone (Bentley et al., 1982; Chuah et al., 2014; Hams et al., 2013). CD4+ T cells are 
thought to be the main T cell subset present within the granuloma, and the majority of 
CD4+ T cells exhibit an effector/memory phenotype that is S. mansoni egg-specific 
(Hogan et al., 2002; Rumbley and Phillips, 1999). Indeed, CD4+ T cells are required 
for granuloma development during S. mansoni infection, as in their absence 
granuloma formation is impaired resulting in severe hepatotoxicity and accumulation 
of damaged and necrotic cells around the egg (Amiri et al., 1992; Byram and 
Lichtenberg, 1977; Cheever et al., 1999; Doenhoff et al., 1981; Dunne and Doenhoff, 
1983; Mathew and Boros, 1986) (section 1.8.1, chapter 1), whilst CD8+ T cells and γδ 
T cell deficient animals form expected granulomatous inflammation in the liver 
(Iacomini et al., 1995; Yap et al., 1997). In fact, CD4+ T cells are the only key cell 
type that is known to date to be an absolute requirement for hepatic granuloma 
formation during S. mansoni infection. Numerous reports have since pointed to a 
dominant role for Th2 cells and IL-4R signalling for granuloma development, as 
granulomas are often reduced or absent when these processes are impaired 
(Chiaramonte et al., 1999; Fallon et al., 2000a; 2000b; Hernandez et al., 1997; 
Jankovic et al., 1999b; Kaplan et al., 1998; MacDonald and Pearce, 2002; MacDonald 
et al., 2002a; McKenzie et al., 1999) (described in section 1.8.1, chapter 1). These 
findings highlight the importance of Th2 associated mechanisms for appropriate 
granuloma formation that protects the surrounding tissue from S. mansoni egg derived 
toxins (Doenhoff et al., 1981; Dunne et al., 1991; Fallon et al., 2000a). This raises the 
question whether DCs play an important role in granuloma formation, as CD11c+ DCs 
are necessary for the induction of Th2 responses during S. mansoni infection 
(Phythian-Adams et al., 2010). 
3.2.1.1 How might dendritic cells be involved in granuloma formation 
during S. mansoni infection? 
Previous research into the activation and function of DCs during S. mansoni infection 
has essentially focused on early priming of Th2 cells in secondary lymphoid tissue 
(Baumgart et al., 2006; Grzych et al., 1991; McKee and Pearce, 2004; Pearce et al., 
1991; Taylor et al., 2009) (section 1.9, chapter 1), whereas the lack of specific DC 
surface markers and their overall scarcity have discouraged investigation into their 
role during granuloma formation. Given that CD11c+ DCs are required for Th2 
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induction during S. mansoni infection (Phythian-Adams et al., 2010), it is plausible 
that DCs may be required for granuloma formation indirectly (Banchereau and 
Steinman, 1998). This mechanism would involve the polarisation of naïve CD4+ T 
cells towards a Th2 type in lymphoid tissues by S. mansoni egg experienced DCs, and 
subsequent migration of antigen-specific CD4+ T cells to the tissue site (Banchereau 
and Steinman, 1998). In support of this hypothesis, DC co-stimulation has been 
shown to be important for hepatic granuloma formation, as granulomas are reduced in 
size in CD154-/- mice, where DC co-stimulation and Th2 induction are impaired 
(MacDonald et al., 2002a).  
 
Although it can be postulated that DCs are activating naïve CD4+ T cells in the 
granuloma, this is unlikely as the majority of CD4+ T cells within the granuloma are 
effector/memory cells (Rumbley and Phillips, 1999), and naïve T cells are not thought 
to enter the site of inflammation directly and instead recirculate secondary lymphoid 
organs (Girard et al., 2012). However, a growing body of evidence supports the 
concept that the liver is a secondary lymphoid organ (Crispe, 2009). For example, 
hepatic DCs have been reported to mature within the granuloma during P. acnes 
induced granulomatous liver disease and then migrate to the portal tract-associated 
lymphoid tissue (PALT) where they activate naïve T cells (Yoneyama et al., 2001). 
Blood-LN translocation via the hepatic sinusoids has been reported in the rat, creating 
a potential important niche for circulating DCs in the liver (Kudo et al., 1997). 
Therefore, primary T cell activation by DCs in the liver is possible, but it is unlikely 
that this process is occurring locally in the granuloma. This stipulates that DCs 
interact with effector/memory CD4+ T cells in the granuloma (Hogan et al., 2002; 
Rumbley and Phillips, 1999), which could be important for the local maintenance of 
CD4+ T cell responses. Yet, it remains unknown whether DCs interact with 
effector/memory CD4+ T cells within the hepatic granuloma, and little is known about 
DC function in more chronic infection settings when granulomas are well established 
(Pearce and MacDonald, 2002). Effector/memory CD4+ T cells can interact with other 
APCs that express MHC-II, such as B cells (Croft et al., 1994), which are activated at 
the onset of egg production and undergo clonal proliferation during S. mansoni 
infection (Hernandez et al., 1997). Thus, antigen-specific B cells should provide 
another source of TCR stimulation during S. mansoni infection, indicating that DCs 
may not be a fundamental requirement for the maintenance of antigen-specific CD4+ 
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T cell responses. Work in this chapter seeks to better understand DC contribution to 
the development of granulomas during S. mansoni infection, and to determine 
whether DCs are interacting with T cells within the granuloma.  
 
DC subsets perform distinct functions during immune responses against a pathogen, 
and various studies have proposed a dominant role for IRF4 dependent cDCs in the 
induction of Th2 immune responses during allergic inflammation and parasitic 
infection with N. brasiliensis (Gao et al., 2013; Kumamoto et al., 2013; Plantinga et 
al., 2013; Williams et al., 2013) (section 1.9.3, chapter 1). The best example of this 
was shown recently by Plantinga et al., (2013), who used various transgenic mouse 
models to delineate that CD11b+ cDCs are required for the induction of Th2 responses 
against the HDM allergen in the lung. On the other hand, CD8α+ cDCs that are 
dependent on Batf3 have emerged as essential players in the promotion of Th1 and 
CTL responses against acute viral and bacterial infection (Edelson et al., 2010; 
Hildner et al., 2008; Torti et al., 2011; Waithman et al., 2013), and are the main 
producers of IL-12 during T. gondii and L. major infection (Ashok et al., 2014; 
Mashayekhi et al., 2011). The importance of CD8α+ cDCs during chronic infection 
and in Th2 settings has not previously been addressed. Given that mixed/balanced 
Th1/Th2 immune responses are crucial to prevent severe pathology during S. mansoni 
infection (section 1.8.1, chapter 1) (Hoffmann et al., 2000; Wynn et al., 2004), we 
reasoned that the absence of CD8α+ cDCs could alter granuloma formation if Th1 
responses are impaired. Thus, we investigated the role of Batf3 dependent cDCs in 
granuloma formation during S. mansoni infection. Subsequently, the impact of Batf3 
deficiency on the induction of Th1 and Th2 immune responses against S. mansοni 
will be investigated in chapter 4. 
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3.3 Study Rationale 
In this chapter, the role of CD11c+ DCs in hepatic granuloma formation and the 
development of the immune response during the course of murine S. mansoni 
infection were investigated using flow cytometry and microscopy techniques. To 
increase fundamental understanding of how granulomas are generated during 
infection, novel microscopy techniques were developed to determine the total burden 
of granulomatous inflammation (immune cell aggregation and collagen deposition) on 
the liver and the extent of fibrosis over a defined time-course following the initiation 
of egg laying by the parasite. To complement this approach, confocal microscopy was 
used to better define the immune cells present and their location in the granuloma 
over the same time-course, focusing on DCs, MΦs, eosinophils and T cells. 
 
To directly assess the importance of DCs during granuloma formation, the 
CD11c.DOG model was used to enable inducible depletion of cDCs and pDCs 
expressing high levels of CD11c for a window of up to 12 days (section 1.2.2, chapter 
1) (Hochweller et al., 2008). Granuloma formation was examined at D42 (early stage 
granuloma development, with low Th2 responses and minimal hepatic pathology) or 
D52 (later stage granuloma development, with high Th2 responses and more evident 
hepatic pathology) post S. mansoni infection of mice in which CD11c+ DCs had been 
depleted (Pearce and MacDonald, 2002). 
 
To refine our understanding of the relative importance of DC subsets, Batf3-/- mice, 
which specifically lack CD8α+ and migratory CD103+ cDCs (described in section 
1.2.2, chapter 1) (Hildner et al., 2008), were used to determine the role of this 
conventional DC subset in granuloma development during S. mansoni infection.  
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3.4 Results 
3.4.1 Granuloma development during S. mansoni infection 
Granulomatous inflammation in the liver was examined during a time-course 
experiment from D28 to D105 to assess how granuloma area changes during the 
course of infection. This time-frame encompasses various stages in parasite 
development including the pairing of mature S. mansoni adult worms in the mesentery 
(approximately D28) and the onset of egg production (D28-D42), which induces a 
dominant Th2 immune response by the host that becomes downmodulated in more 
chronic stages of infection (approximately D56 to D105) (Pearce and MacDonald, 
2002). As expected, analysis of the parasitology during this time-course revealed no 
major changes in worm burden over time, but a significant increase in the number of 
eggs that accumulated in the liver from D42 onwards (Fig. 3.1A-B). In previous 
literature, hepatic and pulmonary granuloma area has been estimated using various 
different techniques, often subjective and involving time-consuming analysis of 
individual granulomas, typically excluding multiple egg granulomas or those 
containing eggs of certain maturity states from the analysis (Colley, 1975; Domingo 
and Warren, 1968; Hoffmann et al., 1999; Kaplan et al., 1998; Layland et al., 2005; 
Lichtenberg, 1962). Commonly, such techniques would only focus on single egg 
granulomas in a clear cross-section. To objectively quantify the total area of 
granulomatous inflammation in liver sections a novel method was developed (Fig. 
3.1C-D) (this method is described in section 2.6.1, chapter 2). Liver sections (5 µM 
thick) from the median lobe (or left medial lobe (Fiebig et al., 2012)) were stained 
with Masson’s Trichrome (MT), which differentially stains the granuloma as well as 
vascular tissue compared with the surrounding liver parenchyma (Amin and 
Mahmoud-Ghoneim, 2011; Krishna, 2013). An algorithm was used to identify stained 
granulomas or whole tissue, and the number of pixels in the region of interest was 
measured to calculate the total proportion of granulomatous inflammation per liver 
section. The staining of vascular tissue accounts for background values measured in 
naïve animals. Using this novel technique, the total area of granulomatous 
inflammation was observed to increase significantly from D42 until it reached a 
plateau at D84 (Fig. 3.1C). Granulomatous inflammation accounted for up to 50% of 
the total tissue section area from D84 to D105. Eggs continued to accumulate in the 
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liver in this time-frame, suggesting ongoing arrival and deposition of new eggs in 
these more chronic stages of infection (Fig. 3.1B). 
3.4.2 Th2 development during S. mansoni infection  
The type of immune response induced during S. mansoni infection ultimately 
determines the cellular composition of granulomas, and therefore plays an important 
role in the formation of granulomatous inflammation as discussed in section 1.8.1. 
Previous literature investigating T cell responses in the spleen during S. mansoni 
infection have shown that CD4+ T cell responses shift from mixed Th1/Th2 responses 
to a dominant Th2 responses at the onset of egg production (Baumgart et al., 2006; 
Grzych et al., 1991; McKee and Pearce, 2004; Pearce et al., 1991; Taylor et al., 2009), 
but to the best of our knowledge detailed analysis of immune responses in the liver 
has not yet been conducted. To assess how T cell populations change during the 
course of the infection in the liver, ex vivo CD4+ and CD8+ T cell populations were 
examined by flow cytometry (Fig. 3.2A-C). The proportion of hepatic TCR-β+ cells 
stayed at a consistent level during infection until D105 when values were similar to 
naïve levels (Fig. 3.2A-B & D). Analysis of T cell subsets in the liver at D42 of 
infection showed that approximately 52% of TCR-β+ cells were CD4+ T cells and 
35% were CD8+ T cells, and that these proportions were comparable at all the time-
points measured (Fig 3.2A & D). The fold change of numbers of TCR-β+ cells and 
CD4+/CD8+ T cell subsets from infected animals increased between D28 and D42 and 
remained above the naïve baseline throughout infection (Fig. 3.2C).  
 
The character of the hepatic immune response during the course of murine infection 
was assessed by determining the cytokine profile of isolated liver leukocytes in 
response to restimulation with SEA in culture. Supernatants were harvested and 
analysed by ELISA to measure SEA-specific cytokine production. At D28, the level 
of IFN-γ produced by liver leukocytes from infection after restimulation with SEA 
was significantly increased compared with naïve animals (Fig. 3.3A). At D42, there 
was a significant increase in the amount of antigen-specific IL-4, IL-5, IL-10 and IL-
13 produced by liver leukocytes when compared with naïve controls (Fig. 3.3A). The 
level of IL-5 and IL-13 remained significantly increased compared with the amounts 
produced in the antigen-specific restimulation assay by naïve animals at all the time-
points measured (Fig. 3.3A). Although there was a trend for increased levels of IL-4 
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production by liver leukocytes at each time-point compared with naïve controls, the 
absolute amount of IL-4 detected was lower than that of either IL-5 or IL-13. 
However, there was a significant increase in antigen-specific IL-4 at D42 and D84 
(Fig. 3.3A). The amount of IL-10, which is known to be produced by Tregs, Th2 
cells, DCs, B cells and MΦs during S. mansoni infection (Hesse et al., 2004; Sher et 
al., 1991; Stadecker, 1999), was increased significantly from D42 to D105 during 
infection (Fig. 3.3A). The highest fold changes of IL-10 relative to uninfected 
controls were evident at D28 and D105 (Fig. 3.3B). In contrast, there was a striking 
reduction in the fold change of IFN-γ produced by liver leukocytes from infected 
mice compared with naïve mice at D42 until D84 (Fig. 3.3B), consistent with the 
prevailing view in the literature that it is between D42 and D52 of infection that the 
Th2 response begins to dominate in this infection (Grzych et al., 1991; Pearce and 
MacDonald, 2002). These dramatic changes in SEA-specific cytokine production 
coincided with egg production and their accumulation in the liver (Fig. 3.1B), and are 
in keeping with previous descriptions of the changes in cytokine environment in the 
spleen over the course of murine S. mansoni infection (Grzych et al., 1991; Pearce et 
al., 1991; Pearce and MacDonald, 2002; Sher et al., 1991). 
 
To determine whether the trend in SEA-specific cytokine levels reflects T cell 
cytokine production, liver leukocytes were cultured with αCD3/CD28 and assessed by 
flow cytometry after ICC. Cells from the livers were restimulated with αCD3/CD28, 
as this is thought to be a physiologically relevant stimulation for T cells in culture, 
and is less cytotoxic in comparison with other reagents commonly used in vitro or ex 
vivo including PMA/Ionomycin (Olsen and Sollid, 2013) (section 2.8.2, chapter 2). 
An increase in IL-4+ and IL-13+ CD4+ T cell populations in response to polyclonal 
activation was comparable in trend with total cytokine production after SEA 
restimulation measured by ELISA (Fig. 3.3C-D). Furthermore, liver leukocytes from 
infected animals produced more IL-10 relative to cells from naïve animals at all time-
points (Fig. 3.3C). IFN-γ+ CD4+ T cells were detected at relatively high levels in 
naïve animals, and thus the fold change for IFN-γ production during infection did not 
increase much above naïve controls in early stages of infection (Fig. 3.3C-D). 
However, the fold change of IFN-γ expressed by CD4+ T cells in this assay was 
below the naïve baseline from D42-D105 (Fig. 3.3C). A similar trend was seen for 
IFN-γ produced by CD8+ T cells after polyclonal restimulation (Appendix Fig. 7.1B). 
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Thus, ICC analysis of cytokine positive T cells followed the same overall trend as 
cytokines produced by total liver leukocytes in response to SEA. 
3.4.3 High levels of CD11c expression on cDCs and MΦs 
The need for lineage negative markers to distinguish hepatic DCs from other cells 
provides an additional challenge for visualisation of DCs by confocal microscopy, as 
CD11c is also expressed by various immune cells including MΦs and eosinophils 
(Huh et al., 2014; Jakubzick et al., 2006; Lloyd et al., 2008; Niess et al., 2005; 
Throsby et al., 2000). The overall proportion of CD11c expression in the liver was 
unchanged compared with naïve mice from D28 to D84, but was significantly 
increased at D105 (Fig. 3.4A). To assess whether CD11c can be used as a marker for 
hepatic DCs, the expression of CD11c by DCs, MΦs and eosinophils was investigated 
by flow cytometry at D42 of S. mansoni infection when Th2 immune responses are 
induced (Pearce and MacDonald, 2002). Notably, the staining panel used for this 
analysis was originally designed to enable the analysis of the maximum number of 
different immune cells, including T cells and various different DC subsets. Given that 
eosinophils can be identified by their granularity (side scatter, SSC) and low level 
MHC-II expression (van Rijt et al., 2002), the eosinophil marker Siglec-F was not 
used in this case to allow for the use of other monoclonal antibodies (Zhang et al., 
2004). The analysis of different immune cell populations expressing CD11c at D42 
showed that mainly MΦs and cDCs expressed CD11c in naïve mice, whereas few 
eosinophils and pDCs expressed CD11c at D42 of S. mansoni infection (Fig. 3.4B). 
The geometric mean fluorescence intensity (GMFI) of CD11c expression was also 
analysed by flow cytometry and showed that both naïve and infection derived cDCs 
and CD11c-expressing MΦs expressed high levels of CD11c compared with other 
cell types, whereas the expression level was lower for eosinophils and pDCs (Fig. 
3.4C).  
3.4.4 Similar CD11c and TCR-β staining in the granuloma 
The location of CD11c+ cells was investigated during granuloma formation using 
confocal microscopy to further understand their behaviour during infection (Fig. 3.5). 
To assess the location of CD11c+ cells relative to other immune cells, the presence of 
eosinophils and T cells in hepatic granulomas was also examined. In the liver Siglec-
F is expressed exclusively by eosinophils and thus was used to identify these cells in 
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the granuloma (Zhang et al., 2004). TCR-β was used to detect CD4+ and CD8+ T 
lymphocytes, but TCR-β is also expressed by NKT cells (MacDonald, 1995). Yet, 
less than 10% of total liver ex vivo TCR-β+ cells analysed by flow cytometry were 
NK1.1+, which is a surface marker expressed by NKT cells (Koo and Peppard, 1984) 
(Appendix Fig. 7.2). Thus, it was postulated that the majority of TCR-β+ cells in the 
granuloma were T cells as opposed to NKT cells.  
 
Representative confocal photographs of cross-sections from the left liver lobe stained 
for CD11c, TCR-β and Siglec-F are shown for each time-point, which portrayed 
different stages of granuloma formation (Fig. 3.5A). At D28 no eggs were found in 
the tissue (Fig. 3.1B), but disorganised clusters of immune cells, mostly Siglec-F
+
, 
were observed (Fig. 3.5A). From D42 onwards granulomas gradually matured as 
indicated by the more compact and spherical organisation of TCR-β+ and CD11c+ 
cells (section 1.7, chapter 1). CD11c+ and TCR-β+ cells were found in close 
proximity to each other throughout infection, but due to the high density of immune 
cells within the granuloma accurate co-localisation analysis was not possible (Fig. 
3.5A D28-D105). The location of Siglec-F+ cells in the granuloma appeared to be 
distinct from both TCR-β+ and CD11c+ staining; Siglec-F+ cells were often seen very 
close to the S. mansoni egg as well as occupying more peripheral areas of the 
granuloma. Thus, confocal analysis of CD11c+, TCR-β+ and Siglec-F+ staining in the 
S. mansoni granuloma provided valuable information about the approximate locations 
of cells expressing these markers, even though co-localisation analysis could not be 
conducted. 
 
Measuring the surface area of positive staining around the egg in each confocal image 
enabled quantification of TCR-β+, Siglec-F+ and CD11c+ cells in each granuloma in 
terms of total surface area (Fig. 3.5B) (this method is described in detail in section 
2.6.1, chapter 2). The mean values from figure 3.5B were used to determine the 
representative confocal images shown in figure 3.5A. Siglec-F+ and CD11c+ staining 
around the egg increased from D42 to D56 (Fig. 3.5B), and the area measured was 
higher than values obtained from TCR-β+ staining. After D42, the level of Siglec-F+ 
staining decreased, whereas CD11c+ staining around the egg remained constant until 
D105. TCR-β+ staining around the egg increased from D42 to D56 and then remained 
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constant until D84. After D84, TCR-β+ staining decreased again to similar levels 
detected at D42. The kinetics of CD11c+, TCR-β+ and Siglec-F+ positive staining 
during the time-course determined by confocal microscopy were similar to absolute 
cell numbers in the liver assessed by ex vivo flow cytometry (Fig. 3.5C-D). 
Interestingly, the main difference between confocal microscopy and ex vivo flow 
cytometry data was observed when analysing CD11c+ cells. As mentioned, CD11c+ 
cell staining by confocal microscopy remained at a constant level from D56-D105, 
whereas absolute numbers as assessed by flow cytometry on isolated/mixed liver 
leukocytes decreased from D56 to D84 to similar levels seen at D42 (Fig. 3.5B-D). 
Thus, quantification of positive staining around the egg for certain immune markers 
enabled quantification for kinetic analysis of the presence of those cell types 
specifically in the granuloma throughout infection. 
3.4.5 The proportion of granulomas in the liver strikingly 
increases over the course of several days during S. 
mansoni infection 
All of the data thus far indicated that many immunological and pathological changes 
occur suddenly at some time between D42 and D56 of infection. To better define the 
timing of this pivotal step in the initial formation of granulomatous inflammation in 
more detail at early stages of infection, liver sections from the median lobe were taken 
every 3 days from D36 to D51. Analysis of the total proportion of granulomas 
revealed a dramatic increase after D45 resulting in 20% granulomatous inflammation 
in liver sections by D51 (Fig. 3.6A-B). This increase in hepatic granulomas correlated 
with an increase in the number of eggs measured in the liver during the same time-
frame (Fig. 3.6A). 
 
Confocal analysis of sections from the liver showed that granulomas appeared small 
and disorganised at D36 and D39 (Fig.3.7A), even though some eggs were detected in 
the liver during these time-points (Fig.3.6A). However, by D42 the small number of 
granulomas identified had already started to adopt a more spherical shape and 
increased visibly in size (Fig.3.7A). This is supported by confocal measurements of 
cell types within the granuloma, as TCR-β, Siglec-F and CD11c positive staining 
increased gradually from D36 to D48 (Fig. 3.7B). The area of Siglec-F+ and CD11c+ 
staining around the egg increased further until D51, whereas levels of TCR-β+ 
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staining markedly decreased again. Thus, analysis of immune cell presence in the 
granuloma shows that these cells are present within a few days of initial egg 
deposition (Fig. 3.7).  
3.4.6 Collagen formation in the granuloma at early stages 
of development 
Collagen formation in the granuloma provides structure and support, creating the 
typical spherical shape of a mature granuloma as described in section 1.7, chapter 1. 
Although this transformation was visible by confocal microscopy on sections stained 
for immune cell markers, collagen itself could not be identified. Both MT and PSR 
stains have been previously used in the literature to detect collagen deposition in 
tissue sections, but the two dyes differentially stain collagen: PSR stains type I (thick 
fibres) and type III (thin fibres) collagen, whereas MT stains only type III collagen 
(Calvi et al., 2012). MT often produces variable results in terms of collagen 
measurements, and it has been suggested that the quality of collagen staining with MT 
is dependent on the structural arrangement and density of collagen fibres (i.e. more 
densely packed collagen may prevent the blue dye from entering the structure 
efficiently) (Whittaker et al., 1994). Comparison between liver sections stained with 
MT and PSR revealed slightly different patterns; MT stained the total area of 
granulomatous inflammation including the accumulation of immune cells and 
initiation of fibrosis, whereas PSR highlighted mainly the periphery of the granuloma 
(Fig. 3.8A). Thus MT, but not PSR, stains other features of the granuloma as well as 
collagen including nuclei of immune cells and other basophilic structures 
(components that take up basic dyes) (Amin and Mahmoud-Ghoneim, 2011; Diaz 
Encarnacion et al., 2004; Whittaker et al., 1994). For these reasons MT was used to 
measure overall granulomatous inflammation, whereas PSR staining was used to 
more accurately quantify collagen as a measure of fibrosis. 
 
Collagen deposition in PSR stained median liver lobe sections was measured with the 
same novel technique used previously for MT stained sections (Fig 3.8B-C). The 
level of collagen detected by PSR was only marginally above naïve values until D45 
post infection, after which it significantly increased to approximately 15% of total 
liver area by D51 (Fig. 3.8B) (MT data reproduced from figure 3.6B for ease of direct 
comparison with PSR). 
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3.4.7 TCR-β+ staining around the S. mansoni egg is 
reduced in the absence of CD11c+ DCs at D42 
Having shown that CD11c+ cells are present in the granuloma at early stages of 
formation (Fig. 3.5 & Fig. 3.7), we next investigated the total proportion of 
granulomatous inflammation and immune cell presence in hepatic granulomas 
following targeted depletion of CD11c+ cells. Phythian-Adams et al., (2010) reported 
that CD11c+ DCs are necessary for the induction of Th2 responses during S. mansoni 
infection, which raised the possibility that granuloma formation would also be 
reduced in the absence of these cells. CD11c.DOG mice were used to deplete 
CD11c+/high cells from S. mansoni infected mice by administration of DTx 12 days 
before harvest (from D29 to D40), whereas control animals were treated with PBS. 
Granulomatous inflammation was quantified using liver sections stained with MT as 
before. As shown previously (Fig. 3.1C) the proportion of granulomas as measured by 
MT staining at D42 post infection was very low (<0.4% of tissue), and not 
significantly greater in infected mice relative to naïve controls (Fig. 3.9A). In 
addition, CD11c depletion had little impact on the proportion of granulomatous 
inflammation at this early stage of granuloma formation (Fig. 3.9A). However, 
granuloma specific measurements by confocal microscopy confirmed that depletion 
with DTx significantly reduced levels of CD11c+ and TCR-β+ staining in granulomas 
compared with PBS controls (Fig 3.9B). The variation between the results following 
CD11c depletion suggests that histological quantification of total granulomatous 
inflammation and confocal measurements of immune cells within the granuloma are 
complementary but not directly comparable. As such, confocal microscopy provides a 
method for detailed analysis of specific immune cells as opposed to total 
granulomatous inflammation. Siglec-F staining was not addressed, as the staining for 
this marker had not yet been optimised at the time of the experiment. 
3.4.8 The structure and composition of granulomas is 
altered in the absence of CD11c+ DCs at D52 
I have shown that the proportion of granulomatous inflammation increased 
substantially between D42 and D51 of S. mansoni infection (Fig. 3.6B), which 
suggests that the impact of CD11c depletion may be more dramatic at D51 compared 
with D42. To understand better the role for CD11c+ DCs at later stages of granuloma 
99 
formation, CD11c+ cells were depleted from D42 to D51 of infection (Fig. 3.10). 
Measuring granuloma area at D52 following depletion indicated no change in total 
granulomatous inflammation comparing infected DTx treated with PBS control 
animals (Fig. 3.10A). Again, CD11c+ staining in the granuloma was significantly 
decreased in DTx treated mice compared with controls, confirming depletion of this 
cell type in these animals (Fig. 3.10B). Interestingly, Siglec-F+ staining around the 
egg was also decreased significantly in DTx treated compared with control mice, 
whereas the apparent reduction in TCR-β+ staining was not significant. This indicates 
that although granulomas developed in CD11c depleted animals, the cellular 
composition of their hepatic granulomas was altered as compared with control 
animals. Although confocal images revealed that granulomas formed in DTx treated 
mice, the majority of positive staining for immune cells located to the periphery of the 
granuloma, depicting a different structure compared with granulomas in control mice 
(Fig. 3.10C). In particular, the location of TCR-β+ staining was focused at the 
periphery rather than throughout every region of the granuloma as in undepleted 
controls. 
3.4.9  The composition of granulomas is altered in Batf3-/- 
mice at D42 
To investigate more specifically which DC subsets are important for granuloma 
formation, we used Batf3-/- mice to address the role of CD8α+ cDCs relative to total 
CD11c+ DCs at D42 of infection. The Batf3 deficient phenotype will be addressed 
comprehensively in chapter 4, when the ability of these animals to induce Th2 
immune responses will be assessed. Although Batf3-/- mice showed no significant 
alterations in total granulomatous inflammation at this time-point (Fig. 3.11A), a 
trend for increased fibrosis compared with infected WT mice was observed (Fig. 
3.11B). Notably, the proportion of granulomatous inflammation detected in this 
experiment was higher than in CD11c.DOG control mice at D42 (Fig. 3.9A), and this 
may be due to variability in the onset of egg production during the infection (i.e. 
earlier egg production in WT mice shown in figure 3.11 compared with control mice 
in figure 3.9 would result in advanced granuloma development). The levels of total 
CD11c+ cells in granulomas were significantly decreased, even though only one 
subset of DCs was depleted (Fig. 3.11C). As opposed to the global CD11c+ depletion 
model at D42 (Fig 3.9B), TCR-β+ staining was unchanged in Batf3-/- mice compared 
100 
with WT mice as was Siglec-F + staining (Fig. 3.11C). Finally, confocal images of 
granulomas did not depict obvious differences in granuloma composition when 
CD8α+ cDCs were reduced (Fig. 3.11D), which underlines the value of quantifying 
the presence of specific immune cells in the granuloma.  
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3.5 Summary of main results 
• The induction of Th2 immune responses in the liver correlated with the arrival 
of S. mansoni eggs and the formation of granulomatous inflammation (Fig. 3.1 
& Fig. 3.3). 
• The total proportion of granulomatous inflammation did not decrease in 
parallel with Th2 downmodulation in chronic stages of infection (Fig. 3.1 & 
Fig. 3.3). 
• Granulomatous inflammation, collagen deposition and the arrival of CD11c+, 
Siglec-F+ and TCR-β+ cells in the liver occurred rapidly within a few days 
around D45 of infection following the onset of egg production (Fig. 3.6 & Fig. 
3.7 & Fig. 3.8). 
• CD11c+ and TCR-β+ cells localised in close proximity to each other in the 
granuloma throughout infection (Fig. 3.5). 
• TCR-β+ staining around the egg in the liver decreased in CD11c depleted mice 
(CD11c.DOG mice) at D42 (Fig. 3.9), but not D52 (Fig. 3.10).   
• The location of TCR-β+ staining around the egg was focused at more 
peripheral areas of the granuloma in CD11c deficient mice at D52 of infection 
(Fig. 3.10). 
• The total proportion of granulomatous inflammation in the liver was 
unchanged in DTx treated CD11c.DOG mice at D42 and D52 (Fig. 3.9 & Fig. 
3.10). 
• The total proportion of granulomatous inflammation, fibrosis and Siglec-F+ 
and TCR-β+ staining in the liver was unchanged in Batf3-/- mice at D42 of 





The work presented in this chapter provides further insight into the intimate 
relationship between how long the mammalian host has been infected, immune 
response development and granuloma formation during S. mansoni infection. 
Investigating the role of DCs in these processes revealed that the presence of T cells 
in the granuloma during S. mansoni infection is severely reduced following depletion 
of CD11c+ cells prior to egg arrival in the liver. Furthermore, the location of T cells 
was found to be different when CD11c+ cells were depleted a few weeks later and 
granulomatous processes were already established. In contrast, the absence of CD11c+ 
CD8α+ cDCs alone did not reduce T cell populations in the granuloma at D42, but 
decreased the presence of CD11c+ cells substantially. These novel data elevate current 
understanding of which immune cells are important for granuloma formation, 
suggesting that DCs are critical for normal T cell presence, and that CD11c+ CD8α− 
DCs may play a dominant role in this process.  
3.6.1 Granuloma formation during S. mansoni infection 
The development of CD4+ T cell responses during S. mansoni infection is best 
characterised in the spleen (and to a lesser extent mLNs), and is hallmarked by a 
switch from mixed Th1/Th2 responses to dominant Th2 responses against the eggs at 
approximately D42 of infection (Baumgart et al., 2006; Grzych et al., 1991; McKee 
and Pearce, 2004; Pearce et al., 1991; Taylor et al., 2009) (section 1.8, chapter 1). We 
have shown for the first time that a similar immune response kinetic occurs in the 
liver, an important site for egg deposition and pathology during S. mansoni infection 
(Cheever, 1987); analysis of cytokines produced by liver leukocytes from D42 to D56 
in response to SEA showed that strong Th2 responses were induced during this time-
frame, whereas Th1 responses decreased (Fig. 3.3). In addition, our data indicate that 
the amount of antigen-specific IL-10 produced by liver leukocytes increased in 
parallel with Th2 cytokine production. As might have been expected from the ELISA 
results, qualitative analysis of CD4+ T cell cytokine expression following polyclonal 
restimulation showed that the ratio of CD4+ T cells from infection that stained 
positive for Th2 cytokines and IL-10 increased compared with naïve mice from D42 
to D56, whereas the fold change of IFN-γ+ CD4+ T cells decreased. In line with these 
results, IL-10 production by SEA-restimulated splenocytes has been reported to 
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increase when Th1 responses decrease during S. mansoni infection (Sher et al., 1991). 
Enhanced IL-10 production is thought to represent increases in Th2 as well as iTreg 
responses, since these cell types are the main producers of IL-10 during S. mansoni 
infection (Baumgart et al., 2006; McKee and Pearce, 2004). Thus, we have shown 
that the induction of dominant Th2 and regulatory responses correlates with 
downmodulation of Th1 responses in the liver, which is in line with the previous 
literature that has described this type of immune response development in secondary 
lymphoid organs (Pearce and MacDonald, 2002).  
 
Th2 cytokine production and proliferation in the spleen and liver is downmodulated in 
more chronic stages of infection (after D56) (Wilson et al., 2007), which is associated 
with upregulation of GRAIL expression by hyporesponsive CD4+ T cells (Taylor et 
al., 2009) (section 1.8.2, chapter 1). Th2 downmodulation is an area of active research 
and is currently thought to be mediated by immune cells including Tregs, B cells and 
AAMΦs via IL-10 dependent and/or independent pathways (section 1.8.1, chapter 1) 
(Lundy and Lukacs, 2013; Wilson et al., 2007). Failure to suppress Th2 responses 
during more chronic S. mansoni infection is linked with overt pathology and increased 
mortality due to uncontrolled Th2 mediated fibrosis and granulomatous inflammation 
in both human and murine schistosomiasis (Hoffmann et al., 2000; Wynn et al., 
2004). Although Taylor et al., (2009) reported a decrease in IL-4 production by 
hepatic CD4+ T cells at D112 compared with D56, no reports have conducted a 
detailed kinetic analysis of Th2 cytokine production in the liver during this time-
frame. We show that antigen-specific Th2 responses gradually decreased from D56 to 
D105, whereas IL-10 production relative to naïve animals increased (Fig. 3.3B). As 
such our data is in line with previously published reports that have described 
downmodulation of Th2 responses and increased regulatory responses in later stages 
of infection (Lundy and Lukacs, 2013; Wilson et al., 2007), and we have additionally 
conducted a more comprehensive analysis of the immune response kinetics in the 
liver. 
 
Notably, non CD4+ T cell cytokine production plays an important role during the 
course of S. mansoni infection and should not be underestimated (Herbert et al., 2004; 
Oliphant et al., 2014; Rumbley et al., 1999). For example, CD8+ T cells also produce 
IFN-γ, and innate immune cells such as NK cells and ILCs are likely to be 
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contributing to the cytokine pool during infection (Czaja et al., 1989; Frucht et al., 
2001; Fuchs et al., 2013; Pedras-Vasconcelos and Pearce, 1996; Shang et al., 2000). 
Yet, our data as well as previous literature suggest that CD4+ T cells are the main 
producers of Th1 and Th2 cytokines in response to S. mansoni eggs (Fig. 3.3C 
compared with Appendix Fig. 7.1) (Baumgart et al., 2006; Grzych et al., 1991; 
McKee and Pearce, 2004; Pearce et al., 1991; Taylor et al., 2009).  
 
By developing a novel technique to objectively determine the proportion of 
granulomatous tissue within whole liver sections, we were able to assess changes in 
granulomatous inflammation as CD4+ T cell immune responses develop during the 
course of S. mansoni infection (Fig. 3.1). To our knowledge, this new approach is the 
first to enable objective quantification of the total burden of granulomatous 
inflammation and collagen deposition in the liver during S. mansoni infection. When 
investigating hepatic granulomas it is important to consider that new eggs 
continuously arrive in the tissue (Gryseels et al., 2006; Pearce and MacDonald, 2002), 
which means that individual granulomas are likely to be at different stages of 
maturation. Furthermore, multiple eggs in a cluster could pose more of a threat 
compared with those containing a single egg, and may induce larger and more intense 
granulomas that take longer to mature and control. Previous techniques that have 
selected individual granulomas and estimated area or volume based on manually 
identifying their perimeter potentially bias the readout. In fact, our results show that 
early granulomas are often irregular (Fig. 3.7A). The technique described in this 
thesis largely overcomes these caveats, and provides an efficient method for the 
objective quantification of total granulomatous inflammation at every time-point. 
Additionally, this quantification method can be utilised in future to measure other 
tissue components (i.e. lipid accumulation) as long as the feature of interest can be 
efficiently distinguished from the liver parenchyma.  
 
Using conventional methods for granuloma measurements, various previous studies 
have reported an increase in granuloma volume or area in the liver when Th2 
responses are induced during S. mansoni infection (Boros et al., 1975; Haseeb et al., 
2001). We have shown that the total proportion of granulomatous inflammation, 
including the accumulation of inflammatory immune cells and the initiation of 
fibrosis, increased dramatically from D42 to D56 (Fig. 3.1). This increase in 
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granulomatous inflammation correlated with the detection of S. mansoni eggs in the 
liver (D42). Together these results indicate that initial granuloma formation in the 
liver begins at a time-point when there is a mixed Th1 and Th2 immune response 
(Fig. 3.3), and this supports the literature view that significant increases in the size of 
granulomas is associated with dominance of Th2 responses (Grzych et al., 1991; 
Pearce et al., 1991; Pearce and MacDonald, 2002; Vella and Pearce, 1992).  
 
Following the initial formation of granulomas, we have identified that the total 
proportion of granulomatous inflammation present in the liver markedly increased 
from D56 to D84 post infection, when a plateau is reached (Fig. 3.1). This suggests 
that total granulomatous inflammation continues to increase until regulatory responses 
are well established and Th2 cytokine responses are reduced to levels similar to D28 
prior to egg production (Fig. 3.3B) (Lundy and Lukacs, 2013; Pearce and MacDonald, 
2002). Moreover, granulomatous inflammation persists following Th2 
downmodulation until at least D105. In support of these findings, Hasseeb et al., 
(2001) report that the volume of individual newly formed hepatic granulomas during 
S. mansoni infection increases from D56 to D70 (later time-points were not analysed). 
However, other studies have proposed that the size of newly formed granulomas in 
the lung following egg injection and in the liver during active infection decreases 
from D56 to approximately D140 (8-20 weeks) (Boros et al., 1975; Colley, 1975). 
Indeed, it is frequently thought that granuloma size decreases in correlation with the 
downmodulation of Th2 immune responses during more chronic stages of infection 
(Lundy and Lukacs, 2013; Wilson et al., 2007). The discrepancies between these 
studies may reflect the subjectivity in identifying newly formed granulomas for 
analysis, which are generally determined by pronounced eosinophilia and an intact S. 
mansoni egg (Colley, 1975). This highlights that the kind of quantification method 
used and the types of granulomas included in the analysis are important factors to 
consider when measuring granulomatous inflammation.  
 
Our analysis of granulomatous inflammation during later stages of S. mansoni 
infection suggests that a decrease in Th2 responses does not lead to immediate 
resolution of established granulomas (i.e. collagen degradation) or prevent the 
formation of new granulomas. Indeed, the formation of new granulomas is required 
throughout S. mansoni infection to protect surrounding hepatocytes from toxins 
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produced by the egg, as new eggs continuously arrive in the liver (Fig. 3.1) (Gryseels 
et al., 2006; Pearce and MacDonald, 2002). It is possible that granulomas formed 
against newly arrived eggs in more chronic stages are smaller than those formed 
during peak Th2 responses, which is likely due to reduced immune cell aggregation 
following Th2 downmodulation (Lundy and Lukacs, 2013). Yet, hyporesponsive Th2 
cells are detected in the liver at least until D112, which suggests that these cells 
remain a constituent of the granuloma even though Th2 effector functions are 
suppressed (Taylor et al., 2009). Moreover, granulomas are thought to exhibit a more 
fibrotic phenotype containing predominantly thick type I collagen fibres during more 
chronic stages of infection (Silva et al., 2000), as collagen fibres, fibroblasts and 
numerous innate immune cells including MΦs remain present in hepatic granulomas 
when Th2 responses are downmodulated (Lenzi et al., 1998; Silva et al., 2000). Taken 
together, regulation of Th2 responses in later stages of infection is critical for the 
prevention of overt Th2 dependent pathology (Hoffmann et al., 2000; Wynn et al., 
2004), but granulomas must persist at some level to allow for sufficient protection 
against egg derived toxins (Dunne et al., 1991; Fitzsimmons et al., 2005). Thus, 
investigating the development and resolution of the granulomatous response through 
measurement of total area as performed in this chapter may be a more accurate 
description of egg-induced pathology in the liver during S. mansoni infection 
compared with the analysis of individual granulomas. This has important implications 
for understanding the progression of the disease, as inflammatory and fibrotic 
responses against S. mansoni eggs in the liver are responsible for most of the severe 
pathology experienced by the host (Wynn et al., 2004). 
3.6.2 The presence and location of CD11c+ cells during 
granuloma development 
Once the kinetics of the development of granulomatous pathology throughout S. 
mansoni infection was established, we were able to assess the location of specific 
immune cells within granulomas during the course of infection. Previous studies 
investigating immune cell location during granuloma formation in vivo or in vitro 
have predominantly used light or electron microscopy, which enables analysis of 
cellular size and morphology (Bentley et al., 1982; Lenzi et al., 1998). By using 
confocal microscopy and quantifying the positive staining for cell surface markers, 
we were able to analyse the location and presence of specific immune cells that may 
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be involved locally in granuloma development during infection. Our data show that 
clusters of immune cells (including CD11c+ cells) and disorganisation of the 
parenchyma are visible in the liver before egg arrival (Fig. 3.5A D28). Maturing 
larval schistosomes are carried by the blood flow through the body before settling in 
the mesentery and developing to adulthood (Pearce and MacDonald, 2002). Thus, the 
release of larval and adult antigens into systemic circulation could lead to hepatocyte 
damage and immune activation in affected areas prior to egg deposition (Hams et al., 
2013).  
 
When egg production begins between D28-D42 (Pearce and MacDonald, 2002) (Fig. 
3.1B), it is likely that egg-derived antigens are carried in the bloodstream to the liver 
before the eggs themselves arrive. Additional mechanical injury to the tissue as well 
as toxic damage is then caused when eggs enter the liver through sinusoids (Doenhoff 
et al., 1981; Dunne et al., 1991). At this stage immune cell aggregates become more 
defined and start enveloping the egg (Fig. 3.5A, D42), whilst also creating more space 
by destroying surrounding damaged hepatocytes (Lenzi et al., 2006) (section 1.7, 
chapter 1). The kinetic trend for the presence of CD11c+ cells during granuloma 
formation observed by quantification of surface marker staining detected around the 
egg by confocal microscopy was similar compared with data from ex vivo flow 
cytometry, and provided an indication of the presence of DCs in the granuloma. Both 
techniques showed that CD11c expression drastically increased from D42 to D56 
(Fig. 3.5), when Th2 cytokine production by liver leukocytes and granulomatous 
inflammation in the liver were induced (Fig. 3.3). An interesting deviation in the trend 
observed with flow cytometry and confocal microscopy was found during more 
chronic stages of infection; CD11c+ cells remained in the granuloma at high levels, as 
assessed by confocal analysis focusing on granulomas, whereas flow cytometry 
showed an overall decrease in the number of CD11c+ cells in the liver (Fig. 3.5, D56 
– D105). These data highlight one of the advantages of using confocal microscopy 
quantification techniques over flow cytometry, as the ability to focus on granulomas 
specifically has raised the possibility that CD11c+ cells remain involved in the 
granuloma during resolution in chronic stages of infection, even though flow 
cytometry indicates that their proportions decrease in the whole tissue at these time-
points. Overall, our data suggest that DCs play a role in granuloma development 
108 
throughout infection, including the progression to more mature and fibrotic 
granulomas and possibly subsequent resolution of granulomatous inflammation.  
 
The period of infection between D36 and D51 is crucial during S. mansoni infection, 
as this time-frame encompasses the arrival of eggs into the liver and the induction of 
dominant Th2 immune responses and granuloma formation (Grzych et al., 1991; 
Pearce and MacDonald, 2002). Thus, this time-course experiment enabled a more 
detailed analysis of which immune cells are present during initial stages of granuloma 
development. Eosinophils and MΦs are thought to be the first innate immune cells to 
arrive in the liver when eggs become lodged in the parenchyma (Lenzi et al., 1998), 
but the presence of DCs during this process has not been directly addressed. Using 
confocal microscopy we have shown that CD11c+ cells are present at early stages of 
granuloma formation (Fig. 3.7, D36), which suggests DCs are possibly amongst the 
first responders to arrive around the S. mansoni egg lodged in the liver parenchyma. 
 
One disadvantage associated with using CD11c as a marker for DCs in the granuloma 
for analysis by confocal microscopy is that other immune cells express CD11c (Huh 
et al., 2014; Jakubzick et al., 2006; Niess et al., 2005) (Fig. 3.4). Although CD11c has 
infrequently been used to identify hepatic MΦs (Davies et al., 2013), high levels of 
CD11c expression is common by MΦs present in the LP (Niess et al., 2005) and in 
the lung (Jakubzick et al., 2006). Eosinophils express low levels of CD11c (Huh et al., 
2014), but higher levels are found on some thymic eosinophils (Throsby et al., 2000). 
Thus, we investigated the level of CD11c expression by hepatic MΦs, eosinophils, 
and DC subsets by flow cytometry to better understand which immune cells are likely 
detected when using this marker for confocal microscopy analysis. These data 
indicate that cDCs expressed high levels of CD11c, whereas pDCs and eosinophils 
expressed only low levels of this integrin. In support of this, previous literature has 
shown pDCs (Merad et al., 2013) and eosinophils (Huh et al., 2014) to express low 
levels of CD11c compared with cDCs. Notably, some hepatic MΦs, either monocyte-
derived or resident Kupffer cells (Davies et al., 2013), expressed CD11c at similar 
levels compared with cDCs at D42 of S. mansoni infection. Indeed, it has been 
reported that MΦs detected by confocal microscopy upregulate CD11c in the liver 
during steatohepatitis, which is a model for liver inflammation (Lloyd et al., 2008). 
The authors suggested that CD11c is upregulated on resident hepatic F4/80+ CD11b− 
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MΦs during inflammation, but the possibility that some of these cells may represent a 
subset of DCs was not addressed. Recently, it has also been shown that hepatic F4/80+ 
CD11chigh MΦs can be detected in high frequencies by flow cytometry in S. mansoni 
infected mice (Nascimento et al., 2014). Taken together, CD11c positive staining in 
the granuloma assessed by confocal microscopy most probably identifies CD11chigh 
cDCs and MΦs, whereas pDCs and eosinophils are not detected with this marker. 
Given that it is not possible to definitively distinguish cDCs from MΦs by confocal 
microscopy using CD11c alone, it is conceivable that CD11c expression in the 
granuloma reflects the presence of both of these cell types throughout granuloma 
development.  
3.6.2.1 Functions of dendritic cells and macrophages in the S. mansoni 
granuloma  
Hepatic cDCs and MΦs may exhibit various different functions as the immune 
response and the granuloma develops during S. mansoni infection. Given that DCs are 
thought to be superior APCs (Steinman, 2012), we hypothesised that DCs play a dual 
role in directing T cell responses during granuloma formation: DCs may be important 
indirectly via the priming of CD4+ T cells towards a Th2 phenotype in secondary 
lymphoid tissue, whilst DCs in the liver may support the maintenance of 
effector/memory CD4+ T cells locally (section 3.2.1.1). On the other hand, AAMΦs 
have been reported to mediate the suppression of Th2 responses in the liver during S. 
mansoni infection via the depletion of Arg-1 (Pesce et al., 2009). This suggests that 
AAMΦs are not major players in the maintenance of Th2 responses in established 
granulomas, and instead they exert a level of regulation on effector/memory CD4+ T 
cells indirectly by depleting nutrients that are important for the survival of CD4+ T 
cells (Pesce et al., 2009). Notably, some functions displayed by DCs and MΦs in 
granuloma formation may overlap. For example, the initial recruitment of 
inflammatory cells via the production of cytokines to peripheral sites of inflammation 
is generally a function attributed to CAMΦs (Soehnlein and Lindbom, 2010), but DCs 
also secrete cytokines including TNF-α and IL-6 in response to LPS (Lacy and Stow, 
2011; Morelli et al., 2001). Therefore, it is plausible that in the presence of TSLP 
and/or S. mansoni egg derived antigen cDCs become activated in the liver and recruit 
inflammatory cells to the granuloma (Paul and Zhu, 2010). 
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Another aspect of granuloma formation that may be at least in part orchestrated by 
cDCs and/or MΦs is the synthesis and degradation of collagen. Granuloma formation 
during S. mansoni infection is marked by substantial collagen deposition by HSCs and 
myofibroblasts (Hams et al., 2013; Wilson et al., 2007), which is thought to provide 
an organised extracellular network for the bidirectional movement of immune cells 
from the parenchyma to the egg (Lenzi et al., 2006). It is unlikely that DCs direct 
collagen synthesis during S. mansoni infection, as they have been shown to be 
inefficient activators of myofibroblasts during experimental liver fibrosis (Pradere et 
al., 2013). In contrast, the same study reported that MΦs effectively activate the NF-
κB pathway in HSCs, which increases HSC survival in vitro and in vivo and promotes 
progression into a myofibroblastic phenotype (Pradere et al., 2013). The authors 
propose that both CAMΦs and AAMΦs may contribute to the promotion of collagen 
synthesis during experimental fibrosis in the liver. Therefore, MΦs, but not cDCs, 
may be important to drive initial fibrosis during granuloma formation in S. mansoni 
infection.  
 
During later and more chronic stages of infection, granuloma resolution requires the 
degradation of fibrotic material and the clearance of dead cells when Th2 immune 
responses are downmodulated (Lundy and Lukacs, 2013), which is also a function 
often attributed to MΦs (Wynn and Barron, 2010). In particular AAMΦs are known 
to be important in wound healing processes in the liver as well as the intestine to 
prevent sepsis (Herbert et al., 2004) (section 3.2.1). Notably, a role for DCs in 
collagen degradation has been proposed; DCs mediate the regression of experimental 
hepatic fibrosis via a matrix metallopeptidase (MMP9) dependent mechanism (MMPs 
are enzymes that degrade extracellular matrix components) (Jiao et al., 2012). This 
suggests that cDCs may contribute to collagen degradation during later stages of 
granuloma development in S. mansoni infection. Therefore, CD11c+ cells that were 
present in later stages of infection as shown by confocal microscopy (Fig. 3.5 D56-
D105) may represent both MΦs and cDCs that are involved in granuloma resolution, 
but a role for DCs in this process during S. mansoni infection remains to be 
established.  
 
In summary, MΦs in S. mansoni granulomas are likely important for the initiation and 
regulation of Th2 dependent fibrosis, and the latter may be orchestrated in part by 
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indirect suppression of Th2 immune responses (Pesce et al., 2009; Pradere et al., 
2013). On the other hand, DCs generally possess an unrivalled ability to present 
antigen to T cells particularly during T cell priming events (Mildner and Jung, 2014), 
which suggests that direct interaction with effector/memory T cells is perhaps a more 
likely function performed by DCs locally in the granuloma. 
3.6.3 The kinetics of T cell presence and location in S. 
mansoni granulomas 
When eosinophils, MΦs and likely DCs form the initial barrier around the egg during 
early granuloma formation, the presence of lymphocytes is rare (Lenzi et al., 1998). In 
agreement with this, confocal analysis of TCR-β+ staining in this chapter indicates 
that few T cells are present in the granuloma at this stage compared with CD11c+ 
cells and Siglec-F+ cells (Fig. 3.7 D36 - D45). A delay in T cell ingress to the 
granuloma relative to cDCs, MΦs and eosinophils is likely due to the difference in the 
core functions of innate and adaptive immune cells during characteristic immune 
responses against a pathogen: the adaptive immune response is antigen-specific and 
requires activation mediated by APCs, predominantly DCs, in secondary lymphoid 
tissues (Janeway and Medzhitov, 2002). As such, DC activation and migration to the 
LN must occur prior to the arrival of egg antigen-specific CD4+ T cell arrival in the 
granuloma. The small proportion of T cells present prior to substantial egg antigen-
specific effector CD4+ T cell arrival may represent cross-reactive effector/memory T 
cells responding to antigen from previous parasite life cycle stages (Lukacs and 
Boros, 1991). Overall, we have provided detailed analysis of the timing of T cell 
arrival and distribution in the granuloma, which is in line with expectations from 
previous literature that has shown innate immune cells including eosinophils to 
surround the egg prior to the detection of lymphocytes (Lenzi et al., 1998).   
 
Confocal data showing the presence of T cells from D45 to D51 suggest that at early 
time-points relative to granuloma formation antigen primed T cell populations may 
arrive sequentially into the granuloma, as positive staining for TCR-β increases from 
D45 to D48, but then rapidly decreases again at D51 (Fig. 3.7B). This kinetic has 
been previously described in vivo during repeated antigen exposure with OVA, when 
primary antigen stimulation leads to a first “wave” antigen-specific T cell response 
that is followed by a stronger and faster T cell response when a second antigen dose is 
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administered (Hutchison et al., 2009). However, this hypothesis seems improbable as 
continuous antigen exposure in the liver after the onset of egg production likely 
results in uninterrupted recruitment of T cells to the granuloma. To investigate 
whether T cell recruitment to the granuloma is in fact staggered, a repeat of this time-
course including later time-points could be conducted, and flow cytometric analysis 
of T cell numbers present in the liver or isolated granulomas during this time-frame 
would compliment confocal microscopy data.  
3.6.4 Eosinophil presence and distribution throughout 
granuloma development in S. mansoni infection 
Eosinophils are known to be amongst the first responders in the liver, most likely 
induced by increased IL-5 production as the Th2 immune response is generated 
(Chiaramonte et al., 1999; Fallon, 2000; Reiman et al., 2006; Sher et al., 1990). We 
have also shown that eosinophils were present during initial stages of granuloma 
formation by using confocal microscopy. Close positioning of eosinophils to the egg 
suggests a role for this cell type in egg killing, sequestration of toxic components or 
the formation of an early physical barrier between the egg and surrounding host cells 
(Olds and Mahmoud, 1980) (James and Colley, 1978) (Fig. 3.5 & 3.7). These 
functions are probably not specific to eosinophils, however, as eosinophil ablation 
does not impair granuloma formation (Swartz et al., 2006).  
 
In summary, our data support the concept that granulomatous inflammation against S. 
mansoni eggs lodged in the tissue takes only a few days to initiate (Bentley et al., 
1982). The surprisingly rapid accumulation of immune cells and initiation of fibrosis 
emphasises that pathology during S. mansoni infection is induced promptly when the 
immune response shifts to a dominant Th2 response against the eggs (Grzych et al., 
1991). In addition, the data provide depth to current understanding of the kinetics and 
location of initial immune cell arrival at the egg during S. mansoni infection. 
Although our data implicate D45 specifically as a tipping point in this transition, the 
exact timing may vary between infections since it likely depends on the maturation of 
the parasite, the onset of egg deposition, and the consequent initiation and 
development of a Th2 dominated immune response (Pearce and MacDonald, 2002). 
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3.6.5 Collagen formation during granuloma development  
In addition to the rapid recruitment of immune cells to the granuloma, we have shown 
that collagen type I and III deposition begins to increase substantially within a short 
period of time after the onset of egg production at approximately D45 (Fig. 3.8). In 
support of this finding, a study from 1982 using the in vitro granuloma model 
described in section 3.2.1 has reported the presence of fibroblasts 3 days following 
initiation of culture, and significant collagen deposition was visible after 9 days 
(Bentley et al., 1982). The collagen isotype in granulomas is known to change from 
predominantly type III to type I during murine (Grimaud et al., 1987; Silva et al., 
2000) and human (Adnani, 1985) S. mansoni infection. Type IV collagen, which is 
not detected with PSR staining, has also been found in S. mansoni granulomas (Silva 
et al., 2000), but this isotype is less prevalent compared with type I and III collagen 
(Grimaud et al., 1987). Analysis of PSR stained sections using a microscope 
polarising filter would allow for differentiation of type I and type III collagen in 
future, which is observed red and green respectively (Hoffmann et al., 2000; 
Junqueira et al., 1978; Pauschinger et al., 1999). Furthermore, the analysis of 
profibrotic genes for α-SMA or collagen type I by PCR, measurement of 
hydroxyproline content in liver tissue or determining hepatic injury by ALT 
measurement would provide additional support for fibrotic measurements 
(Loebermann et al., 2009). This data further underlines the rapid onset of 
granulomatous inflammation during S. mansoni infection.  
3.6.6 Are dendritic cells and T cells interacting in the 
hepatic S. mansoni granuloma? 
Having established the presence and kinetics of DCs/MΦs, T cells and eosinophils 
during granuloma development, we assessed the relative location of these cell types. 
Comparison of CD11c+ cell location with other immune cells by confocal microscopy 
showed that they were present in close proximity to TCR-β+ cells at every time-point 
measured (Fig. 3.5A D28 - D105). This lends support to our working hypothesis that 
CD11c+ cells are directly interacting with T cells in the granuloma, whereas direct 
interaction with eosinophils is less likely because Siglec-F+ cells were found in 
different locations. Close positioning of CD11c+ and effector/memory T cells may 
promote the maintenance of Th2 responses in the granuloma during S. mansoni 
infection. Given that MΦs are known to suppress effector/memory Th2 responses 
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during S. mansoni infection, the promotion of CD4+ T cell responses is perhaps more 
likely performed by DCs (Pesce et al., 2009).  
 
If DCs play a role in the maintenance of effector/memory CD4+ T cells during the 
initiation of granuloma formation, this could involve recruitment, retention and/or 
reactivation of antigen-specific T cells. It has been reported that Th2 cells 
preferentially express the receptor CCR4 compared with Th1 cells in vitro (Bonecchi 
et al., 1998; D'Ambrosio et al., 1998; Sallusto et al., 1998), and human DCs 
upregulate the expression of CCL17 and CCL22 (ligands for CCR4) upon interaction 
with TSLP (Fontenot et al., 2009; Ito et al., 2005) (section 1.9.3, chapter 1). A key 
role for CCR4 expression by human effector/memory CD4+ T cells has been 
identified ex vivo and in vivo for the accumulation of effector/memory Th2 cells in 
allergic airway inflammation during asthma (Yoshie and Matsushima, 2015). 
Furthermore, it has been proposed that DC derived CCL17 and CCL22 play a critical 
role in the recruitment of Th2 cells (Perros et al., 2009; Medoff et al., 2009), whereas 
MΦs have not yet been implicated in this process. It has also been shown that CCL17 
or CCL22 depletion reduces the size of pulmonary granulomas during S. mansoni 
infection (Jakubzick et al., 2004). Thus, the expression of CCR4 ligands by DCs may 
be important for the recruitment of effector/memory Th2 cells to the egg. In support 
of this hypothesis, the presence of T cells increased in parallel with CD11c+ cells 
from D45 to D48, whereas Siglec-F+ cells gradually increased from D36 to D51 (Fig. 
3.7B). In addition, this mechanism would also promote close proximity of these cell 
types within granulomatous inflammation, which may be important for the retention 
and reactivation of Th2 cells.  
 
A major role of DCs in the homeostasis of CD4+ T cells is thought to be the provision 
of TCR signalling via peptide loaded MHC-II; naïve CD4+ T cells require peptide 
complexed MHC-II:TCR interaction for antigen-specific activation, and this type of 
interaction promotes efficient effector/memory CD4+ T cell reactivation (Boyman et 
al., 2009) (section 1.4, chapter 1). This suggests that DCs may reactivate 
effector/memory CD4+ T cells in the granuloma through persistent antigen-specific 
MHC:TCR stimulation. The level of MHC-II expression on naïve IL-7Rα+ DCs is 
thought to be controlled by the availability of survival cytokine IL-7 (Guimond et al., 
2009). An increase in IL-7 leads to decreased expression of MHC-II by IL-7Rα+ DCs, 
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which thereby limits the number of CD4+ T cells that undergo homeostatic 
proliferation. Indeed, enhanced proliferation of CD4+ T cells in the absence of antigen 
stimulation occurs in vivo when the number of DCs in the system is increased through 
treatment with Flt3L (Guimond et al., 2009). This process links the number of DCs to 
the size of CD4+ T cell populations. Thus, continuous MHC:TCR interaction within 
the granuloma may be required for optimal reactivation as well as regulation of 
effector/memory CD4+ T cell responses.  
 
In addition to stimulation via the TCR, increasing evidence in the literature points to 
an important role for co-stimulation in the maintenance of effector/memory CD4+ T 
cell responses. For example, consistent CD28 ligation in vitro maintains IL-4 and IL-
5 production by activated CD4+ T cells (Rulifson et al., 1997). Furthermore, ICOS 
and OX40 interaction promotes CD4+ T cell differentiation, effector function, 
proliferation, survival and the formation of memory cells (Chen and Flies, 2013). On 
the other hand, DCs may be involved in the provision of survival cytokines including 
IL-7, IL-15 and IL-2 to prevent effector T cell apoptosis in the granuloma, as a 
decrease in the availability of these factors is thought to promote T cell contraction 
(McKinstry et al., 2010a) (section 1.4, chapter 1). Thus, consistent DC mediated co-
stimulation via numerous molecules and the provision of survival cytokines may 
contribute to the maintenance of Th2 cytokine production and proliferation in the 
granuloma during S. mansoni infection.  
 
In summary, the data in this chapter so far improve our understanding of the possible 
functions of DCs in the liver during S. mansoni infection, as the location of CD11c+ 
cells support our hypothesis that DCs interact with effector/memory CD4+ T cells in 
the granuloma, and there are multiple different possible mechanisms that DCs may 
employ to mediate T cell presence and function in the granuloma. Given that CD4+ T 
cells are necessary for granuloma formation during S. mansoni infection (Amiri et al., 
1992; Byram and Lichtenberg, 1977; Cheever et al., 1999; Doenhoff et al., 1981; 
Dunne and Doenhoff, 1983; Mathew and Boros, 1986), we reasoned that DC 
mediated effector/memory CD4+ T cell maintenance might be a fundamental 
requirement for appropriate granuloma development. 
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3.6.7 The importance of dendritic cells in granuloma 
formation 
To investigate whether DCs are required for the initiation of granulomatous 
inflammation, we used CD11c.DOG mice to deplete CD11c+ cells and investigate 
granuloma formation at D42 of infection. Measuring the total proportion of 
granulomatous inflammation in S. mansoni infected CD11c depleted animals did not 
identify a significant difference compared with control animals (Fig. 3.9A), which 
indicates that CD11c+ cells are not required for the overall recruitment of granuloma 
inflammatory cells and the initiation of collagen synthesis. However, there was no 
significant difference in the proportion of granulomatous inflammation recorded 
comparing naïve with S. mansoni infected animals, which may be due to insufficient 
granuloma formation in this experiment relative to vascular collagen in naïve animals. 
This is most likely attributable to the early time-point analysed, as the specific timing 
of egg production by the parasite can vary in experimental infections. Thus, caution 
should be taken when drawing conclusions from this result, as changes in the total 
proportion of granulomatous inflammation may become more evident when 
granuloma formation is increased.  
 
Given that CD11c+ cells are found in close proximity to T cells in the granuloma 
during S. mansoni infection (Fig. 3.5), we quantified the presence of T cells at D42 by 
confocal microscopy when CD11c+ cells were depleted. These data show that fewer T 
cells were present in depleted compared with control animals, which lends further 
support to our hypothesis that DCs recruit or retain effector/memory CD4+ T cells 
locally to the granuloma, possibly via DC expression of CCL17 and CCL22 
(Jakubzick et al., 2004; Perros et al., 2009; Medoff et al., 2009). To test whether this 
scenario occurs during granuloma formation, the expression of CCR4 by CD4+ T cells 
and CCL17/CCL22 by DCs (i.e. in comparison with MΦs) from the liver or 
preferably from isolated granulomas could be assessed by flow cytometry. Transgenic 
murine models deficient in CCR4, CCL17 or CCL22, or the administration of αCCR4 
or αCCL17/CCL22 antibodies could also be used to test the importance of this 
interaction for Th2 migration to the granuloma during S. mansoni infection in vivo 
(Belperio et al., 2004; Perros et al., 2009; Schuh et al., 2002).  
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To elucidate whether the requirement for CD11c+ to recruit or retain T cells in the 
granuloma extends to later stages of development when granulomas are well 
established, we investigated the impact of CD11c depletion at D52. Given that Th2 
responses are induced approximately 10 days earlier, analysis at D52 also represents a 
relevant time-frame for the assessment of local DC mediated effector/memory Th2 
maintenance. The data from this experiment show that neither the proportion of 
granulomatous inflammation nor T cell presence in the granuloma were altered 
significantly in depleted animals (Fig. 3.10), indicating that CD11c+ cells are not 
essential for T cell recruitment or retention at this time-point. However, the location 
of T cells was focused at more peripheral areas of the granuloma in CD11c deficient 
animals compared with controls (Fig. 3.10C), which suggests that CD11c+ cells are 
important to recruit T cells to normal locations in established granulomas. Indeed, 
CCR4:CCL22 interaction may be important for T cell location, as this type of 
interaction results in firm binding between CD4+ T cells and DCs using an in vitro 
flow arrest assay described in Wu et al., (2001).  
 
If DCs control the location of T cells within the granuloma, this process would 
perhaps promote engagement with activated CD4+ T cells to enable effector/memory 
Th2 reactivation (Wu et al., 2001). This hypothesis is supported by ongoing work in 
the lab which shows that hepatic T cells displayed impaired Th2 cytokine production 
in CD11c depleted animals compared with controls at D52 of infection (Dr. 
Alexander Phythian-Adams, unpublished data). Analysis of CD4+ T cell cytokine 
expression isolated from granulomas specifically would provide more accurate 
information on whether Th2 responses are reduced when CD11c cells are depleted. 
Decreased IL-5 production may explain the reduction of eosinophils observed at D52 
(Sher et al., 1990), although the possibility that the administration of DTx has a direct 
effect on eosinophil populations cannot be dismissed. To exclude this eosinophils in 
DTx treated wild type animals could be examined (Isaksson et al., 2012). Taken 
together, the data from CD11c depletion experiments have provided evidence that 
DCs may be important for the initial recruitment and retention of effector/memory 
CD4+ T cells to the granuloma, and the ability to do so possibly promotes reactivation 
or maintenance of Th2 responses in established granulomas. The capacity of DCs to 
maintain effector/memory CD4+ T cell cytokine production and proliferation will be 
addressed in chapter 5 by using an OT-II co-culture system. 
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To extend our understanding of which specific DC subsets may be involved in T cell 
interactions in the granuloma outlined above, we asked whether CD8α+ cDCs are 
important for this process. We used Batf3-/- mice that specifically lack CD8α+ and 
migratory equivalent CD103+ cDCs to examine granuloma formation employing the 
same techniques as before (Hildner et al., 2008). Investigation of the presence of T 
cells showed that this was not significantly changed in Batf3 deficient mice at D42 of 
infection (Fig. 3.11), which points to a more dominant role for other CD11c+ DCs 
depleted in the CD11c.DOG model including pDCs and CD11b+ cDCs (or CD11chigh 
MΦs) during the recruitment or retention of T cells at this time-point. In addition, 
eosinophil presence was unchanged in Batf3 deficient granulomas, which suggests 
that Th2 responses in these mice are intact and this will be addressed further in 
chapter 4. However, the presence of CD11c+ cells was significantly reduced in 
granulomas formed in Batf3-/- mice. This decrease in granuloma CD11c expression 
may reflect the absence of CD8α+ cDCs in the granuloma, indicating that this subset 
may normally be present at this time-point. However, it is more plausible that CD8α+ 
cDCs mediate the recruitment or retention of other CD11c+ cells including different 
DC subsets or MΦs, as CD8α+ cDCs represent a small proportion (approximately 
10%) of total CD11c+ cDCs in the spleen and LNs (Hildner et al., 2008). Such a 
scenario has not been addressed previously in the literature, but recruitment of 
CD11c+ cells could occur via the soluble factors CD8α+ cDCs are known to produce 
including IL-12, IFN-α, TNF-α, IL-10 and TGF-β (Bamboat et al., 2010; Hochrein et 
al., 2001; Martínez-López et al., 2014; Mashayekhi et al., 2011; Pillarisetty et al., 
2004; Shortman and Heath, 2010; Yamazaki et al., 2008). A role for TNF-α in the 
recruitment of inflammatory cells to S. mansoni granulomas has been proposed 
previously, as neutralisation of TNF-α results in decreased granuloma volume at D56 
of infection (Hoffmann et al., 1998). Flow cytometric analysis of isolated granulomas 
from liver would enable the identification of the CD11c+ cell type(s) that is reduced in 
Batf3 deficient granulomas in future. Subsequently, the migration capacity of such 
CD11c+ cells in response to TNF-α or other CD8α+ cDC derived cytokines could be 
tested in vitro using a migration transwell assay (Bertho, 2005).  
 
Taken together, we have provided evidence that the location of CD11c+ cells and T 
cells may promote direct interaction between these cells types in the granuloma, and 
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that normal presence of T cells is dependent on CD11c+ cells in early stages of 
granuloma development. Although the possibility that CD11chigh MΦs play a role 
cannot be dismissed, our data support the hypothesis that DCs may be important for 
the initial recruitment or retention of T cells to the granuloma. Moreover, we have 
determined that the involvement of a small subset of DCs, CD8α+ cDCs, is not 
essential for the recruitment or retention of T cells, which significantly elevates our 
understanding of which DC subsets are likely interacting with T cells in the 
granuloma and mediate T cell presence and location. 
3.6.8 Limitations of the techniques used and future 
directions 
The use of microscopy for the investigation of granuloma formation in this chapter 
has provided invaluable insight into the location and presence of immune cells in the 
liver throughout S. mansoni infection, which has furthered our understanding of local 
immune cell interactions and the importance of CD11c+ cells during granuloma 
formation. Although microscopy along with the development of novel objective 
quantification methods in this chapter has proved both powerful and beautiful, various 
limitations associated with these techniques should be considered.  
 
First, the median and left liver lobe was used to examine granulomatous inflammation 
in the liver by histology and confocal microscopy respectively, and it was assumed 
that S. mansoni eggs induce comparable granulomatous responses in all liver lobes 
(left, right, median and caudate lobes). Each liver lobe is thought to perform similar 
functions including uptake of amino acids, carbohydrates, bile acids, cholesterol, 
proteins, lipids and vitamins for storage and metabolism (Malarkey et al., 2005). In 
addition every liver lobe receives blood from the portal vein (Malarkey et al., 2005), 
which drains the intestines where mature worm pairs produce eggs (Pearce and 
MacDonald, 2002). This indicates that eggs are delivered into every liver lobe from 
the portal vein. However, possible variation in the timing of egg arrival or the 
distribution of eggs cannot be dismissed. Thus, analysis of granuloma formation and 
development in the right and caudate liver lobes would be advantageous in future to 
determine how representative granulomatous inflammation in the lobes used in this 
chapter are of the whole liver. Second, co-localisation analysis (i.e. for CD11c and 
TCR-β positive staining) was not possible with our confocal photographs due to the 
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high density of immune cells present in each granuloma, and so we cannot 
definitively state that these cells are interacting. Live imaging of granulomas in S. 
mansoni infected mice by multiphoton microscopy would enable the observation of 
cellular movement in the granulomas, which provides a potential tool in future to 
better understand which cells are in direct contact with each other in the granuloma. 
In addition, this method could be used to visualise immune cell interaction with the 
egg in the liver and other potential cellular interactions that we have not addressed. 
 
One disadvantage associated with the use of CD11c.DOG mice is that depletion likely 
results in a loss of hepatic CD11chigh MΦs as well as DCs (van Blijswijk et al., 2013). 
Therefore, a possible role for MΦs in the mechanisms proposed above in mediating T 
cell recruitment, retention or reactivation in the granuloma cannot be dismissed. 
However, CAMΦs are predominantly associated with Th1 responses and are thought 
to be involved in the recruitment of inflammatory immune cells and in parasite killing 
(Chensue et al., 1989; Gazzinelli et al., 1992; Oswald et al., 1992), whilst AAMΦs 
play a role in suppressing Th2 responses and regulating fibrosis during S. mansoni 
infection as mentioned previously (Herbert et al., 2004; Pesce et al., 2009). In 
agreement with the latter, the loss of hepatic CD11chigh MΦs when monocytes are 
ablated (CCR2-DTR mice) results in enhanced Th2 cytokine production by spleen 
cells stimulated ex vivo with SEA (Nascimento et al., 2014). Thus, it is plausible that 
DCs are more likely candidates for the induction and maintenance of Th2 immune 
responses during S. mansoni infection. Nevertheless, future work that assesses the 
distinct functions of DCs and MΦs is required to confirm this hypothesis. To better 
distinguish DCs from MΦs in the S. mansoni granuloma by confocal microscopy in 
future Clec9a+/creRosa+/EYFP mice could be used, which should enable the specific 
detection of cDC precursor derived cells that constitutively express YFP (Schraml et 
al., 2013). Although only the CD8α+ cDC subset expresses high levels of Clec9a on 
their surface (see table 1.1), this Cro-loxP system enables the labelling of all cDCs 
including CD11b+ cDCs, that have historically expressed Clec9a (Schraml et al., 
2013) (see section 1.2.2.1, chapter 1). Therefore, investigation of YFP expression 
during granuloma development would further our understanding of the presence and 
location of DCs specifically during S. mansoni infection in future.  
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Recently, it has been demonstrated that DCs are important for neutrophil homeostasis 
by regulating the release of neutrophils from the BM (Jiao et al., 2014). The exact 
mechanism for this was not described, but it is possible that an increase in G-CSF 
production triggers neutrophil release from the BM after DC depletion (Jiao et al., 
2014). This mechanism highlights another potential drawback using the CD11c 
depletion model, as uncontrolled neutrophil accumulation in hepatic granulomas may 
impact the formation and immune cell composition of granulomas directly (van 
Blijswijk et al., 2013). Indeed, neutrophils release ROIs and other cytotoxic factors 
upon activation, and their presence in hepatic granulomas during S. mansoni infection 
has been associated with severe egg induced immunopathology possibly due to the 
formation of proinflammatory necrotic lesions (Fallon et al., 2000b; Hirata et al., 
2002). To test whether CD11c depletion leads to enhanced neutrophil recruitment to 
the granuloma during S. mansoni infection, the expression Ly-6G in the granuloma 
could be assessed by confocal microscopy or flow cytometry to identify neutrophils 
(Daley et al., 2007). Herbert et al., (2004) depleted neutrophils in S. mansoni infected 
mice by administrating a RB6-8C5 monoclonal antibody, which revealed that 
neutrophils do not play an essential role in mediating the survival of the host. If 
neutrophilia is increased in CD11c ablated mice, the depletion of neutrophils with 
RB6-8C5 in this system would help delineate whether neutrophils contribute to 
impaired Th2 responses and T cell presence and location in CD11c deficient 
granulomas. 
 
Finally, given that we have identified CD8α+ cDCs as non essential players in 
granuloma formation, the use of transgenic mouse models that are deficient in other 
DC subsets such as pDCs (i.e. BDCA2-DTR mice or 120G8 antibody administration) 
or CD11b+ cDCs (i.e. CD11c-crepos IRF4flox or Flt3L-/- mice) would be beneficial in 
future to dissect which specific DC type is important for effector/memory T cell 
recruitment/retention/reactivation in the granuloma (Plantinga et al., 2013; Swiecki et 





We have conducted a detailed analysis of the immune response development (Th1 vs. 
Th2) in the liver throughout S. mansoni infection, and found that hepatic granuloma 
formation increases in parallel with Th2 immune responses upon the onset of egg 
production by the parasite in this tissue (Pearce and MacDonald, 2002). These data 
complement previous literature that has outlined the type of immune response induced 
during S. mansoni infection in the spleen (Baumgart et al., 2006; Grzych et al., 1991; 
McKee and Pearce, 2004; Pearce et al., 1991; Taylor et al., 2009). Our investigation 
of granulomatous inflammation in more chronic stages of infection revealed that a 
decrease in granulomatous processes does not occur immediately when Th2 responses 
are downmodulated. Thus, by developing novel quantification methods for the 
examination of the total burden of granulomatous inflammation on the liver we have 
shown that granulomatous processes persist during later stages of infection, which is 
likely critical for the prevention of damage to the surrounding parenchyma caused by 
continuous egg arrival in the tissue (Hams et al., 2013). 
 
Visualisation of the presence and location of certain immune cells within the 
granuloma indicated that CD11c+ cells and T cells reside in close proximity to each 
other, which provide initial indications that these cells are interacting in the 
granuloma. Moreover, we show that cDCs and/or CD11c-expressing MΦs play a key 
role in the recruitment or retention of T cells in the granuloma, as their depletion 
results in remarkably reduced T cell presence. This was apparent despite incomplete 
depletion of CD11c+ cells, suggesting that other APCs are unable to substitute for 
them during granuloma formation. Interestingly, CD11c depletion at later stages of 
infection did not impair T cell presence but instead altered the location of T cells and 
the composition of the granuloma, suggesting that cDCs or CD11c-expressing MΦs 
may be involved in granuloma maintenance after initial formation. Finally, by 
analysing the impact of Batf3 deficiency, we could show that CD8α+ cDCs are not 
important for T cell presence in granulomas, but this subset is required for the 
appropriate immune cell composition of S. mansoni granulomas.  
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3.8 Figures and tables 











Figure 3.1 Granuloma formation during S. mansoni infection is initiated 
at D42 
A. Animals were perfused via the left heart ventricle and exiting the hepatic portal 
vein to collect adult worms prior to dissection. The number of adult worms and 
worm pairs was counted using a dissection microscope. B. Liver tissue was digested 
with 4% KOH o/n and schistosome eggs counted. The number of eggs per liver and 
eggs per gram of liver was determined. N.D. = not detected C. The median liver lobe 
was fixed with 10% NBF and cut into 5 µM sections for staining with MT. The 
proportion of total granulomatous inflammation represents granulomatous 
inflammatory cells and type I collagen deposition, which was determined by using an 
algorithm for objective quantification. D. Representative images of liver sections 
stained with MT used for calculation of total proportion of granulomas per liver 
section. 1 of 1 (A to D) experiments. Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, 
*** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 7-10 mice/group (A-B) and 5 






















































































































Figure 3.2 T cell populations in the liver at D42 of S. mansoni infection  
Liver leukocytes from naïve or S. mansoni infected mice were isolated. A. Liver 
leukocytes were assessed by flow cytometry for the proportions of total TCR-β+ of 
lineage negative cells (Live / Singlet / Intact / Siglec-F− MHC-II− B220− CD19− 
NK1.1− GR-1− CD11b− PDCA-1− cells), and CD4+ and CD8+ T cells of TCR-β+ cells 
at each time-point. B-C. The fold change for the proportion of T cells (B) and the 
numbers of T cells (C) was calculated relative to the naïve baseline (dotted line). D. 
Representative flow plots from D56 are shown for ex vivo T cell populations per time-
point. Gates were set using FMO controls. 1 of 1 (A to D) experiments. Two-way 
ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Statistics were 
used to compare naïve with infected values. Bars are SEM of 3-4 samples per group. 
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Figure 3.3 Th2 responses are induced at D42 of S. mansoni infection 
Liver leukocytes from naïve or S. mansoni infected mice were isolated. A. Liver 
leukocytes were restimulated with SEA in culture for 72h before supernatant harvest 
and assessment of cytokine levels by ELISA. Background cytokine production 
detected in samples with medium alone was subtracted from SEA-restimulated 
values. B. As naïve levels of cytokine production varied over the time-course, the fold 
change compared with the naïve baseline (dotted line) levels was determined to show 
trends for cytokine production more clearly. The fold change was plotted for Th2, 
IFN-γ and IL-10 cytokines produced in infection. C. Liver leukocytes were 
restimulated o/n with αCD3/CD28, or medium alone for controls. CD4+ T cell 
intracellular cytokine production was assessed by flow cytometry, and the fold change 
was determined as in (B). D. Representative flow plots from D56 of ICC are shown 
for each cytokine. Gates were set using FMO controls. 1 of 1 (A to D) experiments. 
Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). 
Statistics were used to compare naïve to infected values. Bars are SEM of 3-4 samples 
per group. Cells from 2-3 mice were pooled per sample.  
127 








Figure 3.4 Differential CD11c expression on innate immune cells at D42 
Livers from naïve or S. mansoni infected mice were harvested at D42 and liver 
leukocytes were isolated. A. The proportion of total CD11c+ cells in the liver during 
S. mansoni infection was determined ex vivo by flow cytometry. B. The proportion of 
cDCs, pDCs, macrophages (ΜΦ) and eosinophils (Eos) expressing CD11c is shown 
for D42 of infection. C. Flow plots are shown for the GMFI for CD11c expression at 
D42 of infection by the cell types analysed in (B). The FMO control for each group is 
shown in grey. 1 of 1 (A to C) experiments. One-way ANOVA (* P ≤ 0.05, ** P ≤ 
0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 3-4 samples per group. Cells 
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Figure 3.5 CD11c+ and TCR-β+ cells locate to similar areas in the 
granuloma 
Liver tissue from the left liver lobe was embedded in OCT and cut into 20 µM 
sections. Cryosections were fixed in acetone and stained for confocal microscopy. A. 
Representative confocal microscopy images depict granuloma development 
throughout the infection. Scale = 39µM. B. To quantify the data, the surface area of 
positive staining around the egg was measured for TCR-β, CD11c and Siglec-F using 
Volocity imaging software. Only single egg granulomas were photographed. C - D. 
Using values acquired by flow cytometry, the total numbers and numbers / mg of 
tissue for TCR-β+, Siglec-F+ and CD11c+ cells were calculated for each time-point. 1 
of 2 (A) and 1 of 1 (Β - D) experiments. Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, 
*** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 3 granulomas for naïve and 10 
granulomas for infected tissue samples per group. Photos were taken from 3 naïve and 
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Figure 3.6 Granulomatous pathology increases rapidly during infection 
Livers from S. mansoni infected mice were harvested at D36, D39, D42, D45, D48 
and D51. A. The total number of eggs deposited in the caudate liver lobe were 
counted and used to determine the number of eggs per gram of tissue B. The 
proportion of granulomatous inflammation in the median liver lobe was measured for 
each time-point C. Representative images of liver sections stained with MT are shown 
for naïve and S. mansoni infected mice. Scale = 1 mm. Two-way ANOVA (* P ≤ 
0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 3 naïve and 6 
infected mice per group. 1 of 2 (A) and 1 of 1 (B to C) experiments.  
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Figure 3.7 Visualisation and quantification of immune cells during 
granuloma formation 
At the time-point of granuloma formation, confocal microscopy was used to 
investigate the presence and location of TCR-β+, CD11c+ and Siglec-F+ cells every 3 
days from D36-D51 in the left liver lobe. A. Representative confocal microscopy 
images are shown for liver sections from naïve and infected animals. Scale = 48µM. 
B. Quantification of positive staining on confocal images displays the kinetics of 
TCR-β+, Siglec-F+ and CD11c+ staining during initial granuloma development. 1 of 1 
(A to B) experiments. Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, 
****P ≤ 0.0001). Bars are SEM of 3 granulomas from naïve mice and 10 granulomas 
from infected mice per group. Photos of granulomas were taken from 3 naïve and 6 
infected animals.  



















































































Figure 3.8 Collagen deposition begins in early stages of granuloma 
formation 
A. Representative BF images are shown of tissue sections from the same median liver 
lobe stained with MT and PSR to compare total granuloma area staining (blue) with 
collagen deposition staining (red) respectively. Granulomas stained with MT appear 
as different shades of blue, bright blue staining most likely depicting type III collagen 
and pale blue highlighting other features of the granuloma. Scale = 1mm. B. Collagen 
deposition on PSR stained slides was measured using imaging software to provide an 
objective measurement of fibrosis. This showed a comparable trend compared with 
granulomatous inflammation (granulomatous inflammation graph previously shown 
in Figure 3.6). C. Representative images are shown for PSR stained liver sections 
from naïve and infected animals. Scale = 1mm. 1 of 2 (A to C) experiments. Two-way 
ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 































































Figure 3.9 T cell presence in granulomas is reduced in the absence of 
CD11c+ DCs at D42 
CD11c.DOG mice were treated daily with DTx for CD11c depletion or PBS for 
controls from D29 to D40 of S. mansoni infection. Livers were harvested at D42 of 
infection. A. The total proportion of granulomatous inflammation from MT stained 
median liver lobe sections was determined. Very few granulomas were present in the 
tissue resulting in unchanged granuloma area in infection compared with background 
values. B. The surface area of CD11c and TCR-β staining around the egg in left liver 
lobe sections was measured to compare the presence of CD11c+ cells and T cells in 
the granuloma of WT vs. CD11c depleted mice. C. Representative confocal overlay 
and BF images are shown for naïve and infected animals treated with either PBS or 
DTx. Scale = 39 µM. 1 of 1 (A to B) and 1 of 2 (C) experiments. Two-way ANOVA 
(* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 25 
granulomas per group. Photos were taken from 2 naïve mice or 5 infected mice.  
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Figure 3.10  Depletion of CD11c+ cells alters granuloma composition at 
D52 
CD11c.DOG mice were treated daily with DTx for CD11c depletion or PBS for 
controls from D42 to D51 of S. mansoni infection. A. The total proportion of 
granulomatous inflammation in WT and depleted animals was determined using MT 
stained median liver lobe sections. B. Quantification of CD11c, Siglec-F and TCR-β 
staining enabled the comparison of these cell types in granulomas in the left liver lobe 
formed in WT and depleted animals. C. Representative confocal overlay and BF 
images are shown for naïve and infected animals treated with either PBS or DTx. 
Granulomas of DTx treated animals appear structurally distinct from PBS controls. 
Scale = 48 µM. 1 of 1 (A to C) experiments. Two-way ANOVA (* P ≤ 0.05, ** P ≤ 
0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM of 20 granulomas per group. 
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Figure 3.11 Granuloma formation in the absence of CD8α+ DCs at D42 
A. The total area of granulomatous inflammation was measured using MT stained 
median liver lobe sections in WT and Batf3-/- mice at D42 post infection with S. 
mansoni. B. The level of fibrosis in WT and Batf3-/- mice were examined using PSR 
stained median liver lobe sections. C. Granulomas were assessed for the surface area 
of positive staining for TCR-β, CD11c and Siglec-F in the left liver lobe using 
imaging software. D. Representative confocal overlay and BF images are shown for 
naïve and infected WT and Batf3-/- animals. Scale = 48 µM. 1 of 1 (A to D) 
experiments. Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 
0.0001). Bars are SEM of 20 granulomas per group. Photos were taken from 3 naïve 
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4  CD8α+ cDCs are not required for the 
induction of Th2 immune responses 
during S. mansoni infection 
 
4.1  Abstract 
In helminth infection DCs direct T cell responses towards a Th2 phenotype, 
providing an essential link between innate and adaptive immunity. However, the 
specific cDC subsets involved, and the precise mechanisms they use to induce a Th2 
response, remain unclear. Using a murine model of Schistosoma mansoni infection 
we have previously shown that CD11c+ DCs are required for Th2 induction 
(Phythian-Adams et al., 2010). To improve our understanding as to which CD11c+ 
DC subsets are important for this process we have used Batf3-/- mice, which are 
deficient in CD8α+ and migratory CD103+ CD11b− cDCs (Hildner et al., 2008). 
CD8α+ DCs have emerged as essential APCs for antigen cross-presentation and in 
the generation of Th1 immunity, but their function in a Th2 setting is currently 
unknown. S. mansoni egg injection and infection of Batf3-/- mice suggests that 
immune responses against the eggs were dysregulated in the absence of CD8α+ 
cDCs; Th2 immune responses were enhanced and Th1 responses impaired. The data 
indicated that CD8α+ cDCs are not a fundamental requirement for Th2 induction, 





It has been shown that DCs are sufficient to induce Th2 immune responses in vivo 
(Perona-Wright et al., 2006), and our laboratory published that CD11c+ DCs are 
necessary for the induction of a Th2 response during S. mansoni infection (Phythian-
Adams et al., 2010). However, it remains unclear which specific CD11c+ DC subsets 
are essential for appropriate Th2 induction, and whether the type of DC required 
changes depending on the stage of infection. One of these candidates is the CD8α+ 
cDC subset, and the role of this particular DC during the induction of immune 
responses to S. mansoni infection will be investigated in this chapter. CD8α+ cDCs 
(and their CD103+ migratory counterparts) have emerged as important players in 
cross-presentation to CD8+ T cells and Th1 responses against acute viral or bacterial 
infections (Edelson et al., 2010; Hildner et al., 2008; Mashayekhi et al., 2011; Torti et 
al., 2011; Waithman et al., 2013) (Diagram 4.1). In addition, there is some evidence to 
suggest that CD8α+ cDCs are involved in the induction of Tregs in the steady state 
through endogenous production of TGF-β (Scott et al., 2011; Yamazaki et al., 2008). 
However, the role of CD8α+ cDCs during the induction of Th2 immune responses in 
an infection setting, i.e. whether this subset promotes, inhibits or regulates Th2 
responses, remains largely unknown (see diagram 4.1).  
 
In chapter 3, we have shown that the proportion of hepatic granulomatous 
inflammation was unchanged in Batf3-/- mice at D42 of S. mansoni infection (Fig. 
3.11). This result suggests that Th2 immune responses were not impaired in Batf3-/- 
mice, as impairment in the Th2 response such as in MHC-II-/- (Hernandez et al., 1997) 
and STAT6-/- (Kaplan et al., 1998) mice often correlates with reduced granuloma 
formation. Given the importance of CD8α+ cDCs during the induction of Th1 immune 
responses against viral and bacterial infection, it is perhaps more likely that CD8α+ 
cDCs play a critical role during the induction of Th1 responses in S. mansoni 
infection, particularly during early stages of infection when there is a mixed Th1/Th2 
immune response (Pearce and MacDonald, 2002). Thus, we hypothesised that CD8α+ 
cDCs might not be required for the induction of Th2 responses per se, but may play a 
role in the development of appropriately mixed Th1 and Th2 immune responses to S. 
mansoni infection. In support of this hypothesis, recent publications investigating 
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allergic Th2 responses (Engler et al., 2014) and immune responses against L. major 
(Ashok et al., 2014) have provided initial insight into the possible functions of CD8α+ 
cDCs during the induction of Th2 responses. For instance, Batf3-/- mice display 
decreased Th1 responses against infection with L. major, rendering these mice more 
susceptible to the disease, which is controlled in particular by IFN-γ and IL-12 
(Ashok et al., 2014). The authors also reported that Th2 and Th17 responses, as well 
as levels of the antibody isotype IgE in the serum, are enhanced in L. major infected 
Batf3-/- mice (Ashok et al., 2014). Furthermore, it has been shown that CD8α+ cDCs 
play a role in the modulation or regulation of Th2 immune responses during allergic 
airway inflammation with H. pylori (Engler et al., 2014). Yet, the exact mechanisms 
that CD8α+ cDCs may employ to regulate or inhibit Th2 responses in this setting, and 
whether CD8α+ cDCs are important during the induction of Th2 responses during 
chronic helminth infection, have not yet been addressed. 
4.2.1 The Batf3-/- mouse – advantages and disadvantages 
Batf3 is an AP-1 transcription factor (Murphy et al., 2013), which forms a 
heterodimer with Jun before binding AP-1 (Iacobelli et al., 2000). Batf3 is essential 
for the development of CD8α+ cDCs (Hildner et al., 2008), and Batf3-/- mice are an 
excellent tool for investigating the role of this subset in infection settings. Aspects of 
CD8α+ cDC biology have been ably demonstrated in studies using Batf3 deficient 
animals, including those mentioned above (Ashok et al., 2014; Engler et al., 2014) 
and others discussed in section 1.2.2.1 in chapter 1, but as with any biological model 
it is important to understand the potential drawbacks when using the model in order to 
draw the correct conclusion from the results.  
 
Firstly, the initial study using Batf3-/- mice on a 129SV genetic background showed 
complete deficiency of CD8α+ cDCs (Hildner et al., 2008), but it has since been 
reported that this subset is absent in the spleen and mediastinal LNs but not skin 
draining iLNs of C57BL/6 Batf3-/- mice (Edelson et al., 2011; Waithman et al., 2013). 
Secondly, Batf3-independent mechanisms through non-AP-1 factors, such as IRF4 
and IRF8, can induce reconstitution CD8α+ cDCs in a Th1 infection setting 
(Tussiwand et al., 2012). These compensatory mechanisms are driven by cytokines 
IL-12 and IFN-γ that induce the expression of transcription factors Batf and Batf2, 
which are related to Batf3 and are important for the development of Th17 (Schraml et 
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al., 2009) or a subset of lung resident DCs and MΦs (Tussiwand et al., 2012) 
respectively. Batf and Batf2 compensate for the loss of Batf3 by binding to non-AP1 
factors through shared leucine-zipper domains that function as a leucine rich 
dimerisation domain (Tussiwand et al., 2012). It would not be unreasonable to 
hypothesize that the low level of the Th1 relative to Th2 responses in S. mansoni 
infection is insufficient to cause the reconstitution of CD8α+ cDCs (Pearce and 
MacDonald, 2002), unlike scenarios where robust Th1 responses are present, such as 
during viral or bacterial infections (Murphy et al., 2013; Tussiwand et al., 2012). Yet, 
confirming the loss of CD8α+ cDCs in Batf3-/- mice in our system and verifying the 
level of this subset in the tissues of interest after infection with S. mansoni is essential.  
 
Overall, Batf3-/- mice remain a powerful tool for investigating the function of CD8α+ 
cDCs, as the specificity for the loss of this subset is unrivalled by other models such 
Clec9a.DTR (Piva et al., 2012) and CD205.DTR (Fukaya et al., 2012) inducible 
systems (see table 1.2). Therefore, the Batf3-/- model does not suffer from typical 
limitations including deficiency of additional cell types or the requirement to use 
radiation BM chimera mice (i.e. mice that have been heavily irradiated and 
reconstituted with cells from a genetically different mouse). Thus, we felt that Batf3-/- 
mice were an excellent model to use in the investigation of the specific functional role 
of CD8α+ cDCs during the induction of Th2 responses against S. mansoni infection.  
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4.3 Study rationale 
In this chapter the induction of Th2 immune responses against S. mansoni eggs using 
an egg injection model was examined in C57BL/6 Batf3-/- mice, which constitutively 
lack CD8α+ cDCs (Hildner et al., 2008). This provided a tool to assess the immune 
responses in these mice in an acute model of Th2 induction in the absence of cross-
reactive antigens normally found in infection, which is representative of a primary 
response to S. mansoni eggs in vivo. The importance of CD8α+ cDCs during Th2 
induction was investigated, revealing whether they inhibit, promote or regulate Th2 
responses. In addition, the role of CD8α+ cDCs for Th1 induction against S. mansoni 
eggs was addressed. The kinetics of the response to injected S. mansoni eggs were 
examined to investigate whether the lack of CD8α+ cDCs shifts the timing of immune 
responses in Batf3-/- mice. Thus, this experimental egg injection model granted 
analysis of the importance of CD8α+ cDCs during Th2 induction prior to assessing 
their role during S. mansoni infection. 
 
To ascertain the importance of CD8α+ cDCs in the initiation of Th2 responses during 
chronic natural infection, Batf3-/- mice were infected with S. mansoni, and the 
development of the immune response was analysed at D42 of infection. S. mansoni 
induces a strong Th2 immune response against the eggs at this time-point (Pearce and 
MacDonald, 2002), which makes this parasite an excellent tool to investigate Th2 
priming in an infection setting. The deposition of eggs and formation of granulomas 
in the liver and intestine leads to severe detrimental pathology during the progression 
of the S. mansoni infection (Wynn et al., 2004) (section 1.6 & 1.7, chapter 1). To 
elucidate whether CD8α+ cDCs play a role during pathological processes associated 
with egg deposition, granulomatous inflammation was investigated in the liver and 
intestine of Batf3-/- mice S. mansoni infection. The analysis of pathology was 
conducted at D42 as well as D52, as the latter represents a time-point when 
granulomatous inflammation is more prevalent (Pearce and MacDonald, 2002). 
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4.4 Results  
4.4.1 CD8α+ cDCs are reduced in the popliteal lymph nodes 
of S. mansoni egg-injected Batf3-/- mice 
To model an acute Th2 immune response an egg injection experiment was carried out 
to determine the impact of CD8α+ cDC deficiency on the Th2 response normally 
generated against S. mansoni eggs in the popliteal LNs (pLNs) (i.e. the dLN). iLNs 
(i.e. non draining LNs (ndLN)) were additionally harvested and analysed in the same 
way as the pLNs to control for responses primed against S. mansoni eggs in the pLN. 
The proportion of CD11c+ MHC-II+ cDCs that was also CD8α+ in the pLNs and iLNs 
of WT mice was assessed by flow cytometry (Fig. 4.1A). To distinguish the CD8α+ 
cDC subset from other cDCs expressing high levels of CD11c and MHC-II, CD205 
was used as an additional marker (Hildner et al., 2008). To further ascertain the 
identity of CD8α+ cDCs in the LNs analysed, CD8α+ CD205+ cDCs from WT mice 
were shown to be CD11blow, CD103+ and CD24high based on work shown in Hildner 
et al., (2008) (see table. 1.1). In addition to CD8α+ CD205+ cDCs, a population of 
CD8α− CD205+ cDCs was found to be present in pLNs and iLNs of WT mice. This 
CD8α− CD205+ cDC population in the LNs expressed higher levels of CD11b, but 
lower levels of CD24 and CD103 compared with CD8α+ CD205+ cDCs (Fig. 4.1A). 
Based on the literature, it is possible that this population represents cDC precursors 
that are unable to differentiate further in the absence of Batf3 and this will be 
discussed in detail in section 4.6.1 of this chapter (Caminschi et al., 2012; Naik et al., 
2006). Flow cytometric analysis of the pLNs from Batf3-/- mice revealed a significant 
decrease in CD8α+ CD205+ cDCs as a percentage of CD11c+ MHC-II+ cells in this 
system compared with WT mice (Fig. 4.1B). In contrast to pLNs, the proportion of 
CD8α+ CD205+ cDCs was unchanged in iLNs of Batf3-/- mice. Given that migratory 
CD103+ cDCs, which are functionally equivalent to CD8α+ cDCs, are dependent on 
Batf3 for their development (Hildner et al., 2008), cDC populations expressing 
CD103 vs. CD11b were also examined (Fig. 4.1C). The proportions of cDCs 
expressing CD103 were significantly decreased in both the pLNs and iLNs of Batf3-/- 
compared with WT mice. Once the expected Batf3-/- phenotype was confirmed it was 
possible to go on to ask what impact this deficiency has on immune responses 
initiated by parasite eggs.  
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4.4.2 Th2 immune responses are induced in Batf3-/- mice 
against S. mansoni eggs 
The cytokine expression profile of cells from pLNs was examined in order to directly 
assess whether Batf3-/- mice lacking CD8α+ cDCs are able to generate Th2 responses 
against S. mansoni eggs injected into the foot. We first assessed whether Batf3 
deficiency impacts the proportion and number of immune cells within LNs following 
S. mansoni egg injection. The total number of live cells present in the dLN after egg 
injection was calculated using the proportions of live cells present in the pLN 
determined by flow cytometric analysis and total numbers of trypan blue negative 
cells counted with a microscope (Fig. 4.2A). This revealed that the total number of 
live cells in the pLNs was not significantly altered in the absence of CD8α+ cDCs 
compared with WT controls. To investigate T cell populations in Batf3-/- mice after 
egg injection, CD4+ and CD8+ T cell subset proportions were examined by flow 
cytometry, and total numbers of these T cell subsets in pLNs were calculated from 
numbers of total live cells in figure 4.2A. A marginal decrease in the proportion of 
CD8+ T cells as a percentage of live cells was observed at D5 in Batf3-/- mice 
compared with WT mice, whereas proportions of both CD4+ and CD8+ T cells were 
unchanged at D7 but increased at D9 (Fig. 4.2B). The total number of CD4+ and 
CD8+ T cells was unchanged in Batf3-/- mice at all time-points measured in 
comparison with WT animals (Fig. 4.2C).  
 
The immune response was examined by measuring egg antigen-specific cytokine 
production by pLN cells after egg injection, following in vitro culture with SEA for 
72h. The samples in this assay represent pooled pLN cells from 4-5 animals, as 
insufficient cells were available for the analysis of individual samples (Fig. 4.3A). 
This type of analysis was carried out on D5, D7 and D9 post egg injection to assess 
the immune response kinetics in Batf3-/- mice. Batf3-/- mice displayed increased pLN 
cell production of IL-4, IL-5, IL-13, IL-10 and IL-17 compared with WT egg-injected 
mice at every time-point measured. On the other hand, IFN-γ and TNF-α production 
in egg-injected Batf3-/- mice was reduced compared with WT mice at every time-point 
measured (Fig. 4.3A). This phenotype of decreased TNF-α and IFN-γ and increased 
IL-4, IL-5, IL-13, IL-10 and IL-17 production in Batf3-/- mice was also apparent in 
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iLNs, but the amount of each cytokine detected from this tissue was generally lower 
compared with pLNs (with the exception of IL-17) (Fig. 4.3A).  
 
Given that the amount of IL-4 production by pLN cells in response to SEA 
restimulation was significantly increased in Batf3-/- mice and that this could not be 
explained by a substantial increase in the proportion of CD4+ T cells in culture, ICC 
was conducted in order to specifically address cytokine production by T cell subsets 
ex vivo (Fig. 4.3B). For this assay, WT or Batf3-/- pLN or iLN cells were restimulated 
with αCD3/CD28 o/n resulting in polyclonal activation of T cells. T cell specific 
cytokine expression in the LNs was assessed by flow cytometry after ICC. In egg-
injected WT mice, ICC staining showed that the proportions of cytokine positive 
CD4+ T cells were increased in the pLNs compared with the iLNs for every cytokine 
analysed (Fig. 4.3B). When comparing these populations with those present in Batf3-/-
mice, IL-4+ CD4+ and IL-10+ CD4+ T cell populations in pLNs followed a similar 
trend as the ELISA results described above for these cytokines: the proportion of IL-
4+ CD4+ T cells was significantly increased at D7 and D9 in Batf3-/- compared with 
WT mice, and the proportion of IL-10+ CD4+ T cells was significantly increased at 
D5 and D7. The proportion of IL-13+ CD4+ T cells was unchanged when comparing 
Batf3-/- with WT mice (Fig. 4.3B). In line with lower levels of antigen-specific IFN-γ, 
the proportion of IFN-γ+ CD4+ T cells was reduced in the pLNs of Batf3-/- compared 
with WT mice at D9 (Fig. 4.3B). The proportion of IL-17+ CD4+ T cells was also 
decreased in Batf3-/- mice at D9 compared with WT mice (Fig. 4.3B), which 
contradicts the trend for IL-17 production produced by ELISA analysis (Fig. 4.3A). 
The discrepancies within the results may be due to differences in the assays used i.e. 
antigen-specific restimulation for 72h compared with polyclonal restimulation o/n, 
and the details on this will be discussed in section 4.6.5 of this chapter. To assess the 
level of cytokine expression by T cell subsets, the GMFI for cytokine staining was 
measured (Fig. 4.3C). No major differences in Batf3-/- mice were found when 
assessing the GMFI of IL-4, IL-10, or IL-17 staining on CD4+ T cells compared with 
WT mice, with the exception of a marginally lower level of IL-4 expression by Batf3-
/- CD4+ T cells on D5 (Fig. 4.3C-D). Analysing the GMFI of IL-13 staining on CD4+ 
T cells revealed an increase of IL-13 expression at D7 and D9 in the absence of 
CD8α+ cDCs, whereas the GMFI of IFN-γ was significantly reduced in Batf3-/- CD4+ 
T cells compared with WT controls (Fig. 4.3C-D). Together, these data indicated that 
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Th2 immune responses were enhanced, and Th1 responses impaired, following 
subcutaneous injection of Batf3-/- mice with S. mansoni eggs. 
4.4.3 CD8α+ cDCs are reduced during S. mansoni infection 
at D42 in the mLN and the liver 
Since our results from the S. mansoni egg model of acute Th2 induction indicated that 
Batf3-/- mice mounted Th2 responses that appeared enhanced, but failed to develop 
normal Th1 responses, we next addressed whether this phenotype was also evident in 
an infection setting. Batf3-/- mice were infected with S. mansoni and the development 
of the immune response was analysed in the mLN and the liver. These tissue sites are 
of particular interest when studying the immune response developed against S. 
mansoni eggs during infection; the mLN is a priming/restimulation site that drains the 
intestine, and the liver is an effector site where granulomatous legions form around 
the eggs (described in section 1.6 and 1.7, chapter 1). Given that CD8α+ cDCs have 
been shown to reconstitute in Th1 immune environments (Tussiwand et al., 2012), the 
proportion of CD8α+ cDCs in Batf3-/- mice was assessed by flow cytometry at D42 
post S. mansoni infection, when the immune response shifts from a mixed Th1/Th2 to 
a dominant Th2 response (Pearce and MacDonald, 2002). Several markers were used 
to distinguish CD8α+ cDCs including CD205, as previously conducted for the egg 
injection experiment (section 4.4.1, Fig. 4.1). CD8α+ cDCs in the mLNs and livers of 
naïve WT mice were CD103+ CD24+ and CD11blow (Fig. 4.4A). A population of 
CD8α− CD205+ cells was observed in the mLNs and livers of WT mice, which may be 
similar to a population also observed in the pLN of egg-injected mice (section 4.4.1, 
Fig 4.1A). In line with what has been described in the literature (Hildner et al., 2008), 
naïve Batf3-/- mice displayed a significant reduction in CD8α+ cDC populations 
compared with WT mice, although this was more complete in the liver than the mLN 
(Fig. 4.4B).  
 
To investigate whether S. mansoni infection impacts the Batf3-/- phenotype, the 
proportion of this subset was assessed in infected Batf3-/- mice, which showed a 
similar reduction in the proportion of CD8α+ cDCs compared with naïve mice, 
confirming that CD8α+ cDC populations are significantly reduced in these tissues at 
D42 of infection (Fig. 4.4B). In both livers and mLNs, a population of CD8α− 
CD205+ and CD8α+ CD205− cDCs was additionally apparent after flow cytometric 
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analysis in Batf3-/- and WT mice. When CD103+ CD11blow migratory cDCs were 
analysed, they were significantly reduced in naïve and S. mansoni infected Batf3-/- 
mice compared with WT controls (Fig. 4.4C). Deficiency in CD8α+ and migratory 
CD103+ cDCs in livers and mLNs of Batf3-/- mice confirmed the use of this model to 
investigate the impact this has on the immune response during S. mansoni infection. 
4.4.4 Th2 immune responses against S. mansoni infection 
are enhanced at D42 in Batf3-/- mice 
The impact of Batf3 deficiency on immune response development was investigated at 
D42 of S. mansoni infection. Increased numbers of cells in the mLN indicate 
priming/restimulation in Batf3-/- mice resulting in larger adaptive immune cell 
populations, including T cells (Fig. 4.5A). Flow cytometry analysis of T cell subsets 
in the mLN at D42 of infection showed that the proportion of CD4+ TCR-β+ T cells 
was unchanged in Batf3-/- compared with WT mice, whereas the proportion of CD8+ 
TCR-β+ T cells was decreased in Batf3-/- mice (Fig. 4.5B). Total numbers of both T 
cell subsets increased almost 2-fold in Batf3-/- compared with WT mice (Fig. 4.5C). 
Together these data suggest enhanced proliferation of effector T cells in the mLN of 
Batf3-/- mice. 
 
To analyse the character of the immune response, isolated mLN cells were cultured 
with SEA for 72h and cytokine production was measured by ELISA (Fig. 4.5D). It 
should be noted that in some cases (i.e. as stated in figure legends for ELISA 
measurements of antigen-specific cytokine production in figure 4.5 and 4.6 and serum 
antibody in figure 4.8) data were pooled from infection experiments at D40 and D42, 
as these time-points both represent the induction phase of Th2 responses to S. 
mansoni eggs during infection (Pearce and MacDonald, 2002). Although there may be 
subtle differences in the development of the immune response between D40 and D42 
during infection, the use of a mixed model statistical analysis software enabled 
analysis of these data by adding the day as a random factor, thereby compensating for 
any significant differences in the data between D40 and D42. In aid of clarity, I will 
refer to pooled D40/D42 data as D42 data in this chapter from here on. The results 
from the SEA restimulation assay showed that the amount of IL-4, IL-5, IL-10, IL-13 
and IL-17 production by mLN cells followed the trend set in the egg injection 
experiment; the amount of each cytokine was significantly increased in infected Batf3-
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/- compared with WT mice (Fig. 4.5D). On the other hand, the amount of IFN-γ as 
well as TNF-α production was significantly reduced in Batf3-/- mice in comparison 
with infected WT controls.  
 
Qualitative analysis of T cell cytokine production using ICC after o/n αCD3/CD28 
restimulation revealed a significant increase in the proportion of Batf3-/- CD4+ T cells 
that were IL-4+ and IL-10+ in comparison with WT mice, whereas the proportion of 
IL-13+ CD4+ and IL-17+ CD4+ T cells appeared unchanged (Fig. 4.5E). The 
proportion of IFN-γ+ CD4+ T cells measured by ICC after polyclonal restimulation 
was decreased in the mLN of S. mansoni infected Batf3-/- compared with WT mice 
(Fig. 4.5E). Assessing the GMFI of CD4+ T cells producing Th2 cytokines showed 
that the level of IL-4 production by CD4+ T cells was significantly increased in mLNs 
of S. mansoni infected Batf3-/- compared with WT mice, whereas levels of IL-10 and 
IL-13 were unchanged (Fig. 4.5F-G). In contrast, the level of IFN-γ expressed by both 
CD4+ and CD8+ T cells was reduced in Batf3-/- mice (Fig. 4.5F-G). This indicated that 
although CD4+ and CD8+ T cell numbers were increased, fewer T cells were polarised 
to become IFN-γ producing cells and those cells that are activated are less able to 
make IFN-γ. Overall the results from the mLN of Batf3-/- mice infected with S. 
mansoni follow the trends predicted from the egg injection experiment, as the 
production of Th2 cytokines is increased whilst Th1 responses are decreased.  
 
To compare immune responses occurring in the mLN with an effector site, where 
primed T cells mediate mixed Th1 and Th2 responses against S. mansoni eggs (Pearce 
and MacDonald, 2002), the liver was analysed for T cell populations and cytokine 
production utilising the same methods. The total number of live liver leukocytes 
present in Batf3-/- mice was similar to the numbers present in WT controls (Fig. 4.6A). 
When T cell populations were assessed, a significant decrease in the proportion of 
CD8+ T cells was seen in Batf3-/- compared with WT mice, whereas the proportion of 
Batf3-/- CD4+ T cells remained unchanged (Fig. 4.6B). Although a trend for reduced 
hepatic CD8+ T cell numbers was found in Batf3-/- mice, total numbers of both T cell 




Overall, cytokine production in response to SEA by isolated liver leukocytes from 
Batf3-/- mice followed similar trends compared with the results described for the mLN 
above. Liver leukocytes produced increased amounts of IL-4, IL-5 and IL-10 
compared with WT mice (Fig. 4.6D). The amount of IFN-γ produced by liver 
leukocytes was decreased in Batf3-/- mice following SEA restimulation. There were 
no major changes apparent in the proportions of Batf3-/- CD4+ T cells expressing IL-4, 
and IL-13 measured by ICC compared with WT mice, but Batf3-/- mice displayed 
increased proportions of CD4+ T cells that were IL-10+ after restimulation with 
αCD3/CD28 (Fig. 4.6E). CD4+ IFN-γ+ T cells were reduced in Batf3-/- mice compared 
with WT controls. GMFI measurements showed a trend for increased IL-4 and 
significantly increased IL-10, IL-13 and IL-17 expression by hepatic Batf3-/- CD4+ T 
cells (Fig. 4.6F-G). Taken together, the data obtained for the mLN and liver at D42 
post S. mansoni infection indicated that the production of Th2 cytokines was 
enhanced, whereas Th1 cytokines, in particular IFN-γ, were reduced in Batf3-/- mice 
in both priming and effector sites when compared with WT animals.  
 
Given that Th2 immune responses appeared enhanced in Batf3-/- mice, we next 
investigated the activation status of T cells by flow cytometry to determine the 
proportion of effector T cell populations present in Batf3-/- mice. Proportions and 
numbers of CD4+ TCR-β+ T cells expressing the IL-2 receptor and activation marker 
CD25 were significantly increased in S. mansoni infected Batf3-/- mice compared with 
WT controls, and this was the case in both the mLN and the liver (Fig. 4.7A-B & E). 
To assess whether increases in Th2 cytokine production and effector CD4+ T cells 
found in Batf3-/- mice may be due to altered regulation, Treg cell populations were 
also examined by flow cytometry for the expression of Foxp3 and CD25. This 
analysis showed that the proportion of Foxp3+ Treg cells of CD4+ TCR-β+ cells was 
significantly increased in the mLNs and livers of Batf3-/- mice in comparison with WT 
animals (Fig. 4.7C & E), whereas the absolute number of Foxp3+ Tregs was increased 
significantly in the mLN but not the liver (Fig. 4.7D). Given that both effector T cell 
and Treg populations were increased in Batf3-/- mice, the ratio between effector T 
cells and Treg cells was calculated for infected mice to provide an indication as to 
whether Treg populations increased in unison with effector T cells. In the mLNs of 
infected animals the effector T:Treg ratio was approximately 1:14 for WT mice and 
1:7 for Batf3-/- mice, and in the liver the ratio was 1:1.5 and 1:0.5 in WT and Batf3-/- 
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mice respectively. These calculations show that the ratio of Treg cells per effector T 
cell was decreased in Batf3-/- mice compared with WT mice infected with S. mansoni.  
 
To examine another adaptive immune arm during the responses against S. mansoni 
infection at D42 in Batf3-/- mice, B cell populations were analysed by flow cytometry. 
Specifically, increased Th2 cytokine production by T cells and larger populations of T 
effector cells may impact the development of B cell responses that rely on T cell help 
(Cerutti et al., 2012). Numbers of CD19+ cells were significantly increased in the 
mLN of infected Batf3-/- mice compared with WT mice, whilst the proportion CD19+ 
cells (of total live cells) was unchanged (Fig. 4.8A). In the effector site, the analysis 
of hepatic CD19+ B cell populations showed that there were no major differences in 
the proportion and total numbers of CD19+ cells in Batf3-/- mice relative to WT 
controls (Fig. 4.8A). This shows that the expansion of CD19+ B cells was increased in 
the priming site in Batf3-/- mice, but not in the effector site.  
 
Ashok et al., (2012) show that levels of serum IgE and antigen-specific IgG1 antibody 
responses are increased in Batf3-/- mice during L. major infection. IL-4 has been 
reported to drive antibody class-switching to IgE and IgG1, which is associated with a 
dominant Th2 response (Walsh and Mills, 2013). To investigate whether humoral 
responses were altered in a Batf3 deficient environment during S. mansoni infection, 
antibody responses were measured by assessing the isotypes present in the serum 
collected at D41 post infection. Batf3-/- mice displayed significantly increased 
amounts of total IgE in the serum during infection compared with WT animals (Fig. 
4.8B). SEA-specific IgG1 as well as IgG2b, IgM and total Ig were not significantly 
altered in Batf3-/- mice, whereas levels of IgG2c and IgG3 were significantly 
decreased (Fig. 4.8C). These data show that the quality of B cell responses is altered 
in infected Batf3-/- mice at D42 resulting in increased antibody class switching to IgE 
responses, but decreased production of SEA-specific IgG2c and IgG3 compared with 
infected WT mice.  
4.4.5 Critical weight loss and increased fatality in S. 
mansoni infected Batf3-/- mice 
A significant factor contributing to the phenotype of S. mansoni infected Batf3-/- mice 
from D46 was a substantial weight loss experienced by Batf3-/- mice, whereas WT 
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mice maintained their body weight (Fig. 4.9A). We hypothesised that the greater 
weight loss observed in Batf3-/- mice might be due to a greater number of parasite 
larvae surviving to adulthood leading to a greater egg burden. When we analysed the 
number of worm pairs and adult worms (Fig. 4.9B), we found that there were no 
significant differences at D42 of infection comparing Batf3-/- with WT mice. 
Moreover, measurement of egg burdens at D42 in the liver (Fig. 4.9C) and intestine 
(Fig. 4.9D) indicated that these were not significantly different in Batf3-/- mice.  
 
Given that S. mansoni infection frequently causes substantial enlargement of the 
spleen and liver of the host, we assessed whether hepatosplenomegaly was altered 
when CD8α+ cDCs are reduced. Hepatomegaly was unchanged at D42, suggesting 
that immune processes associated with egg deposition in the liver, including 
granulomatous inflammation, did not significantly alter the size of this organ at this 
time-point (Fig. 4.9E). Taken together, at D42 Batf3-/- mice exhibit similar infection 
levels compared with WT mice. However, Batf3-/- mice lost a critical amount of 
weight from D46 post infection, which granted investigation into the pathology in 
more chronic stages of S. mansoni infection.  
4.4.6 Batf3-/- mice exhibit more severe pathology during S. 
mansoni infection 
Th2 immune response are strongly implicated in the development of pathology during 
S. mansoni infection (Wilson et al., 2007; Wynn, 2004), and thus we reasoned that an 
increase in Th2 cytokine production in Batf3-/- mice may alter granulomatous 
pathology. To assess the total burden of granulomas in the liver, total granulomatous 
inflammation present in sections from the median liver lobe stained with MT was 
quantified using the algorithm described in chapter 3 (this method is described in 
chapter 2 section 2.6.1). Given that pathology associated with S. mansoni infection is 
established in more chronic stages of infection (Pearce and MacDonald, 2002), we 
reasoned that any changes in pathology may be more evident a few weeks after the 
onset of egg production. Therefore, we assessed granulomatous inflammation at D42 
and D52 of S. mansoni infection, which also encompasses the time-frame during 
which Batf3-/- mice lose a critical amount of weight. Notably, the time-points analysed 
(D42 and D52) were from two separate experiments rather than a contiguous time-
course, making it difficult to draw direct comparisons between D42 and D52 data sets 
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regarding the proportion of granulomatous inflammation and fibrosis, due to likely 
variation in the initial infective exposure. With this in mind, both time-points will be 
described together from here on in an attempt to better understand the pathology in 
Batf3-/- mice.  
 
The data revealed that total granulomatous inflammation including collagen 
deposition and cellular aggregation at D42 and D52 was unchanged in Batf3-/- 
compared with WT mice (Fig. 4.10A). Although MT stains type III collagen, collagen 
deposition was more accurately measured in the liver using PSR stained sections from 
the median liver lobe, as PSR stains collagen more specifically than MT (as described 
in section 3.4.6, chapter 3). Thus, the deposition of type I and III collagen was 
measured in a similar way to granulomatous inflammation using PSR stained median 
liver lobe sections to measure the level of fibrosis in the tissue (Fig. 4.10B-C). The 
proportion of fibrosis in the liver was not markedly different at D42 (data repeated 
from Fig. 3.11A, chapter 3 for ease of comparison with D52), but was significantly 
greater at D52 in infected Batf3-/- compared with WT controls (Fig. 4.10B-C). Given 
that granulomas present in the liver appeared more fibrotic, granulomas forming in 
the intestine were also examined to identify whether this phenotype was specific to 
the liver. 
 
Histological analysis of ileal sections was conducted to investigate granulomatous 
inflammation that formed as a result of egg transit through the intestinal tissue from 
the mesentery into the lumen. We hypothesised that enhanced Th2 responses and 
impaired Th1 responses in the mLN may alter the granulomatous response in the 
intestines. Due to the more complex architecture of the gut, the novel granuloma area 
analysis method used for the liver could not be used in this tissue. Instead, 
granulomas in the ileum were scored for their intensity and size to compare the 
pathology associated with granulomatous inflammation in Batf3-/- mice with WT 
controls (Fig. 4.10D). This method is described in more detail in section 2.6.1 chapter 
2. WT mice displayed varying severity scores of granulomatous inflammation, but 
when compared with Batf3-/- mice this analysis revealed interesting pathological 
indications. First, high scores were more frequent in infected Batf3-/- than in WT mice 
at D42 post S. mansoni infection (Fig. 4.10D). A similar result was found when 
analysing granulomas in the ileum from D52 infected Batf3-/- and WT mice. Second, 
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some areas of the circular (inner) intestinal muscle of infected mice displayed an 
accumulation of vacuole-like features at D42, which in some cases severely disrupted 
the structure of the muscle indicating damage (Fig. 2.3, chapter 2). This type of 
vacuole formation in the muscle has not yet been described, but may indicate muscle 
injury (Prof. Mark Arends, Western General Hospital). Nevertheless, comparison of 
WT with Batf3-/- mice at D42 of infection revealed that this type of muscle injury was 
increased in the absence of CD8α+ cDCs (Fig. 4.10E). Taken together, initial 
investigations into pathology in the intestines at D42 indicate that the response to eggs 
in this tissue may be aggravated in Batf3-/- mice, though additional analysis is required 
to determine whether this similarly occurs at D52.  
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4.5 Summary of Results 
S. mansoni egg injection  
• Batf3-/- mice developed early and enhanced Th2 but impaired Th1 cytokine 
production in the pLN compared with WT mice after s.c. injection of S. 
mansoni eggs (Fig. 4.3).  
S. mansoni infection 
• At D42 of S. mansoni infection, Batf3-/- mice developed elevated Th2 and 
impaired Th1 cytokine responses in the mLN (Fig. 4.5) and the liver (Fig. 
4.6). 
• The proportion and number of effector CD4+ T cell and CD25+ Foxp3+ Treg 
populations were increased in Batf3-/- mice compared with WT mice (Fig. 
4.7).  
o Approximate effector T:Treg ratios during infection:  
§ mLN = 1:14 for WT mice and 1:7 for Batf3-/- mice.  
§ Liver = 1:1.5 for WT mice and 1:0.5 for Batf3-/- mice  
• CD19+ B cell numbers were increased in the mLN, but not the liver, of Batf3-/- 
mice compared with WT mice (Fig. 4.8).  
• Antibody class-switching to IgE was increased, whereas antigen-specific 
isotypes IgG2c and IgG3 were decreased in the serum of Batf3-/- mice 
compared with WT mice at D42 of infection (Fig. 4.8).  
• Batf3-/- mice lost a critical amount of weight from D46 to D52 of infection 
(Fig 4.9). 
• The proportion of granulomatous inflammation and fibrosis was unchanged in 
Batf3-/- mice, but intestinal granulomas were more severe at D42 of infection 
(Fig. 4.10). 
• At D52, the proportion of granulomatous inflammation was unchanged 
whereas hepatic fibrosis and intestinal granulomas were more severe in S. 




The work presented in this chapter shows that CD8α+ cDCs are not required for the 
induction of Th2 responses after S. mansoni egg injection or at D42 during natural 
infection. Investigating the role of CD8α+ cDCs during S. mansoni infection using 
Batf3-/- mice revealed that a substantial reduction in this subset results in enhanced 
Th2 immune responses in the mLN and the liver, whilst Th1 responses are impaired at 
D42. However, there is some evidence to suggest that CD8α+ cDCs are important for 
the regulation of Th2 responses to ensure the development of “appropriate” immune 
responses and granulomatous pathology during later stages of infection (D52). These 
data provide novel insight into the role of CD8α+ cDCs during chronic infection with 
a parasite, which improves our understanding on the importance of this rare DC type 
during infectious disease.  
4.6.1 CD8α+ cDC lineage cells in Batf3-/- mice 
Since it has become evident that DC subsets fulfil distinct functional roles during 
infectious disease (section 1.2.2, chapter 1) (Mildner and Jung, 2014), specific gene 
deficient or depletion models are essential to unravel the role of DCs in different 
infection settings in vivo. When Batf3-/- mice were generated in 2008 by Hildner et 
al., they provided a promising tool for investigating the role of CD8α+ cDCs during 
infection. However, as the level of deficiency in Batf3-/- mice on the C57BL/6 genetic 
background is variable depending on the tissue analysed (Edelson et al., 2011; 
Tussiwand et al., 2012), it was essential to first examine CD8α+ cDC levels in each 
tissue of interest and in the experimental model used.  
 
In this chapter differential levels of CD8α+ cDC deficiency in Batf3-/- mice were 
revealed in pLNs, iLNs, mLNs and livers using a cocktail of surface markers 
including CD205, CD24 and CD103 to distinguish this subset from other cDCs. In the 
liver the proportion of CD8α+ cDCs in naïve or S. mansoni infected Batf3-/- mice was 
drastically reduced thereby exhibiting the most marked deficiency of this subset 
compared with the other sites examined (Fig. 4.4). On the other hand, residual CD8α+ 
cDCs that express CD8α, CD205 and CD24 were present in pLNs and iLNs of Batf3-/- 
mice after egg injection and in mLNs of naïve or S. mansoni infected Batf3-/- mice 
(Fig. 4.1B & Fig. 4.4B). CD103+ cDCs were decreased by a higher percentage in all 
 
155 
tissues examined compared with CD8α+ cDCs, which indicates that migratory 
CD103+ cDC deficiency is more complete compared with CD8α+ cDCs in these 
tissues. These findings are in line with the literature, as populations of CD8α+ cDCs 
have been reported in iLNs of naive Batf3-/- mice on a C57BL/6 background (Edelson 
et al., 2011; Waithman et al., 2013). In addition, Waithman et al., (2013) showed that 
CD103+ cDCs are absent in iLNs in C57BL/6 Batf3-/- mice. Thus, incomplete 
deficiency of CD8α+ cDCs in C57BL/6 Batf3-/- mice is likely due to differences in the 
genetic background of these mice compared with 129S6/SvEv Batf3-/- mice, which 
results in differential requirement for Batf3 by CD8α lineage cDCs in these mice.  
 
The D42 time-point is critical during S. mansoni infection for it is at this point that the 
switch from a mixed Th1/Th2 to a dominant Th2 immune response occurs (Pearce 
and MacDonald, 2002). Levels of Th1 cytokines are still abundant at D42, as shown 
by the high levels of IFN-y presented in this chapter (Fig. 4.5) and in chapter 3 (Fig. 
3.3). It is well established that Th1 cytokines, in particular IFN-γ and IL-12, can 
trigger Batf3 independent reconstitution of CD8α+ cDCs (Tussiwand et al., 2012), and 
we investigated this phenomenon during S. mansoni infection. Our data indicate that 
infection with S. mansoni does not induce sufficient IFN-γ and IL-12 to trigger 
significant Batf3 independent mechanisms for reconstitution of CD8α+ cDCs at D42, 
as the proportion of CD8α+ cDCs in Batf3-/- mice was unaltered compared with naïve 
levels (Fig. 4.4). However, the possibility that CD8α+ cDCs are reconstituted 
temporarily at earlier stages of S. mansoni infection when Th1 responses are more 
prevalent cannot be dismissed and a time-course covering the period D0 to D42 
would address this. Reconstitution of CD8α+ cDCs during later stages of infection 
(i.e. at D52) is unlikely as Th1 responses are normally downmodulated upon the onset 
of egg production (Pearce et al., 1991), but the proportion of CD8α+ cDCs should also 
be examined at those time-points to exclude this possibility. It has been shown that 
IL-12 and IFN-γ mRNA levels are increased in the lungs at D1 and D3 following 
intravenous egg injection, and thereafter the expression of these cytokines decreases 
(Wynn et al., 1994). A time-course experiment (i.e. D1 to D14) would enable us to 
determine whether S. mansoni egg injection induces the reappearance of CD8α+ cDCs 
in the LNs examined in this chapter, and WT animals could be injected with PBS to 
control for egg injection. Nevertheless, our data indicate that CD8α+ cDCs are not 
reconstituted in Batf3-/- animals at a time-point during infection when Th1 responses 
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are apparent, which argues that immune responses to S. mansoni eggs are not 
sufficient to induce this process.  
 
Given that the deficiency of CD8α+ cDCs was less complete compared with CD103+ 
cDCs, CD8α lineage cDC subtypes were investigated in more detail to better 
understand the Batf3-/- phenotype. In the work detailed in this chapter, closer 
examination of CD8α+ cDCs and various subtypes that belong to this lineage revealed 
that CD8α− CD205+ cDCs remained present in the LNs of Batf3-/- mice (Fig. 4.1 & 
4.4). Splenic immature pre-cursors have been previously reported in naïve Batf3-/- 
mice, expressing CD205, CD24 and Clec9A but not CD8α (Caminschi et al., 2012). 
Therefore, the population of CD8α− CD205+ cDCs found in naïve and S. mansoni 
infected Batf3-/- mice may represent immature pre-cursors of the CD8α+ cDC subset 
lineage, which have not yet reached the developmental stage that requires Batf3 
expression. In addition to CD8α− CD205+ cDCs, a small population of CD8α+ 
CD205− cDCs was evident in the liver and LNs of both WT and Batf3-/- mice. While 
CD8α+ CD205− cDCs may also be pre-cursors to CD8α+ cDCs, it is seems more likely 
that this population represents pDC-related CX3CR1+ CD8α+ DCs (Bar-On et al., 
2010). In support of this finding, CX3CR1+ CD8α+ DCs do not depend on Batf3 for 
their development (Bar-On et al., 2010).  
 
One notable feature of both CD8α+ CD205+ cDCs and CD8α− CD205+ cDCs present 
in the mLNs and the livers of Batf3-/- mice was that they expressed higher levels of 
CD11b and lower levels of CD103 compared with those from WT mice (Appendix 
Fig. 7.3). In line with this finding, Edelson et al., (2011) also showed that residual 
CD8α lineage cDCs in C57BL/6 Batf3-/- mice express lower levels of CD103 
compared with WT mice. This might suggest that residual CD8α lineage cDCs in 
Batf3-/- mice are functionally distinct from their WT counterparts. Supporting this 
hypothesis, Caminischi et al., (2012) have shown that C57BL/6 mice reconstituted 
with BM from 129S6/SvEv Batf3-/- mice are not capable of MHC-I presentation to 
OT-I T cells in vivo compared with the control group, whereas they are able to present 
pOVA via MHC-II to OT-II T cells. Furthermore, it has recently been reported that 
the capacity to cross-present occurs at later stages of CD8α+ cDC development (Sathe 
et al., 2011). MHC-I and MHC-II presentation by CD8α cDC lineage pre-cursors 
could be tested in future by purifying residual cDC subsets from Batf3-/- mice for 
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culture with CD4+ or CD8+ T cells (e.g. from OT-II and OT-I transgenic mice 
respectively) ex vivo to examine their ability to present antigen and induce T cell 
proliferation and cytokine production. In addition the production of cytotoxic 
components such as Granzyme B by CD8+ T cells could be measured to determine the 
cytotoxic capacity of CD8+ T cells in the presence of CD8α lineage cDC subtypes. 
Taken together, our data and previous work in the literature suggest that Batf3-/- mice 
are deficient in mature CD8α lineage cDCs efficient in antigen cross-presentation 
upon stimulation, whereas residual pre-cursor cDCs of this lineage remain present and 
are likely functionally distinct (Caminschi et al., 2012). 
4.6.2 Batf3-/- mice display enhanced Th2 immune 
responses against S. mansoni eggs 
S. mansoni egg injection subcutaneously into the top of the feet of WT mice induces 
an acute Th2 immune response in the pLNs, which can be examined without the 
additional complexities of systemic S. mansoni infection (Phythian-Adams et al., 
2010). The data in this chapter have shown that, as expected, egg injection into WT 
mice induced antigen-specific IL-4 in the pLN from D5 to D9, correlating with 
decreased IFN-γ during this time-frame (Fig. 4.3). Increased antigen-specific IL-4 as 
well as consistent IL-5, IL-13 and IL-10 production against S. mansoni eggs occurred 
in Batf3-/- mice, which reflects unimpaired induction of Th2 immune responses. This 
suggests that CD8α+ cDCs are not required for the induction of Th2 responses to S. 
mansoni eggs in vivo. Furthermore, Batf3-/- mice displayed elevated Th2 immune 
responses even at D5 when WT levels were still low, which might indicate that the 
kinetics of Th2 induction could be altered in these animals. Analysis of D3 responses 
in this type of experiment would provide additional information as to whether Th2 
induction occurs earlier in Batf3-/- compared with WT mice. Thus, Batf3-/- mice were 
not only capable of inducing Th2 responses, they displayed strikingly increased SEA-
specific IL-4 production compared with WT mice. Given that IL-10 is also produced 
by Treg cells (particularly iTregs) during S. mansoni infection (Baumgart et al., 2006; 
McKee and Pearce, 2004), the intact production of this cytokine may also reflect 





Unlike Th2 responses, Batf3-/- mice failed to generate equivalent Th1 responses 
compared with WT mice (Fig 4.3). IFN-γ production by pLN cells was reduced in 
Batf3-/- mice, and this is in line with previous literature that describes CD8α+ cDCs as 
important players in Th1 and antigen cross-presentation responses (Ashok et al., 
2014; Edelson et al., 2010; Haan et al., 2000; Hildner et al., 2008; Mashayekhi et al., 
2011; Torti et al., 2011; Waithman et al., 2013). Further repeats of this egg 
injection/pLN assay need to be undertaken before firm conclusions can be drawn, as 
this time-course has only been carried out once and some samples had to be pooled 
for SEA-specific restimulation due to low numbers of cells (Fig. 4.3). However, the 
same overall trend was found in Batf3-/- mice at D7 alone after SEA restimulation 
when individual samples were analysed by ELISA (Appendix Fig. 7.4). Overall, the 
data underline that although CD8α lineage cDCs were not completely absent in pLNs 
of Batf3-/- mice, the comparison of immune responses generated by Batf3-/- and WT 
mice uncovered dramatically altered cytokine production in response to S. mansoni 
eggs in the absence of Batf3.  
 
Cytokine responses in the iLNs of egg-injected Batf3-/- mice, which did not exhibit as 
significant a decrease in CD8α+ cDCs as pLNs (Fig. 4.1), followed a similar trend to 
responses in the pLN, with higher levels of Th2 cytokines, and lower levels of IFN-γ, 
in the absence of Batf3. We initially selected iLNs on the understanding that these 
were ndLNs for s.c. administration of antigen to the foot (Hebel and Stromberg, 1976; 
Tilney, 1971), as they have been predominantly described as dLNs for the skin (Byrne 
et al., 2008; Edelson et al., 2010; Henri et al., 2001). However, to our surprise, after 
we had carried out these experiments and could detect a low level egg-specific 
response in the iLNs, we found evidence in the literature that iLNs can in fact drain 
the foot site (Harrell et al., 2008). Thus, lower antigen-specific Th2 responses in the 
iLNs compared with the pLNs raises the question of whether S. mansoni egg 
stimulated DCs migrate more efficiently to pLNs compared with iLNs from the foot, 
which has not yet been addressed in the literature. On the other hand, low level 
responses could also occur through recirculation of T cells responding to antigen from 
another site i.e. the pLN or the spleen. Lymphocyte recirculation is an established 
feature of naïve antigen-specific T cells, which migrate through specialised 
endothelium of secondary lymphoid organs (Marelli-Berg et al., 2008). This process 
is critical for immune surveillance of the immune system, but antigen recognition and 
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co-stimulation provided by APCs usually prevent recirculation and promote migration 
of the antigen primed T cell to the site of inflammation (Marelli-Berg et al., 2008) 
(discussed in 1.4, chapter 1). For example, it has been suggested that the co-
stimulatory molecule CD28 is required for efficient T cell localisation to the CNS in 
vivo during experimental encephalomyelitis (Chang et al., 1999; Girvin et al., 2000), 
which perhaps occurs through upregulation of integrin-mediated cell adhesion. 
Although the exact mechanisms that mediate efficient T cell migration to the correct 
tissue site remain unclear, ineffective co-stimulation and/or enhanced co-inhibition 
provided by cDCs within the pLNs could conceivably result in inefficient migratory 
cues from the site of T cell priming, and thus lead to low level systemic recirculation 
of antigen primed T cells in both WT and Batf3-/- mice. In any case, the low level 
responses in the iLN support our line of thinking that Th2 responses are increased in 
Batf3 deficient animals. 
 
One limitation of the bulk culture of LN cells is that the cytokine profiles measured 
may not solely be attributable to T cells, as other lymphoid cells including DCs, B 
cells, FRCs and some MΦs will also be present in culture (Andrian and Mempel, 
2003). To more directly address the impact of Batf3 deficiency on T cell cytokine 
production in the dLN following egg injection, ex vivo intracellular staining of pLN T 
cells was conducted. This approach showed that a larger proportion of CD4+ T cells 
produced IL-4 and IL-10 in Batf3-/- mice, with CD4+ T cells also expressing higher 
amounts of IL-13 per cell (Fig. 4.3). These results strongly support the ELISA data 
from bulk LN cultures after SEA restimulation, indicating that Th2 immune responses 
in Batf3-/- mice following egg injection are not only intact, but enhanced, relative to 
WT mice. In contrast to this enhanced Th2 profile, the ICC data showed that CD4+ 
and CD8+ T cells from Batf3-/- mice were significantly less able to produce IFN-γ 
after polyclonal restimulation. This is in line with our hypothesis that Th1 immune 
responses against S. mansoni eggs are impaired in Batf3-/- mice, and is consistent with 
previous studies in non Th2 systems, which have shown that in the absence of mature 
CD8α+ cDCs, CD4+ and CD8+ Τ cells produce lower levels of IFN-γ (Ashok et al., 
2014; Mashayekhi et al., 2011). Thus, using an egg injection model we were able to 




4.6.3 Immune responses in Batf3-/- mice at D42 of S. 
mansoni infection 
4.6.3.1 Batf3-/- mice display enhanced Th2 and impaired Th1 immune 
responses against S. mansoni infection 
Having identified that Batf3 dependent DCs were not required for the induction of 
Th2 responses following schistosome egg injection, we next addressed whether Batf3-
/- mice were capable of developing Th2 immunity during active infection. The 
immune phenotype in Batf3-/- mice was examined at D42 of infection after the onset 
of egg production, which consequently induces a dominant Th2 immune response in 
WT animals (Pearce and MacDonald, 2002) (Fig. 3.3, chapter 3). Thus, this is an 
early time-point in immune response development against the egg during S. mansoni 
infection, which can be considered as the early phase of Th2 priming (Phythian-
Adams et al., 2010). The mLNs are of particular interest as a site of Th2 initiation by 
intestinal and LN resident DCs, including CD103+ cDCs (Scott, 2011), against 
antigens from eggs produced by adult worms in the mesenteric vessels which transit 
across the intestine wall and into the lumen (Pearce and MacDonald, 2002). The type 
of immune response in the liver was also investigated, as a large proportion of the 
eggs produced by the parasite are swept through the bloodstream into this effector site 
(Cheever, 1987).  
 
Cytokine production by mLN and liver leukocytes from infected Batf3-/- mice was in 
line with the results from the egg injection experiments, as the amount of antigen-
specific Th2 cytokines were enhanced (Fig. 4.5 & 4.6). Cytokine expression by T 
cells detected by ICC after αCD3/CD28 stimulation indicate that mLN CD4+ T cells 
in Batf3-/- mice consist of a larger population of primed polyclonal CD4+ T cells 
producing Th2 cytokines with an enhanced capacity for per cell production of IL-4. In 
the liver, ICC analysis showed that the per cell production of IL-13 and IL-10 by 
hepatic CD4+ T cells was increased, but the proportions of Th2 cytokine positive T 
cells in Batf3-/- mice were unchanged. Thus, the data obtained from the SEA 
stimulation of bulk LN or liver leukocytes in culture generally showed a more distinct 
increase in Th2 responses in Batf3-/- mice during infection, particularly in terms of 
increased IL-4 production, compared with qualitative analysis of T cell cytokine 
production with ICC. Possible explanations for this discrepancy between ICC and 
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ELISA analysis of cytokine production by liver leukocytes will be discussed in more 
detail in section 4.6.5. Nevertheless, in answer to our original question we have 
shown that CD8α+ cDCs are not required for the induction of Th2 responses against S. 
mansoni eggs following egg injection or during natural infection. This is in line with 
our hypothesis and current thinking in the literature that IRF4 dependent cDCs (i.e. 
CD11b+ cDCs) are the principle subset involved in the induction of Th2 responses to 
a pathogen (Gao et al., 2013; Kumamoto et al., 2013; Plantinga et al., 2013; Williams 
et al., 2013). 
 
In contrast to Th2 responses, antigen-specific Th1 responses were decreased in Batf3-
/- mice at D42 of S. mansoni infection in both the mLN and the liver (Fig. 4.5 & 4.6). 
Further, flow cytometric analysis of CD4+ and CD8+ T cell populations in the mLN 
and cytokine production assessed by ICC indicated that, even though the absolute 
numbers of CD4+ and CD8+ T cells were increased in the mLNs of Batf3-/- mice, the 
proportion of IFN-γ+ T cells was decreased. This suggests that priming of CD4+ and 
CD8+ T cells in the mLN renders them unable to produce IFN-γ efficiently in the 
absence of CD8α+ cDCs. Liver investigations revealed that a similar impairment in 
Th1 responses during S. mansoni infection occurred in the effector site, where T cell 
numbers were not drastically changed. Thus, our data build on previous literature 
investigating the role of CD8α+ cDCs in acute bacterial and parasite infection (Ashok 
et al., 2014; Mashayekhi et al., 2011), as we have shown that Batf3-/- mice display 
impaired Th1 responses in a helminth infection setting, where Th2 responses are 
central for the development of the disease (Pearce and MacDonald, 2002).  
 
Given that Batf3 dependent cDCs are known as the main source of IL-12 during T. 
gondii infection (Mashayekhi et al., 2011) and L. major infection (Martínez-López et 
al., 2014), impaired Th1 immune responses in Batf3-/- mice during S. mansoni 
infection shown in this chapter may also be due to reduced levels of IL-12 needed for 
efficient Th1 induction and downstream IFN-γ production (Mashayekhi et al., 2011), 
as well as impaired cytotoxic responses (Hildner et al., 2008). In support of this 
hypothesis, administration of recombinant IL-12 induces IFN-γ mRNA expression in 
the lung following intravenous S. mansoni egg injection, whilst IL-12 neutralisation 
with an αIL-12 antibody impairs IFN-γ expression (Wynn et al., 1994). In addition, it 
has been shown that the maintenance of effector Th1 function in the lung during 
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chronic infection with tuberculosis requires IL-12, as effective Th1 responses in IL-
12p40-/- mice were achieved only through continuous IL-12 administration (Feng et 
al., 2005). The requirement for CD8α+ cDCs in the induction and maintenance of Th1 
responses could in theory be validated by the administration of recombinant IL-12 to 
Batf3-/- mice, as this may lead to reconstitution of CD8α+ cDCs via Batf3 independent 
mechanisms in vivo (Tussiwand et al., 2012). In this experiment, we would expect 
reconstitution of CD8α+ cDCs and IL-12 to restore Th1 responses during S. mansoni 
infection. A specific role for IL-12 could then be assessed in an ex vivo culture system 
where CD4+ T cells and CD8α+ cDCs isolated from S. mansoni infected mice are 
cultured in the presence or absence of recombinant IL-12 or αIL-12 antibody. Indeed, 
the production of IL-12 by CD8α+ cDCs may be a key pathway for the induction of 
appropriately balanced or mixed Th1 and Th2 immune responses during S. mansoni 
infection.  
4.6.3.2 Possible mechanisms that CD8α+ cDCs employ during S. 
mansoni infection 
Having established that Th2 immune responses are enhanced in Batf3-/- mice infected 
with S. mansoni at D42 or following egg injection, it is plausible that CD8α+ cDCs 
either directly or indirectly regulate the induction of Th2 responses. To better 
understand the mechanism responsible for Th2 response regulation by CD8α+ cDCs, 
the impact of cytokines produced by this cDC subset including IL-12, IFN-α, TNF-α, 
IL-10 and TGF-β on T cell function could be investigated in future (Bamboat et al., 
2010; Hochrein et al., 2001; Martínez-López et al., 2014; Mashayekhi et al., 2011; 
Pillarisetty et al., 2004; Shortman and Heath, 2010; Yamazaki et al., 2008).  
 
Direct modulation of Th2 responses in S. mansoni infection by CD8α+ cDCs may 
occur via the production of soluble molecules that are implicated in Th1 immunity, 
such as IL-12 (Schroder, 2003). A reduction in CD8α+ cDCs and Th1 induction via 
IL-12 signalling in Batf3-/- mice during S. mansoni conceivably results in larger pool 
of CD4+ T cells that differentiate into Th2 cells. In fact, it is likely that IL-12 
produced by CD8α+ cDCs is also important for controlling the plasticity of IFN-γ/IL-
4 double-positive T cells present during S. mansoni infection (Deaton et al., 2014; 
Peine et al., 2013) (introduced in section 1.5.1, chapter 1). Thus, a lack of Th1 
polarisation signals may abrogate the development of IFN-γ/IL-4 double-positive T 
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cells in Batf3-/- mice in infection, resulting in a larger population of IL-4 single-
positive T cells.  
 
In addition to skewing naïve CD4+ T cell polarisation, IL-12 may impact the function 
of effector/memory CD4+ T cell populations directly. Various studies have reported 
that IL-12 administration during parasitic infection including S. mansoni infection 
causes a switch from a Th2 to a Th1 response in vivo (Bancroft et al., 1997; Nabors et 
al., 1995; Wynn et al., 1994). Another study reported that committed Th2 cells 
generated in vitro produce less IL-4 and IL-5 and more IFN-γ in response to 
recombinant IL-12, which is thought to be due to retained responsiveness to IL-12 
(Moriggl et al., 1998). Similarly, various studies have shown that administration of 
IL-12 can revert allergen-specific human polarised Th2 cells to a Th0/Th1 phenotype 
in vitro (Kaliński et al., 2000; Smits et al., 2001b; Sornasse et al., 1996). Yet, long-
term stimulated murine Th2 cells are thought to become more resistant to a reversal in 
their phenotype (Murphy et al., 1996), and as such it is thought that the level of 
responsiveness to IL-12 by Th2 cells (i.e. expression of the IL-12 receptor) seems to 
be critical for this process (Szabo et al., 1995). Thus, the impact of IL-12 during S. 
mansoni infection may be dependent on the proportion of IL-12 responsive Th2 cells 
in the primed/effector/memory Th2 cell pool. However, a possible role for IFN-γ or 
other Th1 cytokines in the regulation of Th2 responses particularly during parasitic 
infection cannot yet be dismissed, and the direct affects of IL-12 on established Th2 
cells remain poorly characterised. Indeed, downstream signalling events following IL-
12 stimulation may be key to understanding the impact this cytokine has on CD4+ T 
cell responses (Murphy and Stockinger, 2010), and this will be discussed in more 
detail in chapter 5 when the function of CD8α+ cDCs at D42 of S. mansoni infection 
is investigated. 
 
In addition to IL-12, IFN-α may contribute to direct Th2 immune response 
suppression, as IFN-α has been shown to promote IL-10 production and inhibit IL-4 
production by human CD4+ T cells that were previously activated by CD3/CD28 
stimulation in vitro (Aman et al., 1996). In fact, splenic CD8α+ cDCs are major 
producers of IFN-α compared with other cDC subsets (Hochrein et al., 2001), and 
FLT3L CD24+ cDCs, which are the in vitro equivalent of CD8α+ cDCs (Naik et al., 
2005), produce type I IFNs in response to SEA (work conducted by Dr. Lauren 
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Webb). Yet, the role of type I IFNs during Th2 response setting remain unclear to 
date, and it is possible that IFN-α is positively involved in Th2 induction during S. 
mansoni infection.  
 
Alternative to inflammatory cytokines, TGF-β or IL-10 produced by CD8α+ cDCs 
could directly suppress Th2 responses, as these cytokines are well known for their 
regulatory effects on effector CD4+ T cell responses (Couper et al., 2008; Gorelik and 
Flavell, 2002). Indeed, CD8α+ cDCs, but not CD8α− cDCs, have been shown to 
modulate Th2 responses and reverse airway hyperresponsiveness and eosinophilia in 
an asthma model (Gordon et al., 2005). The production of IL-10 and ΤGF-β by 
CD8α+ cDCs was necessary for downregulation of Th2 cytokine levels and IgE 
responses in vitro by splenocytes isolated from mice that had been sensitised for 
asthma-like disease (Gordon et al., 2005). Interestingly, modulation of allergic 
responses in the asthma model was most efficient when cDCs were in direct contact 
with T cells, but the nature of this interaction i.e. co-stimulatory/-inhibitory signals 
was not addressed (Gordon et al., 2005). While the production of TGF-β was not 
examined in our work, CD8α+ cDCs may produce this cytokine during S. mansoni 
infection as DCs are not conventionally activated (MacDonald et al., 2001). The 
production of TGF-β and IL-10 by CD8α+ cDCs from S. mansoni infection compared 
with naïve or Th1-challenged mice could be tested by PCR, and a bioassay for the 
detection of TGF-β could be used to complement the measurement of gene expression 
(Khan et al., 2012; Tesseur et al., 2006). However, although studies investigating 
CD8α+ cDC function in the steady state or allergic Th2 responses (i.e. in the absence 
of substantial Th1 responses) suggest that Th2 regulation mediated by CD8α+ cDCs 
may involve cytokines that exhibit established functions in the suppression of CD4+ T 
cell responses, the potent capacity of CD8α+ cDCs to induce Th1 and CTL responses 
perhaps argues against this hypothesis when Th1 inflammation is apparent, including 
during S. mansoni infection (Hildner et al., 2008; Maldonado-López et al., 1999; 
Mashayekhi et al., 2011; Pulendran et al., 1999). 
 
The induction of Th1 responses by CD8α+ cDCs may in fact represent an indirect 
mechanism for the regulation of Th2 responses induced by other cDC subsets (Seder 
et al., 1993). Given the established literature on cross-regulation between IL-4 and 
IFN-γ (Paludan, 1998) (section 1.5.1, chapter 1), IFN-γ produced by CD4+ T cells 
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may then indirectly regulate/inhibit Th2 cell differentiation and proliferation 
(Gajewski et al., 1988), and suppress IL-4 production by activated CD4+ T cells 
(Elser et al., 2002; Oswald et al., 1994; S W Chensue, 1994; Trinchieri, 2003). 
However, the impairment of Th1 responses does not automatically equal enhanced 
Th2 responses and certainly does not always result in increased weight loss during S. 
mansoni infection, as found for Batf3-/- mice in this chapter (Fig. 4.9). For example, 
mice deficient in MyD88 that lack antigen-specific Th1 responses develop a 
marginally increased Th2 response, but are able to maintain their body weight 
(Layland et al., 2005). Furthermore, IFN-γ-/- mice do not exhibit increased mortality 
or significant increases in IL-4 production by splenocytes in vivo (Yap et al., 1997). 
This suggests that decreased IFN-γ alone is unlikely to be the sole factor contributing 
to the regulation or inhibition of Th2 responses in WT animals during S. mansoni 
infection, which points to a specific role for CD8α+ cDCs. Thus, the combination of 
numerous soluble factors including IL-12 and IFN-α perhaps determines the 
efficiency of Th2 downmodulation by CD8α+ cDCs. Indeed, IFN-α has been shown to 
augment IL-12 mediated IFN-γ production by CD4+ T cells in vitro (Wenner et al., 
1996).  
 
One additional functional aspect that may be altered in Batf3-/- mice is the phenotype 
of CD8α− cDCs during S. mansoni infection. CD8α− cDCs may be more activated in 
the absence of CD8α+ cDCs, and activation markers (e.g. CD80/86 or CD40) 
(Banchereau et al., 2000; Perona-Wright et al., 2006) on CD8α− cDCs in Batf3-/- mice 
could be examined by flow cytometry to provide an insight into the status of these 
cDCs. Although it is not yet known how/if cytokines secreted by CD8α+ cDCs, such 
as IL-12, impact on other cDC subsets, the hypothesis can be made that CD8α+ cDCs 
are directly inhibiting or regulating the capacity of CD8α− cDCs to induce Th2 
responses against S. mansoni infection. Thus, the combination of reduced CD8α+ cDC 
mediated regulation and altered CD8α− DC activity may result in a breakdown in 
regulatory processes leading to increased Th2 immune responses in Batf3-/- mice 
responding to S. mansoni egg antigens.  
 
To address whether CD8α+ cDCs regulate or inhibit Th2 responses primed by other 
DCs, the capacity of sorted CD8α− (i.e. CD11b+) cDCs to polarise Th2 responses to 
SEA could be tested in a culture system with CD4+ T cells, where CD8α+ cDCs are 
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either absent or present in the culture. The number of CD8α+ cDCs added to the 
culture should be titrated to assess whether regulation/inhibition of CD8α− cDCs is 
dependent on the number of CD8α+ cDCs added. If CD8α+ cDCs regulate Th2 
polarisation by CD8α− cDCs we would expect that decreased Th2 cytokine 
production, including IL-4, would correlate with increased numbers of CD8α+ cDCs 
in the culture. Following experiments could then specifically examine the impact of 
soluble factors secreted by CD8α+ cDCs on Th2 cytokine production. This scenario 
can be tested by adding recombinant cytokine (i.e. rIL-12) to either ex vivo or in vitro 
FLT3L CD11b+ cDCs after sorting and during stimulation in culture with SEA. The 
activation phenotype of these cells could then be analysed, and their potential to 
prime Th2 responses could be examined either in vivo by cell transfer into mice or in 
vitro by culture with CD4+ T cells. Thus, in the process of investigating why CD8α+ 
cDCs are important for balanced immune responses during S. mansoni infection, we 
would aim to delineate key soluble factors involved in orchestrating Th2 cell 
responses. Once identified, the impact of such mediators on multiple aspects of 
CD8α− cDC activation including antigen uptake, processing and presentation and 
cytokine production could then also be interrogated. 
4.6.3.3 The activation status of CD4+ T cells in Batf3-/- mice is increased 
at D42 of S. mansoni infection 
Given that Th2 responses were increased in Batf3-/- mice, we asked whether the 
activation status of CD4+ T cells was altered in the face of reduced CD8α+ cDCs. 
Proportions of CD4+ T cells expressing CD25, but not Foxp3, were analysed to gain 
an insight into whether increased Th2 responses correlated with increased 
proliferation of effector CD4+ T cells. This revealed that the numbers and proportions 
of effector CD25+ Foxp3− CD4+ TCR-β+ T cell populations were increased in both the 
mLNs and livers compared with those observed in WT mice (Fig. 4.7). Thus, 
increased Th2 immune responses in Batf3-/- mice were accompanied by activation and 
expansion of a larger population of effector CD4+ TCR-β+ T cells than is evident in 
WT mice, even in the liver where total CD4+ T cell numbers were unchanged (Fig. 
4.6). To further assess the impact of enhanced effector Th2 cytokine production on 
the adaptive immune response during S. mansoni infection in Batf3-/- mice, Β cell and 
Treg populations were next examined. 
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4.6.3.4 B cell populations and antibody class-switching in Batf3-/- mice 
during S. mansoni infection  
Flow cytometric analysis of B cells during S. mansoni infection when CD8α+ cDCs 
were reduced showed that the number of B cells was increased in mLNs of Batf3 
deficient mice (Fig. 4.8), which may be a direct effect of increased numbers of CD4+ 
T helper cells present in this tissue (Cerutti et al., 2012; Parker, 1993). CD4+ T cells 
activate B cells via CD40L stimulation and cytokine expression including IL-4, and 
this kind of interaction is required for efficient B cell proliferation and Ig class 
switching (Cerutti et al., 2012; Parker, 1993). Thus, enhanced numbers of CD4+ T 
cells and IL-4 production in the mLN conceivably result in larger numbers of B cells 
in Batf3-/- mice due to increased availability of activatory signals.  
 
To assess whether the function of B cells in Batf3-/- mice was altered, antibody 
isotypes present in the serum were examined. This analysis revealed elevated levels of 
Ig class switching to IgE in Batf3-/- mice, which further underlines that Th2 immune 
responses were systemically increased in the absence of CD8α+ cDCs (Fig. 4.8). A 
greater systemic abundance of IgE likely results in increased mast cell and basophil 
degranulation in Batf3-/- mice, which could be examined in future by measuring the 
amount of histamine present in the serum. Increased class-switching to IgE is 
probably a direct result of enhanced IL-4 production in Batf3-/- mice, as IL-4 has been 
shown to mediate IgE class-switching via nuclear factor NFIL3 induction (Kashiwada 
et al., 2010). Thus, enhanced levels of IL-4 may act as a powerful amplifier of B cell 
help provided by T cells as well as IgE production. A role for CD8α+ cDCs in 
regulating IgE production by B cells via the production of IFN-α is possible, as IFN-α 
has been shown to suppress IL-4 induced IgE production by B cells in vitro (Pene et 
al., 1988). In addition, IFN-γ inhibits class-switching to IgE, and has been reported to 
limit B cell proliferation and expansion by IL-4 (Hasbold et al., 1999). Thus, a 
reduction of IFN-γ levels in Batf3-/- mice likely contributes to elevated/less controlled 
levels of antibody class-switching to IgE and increased proportions of B cell 
populations. This lends further support to our hypothesis that CD8α+ cDC derived 





Th2 cytokines IL-4 (Siebenkotten et al., 1992) and IL-5 (Mizoguchi et al., 1999) have 
been described to induce murine Ig class switching in B cells to antibody isotype 
IgG1 in vitro. Yet unlike IgE, levels of SEA-specific IgG1 were not significantly 
enhanced at D42 in the serum of Batf3-/- mice (Fig. 4.8). This indicates that the 
mechanisms for IgE and IgG1 induction are in some way distinct. Indeed, it has been 
reported that high levels of IL-4 can inhibit IgG1 production by B cells, whereas IL-4 
consistently drives IgE class-switching (Snapper et al., 1988). Further, IFN-γ 
mediated inhibition of IL-4 induced class-switching affects IgE more drastically than 
IgG1 (Hasbold et al., 1999), which suggests that levels of IgG1 would be less affected 
by the reduced levels of IFN-γ in Batf3-/- mice. IFN-γ has also been shown to induce 
the production of IgG2c (Barr et al., 2009) and IgG3 (Snapper et al., 1992) in mice, 
and so the reduced levels of IFN-γ most likely explain the reduction in SEA-specific 
antibody isotypes IgG2c and IgG3 in Batf3-/- mice at D42.  
 
Taken together, these results show that B cell antibody production is altered in the 
absence of CD8α+ cDCs, which is likely a direct effect of impaired Th1 and enhanced 
Th2 responses at D42 of S. mansoni infection. To test this hypothesis, sorted CD4+ T 
cells from S. mansoni infected mice could be co-cultured with isolated B cells for the 
examination of antibody isotypes produced in the assay. Activation of B cell subsets, 
including marginal zone and follicular B cells, could also be assessed more 
thoroughly by flow cytometry using surface markers including IgD, IgM, CD19, 
B220 and CD23 (Pillai and Cariappa, 2009). In addition, it can be postulated that 
germinal centre formation in Batf3-/- mice may be enhanced, which could be 
addressed by immunofluorescent staining of mLN or spleen tissue sections for 
fluorescent microscopic analysis. Peanut agglutinin and IgD are commonly used to 
stain B cells in the germinal centre and the mantel (layer of naïve B cells surrounding 
the germinal centre) respectively (Schwickert et al., 2007), and CD3 could be used to 
stain for T cells (Mack and Sokol, 2005). This technique would provide information 
about the size of germinal centres formed, and the location of B and T cells in the 
germinal centre. Along the same lines, it would be of interest to investigate Tfh 
populations in Batf3-/- mice by flow cytometry using cell markers ICOS, PD-1 and 
CXCR5 (Crotty, 2011), as these cells specialise in the provision of B cell help and the 
formation of germinal centres (Crotty, 2011) (section 1.5, chapter 1). Indeed, 
enhanced numbers of CD4+ T cells in the mLN but not the liver may indicate an 
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increase specifically in the Tfh population in the mLN, and this may additionally 
account for increased antibody production by B cells (Crotty, 2011).  
4.6.3.5 Treg populations in Batf3-/- mice during S. mansoni infection 
increase in parallel with Th2 responses 
Dysregulated adaptive immune responses in Batf3-/- mice raised the question whether 
regulatory processes were also altered in these mice, and thus analysis of Treg cell 
populations and IL-10 production by flow cytometry was conducted. The data show 
that the proportion of Treg populations was increased in infected Batf3-/- mice 
compared with WT controls. This correlates with previous literature, which reports 
that Treg populations increase in parallel with Th2 responses during S. mansoni 
infection (Taylor et al., 2006), and contribute towards the regulation of Th2 responses 
(Baumgart et al., 2006). Treg cells also expand during Th1 mediated infection, such 
as Mycobacterium tuberculosis (Arram et al., 2014; Shafiani et al., 2013). Therefore, 
Treg populations may increase as a direct result of enhanced Th2 populations in 
Batf3-/- mice, in an attempt to exert a level of control on the exaggerated Th2 response 
during S. mansoni infection.  
 
Notably, the comparison of effector T cell with Treg cell populations revealed that in 
relation to effector T cells the ratio of Treg cells was decreased in Batf3 deficient 
mice compared with WT controls. An altered ratio suggests that the number of Tregs 
per effector CD4+ T cell is reduced in Batf3-/- animals at D42 of S. mansoni infection, 
which argues that enhanced Th2 responses in Batf3-/- mice may not be efficiently 
regulated. This raises the question whether the quality of Treg responses is altered in 
Batf3-/- mice. Therefore, the possibility that CD8α+ cDCs are involved in the 
differentiation of Tregs that suppress Th2 responses cannot be dismissed. Indeed, 
splenic naïve CD8α+ cDCs have been reported to induce iTreg cells via TGF-β both in 
vitro and in vivo following CD4+ T cell stimulation with low antigen doses (Yamazaki 
et al., 2008). Yet, increased antigen-specific IL-10 and proportions of IL-10+ CD4+ T 
cells in infected Batf3-/- mice (Fig. 4.5 & 4.6) suggest that enhanced IL-10 production 
may at least be partially due to increased Treg function as well as enhanced Th2 
immune responses. Further experiments determining the source of IL-10 are 
necessary for full interpretation of this result and to clarify whether the function of 
regulatory responses is sufficient to compensate for a reduced number of Tregs per 
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effector T cell in Batf3-/- mice. For more specific qualitative analysis to determine 
both the source of IL-10 and the functionality of Tregs during S. mansoni infection in 
Batf3 deficient environments, IL-10 cytokine reporter mice could be infected with S. 
mansoni to examine IL-10 producing populations by flow cytometry. Nevertheless, 
the data indicate that the CD8α+ cDCs are not required for the induction of Treg 
populations during S. mansoni infection, which is in line with the current literature 
that reports CD8α+ cDCs as key players for the induction of Th1 responses during 
infectious diseases (Ashok et al., 2014; Mashayekhi et al., 2011). 
4.6.3.6 Th17 responses in Batf3-/- mice during S. mansoni infection 
IL-17 is commonly found at only very low levels in S. mansoni infected C57BL/6 
mice (Perona-Wright et al., 2012). This likely explains why IL-17 production was 
generally observed only marginally above the detection limit when measured both by 
ELISA and ICC in the work detailed in this thesis, increasing the possibility of 
technical error (Fig 4.5 & 4.6). Although close to the detection limit, antigen-specific 
IL-17 was increased in Batf3-/- mice at D42 post infection in the mLN, which is 
similar to pLN IL-17 production observed following Batf3-/- egg injection (Fig 4.3). 
This raises the possibility that CD8α+ cDCs are important for regulating the 
expression of IL-17 by CD4+ T cells. In support of our data, it has been reported that 
S. mansoni infected IFN-γ deficient mice (Rutitzky and Stadecker, 2011) and L. major 
infected Batf3-/- mice (Ashok et al., 2014) display enhanced Th17 responses. IFN-γ 
inhibits IL-17 production (Harrington et al., 2005; Hoeve et al., 2006; Park et al., 
2005) and so a lack of IFN-γ produced by T cells in Batf3-/- mice may also be 
contributing to the modest increase in Th17 responses observed in our experiments 
(Harrington et al., 2005; Park et al., 2005). Thus in our work, a reduction in CD8α+ 
cDCs may result in reduced IL-12 levels in Batf3-/- mice, leading to decreased 
regulation of IL-17 production mediated by IFN-γ. This is a noteworthy point to 
consider, as elevated IL-17 is associated with increased pathology in schistosome 
infection (Rutitzky and Stadecker, 2006), Measurement of IL-12 levels in the serum 
or administration of recombinant IL-12 or IFN-γ to Batf3-/- mice and analysis of Th17 
responses would address this scenario following egg injection or during S. mansoni 
infection. Notably, IL-17 detected by ICC in Batf3-/- was not significantly increased in 
the mLN or the pLN (Fig. 4.5 & 4.3 respectively), which could suggest a non- αβ T 
cell IL-17 source, such as γδ T cells, may be dysregulated in these animals (O'Brien et 
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al., 2009). Alternatively, the discrepancy between IL-17 production measured by 
ELISA and ICC may reflect the limits of detection of these assays. 
 
In summary, the absence of CD8α+ cDCs in our system results in impaired Th1 
immune responses, and likely a reduction in direct and/or indirect Th2 regulation by 
CD8α+ cDCs at D42 of S. mansoni infection. Consequently, defective Th2 regulation 
may increase the available help for B cell activation in lymphoid tissues, resulting in 
enhanced B cell proliferation and increased antigen-specific antibody production. 
Treg populations increased in parallel with Th2 populations to regulate the 
exaggerated response against S. mansoni eggs, but regulation per antigen primed 
CD4+ T cell may be decreased. Furthermore, CD8α+ cDCs may be involved in the 
regulation of Th17 responses against S. mansoni eggs. Thus, these data underline that 
systemic immune responses to S. mansoni are dysregulated in Batf3-/- mice resulting 
in increased Th2 responses, compared with WT animals.  
4.6.4 Increased pathology in Batf3-/- mice during S. 
mansoni infection  
We have shown that the removal of a rare cDC subset results in substantially 
increased mortality during S. mansoni infection as well as dysregulated CD4+ T cell 
responses (Fig. 4.5 & 4.6). Knowing that Th2 responses peak around D56 during 
murine S. mansoni infection (Pearce and MacDonald, 2002) (Fig. 3.3 Chapter 3), it 
was hypothesised that Batf3-/- Th2 responses would remain higher than WT at later 
stages of infection. The assessment of CD4+ T cell responses in the mLN and the liver 
at D52 was unsuccessful due to limited numbers of cells in the Batf3-/- group for this 
analysis, and this is an aspect to pursue in future. Nevertheless, it was possible to 
examine the pathology in Batf3-/- mice at D52, which provided an initial insight into 
the possible reasons for the extreme weight loss exhibited by these animals in this 
time-frame.  
 
The data obtained from analysing the parasitemia and hepatosplenomegaly at D42 
suggest that increased weight loss in Batf3-/- mice is not due to altered parasite 
burdens. TNF-α mediated cachexia and mortality have been previously described in 
IL-4-/- mice infected with S. mansoni (Brunet et al., 1997). Our laboratory has 
observed a similar weight loss phenotype during an equivalent time-frame when bulk 
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CD11c+ DCs were depleted, resulting in impaired Th2 immune induction during S. 
mansoni (Dr. Alexander Phythian-Adams, unpublished data). However, in the current 
Batf3-/- model the induction of Th2 responses was unimpaired and TNF-α production 
reduced (Fig. 4.5 & 4.6), suggesting alternative reasons for the death of these animals. 
Given that Th2 cytokines are important for fibrotic mechanisms in both murine and 
human schistosomiasis (de Jesus et al., 2004; Fallon et al., 2000a; Wynn, 2004), we 
assessed whether pathology in liver and intestinal tissue of Batf3-/- mice was altered 
following S. mansoni infection.   
 
We investigated granulomatous pathology in the liver and small intestine in Batf3-/- 
mice both at D42 and D52 to address whether changes in pathology contribute to 
increased mortality in later stages of infection. In the liver, granulomatous 
inflammation and fibrosis were measured using the novel quantification method 
developed for chapter 3 (Fig. 3.1). Although the proportion of total granulomatous 
inflammation in the liver was not altered in Batf3-/- mice compared with WT mice, 
type I and III collagen deposition around the granuloma appeared increased, 
particularly by D52 post infection (Fig 4.10). IL-13 is thought to be a key Th2 
cytokine for the induction and promotion of fibrosis, as IL-13 but not IL-4 deficient 
mice display decreased hepatic collagen deposition during S. mansoni infection 
(Fallon et al., 2000b). IL-13 is thought to mediate fibrosis through promoting 
alternative activation of MΦs, thereby increasing L-ornithine and L-proline 
production by MΦs, which in turn promotes fibroblast activation and collagen 
production (Hesse et al., 2001). On the other hand, IL-13 may directly activate 
fibroblasts, as these express the IL-13 receptor (Chiaramonte et al., 1999). Thus, it is 
conceivable that increased Th2 responses in Batf3-/- mice at D42 enhanced fibrotic 
processes directly, which results in exacerbated pathology at D52. This is a critical 
point to consider, as uncontrolled fibrosis is detrimental to the host during S. mansoni 
infection and often results in increased mortality due to multiple organ failure (Wynn, 
2004). As such, increased fibrosis in Batf3-/- mice may lead to portal shunting (section 
1.6.1, chapter 1), which causes the blood supply to bypass the liver and prevents T 
cells from entering the granuloma. This may lead to decreased T cell responses 
against the egg in the liver, possibly increasing exposure to egg derived toxins by 
hepatocytes. Thus, an increase in fibrotic processes in Batf3-/- mice may lead to liver 
failure due to a lack of blood supply, which would contribute to the ultimate death of 
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the animal. Liver function could be tested by measuring alanine transaminase (ALT) 
levels, which would provide an indication of the level of hepatocellular damage in the 
tissue (Hoffmann et al., 2000). Furthermore, these results underline that the analysis 
of Th2 responses in Batf3-/- mice at D52 as done in this thesis for D42 would be 
beneficial to better understand the changes in pathology observed in these animals. 
 
In the ileum, single egg granulomas were more severe in Batf3-/- mice at both D42 and 
D52 post infection, resulting in additional damage to the surrounding tissue (Fig. 
4.10). The blind scoring system used to assess this pathology was developed to 
provide an objective measurement of the burden of granulomatous inflammation in 
the gut, where the complex nature of the tissue architecture prevented quantification 
with the slide scanning method developed for use in the liver (Fig. 2.1, chapter 2). As 
an alternative, granuloma size in the small intestine could be measured by selecting a 
range of example granulomas in cross-section manually and using image analysis 
software to estimate area and volume, as has been commonly done in the past 
(Cheever et al., 1984; Hoffmann et al., 2000; Souza et al., 2011; Warren and 
Domingo, 1970; Yap et al., 1997). However, calculating granuloma size by this 
method is quite subjective, and heavily influenced by the particular example and 
cross-section photographed, which could lead to misinterpretation of the results. Thus, 
it was felt that blind scoring the granulomas provided a more objective and accurate 
read out of the severity of granulomatous inflammation in the gut, as this technique 
takes into account the density of the granuloma, damage to the surrounding tissue, 
collagen deposition and the type of immune cells present as well as the size of the 
granuloma.  
 
Our identification of elevated pathological scores for ileal granulomas in Batf3-/- mice 
(Fig. 4.10) leads to interesting questions concerning the role of intestinal CD103+ 
cDCs and RA production during S. mansoni infection. Intestinal CD103+ cDCs 
originate in the LP and migrate to the mLNs where they induce iTreg responses and 
provide signals for iTreg migration to the intestine (Jaensson et al., 2008; Strauch et 
al., 2001). This process could be abrogated in Batf3-/- mice, resulting in uncontrolled 
Th2 responses in the mLN as well as more severe intestinal granulomatous 
inflammation due to a lack of iTreg mediated regulation. To address this hypothesis, 
an ex vivo functional assay could be conducted by culturing sorted cDC subsets from 
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S. mansoni infected WT or Batf3-/- mice with CD4+ T cells to examine the expansion 
of CD25+ Foxp3+ Tregs. However, a role for DC mediated induction of Treg 
responses including intestinal RA producing CD103+ cDCs, or whether their function 
to promote Treg differentiation changes during helminth infection, has not yet been 
shown in the literature. Indeed, the function of intestinal CD103+ cDCs is likely to 
change following helminth infection considering recent findings that have implicated 
these cells in the induction of Th17 responses against pathogenic bacteria (Persson et 
al., 2013; Satpathy et al., 2013). Therefore, severe intestinal granulomatous 
inflammation is perhaps more likely a consequence of increased Th2 immune 
responses leading to enhanced immune cell recruitment and collagen deposition 
mediated by IL-13 in the granuloma (Fallon et al., 2000a). Future studies 
investigating the type of immune response in the small intestine through analysing 
cytokine production by CD4+ T cells and the proportion of intestinal CD103+ cDCs 
and Tregs would address this hypothesis. 
  
During the analysis of ileal granulomas, vacuole-like structures present in the circular 
muscle of the intestine were observed in S. mansoni infected mice. Vacuole formation 
can occur due to hydropic damage during colitis (Perše and Cerar, 2012) or due to 
lipid accumulation in non-alcoholic fatty liver disease (also known as steatosis) (Yeh 
and Brunt, 2014), but this type of vacuole formation in the muscle has not to our 
knowledge been documented during S. mansoni infection previously. The presence of 
lipids in the muscle could be assessed by histology in future by using Oil Red O or 
sudan black stains (Boyle et al., 2012). Irrespective of the nature of muscle vacuoles 
in S. mansoni infected mice, the presence of vacuoles is likely an indication of muscle 
damage, as a severe breakdown in the muscle structure due to large and multiple 
vacuoles was observed in some cases (Fig. 2.3, chapter 2). Exacerbated muscle injury 
was found in Batf3-/- mice, which may inhibit efficient functioning of the intestine 
(Fig 4.10). Whether this is also the case at D52 needs to be determined, yet this could 
indicate that disrupted intestinal muscle tissue may contribute to the weight loss 
shown in figure 4.9.  
 
Given that Batf3-/- mice display impaired Th1 and CTL responses (Edelson et al., 
2010; Hildner et al., 2008; Mashayekhi et al., 2011; Torti et al., 2011; Waithman et 
al., 2013), it is possible that Batf3-/- mice are more susceptible to certain bacterial or 
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viral infections or commensals normally found in SPF facilities that are not 
immunogenic in WT mice, or are less able to maintain a protective barrier in the 
intestine. For example, “co-infection” with S. mansoni in such circumstances could 
lead to altered activation phenotype of DCs and induction of helminth-specific Th17 
responses (Perona-Wright et al., 2012). However, the intestinal architecture shown in 
figure 2.2 and figure 2.3 does not suggest significant bacterial infiltration compared 
with the intestinal architecture following experimental colitis (Laroui et al., 2012), 
and together with increased fibrosis (Fig. 4.10) this argues against the breakdown of 
the mucosa in the intestine. Nevertheless, the occurrence of sepsis in Batf3-/- mice 
could be assessed more accurately by measuring levels of IL-6, TNF-α and IL-12 in 
the serum.  
 
In summary, increased granulomatous inflammation in the intestine and fibrosis in the 
liver, as well as severe injury to the circular intestinal muscle in Batf3-/- mice due to 
early and enhanced Th2 responses conceivably deteriorate the health of the animal 
during S. mansoni infection. This highlights the importance of the induction of Th1 
responses during infection to counter-regulate Th2 mediated pathology (Hoffmann et 
al., 2000; Wynn et al., 1997), placing CD8α+ cDCs as a key cell type for maintaining 
balanced immune responses during S. mansoni infection. 
4.6.5 Limitations and future directions 
Although the techniques used in this chapter provided an excellent overview of the 
induction and character of immune responses as well as the extent of pathology in 
Batf3-/- mice during S. mansoni infection, understanding the limitations associated 
with the approach used is critical. The discrepancy between ELISA and ICC 
techniques observed in some cases (e.g. the liver at D42, Fig. 4.6) may suggest that 
the production of Th2 cytokines measured by ELISA is not solely T cell derived. 
Innate cells including MΦs, ILCs, NK or NKT cells could be contributing to the 
cytokine pool detected in bulk culture supernatants by ELISA. Notably, the innate 
immune system is located primarily in peripheral tissues rather than priming sites 
(Murphy et al., 2014), which indicates that contribution by innate immune cells is 
more likely in the liver compared with the mLNs. In particular, investigation of NKT 
cell populations in our model would be interesting, as CD8α+ cDCs have been 
reported to determine the NKT cell cytokine production profile in response to 
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glycolipid antigens (Arora et al., 2014). Therefore, a deficiency in CD8α+ DCs may 
alter NKT cell cytokine production in the liver, perhaps leading to decreases in IFN-γ 
and increases in IL-4 production, which may contribute to increased Th2 responses in 
Batf3-/- mice. Unfortunately analysis of NKT cell cytokine production using our 
current ICC assay is not ideal as NKT cells lose expression of NK1.1 in vitro (Chen et 
al., 1997). Cytokine reporter mice would be beneficial for the analysis of NKT cell 
cytokine production in future. However, analysis of total TCR-β− cell populations 
after restimulation with αCD3/CD28 did not suggest a significant contribution from 
non-conventional T cells to the cytokine pool (Appendix, Fig. 7.1C). This is in line 
with the expectation and αCD3/CD28 preferentially stimulates conventional T cells 
compared with other immune cells (Trickett and Kwan, 2003).  
 
Discrepancies between ELISA and ICC results could alternatively reflect technical 
differences between the assays. Analysis by ICC provides more specific information 
about T cell cytokine production, but unsatisfactory results were obtained by SEA 
restimulation for ICC with which very few cytokine positive cells could be detected 
by flow cytometry (Dr. Alexander Phythian-Adams & Angela Marley, unpublished 
data). Therefore, although not antigen-specific, polyclonal stimulation with 
αCD3/CD28 was necessary to detect sufficient cytokine positive T cells by flow 
cytometry. Thus, it can be postulated that differences in SEA-specific responses are 
somewhat muted by measuring total antigen independent T cell cytokine production. 
 
In addition to affecting immune cell development, differences in the types of APC 
present from birth may also affect parasite development, as it has been shown that 
CD4+ T cell help mediated by innate immune cells including DCs or MΦs facilitates 
the development of male worms and egg production by worm pairs (Lamb et al., 
2010). Furthermore, cross-reactive antigens are produced during early stages of the S. 
mansoni infection (Lukacs and Boros, 1991), which may initiate immune responses 
that are key to later regulation of immune responses to the egg (Pearce and 
MacDonald, 2002). Thus, to assess the specific role of CD8α+ cDCs at particular 
stages of infection would require an inducible depletion model. The first inducible 
depletion model for Batf3 deficiency was developed recently by Ashok et al., (2014) 
by creating mixed BM chimeras (CD11c-DTR x Batf3-/-) to investigate the impact of 
depletion in early and later stages of L. major infection. Such an approach would be 
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advantageous in future studies to confirm the importance of CD8α+ cDCs during 
specific stages of infection and immune response development, which would build on 
the understanding gained by the data in this chapter that this DC subset is likely 
involved in the regulation of Th2 responses during S. mansoni infection. 
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4.7 Conclusion 
In conclusion, we have shown that the immune response against S. mansoni eggs or 
during active infection in Batf3-/- mice is dysregulated, and that the outcome of this 
seems to be dependent on the time-point analysed. The field of DC subsets is 
expanding, and it is becoming increasingly clear that distinct DC types are important 
for functional and appropriate immune responses to pathogenic agents. The data 
described in this chapter indicate that early and enhanced Th2 as well as impaired 
Th1 responses may lead to exacerbated pathology in Batf3-/- mice, ultimately 
resulting in critical weight loss and death of Batf3-/- mice during S. mansoni 
infection. The imbalance in the immune response may be a direct result of the loss of 
CD8α+ cDCs, and/or indirectly due to the lack of Th1 responses. Therefore, the data 
shown in this chapter improve our understanding of the type of DCs involved during 
schistosome infection by showing that CD8α+ cDCs are not a fundamental 
requirement for Th2 induction, but they contribute to the induction of an 
“appropriate” immune response to S. mansoni.  
 
Excluding CD8α+ cDCs as the most important subset for Th2 induction narrows the 
potential subsets that are involved in this process to CD8α− cDCs. It is tempting to 
suggest that CD11b+ cDCs may be the more likely candidates due to their enhanced 
ability to present antigen compared with pDCs (Merad et al., 2013). Indeed, CD11b+ 
cDCs have been described as the main subset for Th2 induction in various settings 
such as allergy (Kumamoto et al., 2013; Plantinga et al., 2013; Williams et al., 2013). 
Further investigation into the role of CD11b+ cDCs during S. mansoni will help in 
unravelling the mechanisms responsible for inducing Th2 immune responses, and 
better understanding of this will assist in the development of therapeutics for Th2 
mediated disease. 
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4.8 Figures and tables 
Diagram 4.1  
 
Diagram 4.1 CD8α+ cDCs function in immunity 
The role of CD8α+ cDCs in the induction of Th1 responses and CTL immunity 
against viral and bacterial infection is well established (Ashok et al., 2014; Edelson 
et al., 2011; Hildner et al., 2008; Mashayekhi et al., 2011; Torti et al., 2011; 
Waithman et al., 2013). However, the role of CD8α+ cDCs during Th2 responses, in 
particular in chronic helminth infection is largely unknown. We used Batf3-/- mice, 
which specifically lack this subset, to investigate the function of CD8α+ cDCs during 
infection with S. mansoni. 
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Figure 4.1 CD8α+ cDCs are reduced in the popliteal LNs in Batf3-/- mice 
S. mansoni eggs were injected s.c. into WT or Batf3-/- mice. Popliteal LNs (pLNs) and 
inguinal LNs (iLNs) were harvested 7 days later for flow cytometric analysis. A. DCs 
present in pLNs and iLNs from WT mice were assessed for CD8α and CD205 
expression. Relative expression of CD103, CD24 and CD11b is shown for CD8α+ 
CD205+, CD8α− CD205+ and CD8α− CD205− cDC populations. B. The proportion of 
CD8α+ CD205+ cDCs of the CD11c+ MHC-II+ cDC population is shown for S. 
mansoni egg-injected WT and Batf3-/- mice. Batf3-/- cells are shown in blue and WT 
cells in black. C. CD103+ cDCs and CD11b+ cDCs were examined, and proportions 
of CD103+ DCs in WT and Batf3-/- mice are shown. 1 of 3 experiments (A to C). One-
way ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001). SEM is 
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Figure 4.2  
 
Figure 4.2 T cell populations in S. mansoni egg-injected Batf3-/- mice 
S. mansoni eggs were injected s.c. into WT or Batf3-/- mice. 5, 7, and 9 days later 
pLNs were harvested for flow cytometric analysis. A. Total cell numbers for pLNs of 
WT and Batf3-/- mice were determined using trypan blue counts. B. pLN cells from 
egg-injected WT and Batf3-/- mice were analysed by flow staining for TCR-β+ T cells 
to examine CD4+ and CD8+ T cell proportions as a percentage of live/single/intact 
cells. C. Trypan blue counts from (A) were used to calculate the absolute numbers of 
CD4+ and CD8+ T cells per pLN pair per mouse. Data are 1 of 1 experiment (A to 
C). Two-way ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001). 
Mean values ± SEM are shown for 4-5 mice/group.  
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Figure 4.3 Th2 induction against S. mansoni eggs is unimpaired in 
Batf3-/- mice 
S. mansoni eggs were injected into WT or Batf3-/- mice. 5, 7, and 9 days later pLNs 
and iLNs were harvested for analysis of cytokine production in vitro in response to 
SEA A. Cells from pLNs or iLNs of WT or Batf3-/- mice were pooled and cultured 
for 72h with 15 µg/ml SEA or media alone. Supernatants were collected to assess 
cytokine production by ELISA (data presented with medium alone background 
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subtracted). N = 1 (pools of 4-5 mice). B. Cells from pLNs and iLNs were 
restimulated with αCD3/CD28 o/n and assessed for ICC by flow cytometry. CD4+ 
TCR-β+ and CD8+ TCR-β+ T cells were analysed for cytokine expression. C. The 
GMFI was determined to assess the level of cytokine expression by CD4+ and CD8+ 
T cells. D. Representative flow cytometry plots are shown for CD4+ T cell cytokine 
expression at D7. Gates were set using FMO controls. Data are 1 of 1 experiment (A 
to D). Two-way ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 
0.0001). Mean values ± SEM are shown for 4-5 mice/group.  
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Figure 4.4 The proportion of CD8α+ DCs is reduced in the mLN and the 
liver of Batf3-/- mice at D42 
The mLNs and livers from naïve or D42 S. mansoni infected WT or Batf3-/- mice were 
harvested and isolated. mLN and liver leukocytes were analysed by flow cytometry 
for the presence of CD8α+ cDCs A. CD8α+ CD205+, CD8α− CD205+ and CD8α− 
CD205− cDCs in the mLN and the liver from naïve WT mice were assessed for their 
expression of CD103, CD24 and CD11b. B. Representative flow plots for CD11c+ 
MHC-II+ cDC subsets are shown to display expression of CD8α and CD205 in the 
C. 
B. 
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mLN and liver leukocytes from naïve and infected animals. Batf3-/- cells are shown in 
blue and WT cells in black and the proportion of CD8α+ cDCs in WT compared with 
Batf3-/- mice is shown graphically. C. In both tissues the proportion of Batf3-
dependent migratory CD103+ cDCs was analysed in WT and Batf3-/- mice as for 
CD8α+ cDCs in (B). Representative flow plots and the proportions of CD103+ cDCs 
for WT and Batf3-/- mice are shown. Gates were set using FMO controls. 1 of 2 
experiments (A to C). Two-way ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, 
****, P < 0.0001). Bars are SEM of 3-4 mice per group.  
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Figure 4.5 In priming sites the induction of Th2 responses at D42 during 
S. mansoni infection does not require CD8α+ DCs 
mLNs from naïve or S. mansoni infected mice were harvested on D42 of infection. A. 
Trypan blue counts were used to calculate the number of total live cells present in the 
mLN. B-C. Flow cytometry analysis of T cell populations expressing CD4 or CD8 are 
shown as total numbers and percentage of live/intact/single TCR-β+ cells. D. Cells 
from naïve or infected WT and Batf3-/- mice were cultured with 15 µg/ml SEA or 
media alone for 72h and supernatants were collected for ELISA analysis of cytokine 
production (data presented with medium alone background subtracted). E. 
Intracellular T cell cytokine staining was assessed by flow cytometry. CD8+ T cells 
did not produce detectable IL-4, IL-13 or IL-10. F. The GMFI of T cell cytokine 
expression was determined by flow cytometry. G. Representative flow plots for T cell 
cytokine production are shown in response to αCD3/CD28 restimulation. Gates were 
set using FMO controls. 1 of 2 experiments (A to C) or 1 of 1 experiments (E to G), 
two-way ANOVA. Data in (D) are from 2 experiments (from D40 and D42 
experiments as described in section 4.4.4) and were analysed by mixed model 
statistics blocking the day of experiment. (*, P < 0.05; **, P < 0.01; ***, P < 0.001, 
****, P < 0.0001). Error bars are SEM of 3-4 mice per group.  
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Figure 4.6 Th2 responses are unimpaired in the liver of Batf3-/- mice at 
D42 of S. mansoni infection 
Livers from naïve or S. mansoni infected mice were harvested on D42 of infection. A. 
Trypan blue counts were used to calculate the number of total live leukocytes present 
in the liver B-C. The proportions (B) and absolute numbers (C) of CD4+ and CD8+ T 
cells in the liver were determined by flow cytometric analysis of naïve or infected WT 
mice compared with Batf3-/- mice. D. As done previously for mLNs, liver leukocytes 
from naïve or infected WT and Batf3-/- mice were analysed for cytokine secretion in 
response to SEA or media alone after 72h of culture (data presented with medium 
alone background subtracted). E. Liver leukocytes were restimulated o/n with 
αCD3/CD28 and stained by ICC. The proportions of T cells expressing IL-4, IL-13, 
IL-10, IFN-γ and IL-17 are graphed. F. The GMFI of cytokine expression by T cells 
is shown. G. Representative flow plots for CD4+ and CD8+ T cell cytokine production 
are shown. Gates were set using FMO controls. 1 of 2 experiments (A-C) or 1 of 1 
experiment (E-G), two-way ANOVA. Data in (D) are from 2 experiments (from D40 
and D42 experiments as described in section 4.4.4) and were analysed by mixed 
model statistics blocking the day of experiment (*, P < 0.05; **, P < 0.01; ***, P < 
0.001, ****, P < 0.0001). Error bars are mean values ± SEM of 3-4 samples per 
group. Each sample was a pool of 2-3 livers (i.e. 8-10 mice per group).  
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Figure 4.7  
 
 
Figure 4.7 Effector CD4+ T cells and Treg populations are increased in 
Batf3-/- mice at D42 of S. mansoni infection 
mLN and liver leukocytes were isolated from naïve or D42 S. mansoni infected WT 
or Batf3-/- mice and examined ex vivo by flow cytometry. A-B. Proportions and 
numbers of CD4+ TCR-β+ cells expressing CD25 but not Foxp3 are shown for the 
mLN (top panel) and the liver (bottom panel). C-D. Proportions of CD4+ TCR-β+ 
cells expressing both CD25 and Foxp3 are presented for the mLN (top panel) and the 
liver (bottom panel). E. Representative flow plots displaying CD25 and Foxp3 
expression of CD4+ TCR-β+ T cells are depicted for the mLN (left) and the liver 
(right). Gates were set using FMO controls. 1 of 1 experiment (A to E). Two-way 
ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001). Error bars are 
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Figure 4.8 Production of antibody isotypes detected in the serum of S. 
mansoni infected Batf3-/- mice is altered at D42 
A. mLN and liver leukocytes were isolated from naïve or D42 S. mansoni infected 
WT or Batf3-/- mice and examined ex vivo by flow cytometry. The proportion of live 
cells and absolute numbers of B cells expressing CD19 are shown for the MLN (top) 
and the liver (bottom). B. Serum was collected from WT or Batf3-/- mice 1 day prior 
to harvest and the total amount of IgE was measured by ELISA. C. The dilution of 
SEA-specific antibody isotypes in the serum was assessed using a serum sample 
known to contain all of the isotypes measured. The dilution that corresponded to half 
the OD of the known serum sample was recorded. 1 of 1 experiment, two-way 
ANOVA (A). Data in (B to C) are from 2 experiments analysed by mixed model 
statistics blocking the day of experiment (from D40 and D42 experiments as 
described in section 4.4.4). (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 
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Figure 4.9 Critical weight loss in Batf3-/- mice during S. mansoni 
infection. 
A. From D36 until D52 of S. mansoni infection body weights of both WT and Batf3-/- 
mice were measured, and the percentage weight change was calculated for each 
mouse. B. The worm burden per mouse was assessed by counting the number of 
adult worms (male and female) and determining the number of worm pairs present in 
the blood at D42. C. The total numbers of eggs in KOH digested liver tissues of D42 
infected WT and Batf3-/- mice was counted to assess the egg burden in infected WT 
compared to Batf3-/- mice. D. The egg burden at D42 was counted in the ileum from 
WT and Batf3-/- mice as in (C). D. Splenomegaly and hepatomegaly were calculated 
as a percentage of body weight in naïve and infected animals at D42. 1 of 1 
experiment (A), 1 of 2 experiments (B to E). Two-way ANOVA (*, P < 0.05; **, P < 
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Figure 4.10  Granulomatous pathology is more severe in Batf3-/- mice 
A-B. Granulomatous inflammation and fibrosis in the median liver lobe was 
measured using MT or PSR staining slides respectively. Image J software was used 
to objectively determine the total proportion of granulomas or collagen deposition 
using a digital slide scanner and an algorithm C. Representative BF images are 
shown of tissue sections from the same liver stained with MT and PSR to compare 
total granulomatous inflammation staining (blue) with collagen deposition staining 
(red) respectively. Scale = 1mm. D. Single egg granulomas present in the ileum were 
scored for their intensity and density of immune cells, the amount of collagen 
deposition, and the severity of damage to the surrounding tissue. Score 0 represents 
absent granuloma formation around the egg and score +++ represents the highest 
pathological score. The percentage of granulomas per score is plotted graphically. 
No statistics can be performed on these scores as they are classed as arbitrary. E. The 
number of vacuoles, the size of vacuoles and the structural damage to the circular 
ileal muscle (termed as muscle injury) at D42 infected WT or Batf3-/- mice were 
scored and graphed in a similar way as granuloma scoring. 1 of 1 experiment (A to 
E). Two-way ANOVA (*, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001). 
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5 The function of dendritic cells during S. 
mansoni infection 
5.1 Abstract 
Although DCs can direct CD4+ T cells towards a potent Th2 response and are 
necessary for this process during S. mansoni infection, the exact mechanisms they 
employ for this process remain elusive. However, the capacity of DCs to induce 
strong Th2 immune responses during S. mansoni infection is not matched by their 
activation phenotype in response to SEA, which appears muted compared with 
classical activation in response to viral or bacterial stimuli (MacDonald et al., 2001). 
Furthermore, the function of distinct DC subsets during S. mansoni infection has not 
yet been addressed. To assess the function of DCs during a dominant Th2 response at 
D42 in the liver during S. mansoni infection, an ovalbumin (OVA) recognition 
system was used to investigate whether infection alters the ability of DCs to take up, 
process and present OVA to CD4+ T cells. This approach has shown that cDCs are 
efficient at inducing and maintaining CD4+ T cell responses during S. mansoni 
infection, but S. mansoni infection does not alter the core functions of cDCs. 
Analysis of cDC subsets revealed that S. mansoni infection enhances the ability of 
CD8α− cDCs, but not CD8α+, to induce naïve CD4+ T cell proliferation and maintain 
Th2 cytokine production by activated T cells. Thus, these data further our 
understanding of the DC subsets required for the induction and maintenance of Th2 
responses, and provide new information on the functional characteristics that DCs 




Current understanding of DC function consists mainly of inflammatory Th1/17 
responses to bacteria, protozoa or viruses orchestrated by effector T cells, which 
have become activated by DCs that have recognised PAMPs or DAMPs associated 
with the pathogen (Janeway, 1989; Kapsenberg, 2003; Matzinger, 2002) (described 
in section 1.1, chapter 1). PAMPs or DAMPs are bound to PRRs on the surface of 
DCs, resulting in NFκB activation via the adaptor protein MyD88 (Kawai and Akira, 
2010). This leads to conventional activation of DCs hallmarked by stable MHC-II 
expression and substantial upregulation of co-stimulatory molecules on the surface of 
DCs, such as CD40, CD80 and CD86, which enables efficient presentation of 
antigen to T cells (Janeway, 1989; Mogensen, 2009) (section 1.3, chapter 1). In 
addition, conventionally activated DCs produce significant amounts of inflammatory 
cytokines including IL-12, TNF-α and IL-6 (Morelli et al., 2001). Yet, how DCs 
orchestrate the induction of Th2 responses, and which DC subsets are involved in 
this process, remains less clear compared with the mechanisms that mediate Th1/17 
responses.  
 
Helminths including S. mansoni commonly fail to conventionally activate DCs 
(Balic et al., 2004; MacDonald et al., 2001; Whelan et al., 2000), even though 
BMDCs and ex vivo splenic DCs are sufficient to induce dominant Th2 responses 
against S. mansoni eggs or in response to SEA (Jankovic et al., 2004; MacDonald et 
al., 2001). Due to the rarity of DCs in the body most published research on DC 
function and activation during S. mansoni infection has focused on BMDCs (Jenkins 
et al., 2007; Kane et al., 2004; MacDonald et al., 2001; MacDonald and Pearce, 
2002), ex vivo splenic DCs (Jankovic et al., 2004; Steinfelder et al., 2009; Straw et 
al., 2003) or human peripheral blood DCs (Agrawal et al., 2003; de Jong et al., 2002) 
(section 1.9.1, chapter 1). This research has elevated our understanding of DC 
components that are essential for the induction of Th2 responses, such as surface 
CD40-CD154 (MacDonald et al., 2002a; 2002b), OX40-OX40-L (Jenkins et al., 
2007) and MHC-II (MacDonald et al., 2001) interactions, as well as intracellular 
NFκB signalling (Artis et al., 2005). In contrast to Th1 responses, MyD88 signalling 
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is not required for the induction of Th2 responses in vivo (Layland et al., 2005). 
Notably, the role of DC subsets in the liver during Th2 induction in murine S. 
mansoni infection has yet to be described, even though this is a crucial effector site 
where the majority of eggs are deposited (Cheever et al., 1987).  
5.2.1 Functions of hepatic dendritic cell subsets in the 
steady state and in response to antigen 
Functions of DCs in liver homeostasis, fibrosis, immune tolerance and pathogenesis 
are all areas of active research. Human liver biopsies have revealed that although 
DCs are distributed sparsely throughout the parenchyma, they are mainly found in 
portal regions (Bosma et al., 2006). This places DCs in an ideal location to monitor 
the portal circulation (Rahman and Aloman, 2013). The liver has many functions, 
including the metabolism of carbohydrates, proteins and lipids as well as the 
clearance of pathogens and toxins that arrive from the intestines to the liver from the 
blood (Protzer et al., 2012). Constant exposure to harmless dietary and commensal 
antigens requires a tolerogenic environment in the liver to avoid unnecessary organ 
tissue damage caused by inflammatory immune responses (Protzer et al., 2012). 
Liver DCs can broadly be grouped into cDCs and pDCs, similar to lymphoid and 
other peripheral tissues (Rahman and Aloman, 2013). Both cDCs and pDCs 
contribute to the tolerogenic environment within the liver by producing IL-10 
(Bamboat et al., 2010; 2009; Goddard et al., 2004; Tokita et al., 2008). Thus, the 
unique environment in the liver makes the comparison of DC functions with other 
tissues problematic and highlights the necessity for research on hepatic DC function 
specifically.  
 
pDCs are generally poor presenters of endocytosed antigen in any tissue due to the 
lack of cellular machinery that is required for the efficient uptake, processing and 
presentation of antigen to T cells (Villadangos and Young, 2008) (section 1.2.2, 
chapter 1). Instead, pDCs produce high levels of type I IFNs against viral infections, 
which leads to activation of numerous immune cells, including NK cells and CD8+ T 
cells (Pinto et al., 2011; Swiecki et al., 2010). Interestingly, the frequency of pDCs in 
the naïve liver is higher than in secondary lymphoid organs (Pillarisetty et al., 2004), 
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yet they are generally less immunogenic (Pillarisetty et al., 2004; Tokita et al., 2008). 
As such, hepatic pDCs produce reduced levels of IFN-α in comparison with splenic 
pDCs (Kingham et al., 2007) and are less efficient at activating CD4+ T cell 
responses (Castellaneta et al., 2009). In contrast to pDCs, cDCs generally display an 
enhanced ability in the capture, processing and presentation of antigen to T cells 
compared with pDCs (Merad et al., 2013), but steady state cDC immunogenicity is 
also lower in the liver compared with the spleen (Abe et al., 2006; Pillarisetty et al., 
2004). Pillarisetty et al., (2004) showed that ex vivo isolated liver cDCs express 
lower levels of activation markers including MHC-II and CD40, and are less 
efficient at taking up FITC labelled dextran or OVA compared with splenic 
counterparts. Furthermore, the same study reported that freshly isolated liver cDCs 
are less proficient at inducing T cell proliferation and cytokine production compared 
with splenic cDCs. This renders hepatic cDCs in the steady state less responsive to 
danger signals in portal blood, compared with their splenic counterparts, a phenotype 
that is crucial for maintaining immunological tolerance against antigen in an 
environment that is continuously exposed to harmless bacterial products from the 
intestines (Protzer et al., 2012).  
 
The function and activation of DCs in the liver in response to antigen and infection 
remains understudied, with only a few reports having addressed this. It is thought 
that activation and immunogenicity of hepatic cDCs requires higher doses of antigen 
compared with their splenic counterparts (Crispe, 2011). For example, the T cell 
stimulatory capacity of ex vivo liver cDCs is reduced compared with splenic cDCs 
following activation with low doses of LPS, as T cell proliferation and production of 
IFN-γ or IL-4 is decreased (De Creus et al., 2005). However, liver and splenic cDCs 
activated with high doses of LPS induce comparable T cell responses (De Creus et 
al., 2005). This result can be replicated in vivo, when ex vivo hepatic or splenic cDCs 
are stimulated with LPS and adoptively transferred s.c. into allogeneic naïve mice 
(De Creus et al., 2005). Thus, liver cDCs likely display a comparatively high 
threshold for activation by LPS, which may be in part due to lower expression levels 




In comparison with splenic cDCs, little is known about the function and T cell 
stimulatory capacity of distinct hepatic cDC subsets. Pillarisetty et al., (2004) 
investigated the phenotype and function of different types of cDCs in the liver and 
showed that hepatic CD8α+ and CD11b+ cDCs display similar T cell activation 
capacities compared with their splenic counterparts (Pillarisetty et al., 2004). 
Therefore, hepatic and splenic CD8α− cDCs induce marginally higher levels of T cell 
proliferation and cytokine production compared with CD8α+ cDCs (Pillarisetty et al., 
2004; Rizzitelli et al., 2005). Pillarisetty et al., (2004) proposed that the liver 
contains a larger number of phenotypically less mature cDC subsets in comparison 
with the spleen, including CD8αlow/- and CD11blow/- cDCs, which may explain the 
overall weaker stimulatory phenotype of “bulk” liver cDCs in the steady state. De 
Creus et al., (2005) compared the function of liver CD8α+ and CD8α− cDC subsets in 
response to antigen with their splenic counterparts, and found that the stimulatory 
capacity of each hepatic subset increased to levels similar in comparison with their 
splenic counterparts at high doses of LPS. However, both studies outlined above did 
not differentiate between CD4+ and CD8+ T cells (De Creus et al., 2005; Pillarisetty 
et al., 2004), which complicates the interpretation of the results, as CD8α+ cDCs and 
CD11b+ cDCs are thought to preferentially interact with CD8+ and CD4+ T cells 
respectively (Merad et al., 2013) (section 1.2.2, chapter 1).  
 
It is clear that various open questions remain about the function of hepatic DC 
subsets in infectious disease, including the relative ability of different types of DCs 
in the liver to induce or maintain CD4+ T cell responses, particularly in Th2 settings 
such as S. mansoni infection. This chapter aims to improve our understanding of the 
function of DCs in the liver during infection with S. mansoni, by systematically 
assessing their ability to take up, process and present antigen to naïve or activated 
CD4+ T cells ex vivo using an OT-II co-culture system (Schnorrer et al., 2006; 
Wilson et al., 2003; Young et al., 2007). Although there is evidence that hepatic DCs 
can prime naïve T cells in the PALT (Yoneyama et al., 2001) (section 3.2.1.1, 
chapter 3), CD4+ T cell activation and priming generally occurs in dLNs following 
DC migration from an effector site, such as the liver (Banchereau and Steinman, 
1998). We hypothesised that examining the capacity of hepatic DCs to induce CD4+ 
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T cell responses ex vivo would provide an insight into the function of recently 
activated DCs in the liver that would normally migrate to the dLN to interact with 
naïve CD4+ T cells. On the other hand, investigating the ability of hepatic DCs to 
present antigen to effector/memory CD4+ T cells enables the assessment of local DC 
mediated maintenance of CD4+ T cell responses in the liver/granuloma. In fact, the 
consistent delivery of new eggs into the liver indicates that DCs may play a dual role 
during the course of infection: inducing Th2 responses in the dLN as well as 
maintaining established effector/memory CD4+ T cell responses in the liver during 
granuloma development (Pearce and MacDonald, 2002). Thus, this chapter 
investigates the function of hepatic DC subsets isolated from S. mansoni infection in 





5.3 Study Rationale 
To assess whether S. mansoni infection changes the ability of hepatic DCs to take up, 
process and present exogenous antigen, cDCs and pDCs were isolated from livers of 
infected mice and cultured with CD4+ T cells ex vivo. DCs were isolated at D42, a 
time-point during infection, which is critical for the induction of Th2 immune 
responses to S. mansoni eggs (Pearce and MacDonald, 2002) (Fig. 3.3, chapter 3). To 
address the capacity of hepatic DCs to induce or maintain CD4+ T cell responses, we 
used an OVA-recognition assay with OT-II transgenic CD4+ T cells as described in 
Cook et al., (2012), since transgenic mice that develop SEA-specific T cells are not 
available. OT-II CD4+ T cells express a TCR that is specific for class II OVA peptide 
(323-339) (pOVA) (Barnden et al., 1998), and culturing OT-II T cells with OVA-
pulsed DCs provides a measurement of the potential of DCs to present peptide to 
CD4+ T cells (Wilson et al., 2004). To investigate the capacity of ex vivo sorted 
hepatic DC subsets to induce and maintain CD4+ T cell responses, pOVA-pulsed DC 
subsets were co-cultured with naïve or in vitro activated CD4+ T cells respectively. 
In a complementary assay, soluble OVA protein (OVA) was added to the co-cultures 
to examine the ability of DCs to take up, process and present antigen. CD4+ T cell 
proliferation and cytokine production were measured as readouts of DC APC 
function. This ex vivo OT-II co-culture system approach is well documented in the 
literature (Schnorrer et al., 2006; Wilson et al., 2003; Young et al., 2007), and 
enabled controlled investigation of core hepatic DCs functions following S. mansoni 
infection.  
 
Although specific subsets display distinct functions, cDCs are described mainly as 
superior APCs, whereas pDCs specialise in the secretions of type I IFNs (Merad et 
al., 2013). Therefore, hepatic cDCs (CD11chigh PDCA-1−) were sorted separately 
from pDCs (CD11clow PDCA-1+) to unravel functional differences between these 
two major subsets during S. mansoni infection (Rahman and Aloman, 2013) (see 
table 1.1). While focusing on the function of cDCs and pDCs, the capacity of hepatic 
CD8α+ and CD8α− cDC subsets to induce or maintain CD4+ T cell responses was 
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also investigated (Pillarisetty et al., 2004). The markers used for these subsets were 
CD8α and CD205, as conducted in chapter 4 (Fig. 4.1 & 4.4) (Hildner et al., 2008; 





5.4.1 The activation phenotype of cDCs and pDCs is 
marginally increased during S. mansoni infection at 
D42 
To investigate the function of hepatic cDCs and pDCs during S. mansoni infection at 
a time-point when Th2 responses are induced, WT mice were infected with S. 
mansoni and livers were harvested at D42 of infection, when a switch from a mixed 
Th1/Th2 to a dominant Th2 response occurs (Pearce and MacDonald, 2002). Liver 
leukocytes were isolated and enriched for DCs by using magnetic Dynabeads that 
removed lineage negative cells from the cell population including T cells, IgM+ B 
cells, NK cells, erythrocytes and most granulocytes (section 2.8.3, chapter 2). 
Enriched hepatic DCs were then sorted by FACS to obtain pure cell populations of 
live cDCs and pDCs for use in the co-culture assay with CD4+ T cells (Fig. 5.1A-B). 
Examining F4/80 expression revealed that a F4/80+ PDCA-1+ CD11cint population 
was present in both naïve and infection derived enriched liver DC populations (Fig. 
5.1A-B). This cell population may represent MΦs (Nobumoto et al., 2009), and so 
would contaminate sorted DC populations if not excluded during the sort procedure. 
Thus, enriched hepatic F4/80− DCs from both naïve and S. mansoni infected mice 
were FACS sorted into live cDCs (CD11chigh PDCA-1−) and pDCs (CD11cint PDCA-
1+) that were >95% pure (Fig. 5.1A-B) (Rahman and Aloman, 2013) (Table 1.1). The 
proportion of cDCs in the liver (M = 14.4, SEM = 2.434) in naïve mice was 
unchanged compared with cDCs from S. mansoni infected mice (M = 18.47, SEM = 
2.325), t(1)=1.208, p=0.2935. Similarly, the proportion of pDCs from naïve mice (M 
= 7.43, SEM = 0.4010) was not significantly different compared with hepatic pDCs 
in infected mice (M= 5.543, SEM = 1.461), t(1)=1.245, p=0.2809.  
 
To examine whether S. mansoni infection alters hepatic DC activation phenotype, the 
expression of cell surface activation markers CD40, MHC-II and CD80 by cDCs and 
pDCs was assessed by flow cytometry (Fig. 5.1C-D). CD86 could not be 
investigated as an αCD86 antibody with the appropriate fluorochrome for addition to 
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the flow panel was not available at the time of the experiment. There were no 
significant changes in the proportion of infection derived cDCs expressing CD40, 
MHC-II or CD80 compared with cDCs from naïve mice (Fig. 5.1C). Due to the 
rarity of pDCs in the liver, insufficient cells were present for accurate flow 
cytometric analysis (6,000-9,000 per liver from naïve and 10,000-20,000 per liver 
from infected mice). Nevertheless, an increase in hepatic pDC populations 
expressing MHC-II was found in pDCs isolated from infected compared with naïve 
animals, although this result was not significant. Analysis of the GMFI revealed that 
the expression level of MHC-II and CD40 on all infection derived sorted cDCs 
increased marginally compared with hepatic cDCs from naïve mice, whereas the 
level of CD80 expression decreased (Fig. 5.1D). The staining on available hepatic 
pDCs showed subtle increases in the level of CD40, CD80 and MHC-II expressed 
during infection, but overall expression of these markers was markedly lower 
compared with cDCs (Fig. 5.1D).  
 
For naïve CD4+ T cell isolation, splenic and LN CD4+ T cells expressing a TCR 
specific for class II pOVA (323-339) (Barnden et al., 1998) were enriched from OT-
IIxLy5.1 mice by negative selection using Dynabeads. This method depleted CD8+ T 
cells, B cells, monocytes, MΦs, NK cells, DCs, erythrocytes and granulocytes. 
Freshly isolated class II OVA specific CD4+ T cells were then assessed for purity and 
activation status by flow cytometry (Fig. 5.1E). Surface markers Vα2 and CD4 were 
used to determine the purity of OT-II T cells following Dynal negative selection 
(Barnden et al., 1998), which revealed approximately 80% purity for mixed splenic 
and lymphoid CD4+ T cells. To assess the activation status of isolated CD4+ T cells, 
the expression of CD44 and CD69 was examined and showed that approximately 
>95% of CD4+ T cells were CD44− CD69− indicating a naïve phenotype (Sprent and 
Surh, 2011) (Fig. 5.1E).  
 
To obtain a population of effector/memory CD4+ T cells, splenocytes were isolated 
from OT-IIxLy5.1 mice and cultured in vitro for 7 days in the presence of endotoxin-
free soluble OVA protein as well as IL-2, IL-7 and IL-15 to promote 
effector/memory CD4+ T cell differentiation and proliferation (section 1.4, chapter) 
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(Caserta et al., 2010; Van Belle et al., 2012). After 7 days, splenocytes were assessed 
by flow cytometry for CD4+ T cell purity and activation status prior to culture with 
DCs. The proportion of CD4+ Vα2+ cells was approximately 90-95%, and 65-70% of 
CD4+ Vα2+ T cells were CD44+ and CD69+ (Fig. 5.1E). The presence of APCs was 
assessed by analysing the proportion of MHC-II+ cells in naïve or activated CD4+ T 
cell populations, which showed that <1% of cells in samples containing naïve or 
activated CD4+ T cell populations expressed MHC-II (Fig. 5.1E).  
5.4.2 cDCs and pDCs display a differential capacity for 
antigen presentation to naïve CD4+ T cells  
To assess whether S. mansoni infection alters the ability of DC subsets to present 
antigen to naïve CD4+ T cells, sorted cDCs and pDCs from naïve or D42 infected 
mice were pulsed with pOVA for 45min and washed to remove unbound peptide 
(Fig. 2.4, chapter 2). To investigate CD4+ T cell proliferation in response to pOVA-
pulsed cDCs, naïve OT-II CD4+ T cells were labelled with CFSE before culture. 
5000 pOVA-pulsed cDCs or pDCs were then co-cultured with 50,000 freshly 
isolated naïve CFSE-labelled pOVA specific CD4+ T cells for 72h (Fig. 5.2 & Fig. 
5.3) (this OT-II co-culture system is described in detail in section 2.8.7, chapter 2) 
(Schnorrer et al., 2006; Wilson et al., 2003; Young et al., 2007). The dose of pOVA 
was titrated from 10 µM down to 0.01 µM to ensure that responses observed were 
dose dependent, and to provide a measure of whether the dose of antigen impacts DC 
function. In addition, naïve CD4+ T cells were co-cultured with sorted cDCs or pDCs 
that were not pulsed with pOVA to control for antigen-specific CD4+ T cell 
responses. Proliferation of naïve CD4+ T cells was determined by analysing CFSE 
staining after culture by flow cytometry; the level of CFSE detected decreased by 
half with every round of CD4+ T cell division (Lyons and Parish, 1994). When 
pOVA-pulsed cDCs from naïve mice were cultured with naïve CD4+ T cells, the 
proportion of proliferating CD4+ T cells was highest (approximately 83%) when they 
were cultured with cDCs pulsed with 10 µM compared with cDCs pulsed with 1 or 
0.01 µM pOVA (Fig. 5.2A-B). cDCs from S. mansoni infected mice pulsed with 10 
µM pOVA induced a similar proportion of CD4+ T cells to proliferate compared with 
naïve cDCs (Fig. 5.2A). However, when sorted cDCs from infection were pulsed 
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with 1 µM pOVA a marginal, but significant, increase in CD4+ T cell proliferation 
was found compared with cDCs from naïve mice.  
 
In contrast to cDCs, both naïve and S. mansoni infection derived pOVA-pulsed pDCs 
induced less than 10% naïve CD4+ T cells to proliferate at every concentration of 
pOVA tested (Fig. 5.2C-D). This suggests that cDCs are more efficient at inducing 
CD4+ T cell proliferation than pDCs irrespective of whether the DCs were isolated 
from naïve or infected mice, and this will be discussed in more detail later. 
 
To examine the average number of divisions performed by dividing CD4+ T cells, 
the proliferation index was calculated using the proliferation tool in Flowjo (Fig. 
5.2E). This function could be used for samples where distinct proliferation peaks 
were recorded, whereas samples with no apparent proliferation (i.e. low peptide 
doses or pDC cultures) were not recognised by the software for analysis. These data 
showed that the average number of divisions by proliferating CD4+ T cells was 
marginally albeit significantly increased in culture with 1 µM pOVA-pulsed cDCs 
from infected compared with naïve mice, whereas the number of CD4+ T cell 
divisions was unchanged in culture with naïve or infection derived cDCs pulsed with 
10 µM pOVA (Fig. 5.2E).  
 
To assess the ability of cDCs and pDCs to influence CD4+ T cell polarisation, 
cytokines present in co-culture supernatants were measured by ELISA (Fig. 5.3). 
Cytokine production by naïve CD4+ T cells in culture with cDCs was minimal in 
every condition, such that the amounts of IL-4, IL-5, IL-10 and IFN-γ were below 
the optimal detection limit of the ELISA assay (shown by a dotted line) (Fig. 5.3A). 
Although the amounts of IL-13, IFN-γ and TNF-α were above the detection limit for 
the ELISA, no significant difference was seen when comparing the amount of these 
cytokines in culture with naïve or infection derived cDCs. In culture with pOVA-
pulsed naïve or infection derived pDCs, the amount of every cytokine measured was 
not significantly above the detection limit of the ELISA (Fig. 5.3B).  
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5.4.3 cDCs, but not pDCs, take up, process and present 
antigen to naïve CD4+ T cells 
To determine whether the ability of DCs to take up and process antigen in addition to 
mere peptide presentation is altered at D42 of S. mansoni infection, DC subsets and 
naïve CD4+ T cells were cultured for 72h in the presence of soluble OVA protein 
(OVA). The amount of OVA used in the assay was titrated from 500 µg/ml to 0.5 
µg/ml to control for antigen dependent stimulation (Schnorrer et al., 2006; Young et 
al., 2007). CFSE analysis showed that cDCs from naïve mice induced approximately 
40% and 75% naïve CD4+ T cells to proliferate when either 50 µg/ml or 500 µg/ml 
OVA was present in culture (Fig. 5.4A-B). Fewer that 5% of CD4+ T cells 
proliferated in culture with naïve or infection derived cDCs with 0.5 µg/ml OVA 
protein. Infection derived cDCs induced similar levels of T cell proliferation 
compared with naïve cDCs at all OVA concentrations tested.  
 
When in culture with either naïve or infection derived pDCs in the presence of OVA, 
the proportion of proliferating CD4+ T cells was less than 5% in every sample, and 
no defined division peaks were detected (Fig. 5.4C-D). Thus, analysis of the 
proliferation index could once again not be performed with pDC cultures.  
 
Assessment of the proliferation index for cDC cultures in the presence of 50 µg/ml or 
500 µg/ml OVA protein showed no significant differences in the average number of 
divisions by proliferating CD4+ T cells in culture with naïve or infection derived 
cDCs (Fig. 5.4E). 
 
Cytokine production in the cDC:CD4+ T cell co-culture with OVA was minimal, as 
levels of IL-4, IL-5, IL-13 and IL-10 were below the detection limits of the assay 
(Fig. 5.5A). Although the amount of TNF-α, IFN-γ and IL-17 was above the 
detection limit of the assay when cDCs were cultured with naïve CD4+ T cells in the 
presence of 500 µg/ml OVA protein, no significant differences between S. mansoni 
infection derived and cDCs from naïve mice were detected for every cytokine 
measured (Fig. 5.5A). The amount of cytokine detected in cultures with pDCs was 
not above the ELISA detection limit for each cytokine analysed (Fig. 5.5B). These 
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data, in addition to the cytokine data from figure 5.3A-B, indicate that the amount of 
cytokine production in cultures with naïve CD4+ T cells was not sufficient for 
optimal analysis of T cell priming.  
5.4.4 Differential ability of cDCs and pDCs to maintain 
CD4+ T cell responses 
Given that the majority of T cells in the liver during S. mansoni infection are 
effector/memory CD4+ T cells (Hogan et al., 2002; Rumbley et al., 1999), we next 
examined the ability of DCs to maintain effector/memory CD4+ T cell responses. 
Hepatic cDCs or pDCs isolated from naïve or infected mice were co-cultured ex vivo 
with previously activated CFSE-labelled CD4+ T cells from OT-II mice. No major 
differences in the proportion of proliferating effector/memory CD4+ T cells were 
seen in culture with S. mansoni infection derived cDCs compared with naïve cDCs 
pulsed with 1 or 10 µM pOVA (Fig. 5.6A). However, a significant subtle decrease in 
the ability of cDCs from infection compared with naïve cDCs to induce 
effector/memory CD4+ T cell proliferation was apparent at the lowest pOVA dose 
(0.01µM). In contrast to naïve CD4+ T cell proliferation, CFSE staining of activated 
CD4+ T cells did not produce defined peaks for each division, as all CD4+ T cells 
were already proliferating prior to culture with DCs (Fig. 5.6B). Therefore, the whole 
population of CFSE stained CD4+ T cells was observed as one fairly broad peak, 
which expressed less CFSE as CD4+ T cell proliferation of the whole population 
increased. Thus, analysis of the proliferation index of dividing CD4+ T cells was not 
possible with this assay due to the absence of defined proliferation peaks. 
 
In contrast to cDCs, the level of proliferation observed was minimal when in vitro 
activated CD4+ T cells were cultured with pOVA-pulsed pDCs, and culture with 
both 10 µM pOVA-pulsed naïve or infection derived pDCs induced approximately 
20% of effector/memory CD4+ T cells to proliferate (Fig. 5.6C-D). Further, no 
significant differences were evident when comparing culture with naïve or S. 




To assess the capacity of cDCs and pDCs from S. mansoni infection to maintain 
CD4+ T cell cytokine production, the amount of cytokine present in co-cultures was 
measured by ELISA. Unlike co-cultures with naïve CD4+ T cells, the levels of 
cytokine produced in cultures with in vitro activated CD4+ T cells was above the 
detection limit of the assay, with the exception of IL-5 and IL-17. An increase in 
trend for the amount of IL-4, IL-13 as well as IL-17 produced in culture with 
effector/memory CD4+ T cells was seen with infection derived cDCs compared with 
naïve cDCs, but no significant differences were found for any of the cytokines 
measured (Fig. 5.7A).  
 
Overall, levels of all cytokines assessed were substantially lower in cultures of 
effector/memory CD4+ T cells with pDCs compared with cDCs, with the amounts of 
IL-5, IL-10, IL-13 and IL-17 being below the detection limit of the ELISAs (Fig 
5.7B). Although marginally increased TNF-α was found after co-culture of 
effector/memory CD4+ T cells with pOVA-pulsed pDCs from infection compared 
with pDCs from naïve mice (Fig. 5.7B), this was not above the amount of TNF-α 
produced by effector/memory CD4+ T cells in the absence of DCs (Appendix Fig. 
7.6). No significant differences were seen in the levels of IL-4 or IFN-γ produced in 
culture with effector/memory CD4+ T cells and pDCs from naïve or infected mice. 
Thus, overall pDCs were inefficient in presenting pOVA to effector/memory CD4+ T 
cells. 
5.4.5 cDCs, but not pDCs can take up, process and 
present antigen to maintain CD4+ T cell responses 
To assess antigen uptake and processing, as well as presentation, to in vitro activated 
CD4+ T cells, cDCs and pDCs from D42 S. mansoni infected or naïve mice were 
FACS sorted and co-cultured for 72h with in vitro activated OT-II CD4+ T cells in 
the presence of endotoxin-free soluble OVA protein. CFSE staining assessed by flow 
cytometry showed that, in the presence of 500 µg/ml OVA, S. mansoni infection 
derived cDCs induced comparable levels of CD4+ T cell proliferation compared with 
naïve cDCs (approximately 75-78%; Fig. 5.8A-B). Further, there were no significant 
differences in CD4+ T cell proliferation in culture with naïve cDCs compared with 
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infection derived cDCs in the presence of 500, 50 or 0.5 µg/ml OVA. Unlike cDCs, 
both naïve and infection derived pDCs once again failed to maintain substantial 
proliferation of effector/memory CD4+ T cells on addition of OVA, as the proportion 
of proliferating CD4+ T cells was <15% at every concentration of OVA tested (Fig. 
5.8C-D).  
 
ELISA analysis of cytokines present in culture supernatants showed that the amount 
of TNF-α produced by effector/memory CD4+ T cells and 500 µg/ml OVA was 
significantly increased in the presence of infection derived cDCs compared with 
naïve cDCs (Fig. 5.9A). Yet, the amount of IL-4, IL-10, IL-13 and IFN-γ produced 
in culture in the presence of 500 µg/ml OVA with infection derived cDCs was 
unchanged compared with naïve cDCs. As with previous cultures, levels of IL-5 and 
IL-17 were below the detection limit of the ELISA.  
 
The production of all cytokines in co-cultures with pDCs in the presence of OVA 
protein was minimal, such that the amounts detected by the ELISA for each cytokine 
(with the exception of IL-4) were below the limits of the assay. Although the amount 
of IL-4 in cultures with pDCs and effector/memory CD4+ T cells in the presence of 
500 µg/ml OVA was above the detection limit of the ELISA, no significant 
difference was found when comparing S. mansoni infection derived pDCs with naïve 
pDCs (Fig. 5.9B). In summary, ex vivo hepatic pDCs from naïve or S. mansoni 
infected mice did not maintain substantial CD4+ T cell proliferation or cytokine 
production. 
 
To assess whether poorer antigen presentation capacity observed with pDCs 
compared with cDCs was due to increased pDC cell death in culture, the proportion 
of cDCs and pDCs present after 1 day of culture was examined. These data revealed 
that both subsets were present in equal proportions (approximately 50%) after 1 day 
of culture (Appendix Fig. 7.5), and it is unlikely that increased death of pDCs ex vivo 
is the main cause for decreased CD4+ T cell proliferation and cytokine production 
compared with cDCs. In summary, S. mansoni infection at D42 did not significantly 
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alter the ability of cDCs and pDCs to take up, process and present antigen to naïve or 
effector/memory CD4+ T cells.  
5.4.6 S. mansoni infection derived cDC subsets display 
distinct functional differences in inducing CD4+ T 
cell responses  
Although S. mansoni infection at D42 did not significantly alter the ability of cDCs 
to take up, process and present antigen to naïve or effector/memory CD4+ T cells, it 
was hypothesised that distinct subsets belonging to this group of DCs may exhibit 
differential interaction with CD4+ T cells. In support of this, CD8α+ cDCs are 
important for the induction of Th1 and CTL responses during bacterial and viral 
infections (Hildner et al., 2008; Mashayekhi et al., 2011), whereas CD8α− cDCs (i.e. 
CD11b+ cDCs) preferentially interact with CD4+ T cells and are thought to induce 
Th2 responses (Gao et al., 2013; Kumamoto et al., 2013; Plantinga et al., 2013; 
Williams et al., 2013). To investigate the function of liver cDC subsets at D42 of S. 
mansoni infection, isolated liver leukocytes were enriched for DCs as before, and 
sorted by FACS into CD8α+ and CD8α− cDC subsets for culture with CFSE-labelled 
naïve or in vitro activated CD4+ T cells. Surface markers CD8α and CD205 were 
used to sort CD8α+ CD205+ and CD8α− CD205− liver cDC populations that were 
95.3% and 90.2% pure respectively (Hildner et al., 2008; Pillarisetty et al., 2004) 
(Fig. 5.10A-B). For the purpose of clarity, these subsets will be referred to as CD8α+ 
and CD8α− cDCs from here on. The proportion of CD8α+ cDCs did not change 
substantially following S. mansoni infection compared with naïve animals (Fig. 
5.10A-B). This experiment was conducted once, and so statistical analysis of the 
proportion of cDC subsets in naïve or infection derived livers was not possible. 
 
The ability of isolated hepatic CD8α+ and CD8α− cDC subsets to present antigen to 
naïve CD4+ T cells was tested in the same assay that was used to compare the 
function of cDCs and pDCs previously. In culture with naïve CD4+ T cells, CD8α+ 
cDCs and CD8α− cDCs from naïve mice pulsed with 10 µM pOVA induced 
approximately 70% of naïve CD4+ T cells to proliferate after 72h of culture (Fig. 
5.11A-B). Culture with additional concentrations of pOVA or with soluble OVA 
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protein was not possible due to insufficient CD8α+ and CD8α− cDC yields from the 
livers after FACS sorting. When compared with S. mansoni infection derived CD8+ 
cDCs, the proportion of CD4+ T cells that proliferated in culture with CD8α− cDCs 
was significantly increased. Moreover, the proliferation index showed a significant 
increase in the average number of divisions that dividing CD4+ T cells underwent 
during culture with infection derived CD8α− cDCs compared with naïve CD8α− 
cDCs, but there was no significant difference in the proliferation index when 
comparing co-cultures with infection derived CD8α+ to CD8α− cDCs (Fig. 5.11C).  
 
Analysis of cytokines produced in the co-culture assay with naïve CD4+ T cells 
showed that the amounts of IL-4, IL-5, IL-10, IL-13, IL-17 and IFN-γ stimulated by 
10 or 0.01 µΜ pOVA-pulsed naïve CD8α+ or CD8α− cDCs were similar to or below 
the detection limit of the ELISA (Fig. 5.11D). This is in line with previous co-
cultures investigating cDC and pDC function when naïve CD4+ T cells were used 
(Fig. 5.4). Notably, the amount of IL-13 in culture with 10 µM pOVA-pulsed CD8α− 
cDCs from infection was significantly increased to levels above the detection limit 
compared with naïve CD8α+ cDCs (Fig. 5.11D). In contrast, the amount of TNF-α 
measured in the co-culture was significantly higher in the presence of S. mansoni 
infection derived CD8α+ cDCs, in comparison with CD8α− cDCs.  
 
To determine whether the capacity of cDC subsets to maintain CD4+ T cell responses 
is altered during S. mansoni infection, CD8α+ or CD8α− cDCs were pulsed with 
pOVA and co-cultured with in vitro activated OT-II CD4+ T cells that had been 
labelled with CFSE. Analysis of CFSE dilution by flow cytometry revealed that 
approximately 50-55% of CD4+ T cells proliferated in culture with either CD8α+ or 
CD8α− cDCs derived from infected mice pulsed with 10 µΜ pOVA (Fig. 5.12A-B). 
CD8α+ and CD8α− cDCs pulsed with 0.01 µΜ pOVA induced <5% of CD4+ T cells 
to proliferate. Thus, there were no significant differences in the proportion of CD4+ 
T cells that proliferated in culture with infection derived CD8α+ compared with 
CD8α− cDCs. Insufficient numbers of cDC subsets isolated from naïve mice were 
available for comparison with infection derived CD8α+ and CD8α− cDCs in this 




The amount of cytokine detected in the assay with effector/memory CD4+ T cells 
was substantially higher compared with co-cultures with naïve CD4+ T cells (see Fig. 
5.11). The amount of IL-4, IL-13 and IFN-γ in culture with CD8α− cDCs pulsed with 
10 µΜ pOVA was significantly higher compared with CD8α+ cDCs from S. mansoni 
infected mice (Fig. 5.12C). Levels of IL-5, IL-10 and TNF-α were unchanged in 
cultures with infection derived CD8α− cDCs pulsed with 10 µΜ pOVA compared 
with CD8α+ cDCs. At a concentration of 0.01 µM pOVA, a significant increase in 
TNF-α and IFN-γ production was observed in cultures with CD8α− cDCs compared 
with CD8α+ cDCs from infection (Fig. 5.12C).  
 
Together, these co-culture experiments using ex vivo isolated cDCs and  naïve and 
effector/memory CD4+ T cells strongly suggest that CD8α− cDCs from S. mansoni 
infection have increased ability to present peptide to CD4+ T cells compared with 
CD8α+ cDCs, which results in increased induction of naïve CD4+ T cell proliferation 
and IL-13 production, and maintenance of Th2 cytokine production.  
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5.5 Summary of Results 
• S. mansoni infection subtly increased the activation phenotype of cDCs and 
pDCs isolated from the liver (Fig. 5.1). 
• S. mansoni infection did not alter the core functions of hepatic cDCs and 
pDCs to take up, process and present antigen at D42, and cDCs were 
competent in inducing and maintaining CD4+ T cell responses (Fig. 5.2-5.9)   
• CD8α− cDCs displayed enhanced abilities to induce CD4+ T cell proliferation 
and IL-13 production compared with CD8α+ cDCs at D42 of S. mansoni 
infection (Fig. 5.11). 
• CD8α+ cDCs were more efficient at inducing TNF-α production by naïve 
CD4+ T cells compared with CD8α− cDCs (Fig. 5.11). 
• CD8α− cDCs, but not CD8α+ cDCs, maintained Th2 cytokine production by 
effector/memory CD4+ T cells (Fig. 5.12). 
• Both CD8α− and CD8α+ cDCs maintained IFN-γ and TNF-α production by 




To investigate the function of DCs in the liver during S. mansoni infection, we asked 
whether the capacity of DC subsets to take up, process and present antigen to naïve 
or effector/memory CD4+ T cells was altered at a time-point when Th2 immune 
responses against the eggs are induced (Pearce and MacDonald, 2002). To address 
this we used an ex vivo co-culture system utilising soluble OVA or pOVA as an 
antigen and OVA specific CD4+ T cells (Schnorrer et al., 2006; Wilson et al., 2003; 
Young et al., 2007). Functional analysis of ex vivo isolated cDCs and pDCs from 
livers of S. mansoni infected mice showed that cDCs were superior in antigen 
uptake, processing and presentation to naïve or effector/memory CD4+ T cells 
relative to pDCs, but there was no significant difference in the core functions 
exhibited by infection derived cDCs compared with those from naïve mice. These 
data provide an indication that hepatic cDCs, but not pDCs, competently activate 
naïve CD4+ T cells during S. mansoni infection, which would typically occur 
following migration of DCs in the liver to the dLNs in vivo (Bonasio and Andrian, 
2006). Furthermore, cDCs maintained effector/memory Th2 cytokine responses, 
which lends further support to the hypothesis first outlined in chapter 3 that cDCs 
reactivate Th2 responses in the liver/granuloma (section 3.6.6). Analysis of cDC 
subsets extended our understanding of which cDC subsets are involved in the 
induction or maintenance of Th2 responses during S. mansoni infection. These 
results revealed that CD8α− cDCs, but not CD8α+ cDCs, from infection exhibited an 
enhanced ability to induce CD4+ T cell proliferation and IL-13 production compared 
with their counterparts from naïve mice. In addition, hepatic CD8α− cDCs from 
infection were proficient in the maintenance of Th2 cytokine production by 
effector/memory CD4+ T cells. Thus, S. mansoni infection improved the capacity of 




5.6.1 Activation phenotype of cDCs and pDCs following S. 
mansoni infection  
To isolate pure hepatic DC populations, liver leukocytes were enriched for DCs and 
sorted by FACS using various surface markers to distinguish DC subsets. Analysis of 
F4/80 and NK1.1 expression by liver leukocytes enriched for DCs from naïve and S. 
mansoni infected mice revealed that a population of F4/80+ PDCA-1+ cells that was 
also CD11clow was apparent in the cDC and pDC gates prior to FACS sorting (Fig. 
5.1A-B). These F4/80+ PDCA-1+ CD11cint cells are likely MΦs similar to those 
previously identified in peritoneal exudate cells isolated from the peritoneal cavity 
that display a pDC-like phenotype, and are induced in vivo by galectin-9 (a lectin 
that inhibits metastasis of tumour cells) (Nobumoto et al., 2009). This highlights the 
necessity for using F4/80 during FACS sorting of DC subsets in order to prevent 
contamination with pDC-like MΦs in DC populations used for subsequent culture 
with CD4+ T cells in this assay.  
 
It has been shown that the expression level of activation markers including CD40, 
CD80, CD86 and MHC-II by BMDCs is marginally increased after stimulation with 
SEA in vitro, but this activation phenotype is subtle compared with BMDC 
activation with bacterial antigens such as P. acnes (MacDonald et al., 2001). As 
expected from the previous literature, the expression of activation markers by ex vivo 
FACS sorted liver cDCs or pDCs in this chapter was increased to a low level at D42 
of S. mansoni infection compared with those isolated from naïve mice (Fig. 5.1). 
Furthermore, the expression of CD80 by infection derived cDCs was marginally 
decreased at this time-point compared with naïve cDCs. Thus, we have shown that S. 
mansoni infection does not substantially enhance hepatic cDC expression of MHC-II 
and co-stimulatory molecules that are thought to be critical for efficient interaction 
with, and activation of, T cells (Banchereau et al., 2000), and this extends previous 
literature that has reported similar activation marker expression profiles by ex vivo 




5.6.2 cDCs induce and maintain CD4+ T cell responses 
during S. mansoni infection 
To address the capacity of hepatic DCs to induce naïve CD4+ T cell proliferation and 
cytokine production, we co-cultured ex vivo hepatic cDCs from naïve or S. mansoni 
infected mice with freshly isolated naïve or in vitro activated OT-II CD4+ T cells. 
We reasoned that culture with naïve CD4+ T cells would provide an indication of the 
function of recently activated hepatic DCs in the liver that would migrate to dLNs to 
prime CD4+ T cells in vivo at a time-point when Th2 responses are induced (Pearce 
and MacDonald, 2002). Although D42 is relatively early in relation to the Th2 
immune response induced to S. mansoni eggs (Pearce and MacDonald, 2002), cross-
reactive effector/memory CD4+ Th2 cell responses against larval antigens are well 
established at this time-point (Lukacs and Boros, 1991). Thus, culture with 
effector/memory CD4+ T cells provided a measurement of the ability of cDCs to 
maintain Th2 responses locally in the liver. The data from the OT-II co-culture 
assays revealed that proliferation and cytokine production by naïve or 
effector/memory CD4+ T cells was largely unchanged in co-culture with pOVA-
pulsed cDCs from naïve compared with infected mice. This shows that the capacity 
of hepatic cDCs to present processed antigen to naïve or effector/memory CD4+ T 
cells is not altered during S. mansoni infection at this time-point. 
 
A subtle change in the function of S. mansoni derived cDCs was apparent when low 
concentrations of pOVA were used to pulse cDCs; S. mansoni infection derived 
cDCs appeared more efficient at presenting peptide and inducing proliferation of 
naïve CD4+ T cells (Fig. 5.2), but less efficient at maintaining effector/memory CD4+ 
T cell division (Fig 5.6). It is plausible that a subtle functional enhancement to 
activate naïve CD4+ T cells reflects marginal increases in MHC-II and CD40 
expression on infection derived cDCs compared with cDCs from naïve mice. 
Enhanced MHC:TCR interaction and CD40 co-stimulation mediated by DCs may 
lead to more effective interaction with and activation of naïve CD4+ T cells, or could 
increase the number of CD4+ T cells that receive an activatory signal (Banchereau et 
al., 2000). Indeed, CD40 stimulation has been shown to be required for the induction 
of intact Th2 responses to S. mansoni eggs in vivo (MacDonald and Pearce, 2002). 
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On the other hand, reduced effector/memory CD4+ T cell maintenance by infection 
derived cDCs may be in part due to decreased expression of CD80 (Fig. 5.1D), as the 
combined effect of reduced peptide concentration and CD28 stimulation may 
negatively impact CD4+ T cell proliferation (Chang et al., 1999). In support of this, 
studies using CD80/CD86 deficient mice have shown that CD28 stimulation is 
critical for naïve and effector T cell responses during experimental autoimmune 
encephalomyelitis (Chang et al., 1999). However, the biological significance of these 
effects during S. mansoni infection in vivo is negligible, as on-going egg production 
by worm pairs in the mesentery provides a continuous source of a large amount of 
antigen (Pearce and MacDonald, 2002). Therefore, it is more conceivable that 
antigen is in excess in the liver, and both cDCs from naïve mice and antigen-
experienced cDCs present antigen peptide to naïve and effector/memory CD4+ T 
cells efficiently.  
 
Although peptide presentation is a central DC function during CD4+ T cell 
activation, the uptake and processing of antigen in vivo by DCs is critical prior to 
presentation on MHC molecules (Mellman and Steinman, 2001). Pulsing DCs with 
pOVA bypasses the need for antigen uptake and processing, and so peptide assays do 
not enable the examination of such additional core DC functions. To address this 
cDCs were cultured with soluble OVA that requires the generation of peptides that 
can be presented to CD4+ T cells via MHC-II (Guermonprez et al., 2002). Results 
from the co-culture with soluble OVA revealed that sorted liver cDCs from S. 
mansoni infection competently took up, processed and presented antigen to 
responding CD4+ T cells, but this ability was not altered significantly compared with 
cDCs from naïve mice (Fig. 5.4 & Fig. 5.8). In addition, infection did not 
substantially change the capacity of cDCs to induce or maintain cytokine production 
by CD4+ T cells in the presence of OVA, with the exception of enhanced TNF-α in 
culture with effector/memory CD4+ T cells and infection derived cDCs (Fig. 5.9). In 
support of this, elevated levels of TNF-α in the serum of S. mansoni infected mice 
have been previously reported (Haseeb et al., 2001), and possible roles of TNF-α 
during S. mansoni infection will be discussed in more detail later. Yet, overall the 
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functions of hepatic cDCs to take up, process and present antigen to induce or 
maintain Th2 responses were not substantially altered at D42 of infection. 
 
In summary, S. mansoni infection induced a muted activation state of hepatic cDCs 
(Fig. 5.1), but their ability to either initiate or maintain CD4+ T cells responses ex 
vivo was not markedly altered compared with cDCs from naïve mice. This suggests 
that a significant functional enhancement in antigen uptake, processing and 
presentation by cDCs is not required for the induction or maintenance of Th2 
responses against S. mansoni infection. Indeed, the subtle differences observed in 
cDC function described above (e.g. TNF-α production by effector/memory CD4+ T 
cells) seem insignificant in relation to the strong Th2 immune response that is 
induced during S. mansoni infection (MacDonald and Pearce, 2002) (Fig. 3.3, 
Chapter 3). Nevertheless the data indicate that cDCs are functional during infection 
at this time-point, and display a capacity to induce Th2 responses as well as maintain 
effector/memory Th2 responses. In support of the latter, we have shown in chapter 3 
that CD11c+ cells and T cells are found in similar locations throughout hepatic 
granuloma development (Fig. 3.5). Furthermore, CD11c+ cells are necessary for T 
cell recruitment/retention at D42 (Fig. 3.9) and the “normal” T cell location at D52 in 
every region of the granuloma  (Fig. 3.10). Thus, analysis of DC location and 
function during S. mansoni infection in this thesis together provide evidence that 
points towards direct interaction between CD11c+ DCs and T cells in the liver, 
particularly in the granuloma.  
5.6.3 Liver pDCs fail to induce efficient T cell responses 
during S. mansoni infection 
In contrast to cDCs, pOVA-pulsed pDCs from naïve or S. mansoni infected mice did 
not initiate marked CD4+ T cell proliferation or cytokine production, indicating that 
pDCs present exogenous antigen less efficiently to naïve or effector/memory CD4+ T 
cells (Fig. 5.2 & Fig. 5.6). Furthermore, culture of pDCs in the presence of OVA 
showed that both naïve and S. mansoni infection derived pDCs were incapable of 
taking up and processing antigen for presentation to naïve or effector/memory CD4+ 
T cell responses (Fig. 5.4 & Fig. 5.8). The amount of cytokines measured in co-
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cultures with pDCs was generally below the detection limit of the assay and 
cytokines produced by effector/memory CD4+ T cells in the absence of DCs 
(Appendix Fig. 7.6), which argues that pDCs fail to prime or maintain CD4+ T cell 
cytokine production. These findings suggest that pDCs are not principal players in 
the induction of Th2 responses during S. mansoni infection, and that cDCs are the 
main group of DCs that are proficient in the initiation of this process. In line with 
this finding, it has been reported previously that depletion of lung pDCs has no 
impact on the priming of naïve CD4+ T cells in an allergic Th2 model of mouse 
asthma (de Heer et al., 2004). Moreover, we have shown that pDCs are not capable 
of maintaining established Th2 responses and this function is not improved following 
S. mansoni infection.  
 
It is likely that inefficiency in inducing and maintaining CD4+ T cell responses is due 
to ineffective interaction between pDCs and CD4+ T cells (Villadangos and Young, 
2008). Both naïve and S. mansoni infection derived pDCs expressed lower levels of 
MHC-II, CD40 and CD80 compared with cDCs (Fig. 5.1C-D), which likely results 
in reduced TCR stimulation (signal 1) and co-activatory signals (signal 2) 
(Banchereau et al., 2000). Fonteneau et al., (2003) have shown that pDCs exhibit a 
substantial increase in activation markers including CD86 in response to influenza 
antigen, and only activated pDCs can initiate or restimulate influenza specific CTL 
and Th1 responses. Thus, poor antigen presentation by pDCs in our assays may be 
due to insufficient activation marker expression following S. mansoni infection 
compared with viral infection (Fonteneau et al., 2003). In addition to inefficient 
interaction with CD4+ T cells, ineffective uptake, processing and presentation of 
antigen by pDCs is likely due to suboptimal cellular machinery within the cells as 
introduced in section 1.2.2 (Asselin-Paturel et al., 2001; Boonstra et al., 2002; de 
Heer et al., 2004; Young et al., 2008). Taken together, the data are in line with the 
current literature that pDCs do not competently take up, process or present 
exogenous antigen, and that pDCs are not capable of effective interaction with T 




Interestingly, naïve and effector/memory CD4+ T cell proliferation was increased in 
culture with cDCs compared with pDCs even in the absence of antigen, which 
indicates that cDC mediated T cell activation is at least partly independent of 
antigen-specific stimulation. IL-7 has been shown to increase CD4+ T cell expansion 
during infection with LCMV, and IL-7 is required continuously for the persistence of 
the effector CD4+ T cell population (Sun et al., 2006). Thus, cDCs may produce 
increased amounts of survival cytokines including IL-7, IL-2 and IL-15 compared 
with pDCs, and this would maintain the balance of pro- and anti-apoptotic factors in 
the CD4+ T cell in favour of survival (Marrack and Kappler, 2004). The expression 
of survival cytokines by DCs in our system could be tested in future by ICC, the use 
of reporter mice or by examining the gene expression of ex vivo isolated cDCs and 
pDCs for IL-7, IL-15 or IL-2 by PCR. To investigate the contribution of survival 
cytokines to T cell responses in DC:T cell co-cultures, recombinant cytokine could 
be added into culture. If reduced production of IL-2, IL-7 or IL-15 leads to decreased 
CD4+ T cell proliferation and cytokine production in culture with pDCs, we would 
expect the addition of recombinant cytokine to increase the CD4+ T cell responses in 
the assay. Conversely, the addition of anti-cytokine antibodies (i.e. αIL-7) to the co-
culture should reduce the induction or maintenance of CD4+ T cell responses in 
culture with cDCs. Although the production of survival cytokines by DCs has not yet 
been addressed during S. mansoni infection, this provides a potential mechanism by 
which naïve and S. mansoni infection derived cDCs induce and maintain CD4+ T cell 
proliferation more efficiently than pDCs even in the absence of antigen.  
 
One potential drawback of the ex vivo sorting OT-II culture system used in this 
chapter is that cDCs and pDCs may die at different rates during the culture, which 
could impact the interaction with CD4+ T cells. However, we have shown that equal 
proportions of cDCs and pDCs are present after one day of culture (Appendix Fig. 
7.5), which suggests that both types of DCs die at similar rates ex vivo. In support of 
this, Young et al., (2008) isolated cDCs and pDCs from mice expressing a transgene 
that encodes the anti-apoptosis factor Bcl-2 under the control of the Vav promoter, 
which ensured equal survival of pDCs and cDCs in culture. This assay revealed that 
pDCs remain inefficient in antigen presentation to CD4+ T cells in culture compared 
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with cDCs even when the survival rate is unchanged (Young et al., 2008). 
Nevertheless, it remains to be established whether this is true for S. mansoni 
infection derived DCs.   
 
Although we have shown that pDCs are incapable of efficient CD4+ T cell response 
induction and maintenance, it is possible that pDCs may contribute to these 
processes in vivo. It has previously been proposed that DC derived peptide loaded 
MHC complexes can be transferred from one DC to another, or indeed other cells 
such as LN stromal cells (Dubrot et al., 2014; Qu et al., 2009; Smyth et al., 2008). In 
addition, exosomes containing MHC-II/antigen complex can be transferred to DCs 
which are unable to perform antigen processing function and are devoid of MHC-II 
(Théry et al., 2002). Whether DC derived exosomes exist during S. mansoni infection 
remains unknown. However, if cDC derived exosomes are generated during S. 
mansoni infection and/or exosome independent transfer of peptide loaded MHC 
complexes occurs, these represent possible routes used by pDCs to present processed 
antigen (i.e. from S. mansoni eggs) to CD4+ T cells in vivo. Nevertheless, the data 
presented in this chapter argue that induction of CD4+ T cell responses and their 
maintenance during S. mansoni infection is dominantly orchestrated by cDCs rather 
than pDCs, which raised the question whether distinct subsets that belong to the cDC 
group are important for this process. 
5.6.4 A predominant role for S. mansoni infection derived 
CD8α− cDCs in antigen presentation to CD4+ T cells 
The overall observation that S. mansoni infection did not alter core cDC function was 
somewhat intriguing given the importance of CD11c+ DCs for Th2 induction during 
S. mansoni infection (Phythian-Adams et al., 2010). To extend our understanding of 
the function of cDCs in the liver during S. mansoni infection, hepatic CD8α+ CD205+ 
and CD8α− CD205− cDC subsets were sorted for culture in the same assay as above. 
CD8α+ and CD8α− cDCs have been described to exhibit distinct capabilities to 
interact with T cell subsets (section 1.2.2) (Merad et al., 2013), and we hypothesised 
that infection with S. mansoni may differentially impact the ability of these subsets to 
interact with CD4+ T cells. Such differences in the function of CD8α+ and CD8α− 
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cDCs may not be detected in culture with “bulk” cDCs, and this will be discussed in 
more detail in section 5.6.5. The data from co-cultures with cDC subsets with naïve 
or effector/memory CD4+ T cells showed that hepatic CD8α+ cDCs induced similar 
levels of CD4+ T cell proliferation compared with CD8α− cDCs from naïve mice 
(Fig. 5.11). This suggests that the capacity of these types of cDCs in the liver to 
present exogenous antigen to naïve CD4+ T cells is comparable in the steady state. 
These results differ from previous reports that have shown ex vivo splenic CD8α+ 
cDCs from naïve mice to induce less CD4+ T cell proliferation compared with 
CD8α− cDCs (Rizzitelli et al., 2005; Süss and Shortman, 1996). In addition, it has 
been shown that ex vivo hepatic CD8α+ CD11b− cDCs are marginally less efficient at 
inducing T cell proliferation and cytokine production compared with CD8α− CD11b+ 
cDCs in the steady state (Pillarisetty et al., 2004). Following the hypothesis proposed 
by Pillarisetty et al., (2004) that the liver may contain increased proportions of 
immature CD8α−/low CD11b−/low cDCs compared with the spleen, the CD8α− 
(CD205−) cDC population in our study may include a population of CD8α− CD11b− 
cDCs that are poor APCs. In chapter 4, we have shown that liver CD8α+ CD205+ 
cDCs expressed high levels of CD103 and CD24, but not CD11b, whilst CD8α− 
CD205− cDCs expressed CD11b, but not CD103 or CD24 (Fig. 4.4). This result 
justified the use of CD8α and CD205 for the distinction of cDC subsets in our 
experiments, but additional markers could be used in future during the DC sorting 
procedure: an antibody against CD11b could be utilised to further distinguish CD8α− 
cDCs in this assay, and CD103, CD24 or XCR1 would better distinguish CD8α 
lineage cDCs in the liver (Table 1.1). However, Pillarisetty et al., (2004) did not 
investigate CD4+ T cell responses specifically (i.e. both CD4+ and CD8+ T cells were 
present in their assay) or use OVA as an antigen, and these are further possible 
reasons for the discrepancy observed between the results. Clearly additional work is 
required to fully understand the capacity of different cDC subsets in the naïve liver to 
interact with naïve and effector/memory CD4+ T cells, the latter of which could not 
be addressed in this chapter due to a lack of DCs available for the assay. Yet, our 
data so far suggest that core functions of cDC subsets are similar prior to infection 




Following investigation of the ability of cDC subsets from naïve mice to induce 
CD4+ T cell responses, we have shown for the first time that the function of hepatic 
CD8α− cDCs, but not CD8α+ cDCs, is enhanced after infection with S. mansoni 
leading to increased induction of CD4+ T cell proliferation and IL-13 production (Fig 
5.11). Moreover, the amount of IL-4, IL-13 and IFN-γ produced by effector/memory 
CD4+ T cells was significantly increased in culture with CD8α− compared with 
CD8α+ cDCs from infection, even though the proliferation of effector/memory CD4+ 
T cells was similar in both cultures (Fig. 5.12). In this case, the most striking 
differences between the cultures were observed for Th2 cytokines, whereas the 
amount of TNF-α and IFN-γ was more comparable with levels produced in culture 
with CD8α+ cDCs. Together these data suggest that CD8α− cDCs, but not CD8α+ 
cDCs, are proficient in the induction and maintenance of Th2 responses following S. 
mansoni infection, which is in agreement with recent studies that have shown IRF4 
dependent CD11b+ cDCs to be important for the induction of Th2 responses in 
various disease settings including allergic inflammation and infection with N. 
brasiliensis (Gao et al., 2013; Kumamoto et al., 2013; Plantinga et al., 2013; 
Williams et al., 2013).  
 
An enhanced ability to induce CD4+ T cell proliferation indicates that S. mansoni 
infection increased the effectiveness of the interaction between CD8α− cDCs, but not 
CD8α+ cDCs, with naïve CD4+ T cells. Increased expression of surface markers 
involved in the provision of signal 1 and 2 to CD4+ T cells may improve CD8α− cDC 
mediated activation of CD4+ T cells as mentioned previously (Banchereau et al., 
2000). In support of this, Dudziak et al. (2007) showed that naïve CD4+ CD11b+ 
splenic cDCs express higher levels of genes coding for proteins involved in the 
MHC-II pathway compared with CD8α+ cDCs. This suggests that CD4+ CD11b+ 
cDCs are superior antigen presenters to CD4+ T cells compared with CD8α+ cDCs, 
resulting in increased CD4+ T cell proliferation in our system.  
 
One additional possible mechanism that would enable CD8α− cDCs to induce CD4+ 
T cell proliferation more efficiently than CD8α+ cDCs is via the enhanced production 
of growth factors and survival signals, including IL-2, IL-7 and IL-15 (Boyman et 
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al., 2009). This has also been proposed in previous reports in the literature, as naïve 
splenic CD8α+ cDCs that have been transferred into naïve mice stimulate less IL-2 
by D011.10 CD4+ transgenic T cells in vivo (De Smedt et al., 2001). Further, it has 
been shown that insufficient IL-2 reduces CD8+ and CD4+ T cell proliferation ex vivo 
(Kronin et al., 2000; 1996). Upon activation CD4+ T cells become more responsive 
to IL-2 as its receptor, CD25, is upregulated (Boyman and Sprent, 2012). IL-2 
signals through both autocrine and paracrine pathways (Boyman and Sprent, 2012), 
which suggests two possible mechanisms by which CD8α− cDCs from infection may 
augment the amount of IL-2 in the environment. First, infection derived hepatic 
CD8α− cDCs may produce higher levels of IL-2 compared with their naïve 
counterparts and CD8α+ cDCs, which supports CD4+ T cell metabolism and 
proliferation once activated (Boyman and Sprent, 2012). Second, CD8α− cDCs might 
provide increased or more frequent peptide/MHC:TCR interaction and CD28 co-
stimulation via CD80/CD86 compared with naïve CD8α+ cDCs, which together 
stimulate IL-2 production by CD4+ T cells for autocrine signalling (Fathman and 
Lineberry, 2007). In fact, enhanced expression levels of MHC and co-stimulatory 
molecules may also promote CD8α− cDC mediated induction and maintenance of 
Th2 cytokine production, as King et al., (1995) have shown that the production of 
ΙL-4 and IL-5, but not IFN-γ, by CD4+ T cells previously activated in vitro with CD3 
and PMA/I is promoted by continuous stimulation via CD28. Furthermore, 
administration of CTLA4-Ig, which blocks CD28 stimulation, decreases Th2 
responses induced during allergic responses in the lung (Keane-Myers et al., 1997) or 
after infection with S. mansoni (King et al., 1996) or H. polygyrus (Gause et al., 
1996). Thus, enhanced expression of IL-2, MHC-II and co-stimulatory molecules 
may all contribute to increased induction and maintenance of Th2 responses by 
CD8α− cDCs. To test this hypothesis, the activatory capacity of ex vivo hepatic 
CD8α+ and CD8α− cDCs could be assessed by flow cytometric analysis of the 
expression levels of MHC-II, CD80 and CD86 as well as other activation markers 
such as CD40 and OX40-L, which may improve direct interaction with CD4+ T cells 
(Banchereau et al., 2000). The production of IL-2 (and other survival cytokines 
including IL-7 and IL-15) by CD8α+ cDCs, CD8α− cDCs and CD4+ T cells during 
culture could be measured either by PCR, the use of reporter mice or by intracellular 
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flow cytometry as mentioned previously for cDCs. Such investigation will provide 
additional insight into the mechanisms that CD8α− cDCs employ to induce and 
maintain Th2 responses. Yet it remains likely that the provision of signal 3 is key for 
this process, and the identification of this signal in future is critical to progress 
understanding on the mechanisms that orchestrate Th2 induction and maintenance.  
 
By investigating the importance of CD8α+ cDCs in vivo in chapter 4 and examining 
the function of this subset ex vivo in this chapter we have shown that unlike CD8α− 
cDCs, CD8α+ cDCs are not required or sufficient for the induction or maintenance of 
Th2 responses during S. mansoni infection. However, the amount of TNF-α was 
significantly higher in culture with S. mansoni infection derived CD8α+ cDCs 
compared with CD8α− cDCs (Fig. 5.11). These data are in line with levels of TNF-α 
measured in the mLN of S. mansoni infected CD8α+ cDC deficient Batf3-/- mice (Fig. 
4.5); Batf3-/- mice displayed reduced levels of TNF-α compared with WT mice at 
D42 of infection. Thus, we have shown both in vivo and ex vivo data that support the 
hypothesis that CD8α+ cDCs play a role in priming CD4+ T cells to produce TNF-α 
during S. mansoni infection at D42. These findings suggest that CD8α+ cDCs are the 
main subset responsible for increased amounts of TNF-α measured in the co-culture 
with infection derived cDCs compared with cDCs from naïve mice, as described 
earlier (Fig. 5.9).  
 
Numerous studies have suggested that TNF-α may affect the fecundity of S. mansoni 
worms (Amiri et al., 1992; Haseeb et al., 1996), and a recent study reported that 
schistosomula cultured with human TNF-α in vitro exhibit a complex pattern of gene 
regulation related to egg laying when the parasite gene expression profile was 
analysed (Oliveira et al., 2009). In chapter 4, analysis of parasitemia in Batf3-/- mice 
did not suggest a difference in the number of eggs produced per worm pair when 
TNF-α is reduced compared with WT mice, which argues that a reduction in TNF-α 
did not alter the fecundity of S. mansoni in our model (Fig. 4.9). In addition, it is 
unlikely that TNF-α plays a role in the formation of granulomas, as TNF-α has been 
shown to be dispensable for granuloma formation at D42 of S. mansoni infection 
(Davies et al., 2004). Instead, TNF-α may promote the expansion of inflammatory 
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Th1 responses including IFN-γ production in vivo (Chatzidakis and Mamalaki, 
2010). Thus, the induction of TNF-α production by CD4+ T cells during S. mansoni 
infection may represent a process that is predominantly orchestrated by CD8α+ 
cDCs, which contributes to the induction of balanced or mixed Th1/Th2 responses.  
 
In chapter 4 we proposed that CD8α+ cDCs regulate effector/memory Th2 responses 
during S. mansoni infection. One of the possible mechanisms for Th2 regulation by 
CD8α+ cDCs is that the production of IL-12 induces Th1 responses, which then 
indirectly inhibit IL-4 production and Th2 cell proliferation (Paludan, 1998) (section 
4.6.3.2). Yet, the data in figure 5.12 suggests that regulation of Th2 cytokine 
production is not solely mediated by IFN-γ, as this cytokine was present in 
substantial amounts in addition to IL-4 and IL-13 when in culture with CD8α− cDCs. 
In line with this finding, IFN-γ-/- animals do not exhibit markedly increased Th2 
responses during S. mansoni infection (Yap et al., 1997). This indicates that 
additional or alternative mechanisms than the induction of IFN-γ production by 
CD4+ T cells are important for effective regulation of Th2 responses by CD8α+ 
cDCs. 
 
If IFN-γ is not the crucial element in Th2 regulation, perhaps downstream signalling 
events after CD4+ T cell binding of IL-12 represent the principal mechanisms that 
mediate this process. It remains likely that the production of IL-12 by cDC subsets is 
key for the suppression of effector/memory Th2 responses, as IL-12 mediated 
mechanisms are the most potent inhibitors of Th2 induction and maintenance known 
to date (Murphy and Stockinger, 2010). IL-12 induces STAT4 signalling and T-bet 
expression in naïve CD4+ T cells (Lazarevic et al., 2013; Thierfelder et al., 1996), 
which leads to Th1 differentiation and IFN-γ production (Szabo et al., 2000). 
Therefore, IL-12 may also induce T-bet expression and IFN-γ production by 
effector/memory Th2 cells, possibly via T-bet mediated suppression of GATA3 
expression (Lazarevic et al., 2013). Indeed, competition between GATA3 and T-bet 
may be crucial for CD4+ T cell differentiation as well as the maintenance of Th1/Th2 




It has been shown IL-12 can restore IL-12 responsiveness by upregulating the 
expression of the IL-12 receptor (IL-12Rβ2) on established human Th2 cells, which 
results in increased T-bet expression and IFN-γ production and GATA3 
downregulation (Smits et al., 2001b). This and other reports on human CD4+ Th2 
cells suggest that overall responsiveness to IL-12 by effector/memory CD4+ T cells 
may be crucial in regulating Th2 immune responses (Hilkens et al., 1996; Rogge et 
al., 1999; Smits et al., 2001b), and this provides a potential mechanism for IL-12 
produced by CD8α+ cDCs to regulate Th2 responses in vivo. Yet, IL-12 does not 
directly restore IL-12 responsiveness by murine Th2 cells (Heath et al., 2000; 
Nishikomori et al., 2000), and this is thought to be due to rigorous inhibition of T-bet 
by IL-4 in murine systems, which is not yet apparent in human cells (Mullen et al., 
2001; Varga et al., 2000). However, overexpression of T-bet in committed murine 
Th2 cells leads to dampened GATA3 expression and Th2 cytokine production (Usui 
et al., 2006). Thus, it is possible that other cytokines produced by CD8α+ cDCs in 
addition to IL-12, such as IFN-α, may be required to modulate GATA3 and T-bet 
expression in established murine Th2 cells (Smits et al., 2001a). Overall, 
understanding the regulation of the expression of transcription factors involved in 
CD4+ T cell polarization events may be essential to elevate our understanding of how 
CD8α+ cDCs regulate Th2 responses. 
 
To further delineate the distinct polarisation events towards Th1 or Th2 immune 
responses respectively in cultured CD4+ T cells in our system, the expression of 
transcription factors T-bet and GATA3 by could be measured in future by 
intracellular staining and flow cytometry. Analysis of IL-12 production (i.e. IL-
12p40) in culture with isolated CD8α+ and CD8α− cDCs from S. mansoni infection 
by ELISA would clarify whether these cDC subsets produce different amounts of IL-
12 ex vivo. Indeed, CD8α− cDCs may induce IFN-γ independent of IL-12 enabling 
the promotion of Th2 cytokine production, as CD8α+ cDCs are thought to be the 
main producers of IL-12 in certain infectious disease settings (Martínez-López et al., 
2014; Mashayekhi et al., 2011). In agreement with this, IL-12 independent IFN-γ 
production in vitro by SEA restimulated splenocytes isolated from S. mansoni 
infection at D47 has been reported (Patton et al., 2001), and such pathways may 
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involve IL-18 (Schroder, 2003) or Notch dependent signalling (Skokos and 
Nussenzweig, 2007) mediated induction of IFN-γ production by CD4+ T cells in 
vivo. Taken together, CD8α+ cDCs may be important for regulating the expression of 
transcription factors in both naïve and effector/memory CD4+ T cells, and this 
process likely involves the production of IL-12 (Murphy and Stockinger, 2010).  
 
Finally, it is possible that the direct interplay between different cDC subsets during 
the induction and maintenance of Th2 responses in S. mansoni infection is critical in 
vivo, and understanding the impact of one DC subset on the function of another is 
important to unravel the mechanisms for these processes. For example, TGF-β 
production by steady state CD8α+ cDCs may increase the induction of Tregs by 
CD8α− cDCs, as it has been shown that exogenous TGF-β substantially enhances the 
capacity of CD8α− cDCs to induce Tregs in vitro (Yamazaki et al., 2008). The 
impact of CD8α+ cDC derived cytokines on the function of CD8α− cDCs during the 
induction and maintenance of Th2 responses has not yet been described. In future, 
experimental co-cultures containing mixtures of DC subsets at different ratios as 
suggested in chapter 4 could be used to examine whether the function of one DC 
subset impacts other DCs during interaction with CD4+ T cells (section 4.6.3.2).  
 
In summary, we can conclude that hepatic cDCs, but not pDCs, are proficient in the 
induction and maintenance of CD4+ T cell responses during S. mansoni infection. 
More detailed analysis of distinct cDC subsets revealed that hepatic CD8α− cDCs are 
likely candidates involved in the initiation and maintenance of CD4+ Th2 immune 
responses, which extends our understanding of DC function during S. mansoni 
infection considerably. On the other hand, the data from CD8α+ cDC co-cultures 
support the concept that this subset is involved in the regulation of Th2 immune 
responses, which may involve the production of cytokines including IL-12 and the 
induction of Th1 immune responses. Future studies will aim to pinpoint which 
specific cytokines are important in Th2 regulation by CD8α+ cDCs and whether they 
directly interfere with CD8α− cDC function during the induction of Th2 responses. 
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5.6.5 Limitations and future directions 
In this chapter, we have used an ex vivo OT-II co-culture system to assess whether 
infection with S. mansoni alters the function of DC subsets in the liver. Although this 
approach enabled controlled analysis of the ability of DCs to interact with CD4+ T 
cells, there are various limitations that should be considered when using the OT-II 
co-culture assay. For example, low level cytokine production by naïve CD4+ T cells 
in our OT-II co-culture system complicates the analysis of the function of CD4+ T 
cells following activation by DCs in the culture. In fact, only IFN-γ and TNF-α in 
cultures with naïve CD4+ T cells and the highest dose of pOVA pulsed cDCs was 
consistently measured above the detection limit of the assay (Fig. 5.3 and 5.5). Naïve 
CD4+ T cells must become activated and undergo differentiation into effector T cells 
to produce substantial amounts of cytokines (Jelley-Gibbs et al., 2000) (section 1.3, 
chapter 1), and it has previously been reported that upon CD4+ T cell activation in 
vitro the number of cell divisions required for cytokine production varies depending 
on the cytokine measured (Bird et al., 1998). For example, production of IL-5 and 
IL-10 is initiated only after 8+ divisions in culture (Gett and Hodgkin, 1998). 
Furthermore, peak levels of IL-4 are produced by CD4+ T cells at D5 in culture with 
pOVA and APCs (irradiated spleen cells), whereas substantial levels of TNF-α and 
IFN-γ are apparent at D3 of culture (Richter, 1999). In the assays performed in this 
chapter, naïve CD4+ T cells underwent approximately 5 divisions during culture with 
cDCs, hence providing insufficient time for optimal cytokine production (particularly 
for IL-4, IL-5 and IL-10). Therefore, increasing the time of culture in future work 
would be advantageous for the analysis of cytokine production by naïve CD4+ T 
cells in this type of assay.  
 
A further limitation associated with our OT-II co-culture system is the possibility 
that cytokine production by cDCs was detected in the assay. In particular, TNF-α and 
IL-10 are cytokines known to be produced abundantly by hepatic cDCs (Bamboat et 
al., 2010; Pillarisetty et al., 2004) and pDCs (Bamboat et al., 2010; Jiang et al., 2002; 
Kingham et al., 2007; Merad et al., 2013) (as described in section 5.2.1). Indeed, 
BMDC derived TNF-α is important for IL-10 production by CD4+ T cells in vitro, as 
TNF-α-/- DCs fail to induce IL-10 production (Hirata et al., 2010). In addition, DC 
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pre-cursors that do not yet express CD8α have been reported to produce low levels of 
IFN-γ, but this feature is lost when the DCs mature and express CD8α (Vremec et 
al., 2007). Although SEA does not induce substantial production of IL-4 by DCs 
indicating that IL-4 is mainly T cell derived (MacDonald et al., 2001; MacDonald 
and Pearce, 2002), DC IL-4 production has been reported in response to fungal 
infection (d'Ostiani et al., 2000). Thus, performing ICC on CD4+ T cells in the assay 
or using cytokine reporter mice could help uncover the definite source of cytokines 
detected in the assay. However, DC survival rate in the assay is low; 50% of DCs die 
in the first day of culture (Appendix Fig. 7.5). Therefore, it is likely that the majority 
of cytokines detected after 3 days are in fact CD4+ T cell derived.  
 
Our cultures containing ex vivo hepatic DCs and naïve CD4+ T cells provide 
important insight into the capacity of hepatic DCs to interact with naïve CD4+ T cells 
once DCs have migrated to the LN during S. mansoni infection, which is an aspect of 
DC biology that has not previously been addressed. Isolation of cDCs from the liver 
draining celiac LN in this type of assay would provide more accurate information in 
future about the function of antigen-experienced cDCs that have migrated from the 
liver (as well as LN resident DCs) during the induction and priming of CD4+ T cell 
responses against S. mansoni infection. In addition, the Th2 immune response to S. 
mansoni eggs peaks at D56 (Pearce and MacDonald, 2002), making this later time-
point an interesting one for future investigation of DC maintenance of 
effector/memory Th2 cells more accurately. Moreover, the function of DC subsets 
may change during the course of S. mansoni infection, and analysis DC capacity for 
antigen uptake, processing and presentation at different time-points of infection 
would be beneficial to determine whether this is the case.  
 
Having established that S. mansoni infection derived cDCs are the dominant DC 
subset for antigen presentation to CD4+ T cells at D42, it would be advantageous to 
transfer OVA pulsed isolated cDCs or pDCs from infected mice into OT-II mice for 
investigation of the CD4+ T cell response in vivo in future. Given the results in this 
chapter, we would expect CD4+ T cell responses to be enhanced in mice injected 
with OVA pulsed cDCs compared with pDCs. In addition, it would be important to 
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test the impact of naïve or infection derived DCs on ex vivo sorted liver CD4+ T cells 
from S. mansoni infection, as this would provide a scenario that resembles DC:T cell 
interaction during S. mansoni infection more accurately. For this type of assay, a 
MHC-II tetramer specific to immunodominant peptides from SEA would be useful, 
as this would enable the characterisation of SEA-specific CD4+ T cells from S. 
mansoni infection (Cecconi et al., 2008). Unfortunately, a MHC-II tetramer specific 
to SEA is not yet available, which prevents sorting of SEA-specific CD4+ T cells. 
Alternatively, polyclonal CD4+ T cells could be isolated from S. mansoni mice and 
co-cultured with ex vivo DCs in the presence of αCD3/CD28. To more selectively 
sort effector/memory “Th2” cells, IL-4+ CD4+ T cells could be isolated from IL-4 
reporter mice (4get) (León et al., 2012). Thus, future studies would aim to more 
accurately assess interaction between hepatic DC subsets with S. mansoni 
experienced CD4+ T cells. Nevertheless, the OT-II co-culture system used in this 
chapter enabled controlled functional analysis of core DC functions in the livers of S. 
mansoni infected mice, and has provided a valuable insight into the distinct roles of 
different DC subsets during infection. 
 
The functional differences found comparing cultures with CD8α+ and CD8α− cDCs 
were not detected in cultures with “bulk” cDCs, which underlines the importance of 
investigating the role of distinct DC subsets during immune responses and further 
stipulates that examination of these processes in vivo would be beneficial. CD8α+ 
cDC mediated regulation of Th2 responses that are primed by CD8α− cDCs, possibly 
via the secretion of cytokines such as IL-12 and the induction of Th1 responses, may 
result in overall unchanged CD4+ T cell responses in the assay with all cDCs. Such 
regulation may appear more pronounced in ex vivo culture systems than in vivo, as 
DCs, CD4+ T cells and the cytokines they produce are in close proximity and 
perhaps more concentrated in an ex vivo culture compared with in vivo 
microenvironments. Thus, it is plausible that persistent and potent stimulation by S. 
mansoni egg derived antigens in vivo drive a strong Th2 response mediated by 
CD8α− cDCs, which is regulated to a certain extent by CD8α+ cDCs to prevent 
exaggerated Th2 responses. Culturing cDC subsets ex vivo at different ratios with 
CD4+ T cells in the kind of experiment described in the previous section would 
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address whether CD8α+ cDCs are dampening the induction and maintenance of Th2 




The data in this chapter showed that cDCs were more efficient at antigen uptake, 
processing and presentation to naïve or activated CD4+ T cells compared with pDCs, 
as the latter generally failed to induce CD4+ T cell proliferation and cytokine 
production. Furthermore, infection with the helminth S. mansoni did not alter the 
core functions of “bulk” cDCs and pDCs. Analysis of individual cDC subsets 
revealed that CD8α− cDCs displayed an enhanced capacity to induce CD4+ T cell 
proliferation and maintain Th2 cytokine production during S. mansoni infection, 
when compared with CD8α+ cDCs. Nevertheless, CD8α+ cDCs were functional 
during infection and capable of inducing and maintaining effector CD4+ T cell 
responses, in particular the production of TNF-α and IFN-γ. Our data are the first to 
show this kind of functional difference in cDC subsets following infection with S. 
mansoni infection.  
 
In conclusion, the data in this chapter lend further support to our overall hypothesis 
and current thinking in the literature that CD11b+ cDCs are the most likely 
candidates for inducing Th2 responses (Plantinga et al., 2013; Gao et al., 2013; 
Kumamoto et al., 2013; Williams et al., 2013), whereas CD8α+ cDCs may play an 
important role in the regulation of Th2 immunity during this infection. The interplay 
and functional balance between these subsets may be crucial for the induction of 
appropriate immune responses against S. mansoni infection, which is key to promote 
the survival of the host.   
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5.8 Figures  




















































































































































Figure 5.1 Assessing the purity and activation phenotype of cells for ex 
vivo OT-II DC:T cell co-cultures 
WT mice were infected with S. mansoni and livers were harvested at D42 of 
infection. Liver leukocytes were isolated and enriched for DCs by negative selection. 
A-B. Enriched hepatic DCs were FACS sorted into pure cDC (CD11c+ PDCA-1−) 
and pDC (CD11clow PDCA-1+) populations that were F4/80− and NK1.1−. Flow plots 
are shown for enriched and post FACS sorted DCs from naïve (A) or infected (B) 
animals. C. Sorted cDCs and pDCs were assessed by flow cytometry for the 
expression of activation markers CD40, CD80 and MHC-II, and representative flow 
plots of this analysis are shown. D. The GMFI of CD40, CD80 and MHC-II 
expression by cDCs and pDCs is shown graphically. E. To purify naïve CD4+ T 
cells, spleen and LNs were harvested from a naïve OT-IIxLy5.1 mouse. Fresh naïve 
CD4+ T cells were isolated from spleen/LN cell populations by negative selection 
using Dynabeads. To obtain an effector/memory CD4+ T cell population, splenocytes 
from an OT-IIxLy5.1 mouse were isolated 7 days prior to the co-culture set up and 
DC FACS sorting, and cultured in vitro with 1 mg/ml endotoxin-free soluble OVA. 
Freshly isolated naïve CD4+ T cells and in vitro activated CD4+ T cells were 
assessed by flow cytometry for their purity (CD4+ Vα2+) and activation status (CD44 
and CD69 expression) prior to culture with DCs. Gates were set using FMO controls. 
1 of 2 (cDCs) or 1 of 1 (pDCs) experiments (A to D), and 1 of 3 experiments (E). 
One-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Error 
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Figure 5.2 Hepatic cDC, but not pDCs, derived from S. mansoni infected 
mice efficiently present pOVA and induce CD4+ T cell 
proliferation 
FACS sorted naïve or S. mansoni infection derived liver cDCs or pDCs were pulsed 
with pOVA (323-339) before culture. 5000 pOVA-pulsed naïve or infection DCs 
were cultured with 50,000 naïve CFSE-labelled CD4+ T cells for 72h. A-D. Naïve or 
infection derived pOVA-pulsed cDCs (A – B) or pDCs (C – D) were cultured with 
naïve CD4+ T cells. CD4+ T cells were assessed for their expression of CFSE by flow 
cytometry after culture, which is shown graphically (A & C). Representative flow 
plots are shown for CFSE expression by CD4+ T cells in culture with cDCs (B) or 
pDCs (D). E. To determine the average number of divisions by dividing cells, the 
proliferation index was calculated for CD4+ T cells in culture with pOVA-pulsed 
cDCs. The gate for proliferating cells was set using controls where no antigen was 
added to the well. Data are from 3 experiments (A to E). Mixed model analysis 
(blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, 
****P ≤ 0.0001). Bars are SEM. N= 7-10.  




























































































































































Figure 5.3 cDC, but not pDCs, derived from S. mansoni infected mice 
efficiently present OVA peptide to induce CD4+ T cell cytokine 
production 
FACS sorted naïve or D42 S. mansoni infection derived liver cDCs or pDCs were 
pulsed with pOVA (323-339) before culture. pOVA-pulsed naïve or infection DCs 
were cultured with naïve CFSE-labelled CD4+ T cells for 72h as in Fig. 5.2. A-B. 
Supernatants from co-cultures with cDCs (A) or pDCs (B) were harvested and 
analysed by ELISA for cytokine production. The detection limit of the ELISA is 
shown with a dotted line. Data are from 3 experiments (A to B). Mixed model 
analysis (blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P 





























































































































































































































Figure 5.4 cDC, but not pDCs, derived from S. mansoni infected mice 
efficiently take up and process soluble OVA to induce CD4+ T 
cell proliferation 
FACS sorted naïve or D42 S. mansoni infection derived liver cDCs or pDCs were 
cultured with naïve CFSE-labelled CD4+ T cells in the presence of endotoxin-free 
soluble OVA protein for 72h. A-D. Naïve or infection derived cDCs (A – B) or 
pDCs (C – D) were cultured with naïve CD4+ T cells in the presence of OVA protein. 
CD4+ T cells were assessed for their expression of CFSE by flow cytometry (A & C). 
Representative flow plots are shown for CFSE expression by CD4+ T cells in culture 
with cDCs (B) or pDCs (D) and OVA. E. To determine the average number of 
divisions by dividing cells, the proliferation index was calculated for CD4+ T cells in 
culture with naïve or infection cDCs. Data are from 3 experiments (A to E). The gate 
for proliferating cells was set using controls where no antigen was added to the well. 
Mixed model analysis (blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P 
≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are SEM. N= 7-10. 


























































































































































Figure 5.5 cDC, but not pDCs, derived from S. mansoni infected mice 
efficiently take up and process soluble OVA to induce CD4+ T 
cell cytokine production 
FACS sorted naïve or D42 S. mansoni infection derived liver cDCs or pDCs were 
cultured with naïve CD4+ T cells in the presence of endotoxin-free soluble OVA 
protein for 72h. A-B. Supernatants from co-cultures with cDCs (A) or pDCs (B) 
were harvested and analysed by ELISA for cytokine production. The detection limit 
of the ELISA is shown with a dotted line. Data are from 3 experiments (A to B). 
Mixed model analysis (blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P 
























































































































































































































Figure 5.6 cDC, but not pDCs, derived from S. mansoni infected mice 
efficiently present pOVA to maintain CD4+ T cell proliferation 
FACS sorted naïve or D42 S. mansoni infection derived liver cDCs or pDCs were 
pulsed with pOVA (323-339) before culture. A-D. Naïve or infection derived pOVA-
pulsed cDCs (A – B) or pDCs (C – D) were cultured with effector/memory CD4+ T 
cells for 72h, and CD4+ T cells were assessed for their expression of CFSE by flow 
cytometry (A & C). Representative flow plots are shown for CFSE expression by 
effector/memory CD4+ T cells in culture with cDCs (B) or pDCs (D). The gate for 
proliferating cells was set using controls where no DCs were added to the well. Data 
are from 3 experiments (A to D).  Mixed model analysis (blocking day of 
experiment), Tukey’s HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). 
Bars are SEM. N= 7-10.  
 



























































































































Figure 5.7 Hepatic cDCs from S. mansoni infection efficiently present 
pOVA to maintain CD4+ T cell cytokine production 
FACS sorted hepatic cDCs or pDCs from D42 S. mansoni infected or naïve mice 
were pulsed with pOVA before culture. pOVA-pulsed naïve or infection DCs were 
co-cultured with in vitro activated CFSE-labelled CD4+ T cells for 72h. A-B. 
Supernatants from co-cultures were harvested and analysed by ELISA for cytokines 
present. The detection limit of the ELISA is shown with a dotted line. Data are from 
3 experiments (A to B). Mixed model analysis (blocking day of experiment), 
Tukey’s HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are 




















































































































































































































Figure 5.8 cDCs, but not pDCs, derived from S. mansoni infected mice 
take up, process and present OVA efficiently to maintain 
CD4+ T cell proliferation  
Naïve or S. mansoni infection derived liver cDCs or pDCs were FACS sorted for ex 
vivo DC:T cell co-cultures. A-D. Sorted naïve or infection derived cDCs (A – B) or 
pDCs (C – D) were cultured with CFSE-labelled effector/memory CD4+ T cells in 
the presence of OVA protein for 72h. CD4+ T cells were assessed for their expression 
of CFSE by flow cytometry, which is shown graphically (A & C). Representative 
flow plots are shown for CFSE expression by CD4+ T cells in culture with cDCs (B) 
or pDCs (D) and OVA.  Data are from 3 experiments (A to D). Mixed model 
analysis (blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P 
≤ 0.001, ****P ≤ 0.0001). Bars are SEM. N= 7-10.  
A. B. 
C. D. 




























































































































Figure 5.9 cDC, but not pDCs, derived from S. mansoni infected mice 
efficiently take up, process and present OVA to maintain 
effector/memory CD4+ T cell cytokine production 
FACS sorted hepatic cDCs or pDCs from D42 S. mansoni infected or naïve mice 
were cultured with in vitro activated CFSE-labelled CD4+ T cells in the presence of 
endotoxin-free soluble OVA protein for 72h. A-B. Supernatants from co-cultures 
were harvested and analysed by ELISA for cytokine production. The detection limit 
of the ELISA is shown with a dotted line. Data are from 3 experiments (A to B). 
Mixed model analysis (blocking day of experiment), Tukey’s HSD (* P ≤ 0.05, ** P 






























































































































































































































Figure 5.10 Purification and isolation of hepatic CD8α+ and CD8α− cDC 
subsets from naïve or S. mansoni infected mice 
Livers from naïve (A) or D42 S. mansoni infected mice (B) were harvested and liver 
leukocytes isolated and pooled. Naïve or infection derived pooled leukocytes were 
enriched for DCs by negative selection using Dynabeads as done previously for cDC 
vs. pDC cultures. Enriched DCs were then sorted using a FACS cytometer into pure 
CD8α+ cDC (CD11c+ PDCA-1− CD8α+ CD205+) and CD8α− cDC (CD11c+ PDCA-
1− CD8α− CD205−) populations. Gates were set using FMO controls. 1 of 1 
















































































Figure 5.11 CD8α− cDC function is enhanced during S. mansoni 
infection 
FACS purified CD8α+ and CD8α− cDCs from naïve or D42 S. mansoni infected mice 
were pulsed with pOVA and co-cultured with CFSE-labelled naïve CD4+ T cells for 
72h. A. Cells from the cDC subset co-culture were harvested after 72h and assessed 
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proliferation. B. Representative flow plots are shown for CFSE-labelled CD4+ T cells 
in culture with CD8α+ or CD8α− cDCs. C. The proliferation index was determined to 
assess the average number of divisions that dividing CD4+ T cell in culture with 
CD8α+ or CD8α− cDCs underwent. D. Supernatants were harvested from the culture 
after 72h and assessed for cytokine production by ELISA. The detection limit of the 
ELISA is shown with a dotted line. 1 of 1 experiment (A to D). Two-way ANOVA 





















Figure 5.12 CD8α− cDCs, but not CD8α+ cDCs, maintain increased Th2 
cytokine production by effector/memory CD4+ T cells during 
S. mansoni infection. 
FACS purified CD8α+ and CD8α− cDCs from naïve or D42 S. mansoni infected mice 
were pulsed with pOVA and co-cultured with CFSE-labelled in vitro activated CD4+ 
T cells for 72h. A. Effector/memory CD4+ T cells were assessed for CFSE dilution 
by flow cytometry after culture to determine the proportion of CD4+ proliferation. B. 
Representative flow plots are shown for CFSE-labelled CD4+ T cells in culture with 
the cDC subsets. C. Supernatants were harvested from the culture after 72h and 
assessed for cytokine production by ELISA. The detection limit of the ELISA is 
shown with a dotted line. 1 of 1 experiment (A to C). Two-way ANOVA (* P ≤ 0.05, 
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6 General discussion 
At the beginning of the work detailed in this thesis there was a limited understanding 
of the requirement for DCs in the induction of Th2 responses during helminth 
infection. In particular, much remained unexplained about the complexity of distinct 
DC subsets involved in the Th2 process. By assessing the location, importance and 
function of different types of DCs in the context of Th2 responses and S. mansoni 
infection, with a focus on CD8α+ cDCs, we have elevated our understanding of a 
number of key roles assumed by DCs in the orchestration of Th2 immunity. 
Furthermore, we have provided a platform for future work building on our core 
discoveries, which will address the mechanisms that CD8α+ cDCs may employ to 
regulate Th2 responses.  
6.1 The presence and location of DCs in 
granulomas during S. mansoni infection 
The development of granulomatous inflammation during S. mansoni infection is 
dependent on the induction of CD4+ Th2 cells (Amiri et al., 1992; Boros, 1989; 
Byram and Lichtenberg, 1977; Cheever et al., 1993; 1999; Doenhoff et al., 1981; 
Dunne and Doenhoff, 1983; Mathew and Boros, 1986). The formation of hepatic 
granulomas is a key feature of S. mansoni infection, and is thought to represent a 
double-edged sword; although granulomas are necessary to protect surrounding 
hepatocytes efficiently from toxins released by S. mansoni eggs, they are also 
responsible for the majority of fibrotic and inflammatory pathology associated with 
the disease (Wilson et al., 2007). To accurately assess the formation of granulomas 
throughout infection, I have developed a novel technique for efficient and objective 
quantification of the total proportion of granulomatous inflammation in the liver, 
which encompasses immune cell aggregation and collagen deposition. Moreover, 
confocal microscopy allowed for the investigation of the location of immune cells 
(including DCs) within granulomas, and their quantification, during S. mansoni 
infection. Together these techniques enabled detailed examination of the generation 





In chapter 3, I have shown that CD11c+ cells are present in granulomas throughout 
the course of S. mansoni infection, including primary formation of granulomas 
against newly arrived parasite eggs in the liver. Notably, CD11c is not a specific 
marker for DCs by confocal microscopy, as CD11chigh MΦs are likely also detected. 
Nevertheless, close proximity to T cells raises interesting questions about the 
importance of interaction between DCs and CD4+ T cells locally in the granuloma. 
This pattern of CD11c+ and T cell staining in the granuloma is evident throughout 
infection (D28-D105), indicating that interaction between these cell types occurs 
when Th2 responses against S. mansoni eggs are induced and continues, as Th2 
responses are downmodulated (Pearce and MacDonald, 2002). Thus, the location of 
T cells in relation to CD11c+ cells provided reason to speculate that their interaction 
is important for the maintenance of Th2 responses against the S. mansoni egg in the 
granuloma. 
6.2 The role of DCs in granuloma formation and 
development during S. mansoni infection 
Following the working hypothesis that CD11c+ DCs are interacting with T cells in 
early granuloma formation, we asked whether this process was important for the 
formation of granulomas at the onset of egg production. Using the CD11c+ DC 
depletion model (CD11c.DOG mice) we were able to show that DCs (or CD11chigh 
MΦs) in the liver may play a crucial role in the recruitment or retention of 
effector/memory T cells during the initial formation of granulomas. This discovery 
extends our understanding of the function of DCs during S. mansoni infection, as it 
strongly suggests that they are interacting with effector/memory Th2 cells in hepatic 
granulomas, in addition to their more expected role in Th2 priming in secondary 
lymphoid organs (Phythian-Adams et al., 2010). When analysing the impact of 
CD11c deficiency on established granulomas during more chronic stages of infection 
2-3 weeks after the onset of egg production, we found that T cells were located 
primarily in the periphery of granulomas instead of also locating to more central 
regions as found in non-depleted mice. This indicates that CD11c+ cells are needed 
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to retain T cells throughout the granuloma rather than just in the periphery and/or 
recruit effector/memory T cells to more central areas.  
 
Taken together, we propose that DCs may recruit antigen-specific CD4+ T cells to 
the granuloma during early stages of formation, and thereafter retain CD4+ T cells in 
the “appropriate” location throughout every region of the granuloma. The 
localization of T cells with CD11c+ cells in the centre of the granuloma might reflect 
a functional interaction that could be important for the reactivation of 
effector/memory Th2 responses locally. Further studies are required to understand 
the mechanisms that are involved in the recruitment, retention and reactivation of 
effector/memory CD4+ T cells in the granulomas. It is plausible that DCs mediate the 
recruitment and retention of CD4+ T cells via the expression and secretions of 
chemokines such as CCL17 and CCL22 that have previously been shown to be 
important for the recruitment of Th2 cells to airways during human allergic asthma 
(Perros et al., 2009; Yoshie and Matsushima, 2015). On the other hand, persistent 
peptide loaded MHC:TCR stimulation, co-stimulation (i.e. CD28, OX40 or ICOS) or 
the provision of survival cytokines (IL-2, IL-7 and IL-15) by DCs could be key for 
promotion of the reactivation and maintenance of effector/memory Th2 responses in 
the liver (Boyman et al., 2009). Th2 cytokines, in particular IL-13, induce collagen 
production by fibroblasts (Chiaramonte et al., 1999; Fallon et al., 2000a; Hesse et al., 
2001), and so reduced DC:T cell interactions within the granuloma could 
conceivably decrease granuloma integrity. 
 
Previous studies in the MacDonald laboratory using CD11c.DOG mice to deplete 
CD11c+ DCs during S. mansoni infection have shown that these cells are not only 
important for the induction of Th2 responses (Phythian-Adams et al., 2010), but that 
they are also required for the maintenance of established effector/memory Th2 cells 
and the survival of the host (unpublished data, Phythian-Adams et al.,). It was 
hypothesised that an impaired Th2 response may lead to a failure to maintain 
alternative activation of MΦs, resulting in a breakdown of wound healing responses 
and granuloma integrity in the liver (Herbert et al., 2004). This likely causes leakage 
of egg derived toxins from granulomas into the surrounding liver parenchyma 
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causing hepatocyte death, ultimately leading to liver failure (Wilson et al., 2007). 
Thus, additional work in the MacDonald laboratory lends further support to the 
hypothesis raised by work in this thesis that close positioning of DCs and T cells 
may promote the reactivation of effector/memory CD4+ Th2 cells, which may be 
important to ensure that granulomas remain an impermeable structure for egg 
derived toxins. 
 
Given that there is increasing evidence in the literature that suggests the induction of 
Th2 responses is attributed to distinct DC subsets (Tjota and Sperling, 2014), we 
hypothesised that Th2 dependent granuloma formation during S. mansoni infection 
may also rely on the function of specific DC types. In the final section of chapter 3 
we have demonstrated for the first time that at the onset of egg production T cell 
presence in the S. mansoni granuloma is not altered in Batf3-/- mice, which are 
specifically deficient in CD8α+ cDCs and migratory CD103+ cDCs (Hildner et al., 
2008). This extends our understanding of which subsets of DCs are important in 
orchestrating T cell responses and granuloma development in the liver, and points to 
a more important role for CD11b+ cDCs and pDCs in this process. Nevertheless, the 
requirement for CD8α+ cDCs during the induction of Th1 immune responses against 
T. gondii (Mashayekhi et al., 2011) and L. major (Ashok et al., 2014) infection 
previously reported in the literature provided reason to speculate that Batf3 
deficiency may impact the development and character of immune responses against 
S. mansoni infection. This raised numerous questions: are CD8α+ cDCs important 
during the immune response activation against Th2 inducing pathogens such as S. 
mansoni, and if so, are CD8α+ cDCs involved in the induction, regulation or 
inhibition of Th2 responses during S. mansoni infection? 
6.3 The importance of CD8α+ cDCs during S. 
mansoni infection 
In answer to our original question, we have shown for the first time that CD8α+ 
cDCs are not a fundamental requirement for the induction of Th2 responses during S. 
mansoni infection. This carries broad implications for Th2 mediated diseases in 
general such as infection with other Th2 inducing pathogens, atopy and allergic 
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inflammation, as CD8α+ cDCs are likely not required for the initiation of Th2 
responses independent of the antigen. More than this, we have discovered a key and 
perhaps unexpected regulatory role for CD8α+ cDCs in type 2 settings, as Th2 
cytokine production was dramatically elevated in Batf3-/- mice injected with S. 
mansoni eggs.  
 
Whilst we have shown that CD8α+ cDCs are not required for the induction of Th2 
responses, the clear emergence of dysregulated Th1 and Th2 responses in Batf3-/- 
mice injected with S. mansoni eggs and during natural infection indicated that CD8α+ 
cDCs play an important role in the regulation of Th2 immunity, preventing 
exaggerated Th2 responses during infection. Whether CD8α+ cDCs are important for 
the regulation of Th2 responses in other helminth, or indeed non-helminthic Th2 
settings including allergy and atopy, remains to be established. Recent findings in the 
literature suggest this may be the case, as Batf3 dependent DCs modulate allergic 
airway inflammation via the production of IL-10 (Engler et al., 2014), and Th2 
responses are enhanced in Batf3-/- mice infected with the predominantly Th1 
inducing parasite L. major (Ashok et al., 2014). Thus, our data are in line with the 
current literature suggesting that CD8α+ cDCs are important for the induction of Th1 
responses, and that they may play a role in the regulation of Th2 responses.  
 
At the moment we have a number of different candidate pathways that may mediate 
Th2 regulation by CD8α+ cDCs, which will be subject to further research in future 
(Diagram 6.1) (Section 4.6.3.2). Perhaps the most likely mechanism for Th2 
regulation is initiated by the production of IL-12 by CD8α+ cDCs, as there are 
several previous observations in the literature that point to an important role for this 
cytokine in such a process. First, CD8α+ cDCs are known to be the main producers 
of IL-12 in several infection settings, which suggests that this cytokine is a central 
player in the interaction between CD8α+ cDCs and CD4+ T cells (Martínez-López et 
al., 2014; Mashayekhi et al., 2011). Second, IL-12 is the most potent inhibitor of Th2 
responses known to date (Murphy and Stockinger, 2010), which makes this an 
attractive molecule in the regulation of dominant Th2 responses against S. mansoni 
infection. An important question to answer when examining the role of IL-12 in Th2 
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regulation is whether this inflammatory cytokine acts directly on newly primed or 
effector/memory Th2 cells possibly through downstream signalling events in the cell 
(Murphy and Stockinger, 2010), or if the induction of Th1 responses mediated by IL-
12 forms an indirect pathway for Th2 regulation via IFN-γ (Paludan, 1998). There is 
evidence to suggest that responsiveness to IL-12 by CD4+ T cells may be crucial for 
understanding Th2 polarisation or maintenance (Hilkens et al., 1996; Murphy and 
Stockinger, 2010; Smits et al., 2001b). For example, IL-12 can re-establish IL-12 
responsiveness in human Th2 committed cells, resulting in a suppression of GATA3 
expression and an induction of T-bet in CD4+ T cells (Smits et al., 2001b). This 
suggests that lowering CD4+ T cell IL-12 responsiveness perhaps by degrading or 
blocking the IL-12 receptor is a critical requirement during the induction and 
maintenance of Th2 responses (Hilkens et al., 1996; Murphy and Stockinger, 2010). 
Therefore, the key to unravelling the mechanisms underlying Th2 responses may 
likely be to establish a greater understanding of the interplay or crossregulation 
between transcription factors in Th2 populations, including T-bet and GATA3, and 
to investigate how DC subsets influence this process. We intend to address this in 
future by assessing the expression of T-bet and GATA3 by CD4+ T cells ex vivo 
(either OT-II T cells as in chapter 5 or CD4+ T cells isolated from S. mansoni 
infection) in culture with varying ratios of different DC subsets.  
 
Overall, we have shown that CD8α+ cDCs are important for the induction of 
mixed/balanced Th1 and Th2 responses during S. mansoni infection, which may be 
crucial for the subsequent development of Th2 responses in the host. It is possible 
that the kinetics of the immune response against S. mansoni infection are shifted in 
Batf3-/- mice, with the enhanced Th2 responses evident following the onset of egg 
production reflecting an earlier peak in type 2 effector responses, compared with WT 
mice. This could ultimately also result in early CD4+ T cell hyporesponsiveness in 
the liver effector site in infected Batf3-/- mice (Taylor et al., 2009). Taylor et al., 
(2009) described cell intrinsic CD4+ T cell hyporesponsiveness during chronic stages 
of S. mansoni infection, suggesting that this occurs due to persistent antigen 
stimulation, which results in the upregulation of expression of molecules such as 
GRAIL (an E3 ubiquitin ligase that is associated with anergy) (Taylor et al., 2009). 
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We have some preliminary support for this altered kinetic hypothesis, as Th2 
responses against S. mansoni eggs following s.c. injection were substantially 
enhanced in Batf3-/- mice at a time-point prior to notable increases in Th2 cytokine 
production in WT mice. This scenario could be further interrogated in future by 
conducting time-course experiments, including early stages of infection (i.e. D0 to 
D42) or following egg injection (i.e. D0 to D5).  
 
Previous studies have outlined the importance of mixed/balanced Th1 and Th2 
immune responses during S. mansoni infection to prevent excessive Th2 or Th1 
driven pathology, which can, in some cases, result in the death of the host (Hoffmann 
et al., 2000; Wynn, 2004). In chapter 4 we have shown that Batf3-/- mice lose a 
critical amount of weight in later stages of infection and, therefore, do not survive 
acute infection. This discovery resembles the weight loss phenotype displayed by 
CD11c.DOG mice when CD11c+ DCs are depleted between weeks 6-8 of S. mansoni 
infection (Dr. Alexander Phythian-Adams, unpublished data), and by IL-4 deficient 
mice lacking an intact Th2 immune response (Brunet et al., 1997). In the case of IL-4 
deficiency, it is thought that TNF-α mediated cachexia is responsible for death in IL-
4-/- animals (Brunet et al., 1997). This scenario is unlikely in Batf3-/- mice, where we 
have identified that Th2 immune responses were predominantly increased, while 
levels of TNF-α were reduced, compared with WT mice (Fig. 4.5). This suggests that 
the processes responsible for the death of Batf3-/- mice during S. mansoni infection 
are mechanistically distinct from those mediated by TNF-α or Th2 impairment.  
 
Fibrosis, predominantly driven by Th2 cytokines, is one of the major factors 
contributing to severe pathology during schistosomiasis (Wynn et al., 2004). Fibrotic 
legions and scarring in the liver can lead to portal hypertension and shunting of blood 
vessels to the extent that the blood supply bypasses the liver, which can cause organ 
failure (Fallon, 2000; Hams et al., 2013). Thus, given their elevated Th2 profile, one 
possible explanation for premature death of Batf3-/- mice during S. mansoni infection 
may be increased fibrotic pathology, which was indicated by more severe fibrosis in 
the liver in more chronic stages of infection in Batf3-/- mice. Moreover, intestinal 
granulomatous inflammation following the onset of egg production and type I and 
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type III collagen in hepatic granulomas was more severe during infection in Batf3 
deficient animals. A novel and surprising finding was the accumulation of vacuoles 
in the circular intestinal muscle during S. mansoni infection, which was exacerbated 
in Batf3-/- mice and may indicate increased muscle injury. Taken together, severe 
intestinal and hepatic granulomatous pathology may lead to increased fibrotic 
scarring of the tissue when CD8α+ cDCs are reduced, ultimately resulting in organ 
failure and death of the animal (Wilson et al., 2007). It is somewhat intriguing that 
the lack of a rare DC subset such as CD8α+ cDCs, which is not required for the 
induction of Th2 responses, leads to fatal consequences for the host. This highlights 
the importance of diverse DC subsets during the generation of immune responses 
against S. mansoni infection.  
 
Numerous studies have previously investigated how exploiting the functions of 
CD8α+ cDCs in inducing CTL and Th1 responses in vivo could contribute to the 
development of vaccines and therapeutics in various disease settings, where these 
immune responses are beneficial (Shortman et al., 2009). For example, it has been 
proposed that targeting tumour antigens to CD8α+ cDCs may aid the induction of 
protective anti-tumour responses mediated by CD8+ T cells (Sancho et al., 2008). 
The data in this thesis additionally suggest that targeting CD8α+ cDCs could be used 
in future to promote regulation of Th2 mediated disease such as atopy, allergic 
inflammation or indeed severe pathology associated with helminth infection. 
Alternatively, cytokines produced by CD8α+ cDCs that may be important for the 
regulation of Th2 responses could be administered to alleviate excessive Th2 
inflammation. In fact, early work that investigated the role of IL-12 during S. 
mansoni infection focused on the potential of IL-12 as a therapeutic against severe 
pathology associated with S. mansoni infection, through downregulation of Th2 
responses (Oswald et al., 1994; Wynn et al., 1995). However, administration of IL-
12 was ultimately rendered infeasible, particularly during human S. mansoni 
infection, due to deleterious pathology associated with elevated Th1 responses 
(Wynn and Hoffmann, 2000). Irrespective, the work in this thesis presents multiple 
reasons to revisit the impact of IL-12 and Th1 responses during Th2 inflammatory 
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disease including S. mansoni in the context of Th2 regulation and the induction of 
“appropriate” immune responses, particularly in effector sites such as the liver.   
6.4 Defining the function of hepatic DC subsets 
during S. mansoni infection  
cDCs are thought to be superior APCs in comparison with pDCs in various different 
settings, including allergic responses (de Heer et al., 2004), and this is largely due to 
a lack of cellular machinery for efficient uptake, processing and presentation of 
antigen by pDCs (Villadangos and Young, 2008). We have demonstrated in chapter 
5 that S. mansoni infection does not dramatically alter the core APC function of 
hepatic cDCs and pDCs, and that only cDCs can induce and maintain CD4+ T cells 
responses ex vivo. By assessing the function of DC subsets following S. mansoni 
infection we have shown that hepatic CD8α− cDCs, but not CD8α+ cDCs, exhibit an 
enhanced ability to induce CD4+ T cell proliferation and maintain Th2 cytokine 
production. This data and our conclusion that CD8α+ cDCs are dispensable for Th2 
response induction in chapter 4 lend further support to our main hypothesis that 
CD8α− cDCs are key players in this process. In conjunction with recent literature, it 
is tempting to suggest that IRF4 dependent CD11b+ cDCs will be critical for the 
development of Th2 responses during S. mansoni infection (Gao et al., 2013; 
Kumamoto et al., 2013; Plantinga et al., 2013; Williams et al., 2013). Thus, future 
work will aim to assess the importance of CD11b+ cDCs in the induction and 
development of Th2 responses during S. mansoni infection, and this could be 
addressed by using transgenic mouse models such as CD11ccreIRF4flox that are 
deficient in this DC subset (Vander Lugt et al., 2014). 
 
In contrast to CD8α− cDCs, CD8α+ cDCs did not induce or maintain Th2 cytokine 
production. However, the induction of TNF-α production by CD4+ T cells was 
predominantly orchestrated by CD8α+ cDCs (Fig. 5.11). These exciting preliminary 
findings outline the differential roles of DC subsets in the induction of CD4+ T cell 
responses and the maintenance of effector/memory CD4+ T cells in the effector site. 
To improve our understanding of DC function in the granuloma specifically, DCs 
could be isolated from purified granulomas in future and compared with the 
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functions of DCs in the surrounding parenchyma. Comparison of the function of 
lymphoid derived DC subsets with those isolated from the effector site would be 
beneficial for more accurate analysis of the capacity of DCs to induce Th2 responses 
in priming sites. In addition, investigating the function of DC subsets at different 
time-points of S. mansoni infection from priming vs. effector tissue sites will clarify 
whether the capacity to prime or maintain CD4+ T cell responses changes with 
chronicity. Finally, a more global overview of the APC potential exhibited by DCs 
during S. mansoni infection gene expression could be explored by conducting RNA 
sequencing (RNA-seq) analysis on ex vivo FACS sorted DC subsets.  
 
Many questions remain about how Th2 responses are induced or maintained. Which 
specific mechanisms do CD8α− cDCs employ during the Th2 induction and 
maintenance process? Why do only CD8α− cDCs appear to possess an increased 
capacity to induce and maintain CD4+ T cell responses against S. mansoni egg 
antigen? Mechanistically, how do CD8α+ cDCs regulate Th2 responses, either 
directly or indirectly? Yet, by systematically investigating the location, importance 
and function of different DC subsets during S. mansoni infection, work in this thesis 
has significantly elevated our understanding of the role of DC subsets in Th2 
immune responses. As such, we can conclude that CD8α+ cDCs are not important for 
the induction of Th2 responses in priming sites, and are not required for the 
recruitment/retention/reactivation of effector/memory Th2 cells in effector sites 
during S. mansoni infection. This provides further evidence, in addition to that 
already published in the literature, that CD8α− cDCs are involved in the induction 
and promotion of type 2 immunity (Tjota and Sperling, 2014). On the other hand, 
CD8α+ cDCs conceivably play a crucial role in regulating Th2 immune responses, 
which provides a platform for novel therapeutics aimed at reducing deleterious type 



















Diagram 6.1  Possible mechanisms employed by CD8α+ cDCs during 
S. mansoni infection.  
1. CD8α+ cDCs produce IL-12 (Ashok et al., 2014; Mashayekhi et al., 2011), which 
induces Th1 and IFN-γ production by Th1 cells (Szabo et al., 2000) and Th1/Th2 
double positive cells. IFN-α may promote the induction of Th1 responses (Wenner et 
al., 1996) and IFN-γ production by Th2 cells (Hegazy et al., 2010). 2. IFN-γ 
produced by primed CD4+ T cells inhibits Th2 proliferation and IL-4 production by 
Th2 cells and Th1/2 cells (Paludan, 1998). 3. IFN-γ production inhibits IL-17 
production by CD4+ T cells (Hochrein et al., 2001). 4. CD8α+ cDCs produce soluble 
factors including IL-12, TGF-β, INF-α, IL-10 and/or RA, which may inhibit / 
regulate Th2 responses directly. 5. CD8α+ cDC derived cytokines may regulate or 
inhibit the function of other cDC subsets (i.e. CD11b+ cDCs), which prime Th2 
responses in secondary lymphoid organs. Known pathways are shown by continuous 

















































Figure 7.1 Non CD4+ T cell intracellular cytokine production. 
Liver leukocytes from naïve or S. mansoni infected WT mice were isolated. A. Liver 
leukocytes were restimulated with αCD3/CD28 in vitro for 72h before supernatant 
harvest and ELISA analysis of cytokines. Non T cell cytokine production is shown as 
fold change compared with naïve controls (dotted baseline). B. Intracellular hepatic 
CD8+ T cell IFN-γ production during infection after restimulation with αCD3/CD28. 
No other cytokines produced by CD8+ T cells were detected. C. Representative flow 
plots for non CD4+ T cell cytokine production from D56 are shown. Gates were set 
using FMOs. These plots show that cells other than T cells are producing some IL-10 
and IFN-γ but at lower levels. Gates were set using FMO controls. 1 of 1 (A to C) 
experiments. Bars are SEM of 3-4 samples per group. Cells from 2-3 mice were 
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Figure 7.2 Expression of TCR-β by NKT cells 
Liver leukocytes from naïve or S. mansoni infected WT mice were isolated and 
assessed by flow cytometry. A. Proportions of NKT cells that express TCR-β were 
determined, which revealed that NKT cell levels are below 10% at every time-point 
measured. B. The level of expression of TCR-β is similar on T cells compared with 
NKT cells at D56. Gates were set using FMO controls. 1 of 1 (A to B) experiments. 
Two-way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Bars are 
SEM of 3-4 samples per group. Cells from 2-3 mice were pooled per sample. 
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Figure 7.3 Surface marker expression of residual CD8α+ cDCs and 
possible pre-cursors in the mLN and the liver of Batf3-/- mice 
during S. mansoni infection 
mLN cells or liver leukocytes were isolated at D42 of S. mansoni infection and 
CD11c+ MHC-II+ cDCs were analysed ex vivo by flow cytometry. CD8α+ CD205+, 
CD8α+ CD205− and CD8α− CD205+ cDCs were analysed for their expression of 
CD11b, CD103 and CD24. Representative histograms are shown for naïve WT 
(black, dotted), infected WT (black), naïve Batf3-/- mice (grey, dotted) and infected 
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Figure 7.4 Th2 induction is enhanced in Batf3-/- mice at D7 post S. 
mansoni egg injection 
S. mansoni eggs were injected into WT or Batf3-/- mice. 7 days later pLNs were 
harvested for cytokine production and flow cytometry analysis. Cells from pLNs of 
WT or Batf3-/- mice were cultured for 72h with 15 µg/ml SEA or media alone. 
Supernatants were collected to assess cytokine production by ELISA (data presented 
SEA restimulated samples with medium alone background subtracted). Data are 
from 3 experiments. Mixed model analysis (blocking day of experiment), Tukey’s 
HSD (* P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, ****P ≤ 0.0001). Error bars are mean 
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Figure 7.5 The proportion of cDCs and pDCs present in the OT-II co-
culture assay after 1 day 
Livers leukocytes from naïve WT mice were enriched for DCs by negative selection 
using Dynabeads. Pure cDC and pDC populations were FACS sorted from enriched 
DC populations. 20,000 naïve cDCs or pDCs were then pulsed with 10 µM pOVA 
and co-cultured with 200,000 naïve CD4+ T cells for 24h. The number of cells used 
in this experiment was increased proportionally from co-cultures shown in chapter 5 
(5,000 DCs and 50,000 CD4+ T cells, DC:T cell ration 1:10) to enable efficient 
detection of DCs by flow cytometry. cDC and pDC populations were analysed for 
live/dead staining, and the proportion of live cDCs was compared with live pDCs. 


















































Figure 7.6 Cytokine production by naïve or effector/memory CD4+ T 
cells in the absence of DCs 
To control for cytokine production in the presence of DCs, freshly isolated naïve or 
in vitro activated CD4+ T cells isolated from OT-IIxLy5.1 mice were either pulsed 
with 10 µM pOVA or cultured with 500 µg/ml soluble OVA in the absence of DCs. 
Additionally, naïve or activated CD4+ T cells were cultured without antigen or DCs. 
After 72h, the supernatant was harvested and assessed for cytokine production by 
ELISA. Data are from 3 experiments. Two-Way ANOVA (* P ≤ 0.05, ** P ≤ 0.01, 
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